5th Edition - Ministry of Public Health...PINK PAGES 2013-FINAL-July31.indd 41 8/7/2013 1:43:09 PM...
Transcript of 5th Edition - Ministry of Public Health...PINK PAGES 2013-FINAL-July31.indd 41 8/7/2013 1:43:09 PM...
5th Edition
ชอหนงสอ รปแบบเภสชภณฑวตถออกฤทธและยาเสพตดใหโทษภาษาไทย ประเทศไทย 2556
ชอภาษาองกฤษ PNDEX THAILAND 2013 (Psychotropics & Narcotics Index 2013)
ISBN 974-244-092-1
จดท�าและ กองควบคมวตถเสพตด ส�านกงานคณะกรรมการอาหารและยารวบรวมโดย กระทรวงสาธารณสข โทร/โทรสาร 0 2590 7346 อเมล : [email protected]
เรยบเรยงและ บรษท ทมส (ประเทศไทย) จ�ากดจดพมพโดย ชน 2 อาคารผดงเกยรต 27, 29 ซอยสขมวท 62 ถนนสขมวท แขวงบางจาก เขตพระโขนง กรงเทพฯ 10260 โทร 0 2741 5354 โทรสาร 0 2741 5360
All rights reserved.สงวนลขสทธตามพระราชบญญต
OBJECTIVESวตถประสงค
1. สาหรบใชเปนคมอของเจาหนาทสาธารณสขในการพสจนเอกลกษณ และรปพรรณ (Identification) ของวตถออกฤทธ และยาเสพตดใหโทษ กรณทเกดอาการไมพงประสงคจากการใชยา หรอการใชยาเกนขนาด
2. สาหรบใชเปนคมอของเจาหนาทปองกนและปราบปรามดานวตถเสพตดในการพสจนเอกลกษณ และรปพรรณ (Identification) ของวตถออกฤทธ และยาเสพตดใหโทษ กรณทมการกระทาฝาฝนกฎหมาย
3. ใชเปนคมออางองหรอใชประโยชนอนๆ ในทางการแพทย
คณะผจดทา
ทปรกษา
นพ.บญชย สมบรณสข เลขาธการคณะกรรมการอาหารและยานพ.ปฐม สวรรคปญญาเลศ รองเลขาธการคณะกรรมการอาหารและยาภก.วชระ อาพนธ เภสชกรเชยวชาญดานระบาดวทยาของวตถเสพตด
คณะทางาน
นายประพนธ อางตระกล ผอานวยการกองควบคมวตถเสพตดนางจนทนา ธรรมวระพงษ เภสชกรชานาญการพเศษนางสาวธรธร มโนธรรม เภสชกรชานาญการนางสาวฐปนย เจรญสน เภสชกรชานาญการนางสาวกมลชนก สรยกล ณ อยธยา เภสชกรชานาญการนางสาวจตตไพจตร มงเกยรตสกล เภสชกรชานาญการนางสาววณา ทนงคงสวสด เภสชกรปฏบตการ
CONTENTSสารบญ
OBJECTIVES : วตถประสงค 2HOW TO USE : วธการใชหนงสอ 4PRODUCT IDENTIFICATION SEQUENCE : ลาดบการจดภาพยาเมดดวยส รปราง และขนาด 9
PRODUCT IDENTIFICATION CHARTหมวดรปภาพเภสชภณฑ
10-40
สขาว 10 สเหลอง 14 สสม 16สแดง 17
สชมพ 17สมวง 20สฟา/นาเงน 20สเขยว 22
สนาตาล 24สเทา/ดา 24หลายส 24
PINK PAGESหมวดหนาสชมพ
41-63
THAI NARCOTICS ACT B.E. 2522 (1979) พระราชบญญตยาเสพตดใหโทษ พ.ศ. 2522 41
THAI PSYCHOTROPIC SUBSTANCES ACT B.E. 2518 (1975)พระราชบญญตวตถทออกฤทธตอจตและประสาท พ.ศ. 2518
43
CLASSIFICATION OF PSYCHOTROPICS AND NARCOTICSการจดประเภทของวตถออกฤทธและยาเสพตดใหโทษทขนทะเบยนในประเทศไทย
44-45
NATIONAL LIST OF ESSENTIAL MEDICINE (FOR PSYCHOTROPICS AND NARCOTICS)
วตถออกฤทธและยาเสพตดใหโทษในบญชยาหลกแหงชาต46-48
IMPORTANT DRUG NOTESขอมลทสาคญของตวยาทมการขนทะเบยนหรอเคยขนทะเบยนในประเทศไทย
49-63
INDEXหมวดดชนตางๆ
64-98
CONTROLLED SUBSTANCE CLASS INDEXดชนเภสชภณฑเรยงตามประเภทกลมยา และชอตวยาจาก A-Z
64-70
MANUFACTURER’S INDEXดชนเภสชภณฑเรยงตามชอผผลต
71-79
BRAND & GENERIC NAME INDEXดชนรวมชอการคาและชอสามญของยา จดเรยงตาม A-Z
80-98
LIST OF PRODUCT SOLD BY FDAรายการยาทจาหนายโดยกลมเงนทนหมนเวยนยาเสพตด
99-104
HOW TO USEวธการใชหนงสอ
1 ทราบตวอยาง รปพรรณ เอกลกษณ หรอลกษณะของยา
9
PRODUCT IDENTIFICATION SEQUENCEÅíҴѺ¡ÒèѴÀÒ¾ÂÒàÁç´
9
หมายเหต:
สทปรากฏในหนงสออาจคลาดเคลอนกบสจรงของเมดยาแนะนาใหตรวจดวยคณลกษณะอนรวมดวยเชนขนาดสญลกษณ
AW_PNdex front 20100402.indd 9 2/4/2553 13:57:09
PRODUCT IDENTIFICATION SEQUENCEการจดลาดบยาเมดดวยส รปราง ขนาด ... หนา 9
PRODUCT IDENTIFICATION CHARTคนหารปภาพเภสชภณฑ ... หนา 10-40
DIAZEPAM BJ BENJAOSOTH (ºÕਠ(àºÞ¨âÍʶ)) diazepam 5 mg P4 [190.2 mg]
402
POBRAX † (¿ÒÃ�ÁÒÊѹµ� áÅçº) chlordiazepoxide hydrochloride 5 mg XP4
403
WINOPAM (ÅÔÇÔ¹à¹ÍÃ�¿ÒÃ�ÁÒ) diazepam 5 mg XP4
404
MODURAX † (ÂÙâ·à»‚œÂ¹) chlordiazepoxide hydrochloride 5 mg P4 [250 mg]
chlordiazepoxide hydrochloride 5 mg
405
CEBARAX † (ÁÒ«Òáź) chlordiazepoxide hydrochloride 5 mg P4 [250 mg]
406
CHLORDIBRAX † (ÂÙâ·à»‚œÂ¹) chlordiazepoxide hydrochloride 5 mg XP4
407
CLINOPRONT † (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) codeine phosphate 10 mg N3 [283.31 mg]
408
LIBRAX † (âÍÅÔ¤) chlordiazepoxide 5 mg P4 [299 mg]
chlordiazepoxide 5 mg
409
LICON † (äÅ¿Š ¤Í¹à«Ô¹) chlordiazepoxide hydrochloride 5 mg XP4
410
UTORAX † (ÂÙâ·à»‚œÂ¹) chlordiazepoxide hydrochloride 5 mg XP4
411
ZEPOBRAX † (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) chlordiazepoxide hydrochloride 5 mg XP4
412
DIRAX † (ÊËá¾·Â�àÀÊѪ) chlordiazepoxide 5 mg P4 [200 mg]
413
DIAPINE TABLET (á͵ᏵԤ) diazepam 10 mg P4 [320 mg]
414
TERCO-C † (ºÕ àÍçÅ ÎÑéÇ) codeine phosphate 10 mg N3 [591.1 mg]
415
CODEE-C † (ÊËá¾·Â�àÀÊѪ) codeine phosphate 10 mg N3 [345.02 mg]
416
SECO † (àÀÊѪ¡ÃÃÁÈÃÕ»ÃÐÊÔ·¸Ôì) codeine phosphate 10 mg N3 [331.56 mg]
417
TOCODYL † (·Õ âÍ à¤ÁÕ¤ÍÅÊ�) codeine phosphate 10 mg XN3 [325.82 mg]
418
CODESIA † (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) codeine phosphate 10 mg N3 [350 mg]
419
RADIBRAX † (¿ÒÃ�ÁÒÊѹµ� áÅçº) chlordiazepoxide hydrochloride 5 mg XP4
420
ALPRAMED (àÅÔÈÊÔ§Ë�) alprazolam 1 mg P2 [259 mg]
421
CODENOL † (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) codeine phosphate 15 mg N3
422
ROHYPNOL (âê/ÍÂ.) fl unitrazepam 1 mg P2 [175 mg]
423
PARAMED-CO † (ÊËá¾·Â�àÀÊѪ) codeine phosphate 15 mg XN3 [601.1 mg]
424
VASON (ÁÔÅÅÔàÁ´) diazepam 2 mg P4 [110 mg]
425
CELIUM (ÂÙâ·à»‚œÂ¹) medazepam 5 mg P4 [110 mg]
426
GREEN Capsule
EUHYPNOS 20 (ÍÒÃ� ¾Õ àªÍàÃÍÃ�/ÍÂ.) temazepam 20 mg P2 [868.96 mg]
[868.96 mg]
427
TUMAX † (àÀÊѪ¡ÃÃÁÈÃÕ»ÃÐÊÔ·¸Ôì) chlordiazepoxide hydrochloride 5 mg P4 [180 mg]
428
ZEPAM (âÁà´ÍÃ�¹áÁ¹Ù) diazepam 2 mg XP4
429
POSENE (ÊÂÒÁàÁ´Ôá¤Ã�) clorazepate dipotassium 10 mg XP4
430
†Indicates brands that contain more than one ingredientÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
PRODUCT IDENTIFICATION CHART 23 PN DEX 2013
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 23 8/6/2013 2:03:57 PM
*OPIUM TINCTURE GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ/ÍÂ.) morphine 1% x 450 mL N2
585
*ORAMORPH (àºÍÃÔ§à¡ÍÃ� ÍÔ¹à¡ÅäÎÁ�/ÍÂ.) morphine sulfate 10 mg/5 mL x 250 mL N2
586
*ORAMORPH (àºÍÃÔ§à¡ÍÃ� ÍÔ¹à¡ÅäÎÁ�/ÍÂ.) morphine sulfate 20 mg/mL x 30 mL N2
587
*P-CODYL † (âÍʶÍÔ¹àµÍÃ�) codeine phosphate 60 mL XN3
588
*P-CODYL † (âÍʶÍÔ¹àµÍÃ�) codeine phosphate 120 mL XN3
589
*PERCIDYL COUGH † (¾Í¹´�à¤ÁÕ¤ÍÅ) codeine phosphate 100 mL XN3
590
*PHENCODIN † (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) codeine phosphate 60 mL XN3
591
*PHENCODIN † (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) codeine phosphate 500 mL XN3
592
*PHENCODIN † (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) codeine phosphate 1000 mL XN3
593
*PHENOBARB ELIXIR (¾Õ ¾Õ áźÍÃÒµÍÃÕèÊ�) phenobarbital sodium 20 mg/5 mL x 60 mL XP4
phenobarbital sodium 20 mg/5 mL x 60 mL
594
*PHENOBARBITAL ELIXIR ACDHON (áͤ´Í¹) phenobarbital sodium 20 mg/5 mL x 30 mL XP4
phenobarbital sodium 20 mg/5 mL x 30 mL
595
*PHENOBARBITAL ELIXIR ACDHON (áͤ´Í¹) phenobarbital sodium 20 mg/5 mL x 60 mL XP4
596
†Indicates brands that contain more than one ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
32 PRODUCT IDENTIFICATION CHART PN DEX 2013
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 32 8/6/2013 2:04:06 PM
หมายเหต : ยาทเคยขนทะเบยนในประเทศไทย แตปจจบนไมไดขนทะเบยนแลว ใชสญลกษณ X นาหนา class เดม เชน XP3, XP4, XN3
ชอผผลต (Manufacturer’s name) •
ชอการคา (Trade name) •
ชอสามญ (Generic name) •
ประเภทวตถออกฤทธ หรอยาเสพตดใหโทษ •
(Controlled Substance Class)
นาหนกของเมด (Weight) •
ภาพเมดยา จะมขนาดเทาของจรง •
ภาพผลตภณฑทไมใชเมดยา จะเปนขนาดยอ •
หมายเลขของภาพ (Frame No.) •
2
3
ทราบชอการคาหรอชอสามญของวตถออกฤทธ
หรอยาเสพตดใหโทษ
คนหาวตถออกฤทธหรอยาเสพตดใหโทษในบญชยาหลกแหงชาต
บญช ก ร�ยก�รย�ม�ตรฐ�นทใชในก�รปองกนและแกไขปญห�สขภ�พทพบบอยมหลกฐ�นชดเจนทสนบสนนก�รใชมประสบก�รณก�รใชในประเทศไทยอย�งพอเพยงและเปนย�ทควรไดรบก�รเลอกใชเปนอนดบแรกต�มขอบงใชของย�นน
บญช ข ร�ยก�รย�ทใชสำ�หรบขอบงใชหรอโรคบ�งชนดทใชย�ในบญชกไมไดหรอไมไดผลหรอใชเปนย�แทนย�ในบญชกต�มคว�มจำ�เปน
บญช ค ร�ยก�รย�ทตองใชในโรคเฉพ�ะท�งโดยผชำ�น�ญหรอผทไดรบมอบหม�ยจ�กผอำ�นวยก�รของสถ�นพย�บ�ลนนๆโดยมม�ตรก�รกำ�กบก�รใชซงสถ�นพย�บ�ลทใชจะตองมคว�มพรอมตงแตก�รวนจฉยจนถงก�รตดต�มผลก�รรกษ�เนองจ�กย�กลมนเปนย�ทถ�ใชไมถกตองอ�จเกดพษหรอเปนอนตร�ยตอผปวยหรอเปนส�เหตใหเกดเชอดอย�ไดง�ยหรอเปนย�ทมแนวโนมในก�รใชไมตรงต�มขอบงชหรอไมคมค�หรอมก�รนำ�ไปใชในท�งทผดหรอมหลกฐ�นสนบสนนก�รใชทจำ�กดหรอมประสบก�รณก�รใชในประเทศไทยอย�งจำ�กดหรอมร�ค�แพงกว�ย�อนในกลมเดยวกน
บญช ง ร�ยก�รย�ทมหล�ยขอบงใชแตมคว�มเหม�ะสมทจะใชเพยงบ�งขอบงใชหรอมแนวโนมจะมก�รสงใชย�ไมถกตองหรอเปนร�ยก�รย�ทมร�ค�แพงจงเปนกลมย�ทมคว�มจำ�เปนตองมก�รระบขอบงใชและเงอนไขก�รสงใชย�ก�รใชบญชย�หลกแหงช�ตไปอ�งองในก�รเบกจ�ยควรนำ�ขอบงใชและเงอนไขก�รสงใชไปประกอบในก�รพจ�รณ�อนมตก�รเบกจ�ยจงจะกอประโยชนสงสดทงนย�ในบญชงจำ�เปนตองใชสำ�หรบผปวยบ�งร�ยแตอ�จทำ�ใหเกดอนตร�ยตอผปวยหรอกอปญห�เชอดอย�ทร�ยแรงก�รสงใชย�ซงตองใหสมเหตผลเกดคว�มคมค�สมประโยชนจะตองอ�ศยก�รตรวจวนจฉยและพจ�รณ�โดยผชำ�น�ญเฉพ�ะโรคทไดรบก�รฝกอบรมในส�ข�วช�ทเกยวของจ�กสถ�นฝกอบรมหรอไดรบวฒบตรหรอหนงสออนมตจ�กแพทยสภ�หรอทนตแพทยสภ�เท�นนและโรงพย�บ�ลจะตองมระบบก�รกำ�กบประเมนและตรวจสอบก�รใชย�(DrugUtilizationEvaluation,DUE)โดยตองมก�รเกบขอมลก�รใชย�เหล�นนเพอตรวจสอบในอน�คตได
บญช จ(1) ร�ยก�รย�สำ�หรบโครงก�รพเศษของกระทรวงทบวงกรมหรอหนวยง�นของรฐทมก�รกำ�หนดวธก�รใชและก�รตดต�มประเมนก�รใชย�ต�มโครงก�รโดยมหนวยง�นนนรบผดชอบและมก�รร�ยง�นผลก�รดำ�เนนง�นตอคณะอนกรรมก�รพฒน�บญชย�หลกแหงช�ตเปนระยะต�มคว�มเหม�ะสมเพอพจ�รณ�จดเข�ประเภทของบญชยอยอนในบญชย�หลกตอไปเมอมขอมลเพยงพอ
บญช จ(2) ร�ยก�รย�สำ�หรบผปวยทมคว�มจำ�เปนเฉพ�ะใหเข�ถงย�ไดอย�งสมเหตผลและคมค�ซงมก�รจดกลไกกล�งเปนพเศษในกำ�กบก�รใชย�ภ�ยใตคว�มรบผดชอบรวมกนของระบบประกนสขภ�พซงดแลโดยกรมบญชกล�งกระทรวงก�รคลงสำ�นกง�นประกนสงคมกระทรวงแรงง�นสำ�นกง�นหลกประกนสขภ�พแหงช�ตและหนวยง�นอนๆทเกยวของโดยมแนวท�งกำ�กบก�รใชย�ต�มภ�คผนวก3
“ร�ยก�รย�สำ�หรบผปวยทมคว�มจำ�เปนเฉพ�ะ”ต�มบญชจ(2)หม�ยคว�มว�ย�ทจำ�เปนตองใชสำ�หรบผปวยเฉพ�ะร�ยโดยย�มคว�มเหม�ะสมทจะใชเพยงบ�งขอบงใชหรอมแนวโนมจะมก�รสงใชย�ไมถกตองหรอเปนย�ทตองอ�ศยคว�มรคว�มชำ�น�ญเฉพ�ะโรคหรอใชเทคโนโลยขนสงและเปนย�ทมร�ค�แพงม�กหรอสงผลอย�งม�กตอคว�มส�ม�รถในก�รจ�ยทงของสงคมและผปวยจงตองมระบบกำ�กบและอนมตก�รสงใชย�(authorizedsystem)ทเหม�ะสมโดยหนวยง�นสทธประโยชนหรอหนวยง�นกล�งทไดรบมอบหม�ยทงนเพอใหเปนไปต�มขอบงใชและเงอนไขก�รสงใชย�จงจะกอประโยชนสงสดโรงพย�บ�ลจะตองมระบบก�รกำ�กบประเมนและตรวจสอบก�รใชย�และมเกบขอมลก�รใชย�เหล�นนเพอใหตรวจสอบโดยกลไกกล�งในอน�คตได
NATIONAL LIST OF ESSENTIAL MEDICINES (NLEM)วตถออกฤทธและย�เสพตดใหโทษในบญชย�หลกแหงช�ต
บญชย�หลกแหงช�ต พ.ศ.2555 มจดประสงคเพอสร�งเสรมระบบก�รใชย�อย�งสมเหตผล
ย�ทอยในบญชย�หลกแหงช�ตนจะแสดงร�ยก�รย�โดยใชชอส�มญของย�ทงในรปเบสเกลอหรอเอสเทอรของย�โดยจะระบคณสมบตเฉพ�ะต�งๆไดแกรปแบบผลตภณฑคว�มแรงขน�ดบรรจ(บ�งร�ยก�ร)ย�ทมคณสมบตครบต�มขอกำ�หนดดงกล�วเท�นนจงจดเปนย�ในบญชย�หลกแหงช�ตทงนสำ�หรบย�ทมเงอนไขหรอมหม�ยเหตจะตองใชต�มเงอนไขและหม�ยเหตทแสดงไวในร�ยละเอยดของย�แตละชนดกอนเสมอ
ก�รจดแบงกลมย�เปนสวนหนงในก�รสงเสรมใหย�ในบญชย�หลกแหงช�ตใชอย�งเหม�ะสมและคมค�โดยมหลกก�รแบงต�มระดบคว�มรคว�มส�ม�รถและคว�มเชยวช�ญของแพทยและผประกอบวช�ชพด�นสขภ�พทจะใชย�แบงเปน5บญชยอยคอบญชก.ข.ค.ง.และจ.โดยแบงยอยอกเปนจ(1)และจ(2)
ย�แตละชนดจะส�ม�รถจดอยในบญชยอยไดม�กกว�1บญชโดยขนกบขอบงชรปแบบและร�ยละเอยดต�งๆทกำ�หนดไว
PINK PAGES 2013-FINAL-July31.indd 46 8/7/2013 1:43:10 PM
BRAND & GENERIC NAME INDEXดชนรวมชอการคาและชอสามญ ... หนา 80-98
PRODUCT IDENTIFICATION CHARTคนหารปภาพเภสชภณฑ ... หนา 10-40
• คนตามหมายเลขภาพมมลางซาย
NATIONAL LIST OF ESSENTIAL MEDICINEขอกาหนดบญชยาหลกแหงชาต ... หนา 46-48
(เฉพาะวตถออกฤทธและยาเสพตดใหโทษ)• คนตามชอสามญ เรยงลาดบชอ A-Z
VISPAM (ÂÙâ·à»‚œÂ¹) diazepam 5 mg XP4 [70.02 mg]
239
ALPRALAN (âÍÅѹ-à¤ÁàÁ´) alprazolam 0.5 mg P2 [157.28 mg]
240
PORA (¾Í¹´�à¤ÁÕ¤ÍÅ) lorazepam 2 mg XP4
241
DIAZEPAM POND'S CHEMICAL (¾Í¹´�à¤ÁÕ¤ÍÅ) diazepam 5 mg P4 [145.6 mg]
242
DIAZEPAM H K PHARM (àͪ ठ¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) diazepam 2 mg P4 [130 mg]
243
LORA (á͵ᏵԤ) lorazepam 2 mg P4 [200 mg]
244
MORPHINE SALUTAS PHARMA («ÒÅÙ·ÑÊ ¿ÒÃ�ÁÒ/ÍÂ.) morphine sulfate 60 mg N2
245
S.CO ZEPAM (àÍÊ â¤ ¿ÒÃ�ÁÒ) diazepam 5 mg XP4
246
BELLADONNA ALKALOIDS W/ PHENOBARBITAL † (ÊÒÁѤ¤ÕàÀÊѪ) phenobarbital sodium 16.2 mg XP4 [160 mg]
247
CENTRODINE CD † (¿ÒÃ�ÁÒÊѹµ� áÅçº) codeine phosphate 10 mg N3 [205.2 mg]
248
DIAZEPAM BJ BENJAOSOTH (ºÕਠ(àºÞ¨âÍʶ)) diazepam 10 mg XP4 [233 mg]
249
DIZEPAM (ÁÒ«Òáź) diazepam 2 mg P4 [170 mg]
250
KENSPA † (हÂÒ¡Ø) chlordiazepoxide hydrochloride 5 mg P4 [246 mg]
251
TAZCINE (ÍØ´Á¾Ã (¿‚ÎÒáÅçº)) pentazocine 50 mg XP3
252
LORAZIN (ÍԹᾤ¿ÒÃ�ÁÒ) lorazepam 2 mg P4 [200 mg]
253
LEXOTAN (âê) bromazepam 3 mg P4 [200 mg]
254
PHENOCON (ÁÒ«Òáź) phenobarbital sodium 60 mg XP4
255
ANAX (ÁÔÅÅÔàÁ´) alprazolam 0.5 mg P2 [130 mg]
256
ANZION (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) alprazolam 0.5 mg P2 [132.5 mg]
257
ALNAX (¾Í¹´�à¤ÁÕ¤ÍÅ) alprazolam 0.5 mg P2 [130 mg]
258
ALCELAM (¿ÒÃ�ÁÒÊѹµ� áÅçº) alprazolam 0.5 mg P2 [130 mg]
259
ALPAZAM (ä·Â¹¤Ã¾Ñ²¹Ò) alprazolam 0.5 mg P2
260
ALPAZAM (ä·Â¹¤Ã¾Ñ²¹Ò) alprazolam 1 mg P2
261
DIZOLAM (á͵ᏵԤ) alprazolam 0.5 mg P2 [130 mg]
262
FARZOLAM (¿ÒÃ�ÁÕ¹‹Ò) alprazolam 0.5 mg P2
263
MANEX (·Õ áÁ¹ ¿ÒÃ�ÁÒ) alprazolam 0.5 mg P2 [130 mg]
264
MARZOLAM (áËÅÁ·Í§¡ÒÃá¾·Â�) alprazolam 0.5 mg P2 [130 mg]
265
MOXINAX (âÁà´ÍÃ�¹áÁ¹Ù) alprazolam 0.5 mg P2 [130 mg]
266
PHARNAX (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) alprazolam 0.5 mg P2 [131.9 mg]
267
PRAZOL (हÂÒ¡Ø) alprazolam 0.5 mg P2 [216.36 mg]
268
SIAMPRAXOL (ÊÂÒÁàÀÊѪ) alprazolam 0.5 mg P2 [125.75 mg]
269
XALAM (¹ÔÇäÅ¿Š¿ÒÃ�ÁÒ) alprazolam 0.5 mg P2
270
XANACINE (àÁ´Ô«Õ¹â»Ã´Ñ¡Ê�) alprazolam 0.5 mg P2 [110 mg]
271
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
18 PRODUCT IDENTIFICATION CHART PN DEX 2013
†Indicates brands that contain more than one ingredient
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 18 8/6/2013 2:03:48 PM
BRAND & GENERIC NAME INDEX 81PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient xIndicates brand may be off-market ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient xIndicates brand may be off-market
BR
AN
D &
GE
NE
RIC
NA
ME
IND
EX
- xSIAMPRAXOL 0.5 mg - 269
- xSIAMPRAXOL 1 mg - 315
- xSUNAX 0.25 mg - 120
- xSUNAX 0.5 mg - 279
- xXALAM 0.25 mg - 112
- xXALAM 0.5 mg - 270
- xXALAM 1 mg - 316
- XANACINE 0.25 mg - 113
- XANACINE 0.5 mg - 271
- XANACINE 1 mg - 317
- XANAX 0.25 mg - 114
- XANAX 0.5 mg - 272
- XANAX 1 mg - 318
- XANAX XR 0.5 mg - 372
- XANAX XR 1 mg - 079
- xXANAX XR 2 mg - 381
- xXIEMED 0.25 mg - 121
- xXIEMED 0.5 mg - 280
- xXIEMED 1 mg - 323
- xZOLAM 0.25 mg - 115
- xZOLAM 0.5 mg - 273
- xZOLAM 1 mg - 319
ALPRAZOLAM FRX 0.25 mg - 122
ALPRAZOLAM FRX 0.5 mg - 282
AMA† P2A 20/55 159
amobarbital:
- AMA† P2A 20/55 159
- AMYTAL 0.5 g - 674
AMYTAL 0.5 g - 674xANAX 0.25 mg - 097xANAX 0.5 mg - 256ANCORIL 0.5 mg P1A 14/51 209xANPRESS 0.25 mg - 102xANPRESS 0.5 mg - 274xANPRESS 1 mg - 309ANTA 0.5 mg P1A 36/53 330ANTA 1 mg P1A 12/54 018ANTA 2 mg P1A 29/52 138ANXENE 5 mg - 455ANXENE 10 mg - 288xANXIELAX 5 mg - 486ANXIRA 0.5 mg P1A 24/52 327ANXIRA 1 mg P1A 25/52 021xANZION 0.25 mg - 098xANZION 0.5 mg - 257xANZION 1 mg - 306xATIVAN 0.5 mg - 332xATIVAN 1 mg - 023xATIVAN 2 mg - 141
xATRACTIL 75 mg - 505xAZEPAM 2 mg - 219xAZEPAM 5 mg - 326A-ZERAX 2 mg P1A 37/52 479A-ZERAX 5 mg P1A 38/52 489
BBELLADONNA ALKALOIDS W/
PHENOBARBITAL† - 247xBELLERGAL† - 232xBELLOID† - 139xBENADRYL CD†
60 mL - 533xBENADRYL CD†
1000 mL - 534xBENERA† - 433BENPINE 5 mg P1A 32/54 435BENPINE 10 mg P1A 17/54 526BENPINE 25 mg P1A 1/49 218BENYLIN CD† 60 mL - 535BLUCO† - 383xBLUCON† - 360BONADINE CD† 60 mL - 536
bromazepam:
- LEXOTAN 1.5 mg P1C 26/55 080
- LEXOTAN 3 mg P1C 27/55 254xBROMTUSSIA DC†
60 mL - 537BRONPECT† - 325BROWN MIXTURE
GPO† 180 mL N2A 15/45 538BROWN MIXTURE
GPO† 450 mL N2A 15/45 539BROWN MIXTURE
OSOTH INTERLAB† 180 mL N2A 13/53 540
buprenorphine hydrochloride:
- xBUPRINE 0.2 mg - 001
- xTEMGESIC 0.3 mg/mL x 1 mL - 666
- xTEMGESIC 0.2 mg - 007xBUPRINE 0.2 mg - 001
butobarbital:
- xBELLOID† - 139
CCALMIPAM 2 mg - 388CALMIPAM 5 mg - 302CALYPSOL
50 mg/mL x 10 mL - 675CAMPHORATED
OPIUM TINCTURE GPO 1000 mL N2A 6/53 541
Registration No. Frame No. Registration No. Frame No.
B&G Name Index-FINAL-Aug1.indd 81 8/7/2013 12:57:34 PM
90 BRAND & GENERIC NAME INDEX PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient xIndicates brand may be off-market
BR
AN
D &
GE
NE
RIC
NA
ME
IND
EX
FENTANYL HEXAL 12 mcg/hr - 689
FENTANYL HEXAL 25 mcg/hr - 690
FENTANYL HEXAL 50 mcg/hr - 691
FENTANYL JANSSEN-CILAG 0.05 mg/mL x 2 mL - 635
FENTANYL JANSSEN-CILAG 0.05 mg/mL x 10 mL - 636
FENTANYL SANDOZ 0.05 mg/mL x 2 mL - 637
FENTANYL SANDOZ 500 mcg/10 mL - 676
FENTANYL-HAMELN 50 mcg/mL x 2 mL - 638
FENTANYL-HAMELN 50 mcg/mL x 10 mL - 639
FENTANYL-SNS 50 mcg/mL x 2 mL - 640
FLULIUM 5 mg P1A 28/55 467FLULIUM 10 mg - 300
flunitrazepam:
- ROHYPNOL 1 mg - 423
flurazepam hydrochloride:
- xDALMADORM 15 mg - 512xFORTWIN
30 mg/mL x 1 mL - 641FREXENE 5 mg - 441FREXENE 10 mg - 445FRISIUM 5 mg P1C 12/53,
P1B 13/53 038FRISIUM 10 mg - 039
GxGARDENAL
200 mg/4 mL P1C 1/50 677GAXENE 5 mg - 474GRANDAXIN 50 mg P1C 27/53 058
HHALCION 0.25 mg - 378HAWKCOPAX 0.5 mg P1A 7/55 348HAWKCOPAX 1 mg - 393xHISEDYL† 60 mL - 557xHISEDYL† 120 mL - 558
IINZOLAM 0.25 mg - 118INZOLAM 0.5 mg - 277INZOLAM 1 mg - 321
KKAPANOL 20 mg - 133KAPANOL 50 mg - 134KAPANOL 100 mg - 135KEMORA 0.5 mg P1A 48/54 434KEMORA 1 mg P1A 49/54 024KENSPA† P2A 36/52 251xKETA-HAMELN
50 mg/mL x 10 mL - 678KETALAR
50 mg/mL x 10 mL - 679
ketamine hydrochloride:
- CALYPSOL 50 mg/mL x 10 mL - 675
- xKETA-HAMELN 50 mg/mL x 10 mL - 678
- KETALAR 50 mg/mL x 10 mL - 679
LxLAYLIUM-10
10 mg/2 mL x 2 mL - 642LEXOTAN 1.5 mg P1C 26/55 080LEXOTAN 3 mg P1C 27/55 254LIBRAX† P2A 3/55 409LICON† - 410LIZAVAN 0.5 mg - 333LIZAVAN 1 mg - 025LOMOTIL† N2A 12/53 004LONZA 0.5 mg P1A 1/54 339LONZA 1 mg P1A 2/54 020LORA 0.5 mg P1A 28/54 397LORA 1 mg P1A 29/54 040xLORA 2 mg P1A 30/54 244LORAMED 0.5 mg - 334LORAMED 1 mg - 026LORAMED 2 mg P1A 50/54 237LORAMET 1 mg - 105LORA-P 0.5 mg - 347LORA-P 1 mg - 013LORA-P 2 mg - 137xLORAPAM 0.5 mg - 336xLORAPAM 1 mg - 027xLORAPAM 2 mg - 142LORAPINE 0.5 mg - 340LORAPINE 1 mg - 033LORAVAN 0.5 mg P1A 22/50 329LORAVAN 1 mg - 028LORAZE 1 mg P1A 31/51 044xLORAZENE 0.5 mg - 328xLORAZENE 1 mg - 014xLORAZENE 2 mg - 143
Registration No. Frame No. Registration No. Frame No.
B&G Name Index-FINAL-Aug1.indd 90 8/7/2013 12:57:35 PM
5
CONTENTSสารบญ ... หนา 3
4 ทราบประเภทของทะเบยนวตถออกฤทธหรอยาเสพตดใหโทษ
CLASSIFICATION OFPSYCHOTROPICS & NARCOTICS
การจดกลมประเภทและสาระตามกฎหมาย ... หนา 44-45• สาระสาคญในการควบคมตามกฎหมาย• รายชอตวยา (ชอสามญ) ของวตถออกฤทธและ
ยาเสพตดใหโทษจดตามกลม/ประเภท ตามกฎหมาย
CONTENTSสารบญ
OBJECTIVES : วตถประสงค 2HOW TO USE : วธการใชหนงสอ 4PRODUCT IDENTIFICATION SEQUENCE : ลาดบการจดภาพยาเมดดวยส รปราง และขนาด 9
PRODUCT IDENTIFICATION CHARTหมวดรปภาพเภสชภณฑ
10-40
สขาว 10 สเหลอง 14 สสม 16สแดง 17
สชมพ 17สมวง 20สฟา/นาเงน 20สเขยว 22
สนาตาล 24สเทา/ดา 24หลายส 24
PINK PAGESหมวดหนาสชมพ
41-63
Thai Narcotics Act B.E. 2522 (1979) พระราชบญญตยาเสพตดใหโทษ พ.ศ. 2522 41
Thai Psychotropics Act B.E. 2518 (1975)พระราชบญญตวตถทออกฤทธตอจตและประสาท พ.ศ. 2518
43
CLASSIFICATION OF PSYCHOTROPICS AND NARCOTICSการจดประเภทของวตถออกฤทธและยาเสพตดใหโทษทขนทะเบยนในประเทศไทย
44-45
NATIONAL LIST OF ESSENTIAL MEDICINE (FOR PSYCHOTROPICS AND NARCOTICS)
วตถออกฤทธและยาเสพตดใหโทษในบญชยาหลกแหงชาต46-48
IMPORTANT DRUG NOTESขอมลทสาคญของตวยาทมการขนทะเบยนหรอเคยขนทะเบยนในประเทศไทย
49-63
INDEXหมวดดชนตางๆ
64-98
CONTROLLED SUBSTANCE CLASS INDEXดชนเภสชภณฑเรยงตามประเภทกลมยา และชอตวยาจาก A-Z
64-70
MANUFACTURER’S INDEXดชนเภสชภณฑเรยงตามชอผผลต
71-79
BRAND & GENERIC NAME INDEXดชนรวมชอการคาและชอสามญของยา จดเรยงตาม A-Z
80-98
LIST OF PRODUCT SOLD BY FDAรายการยาทจาหนายโดยกลมเงนทนหมนเวยนยาเสพตด
99-104
ส�ระสำ�คญในก�รควบคมต�มกฎหม�ยวตถออกฤทธในประเภท 1 (P1)ห�มมใหผใดผลตข�ยนำ�เข�หรอสงออกซงวตถออกฤทธในประเภท1ยกเวนกระทรวงส�ธ�รณสขหรอผซงไดรบมอบหม�ยจ�กกระทรวงส�ธ�รณสข
วตถออกฤทธในประเภท 2 (P2)ห�มมใหผใดผลตข�ยนำ�เข�หรอสงออกซงวตถออกฤทธในประเภท2ยกเวนกระทรวงส�ธ�รณสขหรอผซงไดรบมอบหม�ยจ�กกระทรวงส�ธ�รณสขทงนไมใชบงคบกบผประกอบวช�ชพเวชกรรมหรอผประกอบโรคศลปะแผนปจจบนชนหนงส�ข�ทนตกรรมทข�ยใหแกคนไขของตนหรอผประกอบก�รบำ�บดโรคสตวชนหนงทข�ยเฉพ�ะสำ�หรบใชกบสตวทตนบำ�บดหรอปองกนโรคหรอข�ยโดยกระทรวงทบวงกรมสภ�ก�ช�ดไทย
วตถออกฤทธในประเภท 3 และ 4 (P3, P4)ห�มมใหผใดผลตข�ยนำ�เข�หรอสงออกซงวตถออกฤทธในประเภท3หรอ4หรอนำ�ผ�นวตถออกฤทธทกประเภทเวนแตไดรบอนญ�ตทงนไมใชบงคบกบผประกอบวช�ชพเวชกรรมหรอผประกอบโรคศลปะแผนปจจบนชนหนงส�ข�ทนตกรรมทข�ยใหแกคนไขของตนหรอผประกอบก�รบำ�บดโรคสตวชนหนงทข�ยเฉพ�ะสำ�หรบใชกบสตวทตนบำ�บดหรอปองกนโรคและไมใชบงคบในก�รผลตข�ยนำ�เข�หรอสงออกโดยกระทรวงทบวงกรมสภ�ก�ช�ดไทยองคก�รเภสชกรรม
ยาเสพตดใหโทษในประเภท 1 (N1)ห�มมใหผใดผลตนำ�เข�สงออกจำ�หน�ยหรอมไวในครอบครองซงย�เสพตดใหโทษในประเภท1เวนแตรฐมนตรไดอนญ�ตเฉพ�ะในกรณจำ�เปนเพอประโยชนของท�งร�ชก�ร
ยาเสพตดใหโทษในประเภท 2 (N2)ห�มมใหผใดผลตนำ�เข�หรอสงออกย�เสพตดใหโทษในประเภท2เวนแตไดรบอนญ�ตในกรณจำ�เปนเพอประโยชนของท�งร�ชก�รในกรณจำ�หน�ยหรอมไวในครอบครองตองไดรบอนญ�ต
ยาเสพตดใหโทษในประเภท 3 (N3)ห�มมใหผใดผลตนำ�เข�สงออกจำ�หน�ยหรอมไวในครอบครองเพอจำ�หน�ยซงย�เสพตดใหโทษในประเภท3เวนแตไดรบอนญ�ตทงนไมใชบงคบกบผประกอบวช�ชพเวชกรรมหรอผประกอบโรคศลปะแผนปจจบนชนหนงส�ข�ทนตกรรมจำ�หน�ย/ครอบครองใหแกคนไขของตนหรอผประกอบก�รบำ�บดโรคสตวชนหนงจำ�หน�ย/ครอบครองสำ�หรบใชกบสตวทตนบำ�บด
ยาเสพตดใหโทษในประเภท 4 และ 5 (N4 & N5)ห�มมใหผใดผลตจำ�หน�ยนำ�เข�สงออกหรอมไวในครอบครองซงย�เสพตดใหโทษในประเภท4หรอในประเภท5เวนแตรฐมนตรจะไดอนญ�ตโดยคว�มเหนชอบของคณะกรรมก�รควบคมย�เสพตดใหโทษเปนร�ยๆไป
1. ชอส�มญของวตถออกฤทธในประเทศไทย (ชอทเปนตวหน�หม�ยถงเปนวตถออกฤทธทยงคงมตำ�รบย�ในประเทศไทยถงเดอนพฤษภ�คม2556)
วตถออกฤทธในประเภท 1 (P1)
วตถออกฤทธในประเภท 2 (P2)
วตถออกฤทธในประเภท 3 (P3)
วตถออกฤทธในประเภท 4 (P4)
Cathinone Alprazolam Pemoline Amobarbital Allobarbital MedazepamDET Amfepramone
(Diethylpropion)Phencyclidine Butalbital Barbital Mefenorex
DMHP Phendimetrazine Cyclobarbital Benzphetamine MethyphenobarbitalDMT Amineptine Phenmetrazine Glutethimide Bromazepam MethyprylonEtryptamine Aminorex Phentermine Meprobamate Butobarbital Nordazepam
(Nordiazepam)GHB Brotizolam Phenylpropanolamine Pentazocine CamazepamMethcathinone Buprenorphine Pipradrol Pentobarbital Chloral hydrate and
its adductsOxazepam
Mescaline Butorphanol Pseudoephedrine OxazolamMescaline derivatives Cathine (D-Norpseu-
doephedrine)Quazepam Chlodiazepoxide Perlapine
Mescaline analog e.g. Escaline
Secobarbital Chlophentermine PhenobarbitalEphedrine Temazepam Clobazam Pinazepam
Isoproscaline Estazolam Triazolam Clonazepam PrazepamProscaline Fencamfamin Zalepron Clorazepate Propylhexedrine4-Thiomescaline or 4-TM Fenethylline Zipeprol Clortermine Pyrovalerone4-Thioescaline or 4-TE Flunitrazepam Zopiclone Clotiazepam Secbutabarbital4-Thiooproscaline or 4-TP Flurazepam Zolpidem Cloxazolam SPA (Lefetamine)3- Thiomescaline or 3-TM Haloxazolam Diazepam Tetrazepam3-Thioescaline or 3-TE Ketamine Delorazepam Tofisopam3-Thiometaescaline or 3-TME Loprazolam Ethchlorvynol Vinylbital4-Methylaminorex Lormetazepam EthinamateParahexyl Mazindol Ethyl loflazepatePCE Methylphenidate FenproporexPHP(PCPY) Mesocarb FludiazepamPsilocine Midazolam HalazepamPsilocybine N-Ethylamphetamine Inorganic bromideTCP Nimetazepam KetazolamTetrahydrocannabinol Nitrazepam Lorazepam
CLASSIFICATION OF PSYCHOTROPICS & NARCOTICSประเภทของวตถออกฤทธและย�เสพตดใหโทษในประเทศไทย
PINK PAGES 2013-FINAL-July31.indd 44 8/7/2013 1:43:09 PM
ÄRegistration expired
IMPORTANT DRUG NOTESขอมลสำ�คญของตวย�วตถออกฤทธและย�เสพตดใหโทษ
Provides Useful Information On Significant Contraindications, Precautions, Adverse Reactions And Interactions Of Drugs, Presented According To The Psychotropic & Narcotic Drugs List Of Thailand Note: I: Indications; CI: Contraindications; SP: Precautions; AR: Adverse Reactions; DI: Drug Interactions.
P2 - Psychotropic Substance Schedule 2
• Alprazolam •
ลดอ�ก�รวตกกงวลและอ�ก�รตนตระหนก
I: Management of anxiety and panic attacks.
CI: Acute narrow-angle glaucoma, pre-existing CNS depression or coma, resp depression, acute pulmonary insufficiency or sleep apnoea; severe hepatic impairment; pregnancy, lactation.
SP: Dosage reduction or gradual withdrawal. Dependence. Geriatric or debilitated patients. Muscle weakness, impaired hepatic or renal func-tion; arteriosclerosis; obesity; depression particu-larly suicidal tendency; chronic pulmonary insuf-ficiency. May impair ability to drive or operate machinery. Children <18 yr.
AR: Psychological & physical dependence, with-drawal syndrome; drowsiness, sedation, vertigo, headache, visual disturbances, photosensitivity, GI disturbances, jaundice; fatigue, muscle weakness, ataxia, seizures, delirium, dizziness, confusion & depression. Blood dyscrasias. Mania & hypomania.
DI: Potentiates action of alcohol & CNS depressants. Reduced conc w/ cigarette smoking by 50%. Cimeti-dine & fluoxetine reduce the clearance of alprazolam. Alprazolam enhances activity of imipramine & desip-ramine. Decreased metabolism w/ CYP3A4 inhibitors.
• Amfepramone • (diethylpropion)
ลดคว�มอย�กอ�ห�รในก�รรกษ�ผทมนำ�หนกเกนกว�ปกต
I: Obesity.
CI: Advanced arteriosclerosis. Hyperthyroid-ism. Hypersensitivity. Glaucoma. Agitated states. History of drug abuse. Pulmonary HTN or severe hypertension. Heart murmur or valvular disorders. Emotional instability. History of psychiatric illness. Concomitant use w/ other anorectic agents. MAOI
therapy or w/in 2 wk of discontinuation. Pregnancy & lactation. Childn & elderly.
SP: Increased risk of developing primary pulmonary HTN (PPH). HTN & severe CV disease. Prolonged use may induce dependence w/ withdrawal symp-toms on cessation of therapy; do not use for more than 3 months. May increase convulsions in some epileptic patients. Toxic psychosis. Peptic ulceration. Prostatic hyperplasia. Diabetes mellitus. May impair ability to perform hazardous activities w/c requires mental alertness or physical coordination.
AR: CV & CNS disturbances; GI effects; allergic reactions; impotence; changes in libido, gyneco-mastia, menstrual upset; hematopoietic effects; dyspnea, hair loss, muscle pain, dysuria, increased sweating, polyuria.
DI: Hypertensive risk w/ MAOIs. b-blockers, guanethidine, TCAs, urinary alkalinisers or acidifiers, sibutramine. Alters antidiabetic drug requirements.
• ÄBuprenorphine •
บรรเท�ปวดระดบป�นกล�งถงปวดรนแรงสำ�หรบใชในก�รผ�ตด
I: As a perioperative analgesic supplement. Moder-ate to severe pain. Premedication before anaesthe-sia. Management of opiate dependence. Reversal of fentanyl-induced anesthesia.
CI: Acute alcoholism; convulsive disorders; head injuries; increased intracranial pressure; comatose patients; resp depression & obstructive airway disease; patients on established opioid agonists.
SP: Hepatic or renal disease; pregnancy, lactation; hypothyroidism; adrenocortical insufficiency; asthma; prostatic hyperplasia; shock; hypotension; inflam-matory or obstructive bowel disorders; myasthae-nia gravis; infants/neonates. Reduce dose in elderly & debilitated patients. May precipitate withdrawal symptoms in narcotic addicts. Pulmonary impair-ment. Patients w/ delirium tremens, toxic psycho-ses, kyphoscoliosis, prostatic hypertrophy, urethral stricture, increased intracranial pressure, seizure disorder, dysfunction of biliary tract, hypokalemia. May impair ability to perform hazardous activities w/c requires mental alertness or physical coordination.
PINK PAGES 2013-FINAL-July31.indd 49 8/15/2013 9:50:49 AM
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
P2
alprazolam
ALCELAM 0.25 mg 100ALCELAM 0.5 mg 259ALCELAM 1 mg 308ALLAM 0.25 mg 116ALLAM 0.5 mg 275ALLAM 1 mg 320ALNAX 0.25 mg 099ALNAX 0.5 mg 258ALNAX 1 mg 307ALPAZAM 0.25 mg 101ALPAZAM 0.5 mg 260ALPAZAM 1 mg 261ALPRALAN 0.25 mg 036ALPRALAN 0.5 mg 240ALPRAMED 0.25 mg 276ALPRAMED 0.5 mg 117ALPRAMED 1 mg 421ALPRAX 0.25 mg 161ALPRAX 0.5 mg 195ALPRAX 1 mg 052ALPRAXOL 0.25 mg 017ALPRAXOL 0.5 mg 235ALPRAZOLAM FRX
0.25 mg 122ALPRAZOLAM FRX
0.5 mg 282ANAX 0.25 mg 097ANAX 0.5 mg 256ANPRESS 0.25 mg 102ANPRESS 0.5 mg 274ANPRESS 1 mg 309ANZION 0.25 mg 098ANZION 0.5 mg 257ANZION 1 mg 306DIZOLAM 0.25 mg 103DIZOLAM 0.5 mg 262DIZOLAM 1 mg 324FARZOLAM 0.25 mg 104FARZOLAM 0.5 mg 263FARZOLAM 1 mg 310INZOLAM 0.25 mg 118INZOLAM 0.5 mg 277INZOLAM 1 mg 321
MANEX 0.25 mg 106MANEX 0.5 mg 264MANEX 1 mg 311MARZOLAM 0.25 mg 107MARZOLAM 0.5 mg 265MARZOLAM 1 mg 312MITRANAX 0.25 mg 119MITRANAX 0.5 mg 278MITRANAX 1 mg 322MOXINAX 0.25 mg 108MOXINAX 0.5 mg 266PHARNAX 0.25 mg 109PHARNAX 0.5 mg 267PHARNAX 1 mg 313PRAZOL 0.25 mg 110PRAZOL 0.5 mg 268PRAZOL 1 mg 314SIAMPRAXOL 0.25 mg 111SIAMPRAXOL 0.5 mg 269SIAMPRAXOL 1 mg 315SUNAX 0.25 mg 120SUNAX 0.5 mg 279XALAM 0.25 mg 112XALAM 0.5 mg 270XALAM 1 mg 316XANACINE 0.25 mg 113XANACINE 0.5 mg 271XANACINE 1 mg 317XANAX 0.25 mg 114XANAX 0.5 mg 272XANAX 1 mg 318XANAX XR 0.5 mg 372XANAX XR 1 mg 079XANAX XR 2 mg 381XIEMED 0.25 mg 121XIEMED 0.5 mg 280XIEMED 1 mg 323ZOLAM 0.25 mg 115ZOLAM 0.5 mg 273ZOLAM 1 mg 319
buprenorphine hydrochloride
BUPRINE 0.2 mg 001TEMGESIC
0.3 mg/mL x 1 mL 666TEMGESIC 0.2 mg 007
cathine
D-NORPSEUDOEPHEDRINE SR OSMOPHARM 20 mg 517
MIRAPRONT N 20 mg 516
diethylpropion hydrochloride
DIETIL RETARD 75 mg 096
PREFAMONE 75 mg 191
REGENON RETARD 75 mg 130
REGENON RETARD 75 mg 504
diethylpropion resinate
ATRACTIL 75 mg 505
ephedrine hydrochloride
EPHEDRINE GPO 30 mg/mL x 1 mL 632
flunitrazepam
ROHYPNOL 1 mg 423
flurazepam hydrochloride
DALMADORM 15 mg 512
ketamine hydrochloride
CALYPSOL 50 mg/mL x 10 mL 675
KETA-HAMELN 50 mg/mL x 10 mL 678
KETALAR 50 mg/mL x 10 mL 679
lormetazepam
LORAMET 1 mg 105
CONTROLLED SUBSTANCE CLASS INDEX
ดชนเภสชภณฑจดเรยงตามกลม/ประเภทของทะเบยน
Controlled Substance Class-Aug13.indd 64 8/14/2013 2:43:23 PM
DIAZEPAM BJ BENJAOSOTH (ºÕਠ(àºÞ¨âÍʶ)) diazepam 5 mg P4 [190.2 mg]
402
POBRAX † (¿ÒÃ�ÁÒÊѹµ� áÅçº) chlordiazepoxide hydrochloride 5 mg XP4
403
WINOPAM (ÅÔÇÔ¹à¹ÍÃ�¿ÒÃ�ÁÒ) diazepam 5 mg XP4
404
MODURAX † (ÂÙâ·à»‚œÂ¹) chlordiazepoxide hydrochloride 5 mg P4 [250 mg]
chlordiazepoxide hydrochloride 5 mg
405
CEBARAX † (ÁÒ«Òáź) chlordiazepoxide hydrochloride 5 mg P4 [250 mg]
406
CHLORDIBRAX † (ÂÙâ·à»‚œÂ¹) chlordiazepoxide hydrochloride 5 mg XP4
407
CLINOPRONT † (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) codeine phosphate 10 mg N3 [283.31 mg]
408
LIBRAX † (âÍÅÔ¤) chlordiazepoxide 5 mg P4 [299 mg]
chlordiazepoxide 5 mg
409
LICON † (äÅ¿Š ¤Í¹à«Ô¹) chlordiazepoxide hydrochloride 5 mg XP4
410
UTORAX † (ÂÙâ·à»‚œÂ¹) chlordiazepoxide hydrochloride 5 mg XP4
411
ZEPOBRAX † (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) chlordiazepoxide hydrochloride 5 mg XP4
412
DIRAX † (ÊËá¾·Â�àÀÊѪ) chlordiazepoxide 5 mg P4 [200 mg]
413
DIAPINE TABLET (á͵ᏵԤ) diazepam 10 mg P4 [320 mg]
414
TERCO-C † (ºÕ àÍçÅ ÎÑéÇ) codeine phosphate 10 mg N3 [591.1 mg]
415
CODEE-C † (ÊËá¾·Â�àÀÊѪ) codeine phosphate 10 mg N3 [345.02 mg]
416
SECO † (àÀÊѪ¡ÃÃÁÈÃÕ»ÃÐÊÔ·¸Ôì) codeine phosphate 10 mg N3 [331.56 mg]
417
TOCODYL † (·Õ âÍ à¤ÁÕ¤ÍÅÊ�) codeine phosphate 10 mg XN3 [325.82 mg]
418
CODESIA † (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) codeine phosphate 10 mg N3 [350 mg]
419
RADIBRAX † (¿ÒÃ�ÁÒÊѹµ� áÅçº) chlordiazepoxide hydrochloride 5 mg XP4
420
ALPRAMED (àÅÔÈÊÔ§Ë�) alprazolam 1 mg P2 [259 mg]
421
CODENOL † (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) codeine phosphate 15 mg N3
422
ROHYPNOL (âê/ÍÂ.) fl unitrazepam 1 mg P2 [175 mg]
423
PARAMED-CO † (ÊËá¾·Â�àÀÊѪ) codeine phosphate 15 mg XN3 [601.1 mg]
424
VASON (ÁÔÅÅÔàÁ´) diazepam 2 mg P4 [110 mg]
425
CELIUM (ÂÙâ·à»‚œÂ¹) medazepam 5 mg P4 [110 mg]
426
GREEN Capsule
EUHYPNOS 20 (ÍÒÃ� ¾Õ àªÍàÃÍÃ�/ÍÂ.) temazepam 20 mg P2 [868.96 mg]
[868.96 mg]
427
TUMAX † (àÀÊѪ¡ÃÃÁÈÃÕ»ÃÐÊÔ·¸Ôì) chlordiazepoxide hydrochloride 5 mg P4 [180 mg]
428
ZEPAM (âÁà´ÍÃ�¹áÁ¹Ù) diazepam 2 mg XP4
429
POSENE (ÊÂÒÁàÁ´Ôá¤Ã�) clorazepate dipotassium 10 mg XP4
430
†Indicates brands that contain more than one ingredientÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
PRODUCT IDENTIFICATION CHART 23 PN DEX 2013
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 23 8/6/2013 2:03:57 PM
IMPORTANT DRUG NOTESขอมลสาคญของตวยา ... หนา 49-63• คนตามชอสามญ จาก A-Z ในแตละกลม
CONTROLLED SUBSTANCECLASS INDEX
ดชนกลม/ประเภทของทะเบยน ...หนา 64-70
• คนตามชอสามญ เรยงลาดบชอ A-Z ในแตละกลม
6
5
6
คนหา ขอหาและโทษ จากพระราชบญญตฯ ทเกยวของ
คนหาจากชอบรษทผผลต
THAI NARCOTICS ACTพระราชบญญตยาเสพตดใหโทษ ... หนา 41
THAI PSYCHOTROPIC SUBSTANCES ACT
พระราชบญญตวตถทออกฤทธตอจตและประสาท ... หนา 43
ตารางบนทกขอหาและบทกำาหนดโทษ ทมา : บนทก ป.ป.ส. 2556 สำานกงาน ป.ป.ส. กระทรวงยตธรรม
ขอหา ยาเสพตดใหโทษประเภท 1
ผลตนำาเขาสงออก(ม.15, 65)
•จำ�คกตลอดชวตและปรบ1ล�น-5ล�นบ�ท•ถ�กระทำ�เพอจำ�หน�ยประห�รชวตถ�ปรม�ณตอไปนขนไปใหถอว�ผลตนำ�เข�สงออกครอบครองเพอจำ�หน�ยแอลเอสดส�รบรสทธ0.75มลลกรมหรอ15หนวยก�รใชหรอนำ�หนกสทธ300มลลกรม(หนวยก�รใช=เมด,ซอง,ขวดหรอหนวยอย�งอนททำ�ขนโดยปกตสำ�หรบก�รใชเสพหนงครง)ยาบาส�รบรสทธ375มลลกรมหรอ15หนวยก�รใชหรอนำ�หนกสทธ1.5กรมยาเสพตดใหโทษประเภท 1 อนๆส�รบรสทธ3กรม•ถ�เปนก�รผลตโดยก�รแบงบรรจหรอรวมบรรจจำ�คก4-15ปหรอปรบ80,000-300,000บ�ทหรอทงจำ�ทงปรบถ�กระทำ�เพอจำ�หน�ยจำ�คก4ป-ตลอดชวตและปรบ400,000-5ล�นบ�ท
จำาหนายครอบครองเพอจำ�หน�ย(ม.15, 66)
•จำ�คก4-15ปหรอปรบ80,000-300,000บ�ทหรอทงจำ�ทงปรบ•ถ�มส�รบรสทธปรม�ณตอไปนแอลเอสด0.75มลลกรม-20กรมหรอย�บ�375มลลกรม-20กรมหรอย�เสพตดใหโทษประเภท1อนๆ3-20กรมจำ�คก40ป-ตลอดชวตและปรบ400,000-5ล�นบ�ท•ถ�มส�รบรสทธเกน20กรมจำ�คกตลอดชวตและปรบ1ล�นบ�ท-5ล�นบ�ทหรอประห�รชวต
ครอบครอง(ม.15, 67)
•จำ�คก1-10ปหรอปรบ20,000-200,000บ�ทหรอทงจำ�ทงปรบ
เสพ(ม.57, 91)
•จำ�คก6เดอน-3ปหรอปรบ10,000-60,000บ�ทหรอทงจำ�ทงปรบ
หลอกลวง หรอขมขนใจใหผอนเสพ(ม.93)
•จำ�คก1-10ปและปรบ100,000-1,000,000บ�ท•ถ�กระทำ�โดยมอ�วธหรอรวมกระทำ�ตงแต2คนขนไปจำ�คก2-15ปและปรบ200,000-1,500,000บ�ท•ถ�กระทำ�ตอหญงหรอบคคลซงยงไมบรรลนตภ�วะหรอเพอจงใจใหผอนกระทำ�ผดท�งอ�ญ�หรอเพอประโยชนในก�รกระทำ�ผดท�งอ�ญ�จำ�คก3ป–ตลอดชวตและปรบ300,000-5,000,000บ�ทถ�เปนเฮโรอนตองระว�งโทษเปนสองเท�และถ�กระทำ�ตอหญงหรอตอบคคลซงยงไมบรรลนตภ�วะประห�รชวต
ขอหา ยาเสพตดใหโทษประเภท 2
ผลตนำาเขาสงออก(ม.16, 68)
•จำ�คก1-10ปและปรบ100,000-1ล�นบ�ท•ถ�เปนมอรฟนฝนหรอโคค�อนจำ�คก20ป-ตลอดชวตและปรบ2ล�น-5ล�นบ�ท
จำาหนายครอบครองเพอจำาหนาย(ม.17, 69)
•จำ�คก1-10ปหรอปรบ20,000บ�ท-200,000บ�ทหรอทงจำ�ทงปรบ•ถ�เปนมอรฟนฝนหรอโคค�อนปรม�ณส�รบรสทธไมถง100กรมจำ�คก3-20ปหรอปรบ60,000-400,000บ�ทหรอทงจำ�ทงปรบถ�มส�รบรสทธ100กรมขนไปจำ�คก5ป-ตลอดชวตและปรบ500,000-5ล�นบ�ท
ครอบครอง(ม.17, 69)
•จำ�คกไมเกน5ปหรอปรบไมเกน100,000บ�ทหรอทงจำ�ทงปรบ
เสพ(ม.58, 91)
•จำ�คก6เดอน-3ปหรอปรบ10,000-60,000บ�ทหรอทงจำ�ทงปรบเวนแตเปนก�รเสพเพอรกษ�โรคต�มคำ�สงของแพทยทไดรบใบอนญ�ต
หลอกลวง หรอขมขนใจใหผอนเสพ(ม.93)
•จำ�คก1-10ปและปรบ100,000-1,000,000บ�ท•ถ�กระทำ�โดยมอ�วธหรอรวมกระทำ�ตงแต2คนขนไปจำ�คก2-15ปและปรบ200,000-1,500,000บ�ท•ถ�กระทำ�ตอหญงหรอตอบคคลซงยงไมบรรลนตภ�วะหรอเพอจงใจใหผอนกระทำ�ผดท�งอ�ญ�หรอเพอประโยชนในก�รกระทำ�ผดท�งอ�ญ�จำ�คก3ป-ตลอดชวตและปรบ300,000–5,000,000บ�ทถ�เปนมอรฟนหรอโคค�อนตองระว�งโทษเพมขนอกกงหนงและถ�กระทำ�ตอหญงหรอตอบคคลซงยงไมบรรลนตภ�วะจำ�คกตลอดชวตและปรบ1,000,000–5,000,000บ�ท
Thai Narcotics Act B.E. 2522 (1979)พระร�ชบญญตย�เสพตดใหโทษพ.ศ.2522
PINK PAGES 2013-FINAL-July31.indd 41 8/7/2013 1:43:09 PM
ตารางบนทกขอหาและบทกำาหนดโทษ ทมา : บนทก ป.ป.ส. 2556 สำานกงาน ป.ป.ส. กระทรวงยตธรรม
ขอหา ประเภท 1 (P1) ประเภท2(P2) ประเภท 3 (P3) ประเภท 4 (P4)
ผลตนำ�เข�สงออกข�ย
•จำ�คก5-20ปและปรบตงแต100,000-400,000บ�ท(ม.13,13ทว,89)
•จำ�คกไมเกน5ปและปรบไมเกน100,000บ�ท(ม.16,90)
นำ�ผ�น •จำ�คกไมเกน5ปและปรบไมเกน100,000บ�ท(ม.16,90)
ครอบครองใชประโยชน •จำ�คก1-5ปและปรบ20,000-100,000บ�ท(ม.62,106)•ถ�ปรม�ณเกนทกำ�หนดในประก�ศกระทรวงส�ธ�รณสข(ปจจบนคอฉบบพ.ศ.2555)จำ�คก5-20ปและปรบ100,000-400,000บ�ท(ม.62,106ทว)
•จำ�คกไมเกน1ปหรอปรบไมเกน20,000บ�ทหรอทงจำ�ทงปรบ(ม.62,106)
เสพ •จำ�คก1-5ปและปรบ20,000-100,000บ�ท(ม.62ทว,106ตร)
•จำ�คก1-5ปและปรบ20,000-100,000บ�ทเวนแตเสพต�มคำ�สงแพทย(ม.62ตร,106ตร)
•ไมมคว�มผด
จงใจชกนำ�ยยงสงเสรมใชอบ�ยหลอกลวงขเขญใหผอนเสพ
•จำ�คก2-10ปและปรบ40,000-200,000บ�ท(ม.62จตว�,106จตว�)•ถ�กระทำ�ตอหญงหรอบคคลไมบรรลนตภ�วะหรอเพอจงใจใหผอนกระทำ�คว�มผดท�งอ�ญ�หรอเพอประโยชนแกตนเองหรอผอนในก�รกระทำ�คว�มผดอ�ญ�จำ�คก3ป-ตลอดชวตและปรบ60,000-500,000บ�ท(ม.62จตว�,106จตว�)
Thai Psychotropic Substances Act B.E. 2518 (1975)พระร�ชบญญตวตถทออกฤทธตอจตและประส�ทพ.ศ.2518
PINK PAGES 2013-FINAL-July31.indd 43 8/16/2013 3:28:00 PM
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
2M (Med-Maker)2 เอม (เมด-เมเกอร)
ANPRESS 0.25 mg 102ANPRESS 1 mg 309CONVULSIL 2 mg 070XIEMED 0.5 mg 280
a N H Productsเอ เอน เอช โปรดคส
COMOBEN 5 mg 390COMOBEN 10 mg 510COMODINE COUGH†
60 mL 550DIVOPAN 2 mg 056DIVOPAN 5 mg 166
acdHoNแอคดอน
CHLORDIAZEPOXIDE ACDHON 10 mg 529
DIADON 5 mg 377DIAZEPAM
ACDHON 2 mg 498LORAZEPAM
ACDHON 0.5 mg 344LORAZEPAM
ACDHON 1 mg 034PHENOBARBITAL
ACDHON 15 mg 384PHENOBARBITAL
ACDHON 30 mg 136PHENOBARBITAL
ACDHON 60 mg 030PHENOBARBITAL
ELIXIR ACDHON 20 mg/5 mL x 30 mL 595
PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 60 mL 596
PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 120 mL 597
PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 240 mL 598
PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 450 mL 599
PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 500 mL 600
PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 1000 mL 601
TRANADON-S 5 mg 475
all PlaNtsออลแพลนทส
PENTAZOCINE ALL PLANTS 30 mg/mL x 1 mL 655
alPHaPHarM/Fdaอลฟาฟารม/อย.
ALODORM 5 mg 090
TRIALAM 0.25 mg 185
aNtigeN/Fdaแอนตเจน/อย.
FENTANYL ANTIGEN 0.05 mg/mL x 2 mL 633
FENTANYL ANTIGEN 0.05 mg/mL x 10 mL 634
asiaN PHarMเอเชยนฟารมาซตคล
ALPRAXOL 0.25 mg 017
ALPRAXOL 0.5 mg 235
A-ZERAX 2 mg 479
A-ZERAX 5 mg 489
BROMTUSSIA DC† 60 mL 537
CODENOL† 15 mg 422
CODESIA† 419
CODESIA† 60 mL 542
DIPOT 5 mg 459
DITROPINE† 008
LORAZEP 0.5 mg 337
LORAZEP 1 mg 005
LORAZEP 2 mg 385
PHENOTAL ELIXIR 20 mg/5 mL x 60 mL 606
asiaN PHarM/Fdaเอเชยนฟารมาซตคล/อย.
PSEUDOEPHEDRINE ASIAN PHARM 30 mg 158
PSEUDOEPHEDRINE ASIAN PHARM 60 mg 048
PSEUDOEPHEDRINE ASIAN PHARM 30 mg/5 mL x 60 mL 616
atlaNtic labแอตแลนตค
AMA† 159BENPINE 5 mg 435BENPINE 10 mg 526BENPINE 25 mg 218DIAPINE
5 mg/mL x 1 mL 625DIAPINE
10 mg/2 mL x 2 mL 626DIAPINE CAPSULE
2 mg 499DIAPINE CAPSULE
5 mg 506DIAPINE TABLET
2 mg 011DIAPINE TABLET
5 mg 183DIAPINE TABLET
10 mg 414DIZOLAM 0.25 mg 103DIZOLAM 0.5 mg 262DIZOLAM 1 mg 324LORA 0.5 mg 397LORA 1 mg 040LORA 2 mg 244PHENOBARBITAL
ATLANTIC 16.25 mg 234PHENOBARBITAL
ATLANTIC 32.5 mg 436PHENOBARBITAL
ATLANTIC 65 mg 015PHENOBARBITAL
ATLANTIC 100 mg 303
aveNtisอเวนตส
FRISIUM 10 mg 039
MANUFACTURER’S INDEX
ดชนเภสชภณฑจดเรยงตามชอผผลต
MNF INDEX CLASS-FINAL-Aug13.indd 71 8/14/2013 2:48:37 PM
MANUFACTURER’S INDEXดชนรวมชอผผลต ... หนา 71-79
PRODUCT IDENTIFICATION CHARTคนหารปภาพเภสชภณฑ ... หนา 10-40
• คนตามหมายเลขภาพมมลางซาย
VISPAM (ÂÙâ·à»‚œÂ¹) diazepam 5 mg XP4 [70.02 mg]
239
ALPRALAN (âÍÅѹ-à¤ÁàÁ´) alprazolam 0.5 mg P2 [157.28 mg]
240
PORA (¾Í¹´�à¤ÁÕ¤ÍÅ) lorazepam 2 mg XP4
241
DIAZEPAM POND'S CHEMICAL (¾Í¹´�à¤ÁÕ¤ÍÅ) diazepam 5 mg P4 [145.6 mg]
242
DIAZEPAM H K PHARM (àͪ ठ¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) diazepam 2 mg P4 [130 mg]
243
LORA (á͵ᏵԤ) lorazepam 2 mg P4 [200 mg]
244
MORPHINE SALUTAS PHARMA («ÒÅÙ·ÑÊ ¿ÒÃ�ÁÒ/ÍÂ.) morphine sulfate 60 mg N2
245
S.CO ZEPAM (àÍÊ â¤ ¿ÒÃ�ÁÒ) diazepam 5 mg XP4
246
BELLADONNA ALKALOIDS W/ PHENOBARBITAL † (ÊÒÁѤ¤ÕàÀÊѪ) phenobarbital sodium 16.2 mg XP4 [160 mg]
247
CENTRODINE CD † (¿ÒÃ�ÁÒÊѹµ� áÅçº) codeine phosphate 10 mg N3 [205.2 mg]
248
DIAZEPAM BJ BENJAOSOTH (ºÕਠ(àºÞ¨âÍʶ)) diazepam 10 mg XP4 [233 mg]
249
DIZEPAM (ÁÒ«Òáź) diazepam 2 mg P4 [170 mg]
250
KENSPA † (हÂÒ¡Ø) chlordiazepoxide hydrochloride 5 mg P4 [246 mg]
251
TAZCINE (ÍØ´Á¾Ã (¿‚ÎÒáÅçº)) pentazocine 50 mg XP3
252
LORAZIN (ÍԹᾤ¿ÒÃ�ÁÒ) lorazepam 2 mg P4 [200 mg]
253
LEXOTAN (âê) bromazepam 3 mg P4 [200 mg]
254
PHENOCON (ÁÒ«Òáź) phenobarbital sodium 60 mg XP4
255
ANAX (ÁÔÅÅÔàÁ´) alprazolam 0.5 mg P2 [130 mg]
256
ANZION (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) alprazolam 0.5 mg P2 [132.5 mg]
257
ALNAX (¾Í¹´�à¤ÁÕ¤ÍÅ) alprazolam 0.5 mg P2 [130 mg]
258
ALCELAM (¿ÒÃ�ÁÒÊѹµ� áÅçº) alprazolam 0.5 mg P2 [130 mg]
259
ALPAZAM (ä·Â¹¤Ã¾Ñ²¹Ò) alprazolam 0.5 mg P2
260
ALPAZAM (ä·Â¹¤Ã¾Ñ²¹Ò) alprazolam 1 mg P2
261
DIZOLAM (á͵ᏵԤ) alprazolam 0.5 mg P2 [130 mg]
262
FARZOLAM (¿ÒÃ�ÁÕ¹‹Ò) alprazolam 0.5 mg P2
263
MANEX (·Õ áÁ¹ ¿ÒÃ�ÁÒ) alprazolam 0.5 mg P2 [130 mg]
264
MARZOLAM (áËÅÁ·Í§¡ÒÃá¾·Â�) alprazolam 0.5 mg P2 [130 mg]
265
MOXINAX (âÁà´ÍÃ�¹áÁ¹Ù) alprazolam 0.5 mg P2 [130 mg]
266
PHARNAX (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) alprazolam 0.5 mg P2 [131.9 mg]
267
PRAZOL (हÂÒ¡Ø) alprazolam 0.5 mg P2 [216.36 mg]
268
SIAMPRAXOL (ÊÂÒÁàÀÊѪ) alprazolam 0.5 mg P2 [125.75 mg]
269
XALAM (¹ÔÇäÅ¿Š¿ÒÃ�ÁÒ) alprazolam 0.5 mg P2
270
XANACINE (àÁ´Ô«Õ¹â»Ã´Ñ¡Ê�) alprazolam 0.5 mg P2 [110 mg]
271
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
18 PRODUCT IDENTIFICATION CHART PN DEX 2013
†Indicates brands that contain more than one ingredient
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 18 8/6/2013 2:03:48 PM
7
7 พสจนสญลกษณจาก แผนดวด PNdex
(powered by MIMS.com)
แผนดวดระบบการสบคน MIMS PNdex จะใชงานไดด กบอปกรณของเครองทมคณสมบตอยางตาดงน
• Windows XP SP3• Intel® Pentium® 4 CPU 2.80GHz• 1GB RAM• มพนทวางสาหรบขอมลไมนอยกวา 3GB • Screen display resolution ไมตากวา 1280 x 800 pixels
ขอควรระวง
MIMS PNdex เปนโปรแกรมการสบคนหรอพสจนเอกลกษณ ของวตถออกฤทธและยาเสพตดใหโทษในประเทศไทย อาจมความคลาดเคลอนในการแสดงสของภาพเภสชภณฑ โดยขนกบการตงคาสและความละเอยดของหนาจอคอมพวเตอรแตละเครอง จงควรอานคาสและดคณสมบตอนเชน ขนาด หรอสญลกษณ รวมในการยนยนการพสจนใหตรงกนดวยเสมอ และขอมลทงหมดปรบปรงลาสดถง 30 มถนายน 2556 เทานน
หากมขอแนะนา ต ชม หรอมคาถาม ทเกยวกบโปรแกรมการสบคน MIMS PNdexกรณาตดตอไดทอเมล [email protected]
9
PRODUCT IDENTIFICATION SEQUENCEÅíҴѺ¡ÒèѴÀÒ¾ÂÒàÁç´
9
หมายเหต:
สทปรากฏในหนงสออาจคลาดเคลอนกบสจรงของเมดยาแนะนาใหตรวจดวยคณลกษณะอนรวมดวยเชนขนาดสญลกษณ
AW_PNdex front 20100402.indd 9 2/4/2553 13:57:09
8
9
PRODUCT IDENTIFICATION SEQUENCEÅíҴѺ¡ÒèѴÀÒ¾ÂÒàÁç´
9
หมายเหต:
สทปรากฏในหนงสออาจคลาดเคลอนกบสจรงของเมดยาแนะนาใหตรวจดวยคณลกษณะอนรวมดวยเชนขนาดสญลกษณ
AW_PNdex front 20100402.indd 9 2/4/2553 13:57:09
ATIVAN (äÇàÍ· (»ÃÐà·Èä·Â)) lorazepam 1 mg XP4
023
KEMORA (âÍÅѹ-à¤ÁàÁ´) lorazepam 1 mg P4 [100 mg]
024
LIZAVAN (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) lorazepam 1 mg XP4 [100.4 mg]
025
LORAMED (âÍÅѹ-à¤ÁàÁ´) lorazepam 1 mg XP4
026
LORAPAM (ÊÂÒÁàÀÊѪ) lorazepam 1 mg XP4
027
LORAVAN (Êؾ§É�àÀÊѪ) lorazepam 1 mg XP4 [100 mg]
028
ORA (ÁÒ«Òáź) lorazepam 1 mg P4 [100 mg]
029
PHENOBARBITAL ACDHON (áͤ´Í¹) phenobarbital sodium 60 mg XP4
030
RAZEPAM (ä·Â¹¤Ã¾Ñ²¹Ò) lorazepam 1 mg XP4
031
VALAX (·Õ àÍçÁ àÍç¹ ÍÔÁᾡ«�) diazepam 2 mg XP4
032
LORAPINE (ÂÙâ·à»‚œÂ¹) lorazepam 1 mg XP4
033
DIAZEPAM T P DRUG (·Õ ¾Õ ´ÃÑ¡) diazepam 2 mg XP4
012
LORA-P (¾Õ ¾Õ áźÍÃÒµÍÃÕèÊ�) lorazepam 1 mg XP4 [113.37 mg]
013
LORAZENE (àºÍÃ�ÅÔ¹¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) lorazepam 1 mg XP4
014
PHENOBARBITAL ATLANTIC (á͵ᏵԤ) phenobarbital sodium 65 mg P4 [95 mg]
015
ZEDA (Íѧ¡ÄɵÃÒ§Ù (áÍÅ ¾Õ)) lorazepam 0.5 mg P4 [90 mg]
016
ALPRAXOL (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) alprazolam 0.25 mg P2
017
ANTA (¿ÒÃ�ÁÒÊѹµ� áÅçº) lorazepam 1 mg P4 [100 mg]
018
CODEINE GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ/ÍÂ.) codeine phosphate 30 mg N2 [113 mg]
019
LONZA (àÁ´Ô«Õ¹â»Ã´Ñ¡Ê�) lorazepam 1 mg P4 [85 mg]
020
ANXIRA (ÂÙâ·à»‚œÂ¹) lorazepam 1 mg P4 [100 mg]
021
MEILAX (àÁ¨Ô) ethyl lofl azepate 1 mg XP4
022
WHITE Tablet
BUPRINE (ÊÂÒÁàÀÊѪ/ÍÂ.) buprenorphine hydrochloride 0.2 mg P2 [50 mg]
001
DILOMIL † (ÊÂÒÁàÀÊѪ) diphenoxylate hydrochloride 2.5 mg XN3
002
CODEINE GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ/ÍÂ.) codeine phosphate 15 mg N2 [73 mg]
003
LOMOTIL † (âÍÅÔ¤) diphenoxylate hydrochloride 2.5 mg N3 [63 mg]
004
LORAZEP (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) lorazepam 1 mg P4 [65 mg]
005
PHENOBARBITONENEW LIFE PHARMA (¹ÔÇäÅ¿Š¿ÒÃ�ÁÒ) phenobarbital sodium 30 mg XP4
006
TEMGESIC (àá¤Ô··� ູ¤Õà«ÍÃ�/ÍÂ.) buprenorphine hydrochloride 0.2 mg P2 [59.98 mg]
007
DITROPINE † (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) diphenoxylate hydrochloride 2.5 mg XN3
008
SPASIL † (àÀÊѪ¡ÃÃÁÈÃÕ»ÃÐÊÔ·¸Ôì) diphenoxylate hydrochloride 2.5 mg N3 [79.97 mg]
009
DIANO (ÁÔÅÒâ¹) diazepam 2 mg P4 [80 mg]
010
DIAPINE TABLET (á͵ᏵԤ) diazepam 2 mg P4 [100 mg]
011
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
10 PRODUCT IDENTIFICATION CHART PN DEX 2013
†Indicates brands that contain more than one ingredient
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 10 8/13/2013 5:30:53 PM
LORAZEPAM ACDHON (áͤ´Í¹) lorazepam 1 mg XP4
034
TRANAVAN (â»ÅÔ¿ÒÃ�Á) lorazepam 1 mg P4 [100 mg]
035
ALPRALAN (âÍÅѹ-à¤ÁàÁ´) alprazolam 0.25 mg P2 [154.7 mg]
036
DIPAM (¹ÔÇäÅ¿Š¿ÒÃ�ÁÒ) diazepam 2 mg XP4
037
FRISIUM («Ò⹿‚›-ÍàǹµÕÊ) clobazam 5 mg P4 [120 mg]
038
FRISIUM (ÍàǹµÕÊ) clobazam 10 mg XP4
039
LORA (á͵ᏵԤ) lorazepam 1 mg P4 [130 mg]
040
MED-ZEPAM (àǪºÃÔ¡ÒÃ) diazepam 2 mg XP4
041
RITALIN (â¹ÇÒÃ�µÕÊ/ÍÂ.) methylphenidate hydrochloride 10 mg P2 [140 mg]
042
RUBIFEN (áÅçº ÃÙºÔâÍ/ÍÂ.) methylphenidate hydrochloride 10 mg P2 [190 mg]
043
LORAZE (हÂÒ¡Ø) lorazepam 1 mg P4
044
LORAZIN (ÍԹᾤ¿ÒÃ�ÁÒ) lorazepam 1 mg P4 [103.02 mg]
045
PSEUDOEPHEDRINEMILANO (ÁÔÅÒâ¹/ÍÂ.) pseudoephedrine hydrochloride 60 mg P2 [130 mg]
046
PHENOBARB (¾Õ ¾Õ áźÍÃÒµÍÃÕèÊ�) phenobarbital sodium 60 mg XP4 [130 mg]
047
PSEUDOEPHEDRINEASIAN PHARM (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ/ÍÂ.) pseudoephedrine hydrochloride 60 mg P2 [155 mg]
048
PSEUDOEPHEDRINE DEFENCE OF PHARMACEUTICAL FACTORY (âç§Ò¹àÀÊѪ¡ÃÃÁ·ËÒÃ) pseudoephedrine hydrochloride 30 mg P2
049
PSEUDOEPHEDRINE DEFENCE OF PHARMACEUTICAL FACTORY (âç§Ò¹àÀÊѪ¡ÃÃÁ·ËÒÃ) pseudoephedrine hydrochloride 60 mg P2
050
ZOPAM (¿ÒÃ�ÁÒÊѹµ� áÅçº) diazepam 2 mg P4 [160 mg]
051
ALPRAX (·ÍÃ�àù·�) alprazolam 1 mg P2 [190 mg]
052
DACTIVE 10 (¤ÒÅÔÅÒ àÎÅ·�á¤Ã�/ÍÂ.) zolpidem tartrate 10 mg P2
053
DIAZEPAM BJ BENJAOSOTH (ºÕਠ(àºÞ¨âÍʶ)) diazepam 2 mg XP4 [158.25 mg]
054
DIAZEPAM GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ) diazepam 2 mg P4 [182 mg]
055
DIVOPAN (àÍ àÍç¹ àͪ â»Ã´Ñ¤Ê�) diazepam 2 mg P4 [180 mg]
056
DONNATAL † (äÇ·�ÎÍÅÅ�) phenobarbital 16.2 mg XP4
057
GRANDAXIN (ÍÕ¨ÕÊ) tofi sopam 50 mg P4 [180 mg]
058
MED-ZEPOXIDE (àǪºÃÔ¡ÒÃ) chlordiazepoxide hydrochloride 10 mg XP4 [198.8 mg]
059
METHYLPHENIDATE HEXAL («ÒÅÙ·ÑÊ ¿ÒÃ�ÁÒ/ÍÂ.) methylphenidate hydrochloride 10 mg P2 [174.98 mg]
060
PRENARPIL (ÊËá¾·Â�àÀÊѪ) clonazepam 2 mg P4 [148.76 mg]
061
PSEUDOEPHEDRINE GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ) pseudoephedrine hydrochloride 30 mg P2
062
†Indicates brands that contain more than one ingredientÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
PRODUCT IDENTIFICATION CHART 11 PN DEX 2013
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 11 8/13/2013 5:30:55 PM
PSEUDOEPHEDRINE GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ) pseudoephedrine hydrochloride 60 mg P2
063
RIVOTRIL (âê) clonazepam 2 mg P4 [170 mg]
064
SIPAM (ÊÂÒÁàÀÊѪ) diazepam 2 mg P4 [164 mg]
065
TAZCINE (ÍØ´Á¾Ã (¿‚ÎÒáÅçº)) pentazocine 25 mg XP3 [149 mg]
066
VOMED (ÂÙâ·à»‚œÂ¹) diazepam 2 mg XP4
067
ZAM (àÁ´Ô«Õ¹â»Ã´Ñ¡Ê�) diazepam 2 mg P4
068
CLONARIL (ÂÙâ·à»‚œÂ¹) clonazepam 2 mg P4
069
CONVULSIL (2 àÍçÁ (àÁ´-àÁà¡ÍÃ�)) clonazepam 2 mg P4
070
DIAZ (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) diazepam 2 mg XP4 [180 mg]
071
NITRADOS (´Ñ¡ÅÒÊ/ÍÂ.) nitrazepam 5 mg P2
072
VORAPAM (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) diazepam 2 mg P4 [180 mg]
073
WINOPAM (ÅÔÇÔ¹à¹ÍÃ�¿ÒÃ�ÁÒ) diazepam 2 mg XP4
074
DIAZEPAM LERD SINGH (àÅÔÈÊÔ§Ë�) diazepam 2 mg P4 [180 mg]
075
POVANIL (¿ÒÃ�ÁÒÊѹµ� áÅçº) clonazepam 2 mg P4 [150 mg]
076
VALENIUM (हÂÒ¡Ø) diazepam 2 mg XP4
077
DIMED (ÊËá¾·Â�àÀÊѪ) diazepam 2 mg XP4
078
XANAX XR (ä¿à«ÍÃ�) alprazolam 1 mg P2 [347.19 mg]
079
LEXOTAN (âê) bromazepam 1.5 mg P4 [200 mg]
080
CEMOL CODEINE † (¿ÒÃ�ÁÒÊѹµ� áÅçº) codeine phosphate 15 mg XN3
081
COCET † (¹ÔÇäÅ¿Š¿ÒÃ�ÁÒ) codeine phosphate 15 mg XN3
082
PARA WITH CODEINE † (áÍÅ ºÕ àÍÊ áźºÍàõÍÃÕè) codeine phosphate 15 mg N3
083
PARA WITH CODEINE † (áÍÅ ºÕ àÍÊ áźºÍàõÍÃÕè) codeine phosphate 30 mg N3
084
COTENOL † (·Õ ¾Õ ´ÃÑ¡) codeine phosphate 15 mg XN3
085
PARADEINE † (à¨ÃÔÞàÀÊѪ) codeine phosphate 15 mg N3 [470 mg]
086
TYLENOL WITH CODEINE † (âÍÅÔ¤) codeine phosphate 15 mg N3 [432.5 mg]
087
TYLENOL WITH CODEINE † (âÍÅÔ¤) codeine phosphate 30 mg XN3 [478.72 mg]
088
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
12 PRODUCT IDENTIFICATION CHART PN DEX 2013
†Indicates brands that contain more than one ingredient
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 12 8/13/2013 5:30:56 PM
PARCOD † (·Õ áÁ¹ ¿ÒÃ�ÁÒ) codeine phosphate 15 mg XN3 [600 mg]
089
ALODORM (ÍÑÅ¿Ò¿ÒÃ�Á/ÍÂ.) nitrazepam 5 mg P2 [556 mg]
nitrazepam 5 mg
090
MOGADON (âê/ÍÂ.) nitrazepam 5 mg P2
nitrazepam 5 mg
091
NASA W/ CODEINE † (ÁÔÅÅÔàÁ´) codeine phosphate 15 mg N3 [600 mg]
092
PARCONO † (ÁÔÅÒâ¹) codeine phosphate 8 mg XN3 [600 mg]
093
REINBAMATE (¨ÔǺÃÒà´ÍÃ�Ê) meprobamate 400 mg XP3 [525 mg]
094
PARADYL (ÁÒ«Òáź) codeine phosphate 8 mg XN3
095
DIETIL RETARD (à·Ã¹à¡ÍÃ�/ÍÂ.) diethylpropion hydrochloride 75 mg P2 [755 mg]
096
ANAX (ÁÔÅÅÔàÁ´) alprazolam 0.25 mg P2 [130 mg]
097
ANZION (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) alprazolam 0.25 mg P2 [132.25 mg]
098
ALNAX (¾Í¹´�à¤ÁÕ¤ÍÅ) alprazolam 0.25 mg P2 [130 mg]
099
ALCELAM (¿ÒÃ�ÁÒÊѹµ� áÅçº) alprazolam 0.25 mg P2 [130 mg]
100
ALPAZAM (ä·Â¹¤Ã¾Ñ²¹Ò) alprazolam 0.25 mg P2
101
ANPRESS (2 àÍçÁ (àÁ´-àÁà¡ÍÃ�)) alprazolam 0.25 mg P2 [131.2 mg]
102
DIZOLAM (á͵ᏵԤ) alprazolam 0.25 mg P2 [130 mg]
103
FARZOLAM (ÊËá¾·Â�àÀÊѪ) alprazolam 0.25 mg P2
104
LORAMET (äÇàÍ·-àÍàÂÔÃ�Ê·�/ÍÂ.) lormetazepam 1 mg P2
lormetazepam 1 mg
105
MANEX (·Õ áÁ¹ ¿ÒÃ�ÁÒ) alprazolam 0.25 mg P2 [130 mg]
106
MARZOLAM (áËÅÁ·Í§¡ÒÃá¾·Â�) alprazolam 0.25 mg P2 [129.75 mg]
107
MOXINAX (âÁà´ÍÃ�¹áÁ¹Ù) alprazolam 0.25 mg P2 [130 mg]
108
PHARNAX (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) alprazolam 0.25 mg P2 [131.65 mg]
109
PRAZOL (हÂÒ¡Ø) alprazolam 0.25 mg P2
110
SIAMPRAXOL (ÊÂÒÁàÀÊѪ) alprazolam 0.25 mg P2 [125 mg]
111
XALAM (¹ÔÇäÅ¿Š¿ÒÃ�ÁÒ) alprazolam 0.25 mg P2
112
XANACINE (àÁ´Ô«Õ¹â»Ã´Ñ¡Ê�) alprazolam 0.25 mg P2 [110 mg]
113
XANAX (ä¿à«ÍÃ�) alprazolam 0.25 mg P2 [128.25 mg]
114
ZOLAM (ÊËá¾·Â�àÀÊѪ) alprazolam 0.25 mg P2 [131.55 mg]
115
ALLAM (àͪ ठ¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) alprazolam 0.25 mg P2 [130 mg]
116
ALPRAMED (àÅÔÈÊÔ§Ë�) alprazolam 0.5 mg P2 [130 mg]
117
INZOLAM (ÍԹᾤ¿ÒÃ�ÁÒ) alprazolam 0.25 mg P2 [132 mg]
118
MITRANAX (â»ÅÔ¿ÒÃ�Á) alprazolam 0.25 mg P2 [130 mg]
119
†Indicates brands that contain more than one ingredientÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
PRODUCT IDENTIFICATION CHART 13 PN DEX 2013
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 13 8/16/2013 3:21:59 PM
SUNAX (Êؾ§É�àÀÊѪ) alprazolam 0.25 mg P2 [130.03 mg]
120
XIEMED (ÂÙâ·à»‚œÂ¹) alprazolam 0.25 mg P2 [130.01 mg]
121
ALPRAZOLAM FRX (âÍÅÔ¤) alprazolam 0.25 mg P2 [130 mg]
122
STILNOX («Ò⹿‚›-ÇÔ¹·ÃÍ»/ÍÂ.) zolpidem hemitartrate 10 mg P2 [126 mg]
123
ZOLPIDEM TARTRATERIVOPHARM (ÃÔâÇ¿ÒÃ�Á/ÍÂ.) zolpidem tartrate 10 mg P2
124
ZOPIM (䵌ËÇѹ äºâÍà·¤/ÍÂ.) zolpidem tartrate 10 mg P2
125
POPAM (¿ÒÃ�ÁÒÊѹµ� áÅçº) diazepam 2 mg XP4
126
CODIGESIC † (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) codeine phosphate 15 mg N3 [550 mg]
127
PARAGEN CO † (âÍʶÍÔ¹àµÍÃ�) codeine phosphate 15 mg XN3 [478.77 mg]
128
CONCERTA (ᨹો¹-«ÕáÅ¡/ÍÂ.) methylphenidate hydrochloride 36 mg P2 [515 mg]
129
REGENON RETARD (à·ÁàÅÍÃ�/ÍÂ.) diethylpropion hydrochloride 75 mg P2 [755 mg]
130
PARDEX (àÀÊѪ¡ÃÃÁÈÃÕ»ÃÐÊÔ·¸Ôì) dextropropoxyphene napsylate 32.5 mg X N3
131
WHITE Capsule
ZEPOXIN (¨ÔǺÃÒà´ÍÃ�Ê) chlordiazepoxide hydrochloride 10 mg XP4 [100 mg]
132
KAPANOL (á¡Åç¡â«ÊÁÔ·ä¤Å�¹/ÍÂ.) morphine sulfate 20 mg N2 [142.8 mg]
133
KAPANOL (á¡Åç¡â«ÊÁÔ·ä¤Å�¹/ÍÂ.) morphine sulfate 50 mg N2 [323.3 mg]
134
KAPANOL (á¡Åç¡â«ÊÁÔ·ä¤Å�¹/ÍÂ.) morphine sulfate 100 mg N2 [620.5 mg]
135
YELLOW Tablet
PHENOBARBITAL ACDHON (áͤ´Í¹) phenobarbital sodium 30 mg XP4
136
LORA-P (¾Õ ¾Õ áźÍÃÒµÍÃÕèÊ�) lorazepam 2 mg XP4 [113.43 mg]
137
ANTA (¿ÒÃ�ÁÒÊѹµ� áÅçº) lorazepam 2 mg P4 [100 mg]
138
BELLOID † (¡Õà´Õ¹ ÃÔªàµÍÃ�) butobarbital 30 mg XP4
139
METHADONE GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ/ÍÂ.) methadone hydrochloride 5 mg N2 [110 mg]
140
ATIVAN (äÇàÍ· (»ÃÐà·Èä·Â)) lorazepam 2 mg XP4
141
LORAPAM (ÊÂÒÁàÀÊѪ) lorazepam 2 mg XP4
142
LORAZENE (àºÍÃ�ÅÔ¹¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) lorazepam 2 mg XP4
143
RAZEPAM (ä·Â¹¤Ã¾Ñ²¹Ò) lorazepam 2 mg XP4
144
TRANOLAN (âÍÅѹ-à¤ÁàÁ´) diazepam 2 mg P4 [150.62 mg]
145
VALAX (ÂÙâ·à»‚œÂ¹) diazepam 5 mg XP4
146
DIAZEPAM VESCO (àÇÊâ¡¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) diazepam 5 mg P4 [109 mg]
147
DOPAM (áÍÅ ºÕ àÍÊ áźºÍàõÍÃÕè) clorazepate dipotassium 5 mg XP4 [153 mg]
148
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
14 PRODUCT IDENTIFICATION CHART PN DEX 2013
†Indicates brands that contain more than one ingredient
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 14 8/13/2013 5:30:59 PM
COZEP (¿ÒÃ�ÁÒÊѹµ� áÅçº) chlordiazepoxide hydrochloride 10 mg P4 [179.55 mg]
149
DIPAM (¹ÔÇäÅ¿Š¿ÒÃ�ÁÒ) diazepam 5 mg XP4
150
PORA (¾Í¹´�à¤ÁÕ¤ÍÅ) lorazepam 1 mg XP4
151
PSEUDOEPHEDRINEBJ BENJAOSOTH (ºÕਠ(àºÞ¨âÍʶ)/ÍÂ.) pseudoephedrine hydrochloride 60 mg P2 [158.22 mg]
152
PSEUDOEPHEDRINEMILANO (ÁÔÅÒâ¹/ÍÂ.) pseudoephedrine hydrochloride 30 mg P2 [110 mg]
153
DIANO (ÁÔÅÒâ¹) diazepam 5 mg P4 [110.2 mg]
154
DIAZEPAM SAMAKEEPHAESAJ (ÊÒÁѤ¤ÕàÀÊѪ) diazepam 5 mg XP4
155
MORPHINE SULFATE GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ/ÍÂ.) morphine sulfate 10 mg N2
morphine sulfate 10 mg
156
PHENYLPROPANOLAMINEPHARMASANT (¿ÒÃ�ÁÒÊѹµ� áÅçº/ÍÂ.) phenylpropanolamine hydrochloride 25 mg P2
157
PSEUDOEPHEDRINEASIAN PHARM (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ/ÍÂ.) pseudoephedrine hydrochloride 30 mg P2 [145 mg]
158
AMA † (á͵ᏵԤ) amobarbital 50 mg P3 [208.7 mg]
159
ZOPAM (¿ÒÃ�ÁÒÊѹµ� áÅçº) diazepam 5 mg P4 [160 mg]
160
ALPRAX (·ÍÃ�àù·�) alprazolam 0.25 mg P2 [189.74 mg]
161
DIAZA (áʧä·Â) diazepam 5 mg XP4 [172 mg]
162
DIAZEPAM GENERAL DRUGS HOUSE (à¹à¹ÍÃ�ÃÒÅ´ÃÑê¡Ê�àÎŒÒÊ�) diazepam 5 mg P4 [160 mg]
163
DIAZEPAM GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ) diazepam 5 mg P4 [182 mg]
164
DIAZEPAM T P DRUG (·Õ ¾Õ ´ÃÑ¡) diazepam 5 mg XP4
165
DIVOPAN (àÍ àÍç¹ àͪ â»Ã´Ñ¤Ê�) diazepam 5 mg P4 [209 mg]
166
DIZEPAM (ÁÒ«Òáź) diazepam 5 mg P4 [170 mg]
167
SIPAM (ÊÂÒÁàÀÊѪ) diazepam 5 mg P4 [164 mg]
168
VALENIUM (हÂÒ¡Ø) diazepam 5 mg XP4
169
VALIUM (âÍÅÔ¤) diazepam 5 mg XP4
170
VOMED («ÕàÁ´ â»Ã´Ñ¡Ê�) diazepam 5 mg XP4
171
ZAM (àÁ´Ô«Õ¹â»Ã´Ñ¡Ê�) diazepam 5 mg P4
172
DIAZ (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) diazepam 5 mg XP4 [180 mg]
173
ROPAM (áÍÅ ºÕ àÍÊ áźºÍàõÍÃÕè) diazepam 5 mg XP4 [170 mg]
174
VORAPAM (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) diazepam 5 mg P4 [183 mg]
175
DIAZEPAM H K PHARM (àͪ ठ¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) diazepam 5 mg P4 [160 mg]
176
DIAZEPAM LERD SINGH (àÅÔÈÊÔ§Ë�) diazepam 5 mg P4 [175 mg]
177
DIAZEPAM POND'S CHEMICAL (¾Í¹´�à¤ÁÕ¤ÍÅ) diazepam 5 mg XP4
178
POVANIL (¿ÒÃ�ÁÒÊѹµ� áÅçº) clonazepam 1 mg P4
179
†Indicates brands that contain more than one ingredientÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
PRODUCT IDENTIFICATION CHART 15 PN DEX 2013
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 15 8/13/2013 5:31:02 PM
DIAZEPAM T MAN (·Õ áÁ¹ ¿ÒÃ�ÁÒ) diazepam 5 mg P4
180
DIMED (¸¹¾Ñ²¹�àÀÊѪ) diazepam 5 mg XP4
181
CO-COF † (ÁÔÅÅÔàÁ´) codeine phosphate 10 mg N3 [294.9 mg]
182
DIAPINE TABLET (á͵ᏵԤ) diazepam 5 mg P4 [280 mg]
183
MILA-TERCON † (ÁÔÅÒâ¹) codeine phosphate 8 mg XN3 [410.05 mg]
184
TRIALAM (ÍÑÅ¿Ò¿ÒÃ�Á/ÍÂ.) triazolam 0.25 mg P2 [100 mg]
185
CONCERTA (ᨹો¹-«ÕáÅ¡/ÍÂ.) methylphenidate hydrochloride 18 mg P2 [268 mg]
186
POPAM (¿ÒÃ�ÁÒÊѹµ� áÅçº) diazepam 5 mg XP4
187
DIZEP (Êؾ§É�àÀÊѪ) diazepam 2 mg P4 [115.05 mg]
188
YELLOW Capsule
POSENE (ÊÂÒÁàÁ´Ôá¤Ã�) clorazepate dipotassium 5 mg XP4 [140 mg]
189
TRANCAP (·Õ ¾Õ ´ÃÑ¡) clorazepate dipotassium 10 mg XP4
190
PREFAMONE (à´¤â«/ÍÂ.) diethylpropion hydrochloride 75 mg P2
191
POZAPAM (¿ÒÃ�ÁÒÊѹµ� áÅçº) prazepam 10 mg P4 [336.5 mg]
192
CREAM Tablet
LOZEPAM (¹ÔÇäÅ¿Š¿ÒÃ�ÁÒ) lorazepam 1 mg XP4
193
MST CONTINUS (ºÒÃ�´/ÍÂ.) morphine sulfate 10 mg N2 [154 mg]
194
ALPRAX (·ÍÃ�àù·�) alprazolam 0.5 mg P2 [189.98 mg]
195
PRENARPIL (ÊËá¾·Â�àÀÊѪ) clonazepam 0.5 mg P4 [147.22 mg]
196
RIVOTRIL (âê) clonazepam 0.5 mg P4 [150 mg]
197
MASAPARA W/ CODEINE † (ÁÒ«Òáź) codeine phosphate 15 mg N3 [500 mg]
[500 mg]
198
ORANGE Tablet
MEILAX (àÁ¨Ô) ethyl lofl azepate 2 mg XP4
199
DILIUM (ˌҧ¢ÒÂÂÒµÃÒà¨ç´´ÒÇ) diazepam 2 mg XP4
200
TRANOLAN (âÍÅѹ-à¤ÁàÁ´) diazepam 5 mg P4 [150.85 mg]
201
COZEP (¿ÒÃ�ÁÒÊѹµ� áÅçº) chlordiazepoxide hydrochloride 25 mg P4 [206.23 mg]
202
PHENOBARBITONENEW LIFE PHARMA (¹ÔÇäÅ¿Š¿ÒÃ�ÁÒ) phenobarbital sodium 60 mg XP4
203
VICTAN («Ò⹿‚›-«Ô¹àµÅÒâº) ethyl lofl azepate 2 mg XP4
204
ZORA (à¹à¹ÍÃ�ÃÒÅ´ÃÑê¡Ê�àÎŒÒÊ�) lorazepam 2 mg P4 [130 mg]
205
MST CONTINUS (ºÒÃ�´/ÍÂ.) morphine sulfate 60 mg N2 [154 mg]
206
PSEUDOEPHEDRINEMEDICINE PRODUCTS (àÁ´Ô«Õ¹â»Ã´Ñ¡Ê�/ÍÂ.) pseudoephedrine hydrochloride 60 mg P2 [144.7 mg]
207
MENOBARB (ÁÔÅÒâ¹) phenobarbital 60 mg XP4 [120 mg]
208
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
16 PRODUCT IDENTIFICATION CHART PN DEX 2013
†Indicates brands that contain more than one ingredient
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 16 8/13/2013 5:31:03 PM
ANCORIL (ÂÙâ·à»‚œÂ¹) clonazepam 0.5 mg P4
209
POVANIL (¿ÒÃ�ÁÒÊѹµ� áÅçº) clonazepam 0.5 mg P4 [150 mg]
210
EPOXIDE (¾Õ ¾Õ áźÍÃÒµÍÃÕèÊ�) chlordiazepoxide hydrochloride 10 mg XP4 [284.17 mg]
211
NEOCOF † (ÁÒ«Òáź) codeine phosphate 10 mg XN3
212
PACOGESIC † (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) codeine phosphate 8 mg XN3 [580 mg]
213
DIZEP (Êؾ§É�àÀÊѪ) diazepam 5 mg P4 [115.05 mg]
214
ORANGE Capsule
DIAZEPION (¨ÔǺÃÒà´ÍÃ�Ê) diazepam 10 mg XP4 [100 mg]
215
RED Tablet
PONDNEBIUM (¾Í¹´�à¤ÁÕ¤ÍÅ) chlordiazepoxide hydrochloride 10 mg XP4 [74.82 mg]
216
EPOXIDE (¾Õ ¾Õ áźÍÃÒµÍÃÕèÊ�) chlordiazepoxide hydrochloride 25 mg XP4 [205.49 mg]
217
BENPINE (á͵ᏵԤ) chlordiazepoxide hydrochloride 25 mg P4 [165.2 mg]
218
AZEPAM (áÁ¤â¤Ã¿ÒÃ�) diazepam 2 mg XP4 [100 mg]
219
CHLORDIXIDE (àÅÔÈÊÔ§Ë�) chlordiazepoxide hydrochloride 10 mg XP4 [237 mg]
220
CLINOPECT † (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) codeine phosphate 10 mg XN3 [217 mg]
221
NEO-COPHEN (¾Í¹´�à¤ÁÕ¤ÍÅ) codeine phosphate 10 mg XN3
222
ZORITUSS (â¡Å´� á͹´� «ÔÅàÇÍÃ�àºÅÅ�) codeine phosphate 10 mg XN3
223
NEOPECT † (ÁÒ«Òáź) codeine phosphate 10 mg N3 [399.73 mg]
224
RED Capsule
CORYNIL † (àÁ´Ô᤻) codeine phosphate 10 mg XN3 [430 mg]
225
ROPECT † (¤ÒÃ�´Ô¹ÑÅ àÎÅ·� ÍÍÊàµÃàÅÕÂ) codeine phosphate 10 mg N3 [558.5 mg]
226
CODEPECT † (àÁ¡ŒÒ äÅ¿Šä«áÍ繫�) codeine phosphate 10 mg N3 [430 mg]
227
ROLAR † (àÁ¡ŒÒ äÅ¿Šä«áÍ繫�) codeine phosphate 10 mg N3 [430 mg]
228
ROTUSS † (¤ÒÃ�´Ô¹ÑÅ àÎÅ·� ÍÍÊàµÃàÅÕÂ) codeine phosphate 10 mg N3 [456.5 mg]
229
ZEPOXIN (¨ÔǺÃÒà´ÍÃ�Ê) chlordiazepoxide hydrochloride 5 mg XP4 [100 mg]
230
PINK Tablet
PAM (·Õ ÇÕ ¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) diazepam 5 mg XP4
231
BELLERGAL † (â¹ÇÒÃ�µÕÊ) phenobarbital sodium 20 mg XP4
phenobarbital sodium 20 mg
232
PHENOBARB (¾Õ ¾Õ áźÍÃÒµÍÃÕèÊ�) phenobarbital sodium 30 mg XP4 [90 mg]
233
PHENOBARBITAL ATLANTIC (á͵ᏵԤ) phenobarbital sodium 16.25 mg XP4 [84.99 mg]
234
ALPRAXOL (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) alprazolam 0.5 mg P2
235
DIAZEPAM T MAN (·Õ áÁ¹ ¿ÒÃ�ÁÒ) diazepam 5 mg P4 [62.46 mg]
236
LORAMED (âÍÅѹ-à¤ÁàÁ´) lorazepam 2 mg P4 [100 mg]
237
ORA (ÁÒ«Òáź) lorazepam 2 mg XP4
238
†Indicates brands that contain more than one ingredientÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
PRODUCT IDENTIFICATION CHART 17 PN DEX 2013
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 17 8/13/2013 5:31:06 PM
VISPAM (ÂÙâ·à»‚œÂ¹) diazepam 5 mg XP4 [70.02 mg]
239
ALPRALAN (âÍÅѹ-à¤ÁàÁ´) alprazolam 0.5 mg P2 [157.28 mg]
240
PORA (¾Í¹´�à¤ÁÕ¤ÍÅ) lorazepam 2 mg XP4
241
DIAZEPAM POND'S CHEMICAL (¾Í¹´�à¤ÁÕ¤ÍÅ) diazepam 5 mg P4 [145.6 mg]
242
DIAZEPAM H K PHARM (àͪ ठ¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) diazepam 2 mg P4 [130 mg]
243
LORA (á͵ᏵԤ) lorazepam 2 mg P4 [200 mg]
244
MORPHINE SALUTAS PHARMA («ÒÅÙ·ÑÊ ¿ÒÃ�ÁÒ/ÍÂ.) morphine sulfate 60 mg N2
245
S.CO ZEPAM (àÍÊ â¤ ¿ÒÃ�ÁÒ) diazepam 5 mg XP4
246
BELLADONNA ALKALOIDS W/ PHENOBARBITAL † (ÊÒÁѤ¤ÕàÀÊѪ) phenobarbital sodium 16.2 mg XP4 [160 mg]
247
CENTRODINE CD † (¿ÒÃ�ÁÒÊѹµ� áÅçº) codeine phosphate 10 mg N3 [205.2 mg]
248
DIAZEPAM BJ BENJAOSOTH (ºÕਠ(àºÞ¨âÍʶ)) diazepam 10 mg XP4 [233 mg]
249
DIZEPAM (ÁÒ«Òáź) diazepam 2 mg P4 [170 mg]
250
KENSPA † (हÂÒ¡Ø) chlordiazepoxide hydrochloride 5 mg P4 [246 mg]
251
TAZCINE (ÍØ´Á¾Ã (¿‚ÎÒáÅçº)) pentazocine 50 mg XP3
252
LORAZIN (ÍԹᾤ¿ÒÃ�ÁÒ) lorazepam 2 mg P4 [200 mg]
253
LEXOTAN (âê) bromazepam 3 mg P4 [200 mg]
254
PHENOCON (ÁÒ«Òáź) phenobarbital sodium 60 mg XP4
255
ANAX (ÁÔÅÅÔàÁ´) alprazolam 0.5 mg P2 [130 mg]
256
ANZION (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) alprazolam 0.5 mg P2 [132.5 mg]
257
ALNAX (¾Í¹´�à¤ÁÕ¤ÍÅ) alprazolam 0.5 mg P2 [130 mg]
258
ALCELAM (¿ÒÃ�ÁÒÊѹµ� áÅçº) alprazolam 0.5 mg P2 [130 mg]
259
ALPAZAM (ä·Â¹¤Ã¾Ñ²¹Ò) alprazolam 0.5 mg P2
260
ALPAZAM (ä·Â¹¤Ã¾Ñ²¹Ò) alprazolam 1 mg P2
261
DIZOLAM (á͵ᏵԤ) alprazolam 0.5 mg P2 [130 mg]
262
FARZOLAM (¿ÒÃ�ÁÕ¹‹Ò) alprazolam 0.5 mg P2
263
MANEX (·Õ áÁ¹ ¿ÒÃ�ÁÒ) alprazolam 0.5 mg P2 [130 mg]
264
MARZOLAM (áËÅÁ·Í§¡ÒÃá¾·Â�) alprazolam 0.5 mg P2 [130 mg]
265
MOXINAX (âÁà´ÍÃ�¹áÁ¹Ù) alprazolam 0.5 mg P2 [130 mg]
266
PHARNAX (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) alprazolam 0.5 mg P2 [131.9 mg]
267
PRAZOL (हÂÒ¡Ø) alprazolam 0.5 mg P2 [216.36 mg]
268
SIAMPRAXOL (ÊÂÒÁàÀÊѪ) alprazolam 0.5 mg P2 [125.75 mg]
269
XALAM (¹ÔÇäÅ¿Š¿ÒÃ�ÁÒ) alprazolam 0.5 mg P2
270
XANACINE (àÁ´Ô«Õ¹â»Ã´Ñ¡Ê�) alprazolam 0.5 mg P2 [110 mg]
271
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
18 PRODUCT IDENTIFICATION CHART PN DEX 2013
†Indicates brands that contain more than one ingredient
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 18 8/13/2013 5:31:07 PM
XANAX (ä¿à«ÍÃ�) alprazolam 0.5 mg P2 [128.56 mg]
272
ZOLAM (ÊËá¾·Â�àÀÊѪ) alprazolam 0.5 mg P2 [133.8 mg]
273
ANPRESS (ÂÙâ·à»‚œÂ¹) alprazolam 0.5 mg P2 [130 mg]
274
ALLAM (àͪ ठ¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) alprazolam 0.5 mg P2 [130 mg]
275
ALPRAMED (àÅÔÈÊÔ§Ë�) alprazolam 0.25 mg P2 [130 mg]
276
INZOLAM (ÍԹᾤ¿ÒÃ�ÁÒ) alprazolam 0.5 mg P2 [132.81 mg]
277
MITRANAX (â»ÅÔ¿ÒÃ�Á) alprazolam 0.5 mg P2 [130 mg]
278
SUNAX (Êؾ§É�àÀÊѪ) alprazolam 0.5 mg P2 [129.95 mg]
279
XIEMED (2 àÍçÁ (àÁ´-àÁà¡ÍÃ�)) alprazolam 0.5 mg P2 [130.25 mg]
280
CODICET PINK † (ºÕ àÍçÅ ÎÑéÇ) codeine phosphate 15 mg N3
281
ALPRAZOLAM FRX (âÍÅÔ¤) alprazolam 0.5 mg P2 [130 mg]
282
TRANSPON FORTE (àÅÔÈÊÔ§Ë�) clorazepate dipotassium 10 mg XP4 [190 mg]
283
PINK Capsule
DIPOSEF (Âٹիѹ) clorazepate dipotassium 10 mg XP4 [140 mg]
284
SANOR (äºâÍáÅ») clorazepate dipotassium 10 mg XP4
285
SERENE MASA LAB (ÁÒ«Òáź) clorazepate dipotassium 10 mg XP4 [173.5 mg]
[173.5 mg]
286
TRANMED (ÊËá¾·Â�àÀÊѪ) clorazepate dipotassium 10 mg XP4 [163.13 mg]
[163.13 mg]
287
ANXENE (ÂÙâ·à»‚œÂ¹) clorazepate dipotassium 10 mg XP4
288
MANOTRAN (áËÅÁ·Í§¡ÒÃá¾·Â�) clorazepate dipotassium 10 mg XP4 [150 mg]
289
CLORAMED (àÁ´Ôä¿Ç�) clorazepate dipotassium 10 mg XP4
290
DEDA (àͪ ठ¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) clorazepate dipotassium 10 mg XP4 [130 mg]
[130 mg]
291
CLORAZE (âÁà´ÍÃ�¹áÁ¹Ù) clorazepate dipotassium 10 mg XP4 [120 mg]
[120 mg]
292
UPTRAN (ÍѾ«Ñ¹) clorazepate dipotassium 10 mg XP4
293
POLIZEP (â»ÅÔ¿ÒÃ�Á) clorazepate dipotassium 10 mg XP4 [234 mg]
294
POLYDINE CD † (¿ÒÃ�ÁÒÊѹµ� áÅçº) codeine phosphate 10 mg XN3
295
TENMED (ÍԹᾤ¿ÒÃ�ÁÒ) clorazepate dipotassium 10 mg XP4 [234 mg]
296
TRANCLOR (ÊÂÒÁàÀÊѪ) clorazepate dipotassium 10 mg XP4
297
TRANXENE («Ò⹿‚›-«Ô¹àµÅÒâº) clorazepate dipotassium 10 mg XP4
298
CEXENE (·Õ àÍçÁ àÍç¹ ÍÔÁᾡ«�) clorazepate dipotassium 10 mg XP4
299
FLULIUM (¿ÒÃ�ÁÒÊѹµ� áÅçº) clorazepate dipotassium 10 mg XP4
300
DAVOL † (ºÕਠ(àºÞ¨âÍʶ)) dextropropoxyphene hydrochloride 32.5 mg XN3 [377.5 mg]
301
†Indicates brands that contain more than one ingredientÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
PRODUCT IDENTIFICATION CHART 19 PN DEX 2013
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 19 8/13/2013 5:31:09 PM
PURPLE Tablet
CALMIPAM (à©ÅÔÁªÑÂàÀÊѪ) diazepam 5 mg XP4
302
PHENOBARBITAL ATLANTIC (á͵ᏵԤ) phenobarbital sodium 100 mg P4 [128.97 mg]
303
MST CONTINUS (ºÒÃ�´/ÍÂ.) morphine sulfate 30 mg N2 [154 mg]
304
ZEPOXIDE (·Õ ¾Õ ´ÃÑ¡) chlordiazepoxide hydrochloride 10 mg P4 [91.2 mg]
305
ANZION (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) alprazolam 1 mg P2 [133.12 mg]
306
ALNAX (¾Í¹´�à¤ÁÕ¤ÍÅ) alprazolam 1 mg P2 [100 mg]
307
ALCELAM (¿ÒÃ�ÁÒÊѹµ� áÅçº) alprazolam 1 mg P2 [130.2 mg]
308
ANPRESS (2 àÍçÁ (àÁ´-àÁà¡ÍÃ�)) alprazolam 1 mg P2 [131.2 mg]
309
FARZOLAM (¿ÒÃ�ÁÕ¹‹Ò) alprazolam 1 mg P2
310
MANEX (·Õ áÁ¹ ¿ÒÃ�ÁÒ) alprazolam 1 mg P2 [130 mg]
311
MARZOLAM (áËÅÁ·Í§¡ÒÃá¾·Â�) alprazolam 1 mg P2 [130 mg]
312
PHARNAX (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) alprazolam 1 mg P2 [132.41 mg]
313
PRAZOL (हÂÒ¡Ø) alprazolam 1 mg P2
314
SIAMPRAXOL (ÊÂÒÁàÀÊѪ) alprazolam 1 mg P2
315
XALAM (¹ÔÇäÅ¿Š¿ÒÃ�ÁÒ) alprazolam 1 mg P2
316
XANACINE (àÁ´Ô«Õ¹â»Ã´Ñ¡Ê�) alprazolam 1 mg P2 [110 mg]
317
XANAX (ä¿à«ÍÃ�) alprazolam 1 mg P2 [129.12 mg]
318
ZOLAM (ÊËá¾·Â�àÀÊѪ) alprazolam 1 mg P2 [136.67 mg]
319
ALLAM (àͪ ठ¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) alprazolam 1 mg P2 [130 mg]
320
INZOLAM (ÍԹᾤ¿ÒÃ�ÁÒ) alprazolam 1 mg P2 [134.39 mg]
321
MITRANAX (â»ÅÔ¿ÒÃ�Á) alprazolam 1 mg P2 [130 mg]
322
XIEMED (ÂÙâ·à»‚œÂ¹) alprazolam 1 mg P2 [130 mg]
323
DIZOLAM (á͵ᏵԤ) alprazolam 1 mg P2 [130 mg]
324
BRONPECT † (हÂÒ¡Ø) codeine phosphate 10 mg XN3 [573.5 mg]
325
AZEPAM (áÁ¤â¤Ã¿ÒÃ�) diazepam 5 mg XP4
326
BLUE Tablet
ANXIRA (ÂÙâ·à»‚œÂ¹) lorazepam 0.5 mg P4 [50 mg]
327
LORAZENE (àºÍÃ�ÅÔ¹¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) lorazepam 0.5 mg XP4
328
LORAVAN (Êؾ§É�àÀÊѪ) lorazepam 0.5 mg P4 [50 mg]
329
ANTA (¿ÒÃ�ÁÒÊѹµ� áÅçº) lorazepam 0.5 mg P4 [49.6 mg]
330
LOZEPAM (¹ÔÇäÅ¿Š¿ÒÃ�ÁÒ) lorazepam 0.5 mg XP4
331
ATIVAN (äÇàÍ· (»ÃÐà·Èä·Â)) lorazepam 0.5 mg XP4
332
LIZAVAN (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) lorazepam 0.5 mg XP4 [50.22 mg]
333
LORAMED (àÁ´Ôä¿Ç�) lorazepam 0.5 mg XP4
334
TRANAVAN (â»ÅÔ¿ÒÃ�Á) lorazepam 0.5 mg P4 [50 mg]
335
LORAPAM (ÊÂÒÁàÀÊѪ) lorazepam 0.5 mg XP4 [43.67 mg]
336
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
20 PRODUCT IDENTIFICATION CHART PN DEX 2013
†Indicates brands that contain more than one ingredient
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 20 8/13/2013 5:31:11 PM
LORAZEP (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) lorazepam 0.5 mg P4 [50 mg]
337
ORA (ÁÒ«Òáź) lorazepam 0.5 mg P4 [50.02 mg]
338
LONZA (àÁ´Ô«Õ¹â»Ã´Ñ¡Ê�) lorazepam 0.5 mg P4 [50 mg]
339
LORAPINE (·Õ àÍçÁ àÍç¹ ÍÔÁᾡ«�) lorazepam 0.5 mg XP4
340
PHENOBARBITALCHEW BROTHERS (¨ÔǺÃÒà´ÍÃ�Ê) phenobarbital sodium 30 mg XP4 [70 mg]
341
RAZEPAM (ä·Â¹¤Ã¾Ñ²¹Ò) lorazepam 0.5 mg XP4
342
VEMED (ÂÙâ·à»‚œÂ¹) lorazepam 0.5 mg XP4
343
LORAZEPAM ACDHON (áͤ´Í¹) lorazepam 0.5 mg XP4 [50 mg]
344
DIAZEPAM GENERALDRUGS HOUSE (à¹à¹ÍÃ�ÃÒÅ´ÃÑê¡Ê�àÎŒÒÊ�) diazepam 2 mg P4 [139.83 mg]
345
DIAZEPAM SOMMAI BHAESAJ (ÊÁËÁÒÂàÀÊѪ) diazepam 5 mg XP4
346
LORA-P (¾Õ ¾Õ áźÍÃÒµÍÃÕèÊ�) lorazepam 0.5 mg XP4 [105.2 mg]
347
HAWKCOPAX (áÍÅ ºÕ àÍÊ áźºÍàõÍÃÕè) lorazepam 0.5 mg P4 [100 mg]
348
VALAX (·Õ àÍçÁ àÍç¹ ÍÔÁᾡ«�) diazepam 10 mg XP4
349
VISPAM (ÂÙâ·à»‚œÂ¹) diazepam 10 mg XP4 [102.26 mg]
350
DIAZEPAM VESCO (àÇÊâ¡¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) diazepam 2 mg P4 [110 mg]
351
LORAZIN (ÍԹᾤ¿ÒÃ�ÁÒ) lorazepam 0.5 mg P4 [103.03 mg]
352
DIAZEPAM T MAN (·Õ áÁ¹ ¿ÒÃ�ÁÒ) diazepam 10 mg XP4
353
DILIUM (ˌҧ¢ÒÂÂÒµÃÒà¨ç´´ÒÇ) diazepam 5 mg XP4
354
DIAPAM (à¡Ãç·àµÍÃ�¿ÒÃ�ÁÒ) diazepam 5 mg P4 [152 mg]
355
ZORA (à¹à¹ÍÃ�ÃÒÅ´ÃÑê¡Ê�àÎŒÒÊ�) lorazepam 0.5 mg P4 [130 mg]
356
DIPAM (¹ÔÇäÅ¿Š¿ÒÃ�ÁÒ) diazepam 10 mg XP4
357
MORPHINE SALUTAS PHARMA («ÒÅÙ·ÑÊ ¿ÒÃ�ÁÒ/ÍÂ.) morphine sulfate 30 mg N2
358
ZOPAM (¿ÒÃ�ÁÒÊѹµ� áÅçº) diazepam 10 mg P4 [180 mg]
359
BLUCON † (ºÕ àÍçÅ ÎÑéÇ) codeine phosphate 10 mg +pseudoephedrine hydrochloride 30 mg XN3 [175.2 mg]
360
DIAZA (áʧä·Â) diazepam 2 mg XP4 [172 mg]
361
DIAZEPAM CHAROEN BHAESAJ (à¨ÃÔÞàÀÊѪ) diazepam 2 mg XP4
362
DIAZEPAM GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ) diazepam 10 mg P4 [182 mg]
363
DIAZEPAM T P DRUG (·Õ ¾Õ ´ÃÑ¡) diazepam 10 mg P4
364
MANODIAZO (áËÅÁ·Í§¡ÒÃá¾·Â�) diazepam 10 mg P4 [160 mg]
365
MED-ZEPAM (àǪºÃÔ¡ÒÃ) diazepam 5 mg XP4
366
PRENARPIL (ÊËá¾·Â�àÀÊѪ) clonazepam 1 mg P4 [147.79 mg]
367
SIPAM (ÊÂÒÁàÀÊѪ) diazepam 10 mg XP4 [160 mg]
368
DIAZ (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) diazepam 10 mg XP4 [180 mg]
369
CLONARIL (ÂÙâ·à»‚œÂ¹) clonazepam 1 mg P4 [150 mg]
370
†Indicates brands that contain more than one ingredientÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
PRODUCT IDENTIFICATION CHART 21 PN DEX 2013
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 21 8/13/2013 5:31:13 PM
DIAZEPAM H K PHARM (àͪ ठ¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) diazepam 10 mg P4 [166.62 mg]
371
XANAX XR (ä¿à«ÍÃ�) alprazolam 0.5 mg P2 [346.11 mg]
372
NEOCOD † (ÁÒ«Òáź) codeine phosphate 10 mg XN3 [497.3 mg]
373
NEO-CODEIN † (¾Í¹´�à¤ÁÕ¤ÍÅ) codeine phosphate 10 mg XN3 [503 mg]
374
PARA-CO (ÊËá¾·Â�àÀÊѪ) codeine phosphate 15 mg N3 [390.09 mg]
375
TRYCAM (´Ñ¡ÅÒÊ/ÍÂ.) triazolam 0.25 mg P2
376
DIADON (áͤ´Í¹) diazepam 5 mg XP4
377
HALCION (¿ÒÃ�ÁÒà«ÕÂ/ÍÂ.) triazolam 0.25 mg P2 [97.41 mg]
378
DORMICUM (âê/ÍÂ.) midazolam 15 mg P2 [208 mg]
379
CODICET BLUE 300 † (àÍçÁ á͹´� àÍçª áÁ¹Ùῤà¨ÍÃÔè§) codeine phosphate 15 mg N3 [365 mg]
380
XANAX XR (ä¿à«ÍÃ�) alprazolam 2 mg P2 [345.69 mg]
381
BLUE Capsule
ZEPAM (âÁà´ÍÃ�¹áÁ¹Ù) diazepam 5 mg XP4
382
BLUCO † (àÍçÁ á͹´� àÍçª áÁ¹Ùῤà¨ÍÃÔè§) codeine phosphate 10 mg +pseudoephedrine hydrochloride 30 mg XN3 [249.7 mg]
383
GREEN Tablet
PHENOBARBITAL ACDHON (áͤ´Í¹) phenobarbital sodium 15 mg XP4
phenobarbital sodium 15 mg
384
LORAZEP (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) lorazepam 2 mg P4 [65 mg]
385
CHLORDIXIDE (àÅÔÈÊÔ§Ë�) chlordiazepoxide hydrochloride 5 mg XP4 [232 mg]
386
CHLORZEP (ºÕàÁ´¿ÒÃ�ÁÒ) chlordiazepoxide hydrochloride 5 mg XP4
chlordiazepoxide hydrochloride 5 mg
387
CALMIPAM (à©ÅÔÁªÑÂàÀÊѪ) diazepam 2 mg XP4
388
ZEDA (Íѧ¡ÄɵÃÒ§Ù (áÍÅ ¾Õ)) lorazepam 1 mg P4 [90 mg]
389
COMOBEN (àÍ àÍç¹ àͪ â»Ã´Ñ¤Ê�) chlordiazepoxide hydrochloride 5 mg P4 [125.82 mg]
390
DIAZEPAM SAMAKEEPHAESAJ (ÊÒÁѤ¤ÕàÀÊѪ) diazepam 2 mg XP4
391
DIAZEPAM T MAN (·Õ áÁ¹ ¿ÒÃ�ÁÒ) diazepam 2 mg P4 [115 mg]
392
HAWKCOPAX (áÍÅ ºÕ àÍÊ áźºÍàõÍÃÕè) lorazepam 1 mg XP4
393
VISPAM (ÂÙâ·à»‚œÂ¹) diazepam 2 mg XP4 [140 mg]
394
DIAZEPAM POND'S CHEMICAL (¾Í¹´�à¤ÁÕ¤ÍÅ) diazepam 2 mg P4 [122 mg]
395
DIAPAM (à¡Ãç·àµÍÃ�¿ÒÃ�ÁÒ) diazepam 2 mg P4 [142 mg]
396
LORA (á͵ᏵԤ) lorazepam 0.5 mg P4 [100 mg]
397
PORA (¾Í¹´�à¤ÁÕ¤ÍÅ) lorazepam 0.5 mg XP4
398
PONDNEBIUM (¾Í¹´�à¤ÁÕ¤ÍÅ) chlordiazepoxide hydrochloride 5 mg XP4 [200 mg]
399
LORAZEPAM MACROPHAR (áÁ¤â¤Ã¿ÒÃ�) lorazepam 1 mg XP4 [120 mg]
400
CHLORDIAZEPOXIDE T MAN (·Õ áÁ¹ ¿ÒÃ�ÁÒ) chlordiazepoxide hydrochloride 10 mg P4 [168.8 mg]
401
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
22 PRODUCT IDENTIFICATION CHART PN DEX 2013
†Indicates brands that contain more than one ingredient
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 22 8/13/2013 5:31:15 PM
DIAZEPAM BJ BENJAOSOTH (ºÕਠ(àºÞ¨âÍʶ)) diazepam 5 mg P4 [190.2 mg]
402
POBRAX † (¿ÒÃ�ÁÒÊѹµ� áÅçº) chlordiazepoxide hydrochloride 5 mg XP4
403
WINOPAM (ÅÔÇÔ¹à¹ÍÃ�¿ÒÃ�ÁÒ) diazepam 5 mg XP4
404
MODURAX † (ÂÙâ·à»‚œÂ¹) chlordiazepoxide hydrochloride 5 mg P4 [250 mg]
chlordiazepoxide hydrochloride 5 mg
405
CEBARAX † (ÁÒ«Òáź) chlordiazepoxide hydrochloride 5 mg P4 [250 mg]
406
CHLORDIBRAX † (ÂÙâ·à»‚œÂ¹) chlordiazepoxide hydrochloride 5 mg XP4
407
CLINOPRONT † (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) codeine phosphate 10 mg N3 [283.31 mg]
408
LIBRAX † (âÍÅÔ¤) chlordiazepoxide 5 mg P4 [299 mg]
chlordiazepoxide 5 mg
409
LICON † (äÅ¿Š ¤Í¹à«Ô¹) chlordiazepoxide hydrochloride 5 mg XP4
410
UTORAX † (ÂÙâ·à»‚œÂ¹) chlordiazepoxide hydrochloride 5 mg XP4
411
ZEPOBRAX † (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) chlordiazepoxide hydrochloride 5 mg XP4
412
DIRAX † (ÊËá¾·Â�àÀÊѪ) chlordiazepoxide 5 mg P4 [200 mg]
413
DIAPINE TABLET (á͵ᏵԤ) diazepam 10 mg P4 [320 mg]
414
TERCO-C † (ºÕ àÍçÅ ÎÑéÇ) codeine phosphate 10 mg N3 [591.1 mg]
415
CODEE-C † (ÊËá¾·Â�àÀÊѪ) codeine phosphate 10 mg N3 [345.02 mg]
416
SECO † (àÀÊѪ¡ÃÃÁÈÃÕ»ÃÐÊÔ·¸Ôì) codeine phosphate 10 mg N3 [331.56 mg]
417
TOCODYL † (·Õ âÍ à¤ÁÕ¤ÍÅÊ�) codeine phosphate 10 mg XN3 [325.82 mg]
418
CODESIA † (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) codeine phosphate 10 mg N3 [350 mg]
419
RADIBRAX † (¿ÒÃ�ÁÒÊѹµ� áÅçº) chlordiazepoxide hydrochloride 5 mg XP4
420
ALPRAMED (àÅÔÈÊÔ§Ë�) alprazolam 1 mg P2 [259 mg]
421
CODENOL † (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) codeine phosphate 15 mg N3
422
ROHYPNOL (âê/ÍÂ.) fl unitrazepam 1 mg P2 [175 mg]
423
PARAMED-CO † (ÊËá¾·Â�àÀÊѪ) codeine phosphate 15 mg XN3 [601.1 mg]
424
VASON (ÁÔÅÅÔàÁ´) diazepam 2 mg P4 [110 mg]
425
CELIUM (ÂÙâ·à»‚œÂ¹) medazepam 5 mg P4 [110 mg]
426
GREEN Capsule
EUHYPNOS 20 (ÍÒÃ� ¾Õ àªÍàÃÍÃ�/ÍÂ.) temazepam 20 mg P2 [868.96 mg]
[868.96 mg]
427
TUMAX † (àÀÊѪ¡ÃÃÁÈÃÕ»ÃÐÊÔ·¸Ôì) chlordiazepoxide hydrochloride 5 mg P4 [180 mg]
428
ZEPAM (âÁà´ÍÃ�¹áÁ¹Ù) diazepam 2 mg XP4
429
POSENE (ÊÂÒÁàÁ´Ôá¤Ã�) clorazepate dipotassium 10 mg XP4
430
†Indicates brands that contain more than one ingredientÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
PRODUCT IDENTIFICATION CHART 23 PN DEX 2013
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 23 8/13/2013 5:31:17 PM
STESOLID (´ÙàÁç¡«�) diazepam 2 mg XP4
431
BROWN Tablet
NEURAMIZONE † (àÀÊѪ¡ÃÃÁÈÃÕ»ÃÐÊÔ·¸Ôì) phenobarbital 20 mg P4 [30.3 mg]
432
BENERA † (·Õ âÍ à¤ÁÕ¤ÍÅÊ�) phenobarbital 20 mg XP4 [135.5 mg]
433
GREY Tablet
KEMORA (âÍÅѹ-à¤ÁàÁ´) lorazepam 0.5 mg P4 [50 mg]
434
BENPINE (á͵ᏵԤ) chlordiazepoxide hydrochloride 5 mg P4 [136.82 mg]
435
PHENOBARBITAL ATLANTIC (á͵ᏵԤ) phenobarbital sodium 32.5 mg P4 [86 mg]
436
ZEPOXIDE (·Õ ¾Õ ´ÃÑ¡) chlordiazepoxide hydrochloride 5 mg XP4
437
MORPHINE SALUTAS PHARMA («ÒÅÙ·ÑÊ ¿ÒÃ�ÁÒ/ÍÂ.) morphine sulfate 10 mg N2
438
CONCERTA (ᨹો¹-«ÕáÅ¡/ÍÂ.) methylphenidate hydrochloride 27 mg P2
439
MULTICOLOURED Tablet
CODICET † (ºÕ àÍçÅ ÎÑéÇ) codeine phosphate 15 mg XN3 [565 mg]
440
MULTICOLOURED Capsule
FREXENE (äÅ¿Š ¤Í¹à«Ô¹) clorazepate dipotassium 5 mg XP4
441
TRANPATE (·Õ áÁ¹ ¿ÒÃ�ÁÒ) clorazepate dipotassium 5 mg XP4 [146 mg]
442
DIZAN (áŪáÁ¹) diazepam 5 mg XP4 [175 mg]
443
DITRAN (ˌҧÂÒä·Â 1942) diazepam 2 mg P4 [163 mg]
444
FREXENE (äÅ¿Š ¤Í¹à«Ô¹) clorazepate dipotassium 10 mg XP4
445
CLOZENE (ÂÙàÁ´ŒÒ) clorazepate dipotassium 5 mg XP4 [165 mg]
446
CONZEP (ÁÒ«Òáź) clorazepate dipotassium 10 mg XP4
447
TRANCON (ÂÙâ·à»‚œÂ¹) clorazepate dipotassium 10 mg XP4 [140 mg]
448
POMADOM (¿ÒÃ�ÁÒÊѹµ� áÅçº) clorazepate dipotassium 10 mg XP4 [140 mg]
449
PANBESY (ÍÍÊâÁ¿ÒÃ�Á/ÍÂ.) phentermine hydrochloride 15 mg P2 [310 mg]
450
PHENTERMINE TRENKER (à·Ã¹à¡ÍÃ�/ÍÂ.) phentermine resinate 30 mg P2 [180 mg]
451
TRANMED (ÊËá¾·Â�àÀÊѪ) clorazepate dipotassium 5 mg P4 [163.1 mg]
452
DIPOSEF (Âٹիѹ) clorazepate dipotassium 5 mg XP4 [140 mg]
453
SANOR (äºâÍáÅ») clorazepate dipotassium 5 mg XP4 [149.55 mg]
[149.55 mg]
454
ANXENE (ÂÙâ·à»‚œÂ¹) clorazepate dipotassium 5 mg XP4
455
CLORAMED (àÁ´Ôä¿Ç�) clorazepate dipotassium 5 mg XP4
456
SERENE V S PHARMA (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) clorazepate dipotassium 5 mg XP4 [163.1 mg]
[163.1 mg]
457
CLORAZE (âÁà´ÍÃ�¹áÁ¹Ù) clorazepate dipotassium 5 mg P4 [120 mg]
458
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
24 PRODUCT IDENTIFICATION CHART PN DEX 2013
†Indicates brands that contain more than one ingredient
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 24 8/13/2013 5:31:18 PM
DIPOT (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) clorazepate dipotassium 5 mg P4 [145 mg]
459
TRANZEP (á¾¹´ÃÑ¡Ê�) clorazepate dipotassium 5 mg XP4
460
MANOTRAN (áËÅÁ·Í§¡ÒÃá¾·Â�) clorazepate dipotassium 5 mg XP4 [150 mg]
461
CLORAXENE (·Õ âÍ à¤ÁÕ¤ÍÅÊ�) clorazepate dipotassium 5 mg P4 [121.8 mg]
462
DEDA (àͪ ठ¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) clorazepate dipotassium 5 mg XP4 [160 mg]
463
TRANCLOR (ÊÂÒÁàÀÊѪ) clorazepate dipotassium 5 mg XP4
464
TRANXENE (ÍÔ¹àµÍÃ�ä·Â) clorazepate dipotassium 5 mg P4 [145 mg]
465
CLOZEPATE (¹ÔÇäÅ¿Š¿ÒÃ�ÁÒ) clorazepate dipotassium 5 mg XP4
466
FLULIUM (¿ÒÃ�ÁÒÊѹµ� áÅçº) clorazepate dipotassium 5 mg P4 [160 mg]
467
POLIZEP (â»ÅÔ¿ÒÃ�Á) clorazepate dipotassium 5 mg P4 [234 mg]
468
TAMYLAB-S (¾Í¹´�à¤ÁÕ¤ÍÅ) clorazepate dipotassium 5 mg XP4 [220 mg]
469
TENMED (ÍԹᾤ¿ÒÃ�ÁÒ) clorazepate dipotassium 5 mg P4 [234 mg]
470
T-FIVE (·Õ àÍÊ ¿ÒÃ�ÁÒ) clorazepate dipotassium 5 mg XP4
471
TRANPON (àÅÔÈÊÔ§Ë�) clorazepate dipotassium 5 mg XP4 [173 mg]
472
CEXENE (·Õ àÍçÁ àÍç¹ ÍÔÁᾡ«�) clorazepate dipotassium 5 mg XP4
473
GAXENE (¡ÒÃ�à´Õé¹ ´ÃÑ¡àÎÒÊ�) clorazepate dipotassium 5 mg XP4
474
TRANADON-S (áͤ´Í¹) clorazepate dipotassium 5 mg XP4 [220 mg]
475
ZETRAN (ÁÒ«Òáź) clorazepate dipotassium 5 mg XP4 [166 mg]
476
PHENTERMINE OSMOPHARM (ÍÍÊâÁ¿ÒÃ�Á/ÍÂ.) phentermine hydrochloride 15 mg P2 [130.01 mg]
477
CLOZENE (ÂÙàÁ´ŒÒ) clorazepate dipotassium 10 mg XP4 [165 mg]
478
A-ZERAX (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) diazepam 2 mg P4 [145 mg]
479
CONZEP (ÁÒ«Òáź) clorazepate dipotassium 5 mg XP4
480
POMADOM (¿ÒÃ�ÁÒÊѹµ� áÅçº) clorazepate dipotassium 5 mg XP4
481
TRANCON (ÂÙâ·à»‚œÂ¹) clorazepate dipotassium 5 mg P4 [140 mg]
482
DIZAN (áŪáÁ¹) diazepam 2 mg XP4 [175 mg]
483
PRASEPINE (âÍÅÔ¤) prazepam 5 mg XP4
484
POZAPAM (¿ÒÃ�ÁÒÊѹµ� áÅçº) prazepam 5 mg P4 [170 mg]
485
†Indicates brands that contain more than one ingredientÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
PRODUCT IDENTIFICATION CHART 25 PN DEX 2013
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 25 8/13/2013 5:31:19 PM
ANXIELAX (áÁ¤â¤Ã¿ÒÃ�) clorazepate dipotassium 5 mg XP4 [248 mg]
486
PANBESY (ÍÍÊâÁ¿ÒÃ�Á/ÍÂ.) phentermine hydrochloride 30 mg P2 [320 mg]
487
ZEPAXID (ÍØ´Á¾Ã (¿‚ÎÒáÅçº)) diazepam 5 mg P4
488
A-ZERAX (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) diazepam 5 mg P4 [145 mg]
489
DOMAR (â»ÅÔ¿ÒÃ�Á) pinazepam 5 mg P4 [101 mg]
490
V DAY ZEPAM (¾Õ ¾Õ áźÍÃÒµÍÃÕèÊ�) diazepam 5 mg XP4 [200 mg]
491
PHENTERMINE TRENKER (à·Ã¹à¡ÍÃ�/ÍÂ.) phentermine resinate 15 mg P2 [160 mg]
492
MINOXIDE (ºÕਠ(àºÞ¨âÍʶ)) chlordiazepoxide hydrochloride 10 mg P4 [149.5 mg]
493
MED-ZEPOXIDE (àǪºÃÔ¡ÒÃ) chlordiazepoxide hydrochloride 5 mg XP4
494
MANODIAZO (áËÅÁ·Í§¡ÒÃá¾·Â�) diazepam 2 mg P4 [165 mg]
495
TRANCAP (·Õ ¾Õ ´ÃÑ¡) clorazepate dipotassium 5 mg XP4 [160 mg]
496
DZP2 (¿ÒÃ�ÁÒÊѹµ� áÅçº) diazepam 2 mg XP4
497
DIAZEPAM ACDHON (áͤ´Í¹) diazepam 2 mg XP4
498
DIAPINE CAPSULE (á͵ᏵԤ) diazepam 2 mg P4 [146 mg]
499
DIAZEPION (¨ÔǺÃÒà´ÍÃ�Ê) diazepam 5 mg XP4 [100 mg]
500
DITRAN (ˌҧÂÒä·Â 1942) diazepam 5 mg XP4 [165 mg]
501
V DAY ZEPAM (¾Õ ¾Õ áźÍÃÒµÍÃÕèÊ�) diazepam 2 mg XP4 [200 mg]
502
CHLORDIAZEPOXIDE MARCH PHARMA (áËÅÁ·Í§¡ÒÃá¾·Â�) chlordiazepoxide hydrochloride 25 mg XP4 [346 mg]
503
REGENON RETARD (à·ÁàÅÍÃ�/ÍÂ.) diethylpropion hydrochloride 75 mg P2 [480 mg]
504
ATRACTIL (à·Ã¹à¡ÍÃ�/ÍÂ.) diethylpropion resinate 75 mg P2 [402.64 mg]
505
DIAPINE CAPSULE (á͵ᏵԤ) diazepam 5 mg P4 [147 mg]
506
STESOLID (äºâÍáÅ») diazepam 5 mg XP4
507
EXAN (Âٹիѹ) clorazepate dipotassium 5 mg XP4
508
UPZENE (ÊËá¾·Â�àÀÊѪ) clorazepate dipotassium 5 mg XP4
509
COMOBEN (àÍ àÍç¹ àͪ â»Ã´Ñ¤Ê�) chlordiazepoxide hydrochloride 10 mg P4 [211.36 mg]
[211.36 mg]
510
EXAN (Âٹիѹ) clorazepate dipotassium 10 mg XP4
511
DALMADORM (âê/ÍÂ.) fl urazepam hydrochloride 15 mg P2
512
STESOLID (äºâÍáÅ») diazepam 10 mg XP4
513
DIAZEPION (¨ÔǺÃÒà´ÍÃ�Ê) diazepam 2 mg XP4 [100 mg]
514
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
26 PRODUCT IDENTIFICATION CHART PN DEX 2013
†Indicates brands that contain more than one ingredient
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 26 8/13/2013 5:31:20 PM
METAXIDE (ÍØ´Á¾Ã (¿‚ÎÒáÅçº)) chlordiazepoxide hydrochloride 10 mg XP4 [120 mg]
515
MIRAPRONT N (áÁç¤/ÍÂ.) cathine 20 mg P2
516
D-NORPSEUDOEPHEDRINE SR OSMOPHARM (ÍÍÊâÁ¿ÒÃ�Á/ÍÂ.) cathine 20 mg P2 [173.28 mg]
517
DIAMED (ÊËá¾·Â�àÀÊѪ) diazepam 5 mg P4 [168.5 mg]
518
MEDAZINE (ÊËá¾·Â�àÀÊѪ) medazepam 10 mg P4 [165 mg]
519
MEDAZINE (ÊËá¾·Â�àÀÊѪ) medazepam 5 mg P4 [165 mg]
520
DUROMINE (´Ñ¡ÅÒÊ/ÍÂ.) phentermine resinate 30 mg P2 [291 mg]
521
CODIPRONT † (ÍÔ¹àµÍÃ�ä·Â) codeine 30 mg XN3 [234 mg]
522
CODIPRONT † (âÍÅÔ¤) codeine 30 mg N3 [298.6 mg]
523
CLINEPECT † (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) codeine phosphate 10 mg + phenylpropanolamine hydrochloride 12.5 mg XN3 [270 mg]
524
MONOZIDE (ä·Â ¾Õ ´Õ à¤ÁÕ¤ÍÅÊ�) diazepam 2 mg XP4
525
BENPINE (á͵ᏵԤ) chlordiazepoxide hydrochloride 10 mg P4 [130 mg]
526
DUROMINE (´Ñ¡ÅÒÊ/ÍÂ.) phentermine resinate 15 mg P2 [291.03 mg]
527
CHLORDIAZEPOXIDE CHAROEN BHAESAJ (à¨ÃÔÞàÀÊѪ) chlordiazepoxide hydrochloride 10 mg XP4
528
CHLORDIAZEPOXIDE ACDHON (áͤ´Í¹) chlordiazepoxide hydrochloride 10 mg XP4
529
MANODIAZO (áËÅÁ·Í§¡ÒÃá¾·Â�) diazepam 5 mg P4 [165 mg]
530
DIAMED (ÊËá¾·Â�àÀÊѪ) diazepam 2 mg P4 [165.53 mg]
531
ZEPAXID (ÍØ´Á¾Ã (¿‚ÎÒáÅçº)) diazepam 2 mg XP4
532
OTHERS
*BENADRYL CD † (âÍÅÔ¤) codeine phosphate 60 mL XN3
533
*BENADRYL CD † (âÍÅÔ¤) codeine phosphate 1000 mL XN3
534
*BENYLIN CD † (âÍÅÔ¤) codeine phosphate 60 mL XN3
535
*BONADINE CD † (¿ÒÃ�ÁÒÊѹµ� áÅçº) codeine phosphate 60 mL XN3
536
*Shown smaller than the actual sizeÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
PRODUCT IDENTIFICATION CHART 27 PN DEX 2013
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 27 8/13/2013 5:31:21 PM
*BROMTUSSIA DC † (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) codeine phosphate 60 mL XN3
537
*BROWN MIXTURE GPO † (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ) camphorated opium tincture 180 mL N3
538
*BROWN MIXTURE GPO † (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ) camphorated opium tincture 450 mL N3
539
*BROWN MIXTURE OSOTH INTERLAB † (âÍʶÍÔ¹àµÍÃ�) camphorated opium tincture 180 mL N3
540
*CAMPHORATED OPIUM TINCTURE GPO † (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ) camphorated opium tincture 1000 mL N3
541
*CODESIA † (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) codeine phosphate 60 mL N3
542
*CODIPRONT SYRUP † (áÁç¤) codeine 60 mL XN3
codeine 60 mL
543
*CODYL COUGH LINCTUS † (ÊËá¾·Â�àÀÊѪ) codeine phosphate 60 mL N3
codeine phosphate 60 mL
544
*CODYL COUGH LINCTUS † (ÊËá¾·Â�àÀÊѪ) codeine phosphate 100 mL N3
545
*CODYL COUGH LINCTUS † (ÊËá¾·Â�àÀÊѪ) codeine phosphate 1000 mL XN3
546
*CODYL COUGH LINCTUS † (ÊËá¾·Â�àÀÊѪ) codeine phosphate 4500 mL XN3
547
*COFCODYL † (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) codeine phosphate 60 mL N3
548
†Indicates brands that contain more than one ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
28 PRODUCT IDENTIFICATION CHART PN DEX 2013
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 28 8/13/2013 5:31:22 PM
*COFCODYL † (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) codeine phosphate 100 mL N3
549
*COMODINE COUGH † (àÍ àÍç¹ àͪ â»Ã´Ñ¤Ê�) codeine phosphate 60 mL XN3
550
*CONADYL † (·Õ âÍ à¤ÁÕ¤ÍÅÊ�) codeine phosphate 60 mL XN3
551
*COSEDYL † (·Õ ¾Õ ´ÃÑ¡) codeine phosphate 60 mL XN3
552
*COUGH SYRUP GPO † (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ) camphorated opium tincture 60 mL XN3
553
*DECOS † (àÀÊѪ¡ÃÃÁÈÃÕ»ÃÐÊÔ·¸Ôì) codeine phosphate 100 mL N3
554
*DIMETANE EXPECTORANT DC † (äÇ·�ÎÍÅÅ�) codeine phosphate, phenylpropanolamine hydrochloride 2.5 L XN3
hydrochloride 2.5 L
555
*ELIXIR PHENOBARB (Êؾ§É�àÀÊѪ) phenobarbital sodium 60 mL XP4
phenobarbital sodium 60 mL
556
*HISEDYL † (âÍʶÍÔ¹àµÍÃ�) codeine phosphate 60 mL XN3
557
*HISEDYL † (âÍʶÍÔ¹àµÍÃ�) codeine phosphate 120 mL XN3
558
*MANTADYL COUGH † (·Õ áÁ¹ ¿ÒÃ�ÁÒ) codeine phosphate 60 mL XN3
559
*MASADYL COUGH † (ÁÒ«Òáź) codeine phosphate 60 mL XN3
560
*Shown smaller than the actual sizeÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
PRODUCT IDENTIFICATION CHART 29 PN DEX 2013
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 29 8/13/2013 5:31:22 PM
*MASADYL COUGH † (ÁÒ«Òáź) codeine phosphate 100 mL XN3
561
*MASADYL COUGH † (ÁÒ«Òáź) codeine phosphate 240 mL XN3
562
*MENOBARB (ÁÔÅÒâ¹) phenobarbital sodium 15 mg/5 mL x 60 mL XP4
563
*MENOBARB (ÁÔÅÒâ¹) phenobarbital sodium 20 mg/5 mL x 60 mL XP4
564
*METHADONE GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ/ÍÂ.) methadone hydrochloride 10 mg/mL x 1000 mL N2
10 mg/mL x 1000 mL
565
*MILA-CONO † (ÁÔÅÒâ¹) codeine phosphate 60 mL XN3
566
*MIST TUSSIS † (ÇÔ·ÂÒÈÃÁ) camphorated opium tincture 450 mL XN3
camphorated opium tincture 450 mL
567
*MIST. SCILL AMMON. GPO † (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ) camphorated opium tincture 180 mL XN3
568
*MIXTURE SCILLAE AMMON † (âÍʶÍÔ¹àµÍÃ�) camphorated opium tincture 180 mL XN3
569
*MIXTURE TUSSIS † (Êؾ§É�àÀÊѪ) camphorated opium tincture 30 mL N3
570
*MIXTURE TUSSIS † (Êؾ§É�àÀÊѪ) camphorated opium tincture 60 mL N3
571
*MIXTURE TUSSIS † (Êؾ§É�àÀÊѪ) camphorated opium tincture 120 mL N3
572
†Indicates brands that contain more than one ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
30 PRODUCT IDENTIFICATION CHART PN DEX 2013
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 30 8/13/2013 5:31:23 PM
*MIXTURE TUSSIS † (Êؾ§É�àÀÊѪ) camphorated opium tincture 240 mL N3
573
*MIXTURE TUSSIS † (Êؾ§É�àÀÊѪ) camphorated opium tincture 450 mL N3
574
*MIXTURE TUSSIS † (Êؾ§É�àÀÊѪ) camphorated opium tincture 1800 mL XN3
575
*MIXTURE TUSSIS † (Êؾ§É�àÀÊѪ) camphorated opium tincture 3600 mL XN3
576
*MORPHINE SULFATE GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ/ÍÂ.) morphine sulfate 10 mg/5 mL N2
577
*NEO COUGH † (ÁÒ«Òáź) codeine phosphate 60 mL XN3
578
*NEO COUGH † (ÁÒ«Òáź) codeine phosphate 100 mL XN3
579
*NEO COUGH † (ÁÒ«Òáź) codeine phosphate 240 mL XN3
5 80
*NORDYL LINCTUS † (âÃÊÁ͹·� ¿ÒÃ�Á«ÙµÔ¤ÍÅ) codeine phosphate 100 mL XN3
581
*NORDYL LINCTUS † (âÃÊÁ͹·� ¿ÒÃ�Á«ÙµÔ¤ÍÅ) codeine phosphate 500 mL XN3
582
*NORTUSS LINCTUS † (âÃÊÁ͹·� ¿ÒÃ�Á«ÙµÔ¤ÍÅ) codeine phosphate 100 mL XN3
583
*NORTUSS LINCTUS † (âÃÊÁ͹·� ¿ÒÃ�Á«ÙµÔ¤ÍÅ) codeine phosphate 500 mL XN3
584
*Shown smaller than the actual sizeÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
PRODUCT IDENTIFICATION CHART 31 PN DEX 2013
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 31 8/13/2013 5:31:24 PM
*OPIUM TINCTURE GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ/ÍÂ.) morphine 1% x 450 mL N2
585
*ORAMORPH (àºÍÃÔ§à¡ÍÃ� ÍÔ¹à¡ÅäÎÁ�/ÍÂ.) morphine sulfate 10 mg/5 mL x 250 mL N2
586
*ORAMORPH (àºÍÃÔ§à¡ÍÃ� ÍÔ¹à¡ÅäÎÁ�/ÍÂ.) morphine sulfate 20 mg/mL x 30 mL N2
587
*P-CODYL † (âÍʶÍÔ¹àµÍÃ�) codeine phosphate 60 mL XN3
588
*P-CODYL † (âÍʶÍÔ¹àµÍÃ�) codeine phosphate 120 mL XN3
589
*PERCIDYL COUGH † (¾Í¹´�à¤ÁÕ¤ÍÅ) codeine phosphate 100 mL XN3
590
*PHENCODIN † (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) codeine phosphate 60 mL XN3
591
*PHENCODIN † (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) codeine phosphate 500 mL XN3
592
*PHENCODIN † (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) codeine phosphate 1000 mL XN3
593
*PHENOBARB ELIXIR (¾Õ ¾Õ áźÍÃÒµÍÃÕèÊ�) phenobarbital sodium 20 mg/5 mL x 60 mL XP4
phenobarbital sodium 20 mg/5 mL x 60 mL
594
*PHENOBARBITAL ELIXIR ACDHON (áͤ´Í¹) phenobarbital sodium 20 mg/5 mL x 30 mL XP4
phenobarbital sodium 20 mg/5 mL x 30 mL
595
*PHENOBARBITAL ELIXIR ACDHON (áͤ´Í¹) phenobarbital sodium 20 mg/5 mL x 60 mL XP4
596
†Indicates brands that contain more than one ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
32 PRODUCT IDENTIFICATION CHART PN DEX 2013
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 32 8/13/2013 5:31:24 PM
*PHENOBARBITAL ELIXIR ACDHON (áͤ´Í¹) phenobarbital sodium 20 mg/5 mL x 120 mL XP4
phenobarbital sodium 20 mg/5 mL x 120 mL
597
*PHENOBARBITAL ELIXIR ACDHON (áͤ´Í¹) phenobarbital sodium 20 mg/5 mL x 240 mL XP4
598
*PHENOBARBITAL ELIXIR ACDHON (áͤ´Í¹) phenobarbital sodium 20 mg/5 mL x 450 mL XP4
phenobarbital sodium 20 mg/5 mL x 450 mL
599
*PHENOBARBITAL ELIXIR ACDHON (áͤ´Í¹) phenobarbital sodium 20 mg/5 mL x 500 mL XP4
600
*PHENOBARBITAL ELIXIR ACDHON (áͤ´Í¹) phenobarbital sodium 20 mg/5 mL x 1000 mL XP4
601
*PHENOCO ELIXIR (·Õ âÍ à¤ÁÕ¤ÍÅÊ�) phenobarbital sodium 20 mg/5 mL x 450 mL XP4
602
*PHENOCO ELIXIR (·Õ âÍ à¤ÁÕ¤ÍÅÊ�) phenobarbital sodium 20 mg/5 mL x 3800 mL XP4
603
*PHENOSIL ELIXIR (ÊÕÅÁ¡ÒÃá¾·Â�) phenobarbital sodium 20 mg/5 mL x 60 mL XP4
604
*PHENOSIL ELIXIR (ÊÕÅÁ¡ÒÃá¾·Â�) phenobarbital sodium 20 mg/5 mL x 450 mL XP4
605
*PHENOTAL ELIXIR (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) phenobarbital sodium 20 mg/5 mL x 60 mL P4
606
*PHENSEDYL OLIC † (âÍÅÔ¤) codeine phosphate 100 mL XN3
607
*PHENSODI † (à¨ÃÔÞàÀÊѪ) codeine phosphate 60 mL XN3
608
*Shown smaller than the actual sizeÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
PRODUCT IDENTIFICATION CHART 33 PN DEX 2013
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 33 8/13/2013 5:31:25 PM
*PHENSODI † (à¨ÃÔÞàÀÊѪ) codeine phosphate 120 mL XN3
codeine phosphate 120 mL
609
*PHENSODI † (à¨ÃÔÞàÀÊѪ) codeine phosphate 1000 mL XN3
610
*POLY-COF † (ÁÔÅÅÔàÁ´) codeine phosphate 60 mL N3
codeine phosphate 60 mL
611
*POLY-COF † (ÁÔÅÅÔàÁ´) codeine phosphate 100 mL N3
612
*PONDNADYL † (¾Í¹´�à¤ÁÕ¤ÍÅ) codeine phosphate 60 mL XN3
613
*PONDNADYL † (¾Í¹´�à¤ÁÕ¤ÍÅ) codeine phosphate 100 mL XN3
614
*PONDNADYL † (¾Í¹´�à¤ÁÕ¤ÍÅ) codeine phosphate 1000 mL XN3
615
*PSEUDOEPHEDRINE ASIAN PHARM (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ/ÍÂ.) pseudoephedrine hydrochloride 30 mg/5 mL x 60 mL P2
30 mg/5 mL x 60 mL
616
*PSEUDOEPHEDRINE BJ BENJAOSOTH (ºÕਠ(àºÞ¨âÍʶ)/ÍÂ.) pseudoephedrine hydrochloride 30 mg/5 mL x 60 mL P2
617
*PSEUDOEPHEDRINE MILANO (ÁÔÅÒâ¹/ÍÂ.) pseudoephedrine hydrochloride 30 mg/5 mL x 60 mL P2
30 mg/5 mL x 60 mL
618
*SQUILL AND AMMONIA VIDHYASOM † (ÇÔ·ÂÒÈÃÁ) camphorated opium tincture 450 mL XN3
camphorated opium tincture 450 mL
619
*TENADRIN-C † (ºÕ àÍçÅ ÎÑéÇ) codeine phosphate 60 mL XN3
620
†Indicates brands that contain more than one ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
34 PRODUCT IDENTIFICATION CHART PN DEX 2013
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 34 8/13/2013 5:31:26 PM
*TERADENE † (ºÕ àÍçÅ ÎÑéÇ) codeine phosphate, pseudoephedrine hydrochloride 60 mL XN3
621
*TERADYL † (àÍçÁ á͹ � àÍçª áÁ¹Ùῤà¨ÍÃÔè§) codeine phosphate 60 mL XN3
622
*TERADYL † (àÍçÁ á͹ � àÍçª áÁ¹Ùῤà¨ÍÃÔè§) codeine phosphate 1000 mL XN3
623
*TUSSIDYL † (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) codeine phosphate 60 mL XN3
624
*DIAPINE (á͵ᏵԤ) diazepam 5 mg/mL x 1 mL P4
625
*DIAPINE (á͵ᏵԤ) diazepam 10 mg/2 mL x 2 mL P4
626
*DIAZA (áʧä·Â) diazepam 10 mg/2 mL x 2 mL XP4
627
*DIAZEPAM GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ) diazepam 10 mg/2 mL x 2 mL XP4
628
*DIAZEPAM T P DRUG (·Õ ¾Õ ´ÃÑ¡) diazepam 10 mg/2 mL x 2 mL P4
diazepam 10 mg/2 mL x 2 mL
629
*DORMICUM («Ô¹ÔÊÕ/ÍÂ.) midazolam 5 mg/mL x 1 mL P2
midazolam 5 mg/mL x 1 mL
630
*DORMICUM (âê/ÍÂ.) midazolam 15 mg/3 mL x 3 mL P2
631
*EPHEDRINE GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ/ÍÂ.) ephedrine hydrochloride 30 mg/mL x 1 mL P2
632
*Shown smaller than the actual sizeÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
PRODUCT IDENTIFICATION CHART 35 PN DEX 2013
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 35 8/13/2013 5:31:26 PM
*FENTANYL ANTIGEN (á͹µÔਹ/ÍÂ.) fentanyl 0.05 mg/mL x 2 mL N2
fentanyl 0.05 mg/mL x 2 mL
633
*FENTANYL ANTIGEN (á͹µÔਹ/ÍÂ.) fentanyl 0.05 mg/mL x 10 mL N2
fentanyl 0.05 mg/mL x 10 mL
634
*FENTANYL JANSSEN-CILAG (ᨹો¹-«ÕáÅ¡/ÍÂ.) fentanyl citrate 0.05 mg/mL x 2 mL N2
fentanyl citrate 0.05 mg/mL x 2 mL
635
*FENTANYL JANSSEN-CILAG (ᨹો¹-«ÕáÅ¡/ÍÂ.) fentanyl citrate 0.05 mg/mL x 10 mL N2
636
*FENTANYL SANDOZ (᫹´ÍÊ á¤¹Ò´Ò/ÍÂ.) fentanyl citrate 0.05 mg/mL x 2 mL N2
637
*FENTANYL-HAMELN (ÎÒàÁŹ/ÍÂ.) fentanyl citrate 50 mcg/mL x 2 mL N2
638
*FENTANYL-HAMELN (ÎÒàÁŹ/ÍÂ.) fentanyl citrate 50 mcg/mL x 10 mL N2
639
*FENTANYL-SNS (àÍÊàÍç¹àÍÊ/ÍÂ.) fentanyl citrate 50 mcg/mL x 2 mL N2
640
*FORTWIN (áùáºç¡«Õè) pentazocine lactate 30 mg/mL x 1 mL XP3
641
*LAYLIUM-10 (ÂÙàÁ´ŒÒ) diazepam 10 mg/2 mL x 2 mL XP4
642
*MANOLIUM (áËÅÁ·Í§¡ÒÃá¾·Â�) diazepam 10 mg/2 mL x 2 mL P4
643
*MIDAZ (ÍÔ¹·ÑÊ¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ/ÍÂ.) midazolam 5 mg/mL x 1 mL P2
644
†Indicates brands that contain more than one ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
36 PRODUCT IDENTIFICATION CHART PN DEX 2013
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 36 8/13/2013 5:31:27 PM
*MIDAZ (ÍÔ¹·ÑÊ¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ/ÍÂ.) midazolam 5 mg/mL x 3 mL P2
645
*MIDAZOLAM HEXAL (¨Õ¹ÒàΡ«ÒÅ/ÍÂ.) midazolam 5 mg/mL x 1 mL P2
midazolam 5 mg/mL x 1 mL
646
*MIDAZOLAM HEXAL (¨Õ¹ÒàΡ«ÒÅ/ÍÂ.) midazolam 5 mg/mL x 3 mL P2
midazolam 5 mg/mL x 3 mL
647
*MONOZIDE-10 (ä·Â ¾Õ ´Õ à¤ÁÕ¤ÍÅÊ�) diazepam 10 mg/2 mL x 2 mL XP4
648
*MORPHINE SULFATE INJ BLUE (àÍçÁ á͹´� àÍçª áÁ¹Ùῤà¨ÍÃÔè§/ÍÂ.) morphine sulfate 10 mg/mL x 1 mL N2
649
*MORPHINE SULFATE INJ PURPLE (àÍçÁ á͹´� àÍçª áÁ¹Ùῤà¨ÍÃÔè§/ÍÂ.) morphine sulfate 10 mg/mL x 1 mL N2
650
*MORPHINE T P DRUG (·Õ ¾Õ ´ÃÑ¡/ÍÂ.) morphine sulfate 10 mg/mL x 1 mL N2
651
*MORPHINE T P DRUG (·Õ ¾Õ ´ÃÑ¡/ÍÂ.) morphine sulfate 10 mg/mL x 1 mL N2
652
*MORPHINE T P DRUG (·Õ ¾Õ ´ÃÑ¡/ÍÂ.) morphine sulfate 10 mg/mL x 1 mL N2
653
*PANGON (áÍÅ ºÕ àÍÊ áźºÍàõÍÃÕè) pentazocine lactate 30 mg/mL x 1 mL P3
654
*PENTAZOCINE ALL PLANTS (ÍÍÅá¾ÅŒ¹·�Ê) pentazocine 30 mg/mL x 1 mL XP3
655
*PETHIDINE BIOLAB (äºâÍáÅ»/ÍÂ.) pethidine hydrochloride 100 mg/2 mL x 2 mL N2
656
*Shown smaller than the actual sizeÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
PRODUCT IDENTIFICATION CHART 37 PN DEX 2013
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 37 8/13/2013 5:31:28 PM
*PETHIDINE HAMELN (ÎÒàÁŹ/ÍÂ.) pethidine hydrochloride 50 mg/mL N2
657
*PETHIDINE M & H MANUFACTURING (àÍçÁ á͹´� àÍçª áÁ¹Ùῤà¨ÍÃÔè§/ÍÂ.) pethidine hydrochloride 50 mg/mL x 1 mL N2
658
*PETHIDINE M & H MANUFACTURING (àÍçÁ á͹´� àÍçª áÁ¹Ùῤà¨ÍÃÔè§/ÍÂ.) pethidine hydrochloride 100 mg/2 mL x 2 mL N2
pethidine hydrochloride 100 mg/2 mL x 2 mL
659
*PETHIDINE T P DRUG (·Õ ¾Õ ´ÃÑ¡/ÍÂ.) pethidine hydrochloride 50 mg/mL x 1 mL N2
pethidine hydrochloride 50 mg/mL x 1 mL
660
*RIVOTRIL (âê) clonazepam 1 mg/mL x 1 mL XP4
661
*ROPAM (áÍÅ ºÕ àÍÊ áźºÍàõÍÃÕè) diazepam 10 mg/2 mL x 2 mL P4
662
*SIPAM (ÊÂÒÁàÀÊѪ) diazepam 10 mg/2 mL x 2 mL P4
663
*SOSEGON («Ò⹿‚›-«Ô¹àµÅÒâº) pentazocine lactate 30 mg/mL x 1 mL XP3
664
*TAZCINE (ÍØ´Á¾Ã (¿‚ÎÒáÅçº)) pentazocine 30 mg/mL x 1 mL XP3
665
*TEMGESIC (àá¤Ô··� ູ¤Õà«ÍÃ�/ÍÂ.) buprenorphine hydrochloride 0.3 mg/mL x 1 mL P2
0.3 mg/mL x 1 mL
666
*TRANOLAN (âÍÅѹ-à¤ÁàÁ´) diazepam 10 mg/2 mL x 2 mL P4
diazepam 10 mg/2 mL x 2 mL
667
*V DAY ZEPAM (¾Õ ¾Õ áźÍÃÒµÍÃÕèÊ�) diazepam 10 mg/2 mL x 2 mL XP4
668
†Indicates brands that contain more than one ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
38 PRODUCT IDENTIFICATION CHART PN DEX 2013
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 38 8/13/2013 5:31:28 PM
*V DAY ZEPAM NL (¾Õ ¾Õ áźÍÃÒµÍÃÕèÊ�) diazepam 10 mg/2 mL x 2 mL XP4
669
*VALIUM (âê) diazepam 10 mg/2 mL x 2 mL XP4
diazepam 10 mg/2 mL x 2 mL
670
*VESCOPAM (àÇÊâ¡¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) diazepam 10 mg/2 mL x 2 mL P4
671
*ZEPAM (âÁà´ÍÃ�¹áÁ¹Ù) diazepam 10 mg/2 mL x 2 mL XP4
672
*ZEPAXID (ÍØ´Á¾Ã (¿‚ÎÒáÅçº)) diazepam 10 mg/2 mL x 2 mL XP4
673
*AMYTAL (ÍÕäÅ ÅÔÅÅÕè) amobarbital 0.5 g XP3
674
*CALYPSOL (¡Õà´Õ¹ ÃÔªàµÍÃ�/ÍÂ.) ketamine hydrochloride 50 mg/mL x 10 mL P2
675
*FENTANYL SANDOZ (᫹´ÍÊ á¤¹Ò´Ò/ÍÂ.) fentanyl citrate 500 mcg/10 mL N2
676
*GARDENAL («Ò⹿‚›-ÍàǹµÕÊ) phenobarbital sodium 200 mg/4 mL P4
phenobarbital sodium 200 mg/4 mL
677
*KETA-HAMELN (ÎÒàÁŹ/ÍÂ.) ketamine hydrochloride 50 mg/mL x 10 mL P2
678
*KETALAR (¾ÒÃ�¤à´ÇÔÊ/ÍÂ.) ketamine hydrochloride 50 mg/mL x 10 mL P2
679
*NEMBUTAL («ÕÇÒ á͹ÔÁÍÅ àÎÅ·�) pentobarbital sodium 54.7 mg/mL x 100 mL P3
680
*Shown smaller than the actual sizeÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
PRODUCT IDENTIFICATION CHART 39 PN DEX 2013
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 39 8/13/2013 5:31:28 PM
*DUROGESIC PATCH (ᨹો¹ ¿ÒÃ�ÁÒ/ÍÂ.) fentanyl 12 mcg/hr N2
681
*DUROGESIC PATCH (ᨹો¹ ¿ÒÃ�ÁÒ/ÍÂ.) fentanyl 25 mcg/hr N2
682
*DUROGESIC PATCH (ᨹો¹ ¿ÒÃ�ÁÒ/ÍÂ.) fentanyl 50 mcg/hr N2
683
*DUROGESIC PATCH (ᨹો¹ ¿ÒÃ�ÁÒ/ÍÂ.) fentanyl 100 mcg/hr N2
684
*FENTADUR (ÅÒÇÔ¿ÒÃ�Á/ÍÂ.) fentanyl 25 mcg/hr N2
685
*FENTANYL GPO (àΡ«ÒÅ àͨÕ/ÍÂ.) fentanyl 12 mcg/hr N2
686
*FENTANYL GPO (àΡ«ÒÅ àͨÕ/ÍÂ.) fentanyl 25 mcg/hr N2
687
*FENTANYL GPO (àΡ«ÒÅ àͨÕ/ÍÂ.) fentanyl 50 mcg/hr N2
688
*FENTANYL HEXAL (àΡ«ÒÅ àͨÕ/ÍÂ.) fentanyl 12 mcg/hr N2
689
*FENTANYL HEXAL (àΡ«ÒÅ àͨÕ/ÍÂ.) fentanyl 25 mcg/hr N2
690
*FENTANYL HEXAL (àΡ«ÒÅ àͨÕ/ÍÂ.) fentanyl 50 mcg/hr N2
691
†Indicates brands that contain more than one ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
40 PRODUCT IDENTIFICATION CHART PN DEX 2013
TH PNDEX PIC CHART 2013 - FINAL - July31.indd 40 8/13/2013 5:31:29 PM
ตารางบนทกขอหาและบทกำาหนดโทษ ทมา : บนทก ป.ป.ส. 2556 สำานกงาน ป.ป.ส. กระทรวงยตธรรม
ขอหา ยาเสพตดใหโทษประเภท 1
ผลตนำาเขาสงออก(ม.15, 65)
•จำ�คกตลอดชวตและปรบ1ล�น-5ล�นบ�ท•ถ�กระทำ�เพอจำ�หน�ยประห�รชวตถ�ปรม�ณตอไปนขนไปใหถอว�ผลตนำ�เข�สงออกครอบครองเพอจำ�หน�ยแอลเอสดส�รบรสทธ0.75มลลกรมหรอ15หนวยก�รใชหรอนำ�หนกสทธ300มลลกรม(หนวยก�รใช=เมด,ซอง,ขวดหรอหนวยอย�งอนททำ�ขนโดยปกตสำ�หรบก�รใชเสพหนงครง)ยาบาส�รบรสทธ375มลลกรมหรอ15หนวยก�รใชหรอนำ�หนกสทธ1.5กรมยาเสพตดใหโทษประเภท 1 อนๆส�รบรสทธ3กรม•ถ�เปนก�รผลตโดยก�รแบงบรรจหรอรวมบรรจจำ�คก4-15ปหรอปรบ80,000-300,000บ�ทหรอทงจำ�ทงปรบถ�กระทำ�เพอจำ�หน�ยจำ�คก4ป-ตลอดชวตและปรบ400,000-5ล�นบ�ท
จำาหนายครอบครองเพอจำ�หน�ย(ม.15, 66)
•จำ�คก4-15ปหรอปรบ80,000-300,000บ�ทหรอทงจำ�ทงปรบ•ถ�มส�รบรสทธปรม�ณตอไปนแอลเอสด0.75มลลกรม-20กรมหรอย�บ�375มลลกรม-20กรมหรอย�เสพตดใหโทษประเภท1อนๆ3-20กรมจำ�คก40ป-ตลอดชวตและปรบ400,000-5ล�นบ�ท•ถ�มส�รบรสทธเกน20กรมจำ�คกตลอดชวตและปรบ1ล�นบ�ท-5ล�นบ�ทหรอประห�รชวต
ครอบครอง(ม.15, 67)
•จำ�คก1-10ปหรอปรบ20,000-200,000บ�ทหรอทงจำ�ทงปรบ
เสพ(ม.57, 91)
•จำ�คก6เดอน-3ปหรอปรบ10,000-60,000บ�ทหรอทงจำ�ทงปรบ
หลอกลวง หรอขมขนใจใหผอนเสพ(ม.93)
•จำ�คก1-10ปและปรบ100,000-1,000,000บ�ท•ถ�กระทำ�โดยมอ�วธหรอรวมกระทำ�ตงแต2คนขนไปจำ�คก2-15ปและปรบ200,000-1,500,000บ�ท•ถ�กระทำ�ตอหญงหรอบคคลซงยงไมบรรลนตภ�วะหรอเพอจงใจใหผอนกระทำ�ผดท�งอ�ญ�หรอเพอประโยชนในก�รกระทำ�ผดท�งอ�ญ�จำ�คก3ป–ตลอดชวตและปรบ300,000-5,000,000บ�ทถ�เปนเฮโรอนตองระว�งโทษเปนสองเท�และถ�กระทำ�ตอหญงหรอตอบคคลซงยงไมบรรลนตภ�วะประห�รชวต
ขอหา ยาเสพตดใหโทษประเภท 2
ผลตนำาเขาสงออก(ม.16, 68)
•จำ�คก1-10ปและปรบ100,000-1ล�นบ�ท•ถ�เปนมอรฟนฝนหรอโคค�อนจำ�คก20ป-ตลอดชวตและปรบ2ล�น-5ล�นบ�ท
จำาหนายครอบครองเพอจำาหนาย(ม.17, 69)
•จำ�คก1-10ปหรอปรบ20,000บ�ท-200,000บ�ทหรอทงจำ�ทงปรบ•ถ�เปนมอรฟนฝนหรอโคค�อนปรม�ณส�รบรสทธไมถง100กรมจำ�คก3-20ปหรอปรบ60,000-400,000บ�ทหรอทงจำ�ทงปรบถ�มส�รบรสทธ100กรมขนไปจำ�คก5ป-ตลอดชวตและปรบ500,000-5ล�นบ�ท
ครอบครอง(ม.17, 69)
•จำ�คกไมเกน5ปหรอปรบไมเกน100,000บ�ทหรอทงจำ�ทงปรบ
เสพ(ม.58, 91)
•จำ�คก6เดอน-3ปหรอปรบ10,000-60,000บ�ทหรอทงจำ�ทงปรบเวนแตเปนก�รเสพเพอรกษ�โรคต�มคำ�สงของแพทยทไดรบใบอนญ�ต
หลอกลวง หรอขมขนใจใหผอนเสพ(ม.93)
•จำ�คก1-10ปและปรบ100,000-1,000,000บ�ท•ถ�กระทำ�โดยมอ�วธหรอรวมกระทำ�ตงแต2คนขนไปจำ�คก2-15ปและปรบ200,000-1,500,000บ�ท•ถ�กระทำ�ตอหญงหรอตอบคคลซงยงไมบรรลนตภ�วะหรอเพอจงใจใหผอนกระทำ�ผดท�งอ�ญ�หรอเพอประโยชนในก�รกระทำ�ผดท�งอ�ญ�จำ�คก3ป-ตลอดชวตและปรบ300,000–5,000,000บ�ทถ�เปนมอรฟนหรอโคค�อนตองระว�งโทษเพมขนอกกงหนงและถ�กระทำ�ตอหญงหรอตอบคคลซงยงไมบรรลนตภ�วะจำ�คกตลอดชวตและปรบ1,000,000–5,000,000บ�ท
Thai Narcotics Act B.E. 2522 (1979)พระร�ชบญญตย�เสพตดใหโทษพ.ศ.2522
PINK PAGES 2013-FINAL-July31.indd 41 8/15/2013 3:09:49 PM
ขอหา ยาเสพตดใหโทษประเภท 3
ผลตนำาเขา(ม.20, 70)
•จำ�คก1-3ปและปรบ100,000-300,000บ�ท
สงออกจำาหนายครอบครองเพอจำาหนาย(ม.20, 71)
•จำ�คกไมเกน1ปหรอปรบไมเกน20,000บ�ทหรอทงจำ�ทงปรบ•ถ�เกนจำ�นวนต�มประก�ศกระทรวงส�ธ�รณสขจำ�คกไมเกน2ปและปรบไมเกน200,000บ�ท(ประก�ศกระทรวงส�ธ�รณสขฉบบท181พ.ศ.2545กำ�หนดว�ย�เสพตดใหโทษประเภท3ตำ�รบทมโคเดอนเปนสวนผสมเกนจำ�นวน250มลลลตรหรอ30เมดหรอ30แคปซล)
ครอบครองเสพ
•ไมมคว�มผดเพร�ะเปนตำ�รบย�
ขอหา ยาเสพตดใหโทษประเภท 4
ผลตนำาเขาสงออกจำาหนายครอบครองเพอจำาหนาย(ม.26, 73)
•จำ�คก1-10ปและปรบ20,000-200,000บ�ท•ถ�นำ�หนก10กโลกรมขนไปจำ�คก1-15ปและปรบ100,000-1,500,000บ�ท
ครอบครอง(ม.26, 74)
•จำ�คกไมเกน5ปหรอปรบไมเกน100,000บ�ทหรอทงจำ�ทงปรบ
ขอหา ยาเสพตดใหโทษประเภท 5
ผลตนำาเขาสงออก(ม.26, 75)
•จำ�คก2-15ปและปรบ200,000-1,500,000บ�ท•ถ�เปนพชกระทอมจำ�คกไมเกน2ปและปรบไมเกน200,000บ�ท
จำาหนายครอบครองเพอจำาหนาย(ม.26,76/1)
•จำ�คก2-10ปหรอปรบ40,000-200,000บ�ทหรอทงจำ�ทงปรบ•ถ�นำ�หนก10กโลกรมขนไปจำ�คก2-15ปและปรบ200,000-1,500,000บ�ท•ถ�เปนพชกระทอมจำ�คกไมเกน2ปหรอปรบไมเกน40,000บ�ทหรอทงจำ�ทงปรบถ�นำ�หนก10กโลกรมขนไปจำ�คกไมเกน2ปและปรบไมเกน200,000บ�ท
ครอบครอง(ม.26,76)
•จำ�คกไมเกน5ปหรอปรบไมเกน100,000บ�ทหรอทงจำ�ทงปรบ•ถ�เปนพชกระทอมจำ�คกไมเกน1ปหรอปรบไมเกน20,000บ�ทหรอทงจำ�ทงปรบ
เสพ(ม.57,92)
•จำ�คกไมเกน1ปหรอปรบไมเกน20,000บ�ทหรอทงจำ�ทงปรบ•ถ�เปนพชกระทอมจำ�คกไมเกน1เดอนหรอปรบไมเกน2,000บ�ท
หลอกลวง หรอขมขนใจใหผอนเสพ(ม.93)
•จำ�คก1-10ปและปรบ100,000-1,000,000บ�ท•ถ�กระทำ�โดยมอ�วธหรอรวมกระทำ�ตงแต2คนขนไปจำ�คก2-15ปและปรบ200,000-1,500,000บ�ท•ถ�กระทำ�ตอหญงหรอตอบคคลซงยงไมบรรลนตภ�วะหรอเพอจงใจใหผอนกระทำ�ผดท�งอ�ญ�หรอเพอประโยชนในก�รกระทำ�ผดท�งอ�ญ�จำ�คก3ป-ตลอดชวตและปรบ300,000-5,000,000บ�ท
42 PN DEX 2013
PINK PAGES 2013-FINAL-July31.indd 42 8/15/2013 3:09:50 PM
ตารางบนทกขอหาและบทกำาหนดโทษ ทมา : บนทก ป.ป.ส. 2556 สำานกงาน ป.ป.ส. กระทรวงยตธรรม
ขอหา ประเภท 1 (P1) ประเภท2(P2) ประเภท 3 (P3) ประเภท 4 (P4)
ผลตนำ�เข�สงออกข�ย
•จำ�คก5-20ปและปรบตงแต100,000-400,000บ�ท(ม.13,13ทว,89)
•จำ�คกไมเกน5ปและปรบไมเกน100,000บ�ท(ม.16,90)
นำ�ผ�น •จำ�คกไมเกน5ปและปรบไมเกน100,000บ�ท(ม.16,90)
ครอบครองใชประโยชน •จำ�คก1-5ปและปรบ20,000-100,000บ�ท(ม.62,106)•ถ�ปรม�ณเกนทกำ�หนดในประก�ศกระทรวงส�ธ�รณสข(ปจจบนคอฉบบพ.ศ.2555)จำ�คก5-20ปและปรบ100,000-400,000บ�ท(ม.62,106ทว)
•จำ�คกไมเกน1ปหรอปรบไมเกน20,000บ�ทหรอทงจำ�ทงปรบ(ม.62,106)
เสพ •จำ�คก1-5ปและปรบ20,000-100,000บ�ท(ม.62ทว,106ตร)
•จำ�คก1-5ปและปรบ20,000-100,000บ�ทเวนแตเสพต�มคำ�สงแพทย(ม.62ตร,106ตร)
•ไมมคว�มผด
จงใจชกนำ�ยยงสงเสรมใชอบ�ยหลอกลวงขเขญใหผอนเสพ
•จำ�คก2-10ปและปรบ40,000-200,000บ�ท(ม.62จตว�,106จตว�)•ถ�กระทำ�ตอหญงหรอบคคลไมบรรลนตภ�วะหรอเพอจงใจใหผอนกระทำ�คว�มผดท�งอ�ญ�หรอเพอประโยชนแกตนเองหรอผอนในก�รกระทำ�คว�มผดอ�ญ�จำ�คก3ป-ตลอดชวตและปรบ60,000-500,000บ�ท(ม.62จตว�,106จตว�)
Thai Psychotropic Substances Act B.E. 2518 (1975)พระร�ชบญญตวตถทออกฤทธตอจตและประส�ทพ.ศ.2518
PINK PAGES 2013-FINAL-July31.indd 43 8/16/2013 3:28:00 PM
ส�ระสำ�คญในก�รควบคมต�มกฎหม�ยวตถออกฤทธในประเภท 1 (P1)ห�มมใหผใดผลตข�ยนำ�เข�หรอสงออกซงวตถออกฤทธในประเภท1ยกเวนกระทรวงส�ธ�รณสขหรอผซงไดรบมอบหม�ยจ�กกระทรวงส�ธ�รณสข
วตถออกฤทธในประเภท 2 (P2)ห�มมใหผใดผลตข�ยนำ�เข�หรอสงออกซงวตถออกฤทธในประเภท2ยกเวนกระทรวงส�ธ�รณสขหรอผซงไดรบมอบหม�ยจ�กกระทรวงส�ธ�รณสขทงนไมใชบงคบกบผประกอบวช�ชพเวชกรรมหรอผประกอบโรคศลปะแผนปจจบนชนหนงส�ข�ทนตกรรมทข�ยใหแกคนไขของตนหรอผประกอบก�รบำ�บดโรคสตวชนหนงทข�ยเฉพ�ะสำ�หรบใชกบสตวทตนบำ�บดหรอปองกนโรคหรอข�ยโดยกระทรวงทบวงกรมสภ�ก�ช�ดไทย
วตถออกฤทธในประเภท 3 และ 4 (P3, P4)ห�มมใหผใดผลตข�ยนำ�เข�หรอสงออกซงวตถออกฤทธในประเภท3หรอ4หรอนำ�ผ�นวตถออกฤทธทกประเภทเวนแตไดรบอนญ�ตทงนไมใชบงคบกบผประกอบวช�ชพเวชกรรมหรอผประกอบโรคศลปะแผนปจจบนชนหนงส�ข�ทนตกรรมทข�ยใหแกคนไขของตนหรอผประกอบก�รบำ�บดโรคสตวชนหนงทข�ยเฉพ�ะสำ�หรบใชกบสตวทตนบำ�บดหรอปองกนโรคและไมใชบงคบในก�รผลตข�ยนำ�เข�หรอสงออกโดยกระทรวงทบวงกรมสภ�ก�ช�ดไทยองคก�รเภสชกรรม
ยาเสพตดใหโทษในประเภท 1 (N1)ห�มมใหผใดผลตนำ�เข�สงออกจำ�หน�ยหรอมไวในครอบครองซงย�เสพตดใหโทษในประเภท1เวนแตรฐมนตรไดอนญ�ตเฉพ�ะในกรณจำ�เปนเพอประโยชนของท�งร�ชก�ร
ยาเสพตดใหโทษในประเภท 2 (N2)ห�มมใหผใดผลตนำ�เข�หรอสงออกย�เสพตดใหโทษในประเภท2เวนแตไดรบอนญ�ตในกรณจำ�เปนเพอประโยชนของท�งร�ชก�รในกรณจำ�หน�ยหรอมไวในครอบครองตองไดรบอนญ�ต
ยาเสพตดใหโทษในประเภท 3 (N3)ห�มมใหผใดผลตนำ�เข�สงออกจำ�หน�ยหรอมไวในครอบครองเพอจำ�หน�ยซงย�เสพตดใหโทษในประเภท3เวนแตไดรบอนญ�ตทงนไมใชบงคบกบผประกอบวช�ชพเวชกรรมหรอผประกอบโรคศลปะแผนปจจบนชนหนงส�ข�ทนตกรรมจำ�หน�ย/ครอบครองใหแกคนไขของตนหรอผประกอบก�รบำ�บดโรคสตวชนหนงจำ�หน�ย/ครอบครองสำ�หรบใชกบสตวทตนบำ�บด
ยาเสพตดใหโทษในประเภท 4 และ 5 (N4 & N5)ห�มมใหผใดผลตจำ�หน�ยนำ�เข�สงออกหรอมไวในครอบครองซงย�เสพตดใหโทษในประเภท4หรอในประเภท5เวนแตรฐมนตรจะไดอนญ�ตโดยคว�มเหนชอบของคณะกรรมก�รควบคมย�เสพตดใหโทษเปนร�ยๆไป
1. ชอส�มญของวตถออกฤทธในประเทศไทย (ชอทเปนตวหน�หม�ยถงเปนวตถออกฤทธทยงคงมตำ�รบย�ในประเทศไทยถงเดอนพฤษภ�คม2556)
วตถออกฤทธในประเภท 1 (P1)
วตถออกฤทธในประเภท 2 (P2)
วตถออกฤทธในประเภท 3 (P3)
วตถออกฤทธในประเภท 4 (P4)
Cathinone Alprazolam Pemoline Amobarbital Allobarbital MedazepamDET Amfepramone
(Diethylpropion)Phencyclidine Butalbital Barbital Mefenorex
DMHP Phendimetrazine Cyclobarbital Benzphetamine MethyphenobarbitalDMT Amineptine Phenmetrazine Glutethimide Bromazepam MethyprylonEtryptamine Aminorex Phentermine Meprobamate Butobarbital Nordazepam
(Nordiazepam)GHB Brotizolam Phenylpropanolamine Pentazocine CamazepamMethcathinone Buprenorphine Pipradrol Pentobarbital Chloral hydrate and
its adductsOxazepam
Mescaline Butorphanol Pseudoephedrine OxazolamMescaline derivatives Cathine (D-Norpseu-
doephedrine)Quazepam Chlodiazepoxide Perlapine
Mescaline analog e.g. Escaline
Secobarbital Chlophentermine PhenobarbitalEphedrine Temazepam Clobazam Pinazepam
Isoproscaline Estazolam Triazolam Clonazepam PrazepamProscaline Fencamfamin Zalepron Clorazepate Propylhexedrine4-Thiomescaline or 4-TM Fenethylline Zipeprol Clortermine Pyrovalerone4-Thioescaline or 4-TE Flunitrazepam Zopiclone Clotiazepam Secbutabarbital4-Thiooproscaline or 4-TP Flurazepam Zolpidem Cloxazolam SPA (Lefetamine)3- Thiomescaline or 3-TM Haloxazolam Diazepam Tetrazepam3-Thioescaline or 3-TE Ketamine Delorazepam Tofisopam3-Thiometaescaline or 3-TME Loprazolam Ethchlorvynol Vinylbital4-Methylaminorex Lormetazepam EthinamateParahexyl Mazindol Ethyl loflazepatePCE Methylphenidate FenproporexPHP(PCPY) Mesocarb FludiazepamPsilocine Midazolam HalazepamPsilocybine N-Ethylamphetamine Inorganic bromideTCP Nimetazepam KetazolamTetrahydrocannabinol Nitrazepam Lorazepam
CLASSIFICATION OF PSYCHOTROPICS & NARCOTICSประเภทของวตถออกฤทธและย�เสพตดใหโทษในประเทศไทย
PINK PAGES 2013-FINAL-July31.indd 44 8/15/2013 3:09:51 PM
2. ชอส�มญของย�เสพตดในประเทศไทย (ชอทเปนตวหน�หม�ยถงเปนย�เสพตดทยงคงมตำ�รบย�ในประเทศไทยถงเดอนพฤษภ�คม2556)
ยาเสพตดใหโทษในประเภท 1 (N1)
ยาเสพตดใหโทษในประเภท 2 (N2)
Acetorphine MMDA Acetyldihydrocodeine Dipipanone NoracymethadolAcetyl-alpha-Methylfentanyl 3-Methylfentanyl Acetylmethadol Drotebanol NorcodeineAlpha-Methylfentanyl 3-Methylthiofentanyl Alfentanil Ecgonine NorlevorphanolAlpha-Methylthiofentanyl Methylone Allylprodine Ethylmethylthiambutene NormethadoneAmphetamine MMDA Alphacetylmethadol Ethylmorphine NormorphineBeta-Hydroxy-3-methylfentanyl MPPP Alphameprodine Etonitazene NorpipanoneBeta-Hydroxyfentanyl N - ethyl MDA or MDE Alphamethadol Etoxeridine OpiumBZP (Benzylpiperazine) N - hydroxy MDA or
N-OH MDAAlphaprodine Fentanyl Oripavine
2CB Anileridine Furethidine Oxycodone2CD MDA Benzethidine Hydrocodone OxymorphoneDesomorphine Para-Fluorofentanyl Benzylmorphine Hydromorphinol PethidineDexamphetamine PEPAP Betacetylmethadol Hydromorphone Pethidine-Intermediate-ADihydroetophine PMA Betameprodine Hydroxypethidine Pethidine-Intermediate-BDMA (Dimehoxyamphetamine) STP or DOM Betamethadol Isomethadone Pethidine-Intermediate-CDimethylamphetamine TFMPP Betaprodine Levomethorphan PhenadoxoneDOB Thiofentanyl Bezitramide Levomoramide PhenampromideDOET TMA Clonitazene Levophenacylmorphan PhenazocineEtorphine Coca bush Levorphanol PhenomorphanHeroin Cocaine Medicinal Opium PhenoperidineKetobemidone Codeine Metazocine PholcodineLevamphetamine Codoxime Methadone PiminodineLevomethamphetamine Concentrate of Poppy Straw Methadone lntermediate PiritramideLSD Dextromoramide Methyldesorphine ProheptazineMDA Diampromide Methyldihydromorphine ProperidineMDMA Diethylthiambutene Metopon PropiramMecloqualone Difenoxin Moramide-Intermediate RacemethorphanMephedrone Dihydrocodeine Morphine RacemoramideMethamphetamine Dihydromorphine Morphine Methobromide RacemorphanMethaqualone Dimenoxadol Morphine N-Oxide RemifentanilMethylenedioxypyrovalerone
(MDPV)Dimepheptanol Morpheridine SufentanilDimethylthiambutene Myrophine Thebacon
3-Methylfentanyl Dioxaphetylbutyrate Nicocodine Thebaine3-Methylthiofentanyl Diphenoxylate Nicodicodine TilidineMethylone Nicomorphine Trimepridine
ยาเสพตดใหโทษในประเภท 3 (N3)
ยาเสพตดใหโทษในประเภท 4 (N4)
ยาเสพตดใหโทษในประเภท 5 (N5)
ตำ�รบทมย�เสพตดใหโทษประเภท2อยดวย Acetic Anhydride Ergosterol CannabisCamphorated opium tincture Acetyl Chloride Ergotamine Mitragyna speciosaCodeine (antitussive/analgesic) Alpha – Ergocryptine Ergotaminine Papaver somiferumDextropropoxyphene Alpha – Ergocryptinine Ergothioneine Psilocybe cubensisDiphenoxylate Anthranilic Acid Ethylidine Diacetate
Beta – Ergocryptine IsosafroleBeta – Ergocryptinine Lysergic AcidChlorpseudoephedrine LysergamideElymoclavine 3,4-Methylenedioxyphenyl-2-
propanononeErgocornineErgocristine N-acetylanthranilic AcidErgocristinine 1-Phenyl-2-propanoneErgometrine Phenylacetic AcidErgometrinine PiperonalErgosine SafroleErgosinine
45 PN DEX 2013
PINK PAGES 2013-FINAL-July31.indd 45 8/15/2013 3:09:52 PM
บญช ก ร�ยก�รย�ม�ตรฐ�นทใชในก�รปองกนและแกไขปญห�สขภ�พทพบบอยมหลกฐ�นชดเจนทสนบสนนก�รใชมประสบก�รณก�รใชในประเทศไทยอย�งพอเพยงและเปนย�ทควรไดรบก�รเลอกใชเปนอนดบแรกต�มขอบงใชของย�นน
บญช ข ร�ยก�รย�ทใชสำ�หรบขอบงใชหรอโรคบ�งชนดทใชย�ในบญชกไมไดหรอไมไดผลหรอใชเปนย�แทนย�ในบญชกต�มคว�มจำ�เปน
บญช ค ร�ยก�รย�ทตองใชในโรคเฉพ�ะท�งโดยผชำ�น�ญหรอผทไดรบมอบหม�ยจ�กผอำ�นวยก�รของสถ�นพย�บ�ลนนๆโดยมม�ตรก�รกำ�กบก�รใชซงสถ�นพย�บ�ลทใชจะตองมคว�มพรอมตงแตก�รวนจฉยจนถงก�รตดต�มผลก�รรกษ�เนองจ�กย�กลมนเปนย�ทถ�ใชไมถกตองอ�จเกดพษหรอเปนอนตร�ยตอผปวยหรอเปนส�เหตใหเกดเชอดอย�ไดง�ยหรอเปนย�ทมแนวโนมในก�รใชไมตรงต�มขอบงชหรอไมคมค�หรอมก�รนำ�ไปใชในท�งทผดหรอมหลกฐ�นสนบสนนก�รใชทจำ�กดหรอมประสบก�รณก�รใชในประเทศไทยอย�งจำ�กดหรอมร�ค�แพงกว�ย�อนในกลมเดยวกน
บญช ง ร�ยก�รย�ทมหล�ยขอบงใชแตมคว�มเหม�ะสมทจะใชเพยงบ�งขอบงใชหรอมแนวโนมจะมก�รสงใชย�ไมถกตองหรอเปนร�ยก�รย�ทมร�ค�แพงจงเปนกลมย�ทมคว�มจำ�เปนตองมก�รระบขอบงใชและเงอนไขก�รสงใชย�ก�รใชบญชย�หลกแหงช�ตไปอ�งองในก�รเบกจ�ยควรนำ�ขอบงใชและเงอนไขก�รสงใชไปประกอบในก�รพจ�รณ�อนมตก�รเบกจ�ยจงจะกอประโยชนสงสดทงนย�ในบญชงจำ�เปนตองใชสำ�หรบผปวยบ�งร�ยแตอ�จทำ�ใหเกดอนตร�ยตอผปวยหรอกอปญห�เชอดอย�ทร�ยแรงก�รสงใชย�ซงตองใหสมเหตผลเกดคว�มคมค�สมประโยชนจะตองอ�ศยก�รตรวจวนจฉยและพจ�รณ�โดยผชำ�น�ญเฉพ�ะโรคทไดรบก�รฝกอบรมในส�ข�วช�ทเกยวของจ�กสถ�นฝกอบรมหรอไดรบวฒบตรหรอหนงสออนมตจ�กแพทยสภ�หรอทนตแพทยสภ�เท�นนและโรงพย�บ�ลจะตองมระบบก�รกำ�กบประเมนและตรวจสอบก�รใชย�(DrugUtilizationEvaluation,DUE)โดยตองมก�รเกบขอมลก�รใชย�เหล�นนเพอตรวจสอบในอน�คตได
บญช จ(1) ร�ยก�รย�สำ�หรบโครงก�รพเศษของกระทรวงทบวงกรมหรอหนวยง�นของรฐทมก�รกำ�หนดวธก�รใชและก�รตดต�มประเมนก�รใชย�ต�มโครงก�รโดยมหนวยง�นนนรบผดชอบและมก�รร�ยง�นผลก�รดำ�เนนง�นตอคณะอนกรรมก�รพฒน�บญชย�หลกแหงช�ตเปนระยะต�มคว�มเหม�ะสมเพอพจ�รณ�จดเข�ประเภทของบญชยอยอนในบญชย�หลกตอไปเมอมขอมลเพยงพอ
บญช จ(2) ร�ยก�รย�สำ�หรบผปวยทมคว�มจำ�เปนเฉพ�ะใหเข�ถงย�ไดอย�งสมเหตผลและคมค�ซงมก�รจดกลไกกล�งเปนพเศษในกำ�กบก�รใชย�ภ�ยใตคว�มรบผดชอบรวมกนของระบบประกนสขภ�พซงดแลโดยกรมบญชกล�งกระทรวงก�รคลงสำ�นกง�นประกนสงคมกระทรวงแรงง�นสำ�นกง�นหลกประกนสขภ�พแหงช�ตและหนวยง�นอนๆทเกยวของโดยมแนวท�งกำ�กบก�รใชย�ต�มภ�คผนวก3
“ร�ยก�รย�สำ�หรบผปวยทมคว�มจำ�เปนเฉพ�ะ”ต�มบญชจ(2)หม�ยคว�มว�ย�ทจำ�เปนตองใชสำ�หรบผปวยเฉพ�ะร�ยโดยย�มคว�มเหม�ะสมทจะใชเพยงบ�งขอบงใชหรอมแนวโนมจะมก�รสงใชย�ไมถกตองหรอเปนย�ทตองอ�ศยคว�มรคว�มชำ�น�ญเฉพ�ะโรคหรอใชเทคโนโลยขนสงและเปนย�ทมร�ค�แพงม�กหรอสงผลอย�งม�กตอคว�มส�ม�รถในก�รจ�ยทงของสงคมและผปวยจงตองมระบบกำ�กบและอนมตก�รสงใชย�(authorizedsystem)ทเหม�ะสมโดยหนวยง�นสทธประโยชนหรอหนวยง�นกล�งทไดรบมอบหม�ยทงนเพอใหเปนไปต�มขอบงใชและเงอนไขก�รสงใชย�จงจะกอประโยชนสงสดโรงพย�บ�ลจะตองมระบบก�รกำ�กบประเมนและตรวจสอบก�รใชย�และมเกบขอมลก�รใชย�เหล�นนเพอใหตรวจสอบโดยกลไกกล�งในอน�คตได
NATIONAL LIST OF ESSENTIAL MEDICINES (NLEM)วตถออกฤทธและย�เสพตดใหโทษในบญชย�หลกแหงช�ต
บญชย�หลกแหงช�ต พ.ศ.2555 มจดประสงคเพอสร�งเสรมระบบก�รใชย�อย�งสมเหตผล
ย�ทอยในบญชย�หลกแหงช�ตนจะแสดงร�ยก�รย�โดยใชชอส�มญของย�ทงในรปเบสเกลอหรอเอสเทอรของย�โดยจะระบคณสมบตเฉพ�ะต�งๆไดแกรปแบบผลตภณฑคว�มแรงขน�ดบรรจ(บ�งร�ยก�ร)ย�ทมคณสมบตครบต�มขอกำ�หนดดงกล�วเท�นนจงจดเปนย�ในบญชย�หลกแหงช�ตทงนสำ�หรบย�ทมเงอนไขหรอมหม�ยเหตจะตองใชต�มเงอนไขและหม�ยเหตทแสดงไวในร�ยละเอยดของย�แตละชนดกอนเสมอ
ก�รจดแบงกลมย�เปนสวนหนงในก�รสงเสรมใหย�ในบญชย�หลกแหงช�ตใชอย�งเหม�ะสมและคมค�โดยมหลกก�รแบงต�มระดบคว�มรคว�มส�ม�รถและคว�มเชยวช�ญของแพทยและผประกอบวช�ชพด�นสขภ�พทจะใชย�แบงเปน5บญชยอยคอบญชก.ข.ค.ง.และจ.โดยแบงยอยอกเปนจ(1)และจ(2)
ย�แตละชนดจะส�ม�รถจดอยในบญชยอยไดม�กกว�1บญชโดยขนกบขอบงชรปแบบและร�ยละเอยดต�งๆทกำ�หนดไว
PINK PAGES 2013-FINAL-July31.indd 46 8/15/2013 3:09:52 PM
ชอส�มญ(Generic Name)
กลม รปแบบ(Form, Strength)
บญช ลำ�ดบและชอกลมของย�ในบญชย�หลกแหงช�ต
เงอนไข
Alprazolam P2 tab ง 4.1. Hypnotics and anxiolytics
ใหตดต�มก�รสงใช
Buprenorphine hydrochloride
P2 sublingual tab, sterile sol
ค 4.7.1. Opioid analgesics
Chloral hydrate P4 oral sol (hosp) ก 4.1. Hypnotics and anxiolytics
Chlordiazepoxide P4 cap, tab ก 4.1. Hypnotics and anxiolytics
Clonazepam P4 tab ข 4.1. Hypnotics and anxiolytics
4.8.1. Drugs used in the control of epilepsy
4.9. Drugs used in movement disorders
Codeine phosphate N2 tab ค 4.7.1. Opioid analgesics
Diazepam P4 cap, tab
cap, tab, sterile sol
sterile sol
ก
ก
ก
4.9. Drugs used in movement disorders
15.1.4. Sedative and analgesic peri-operative drugs
4.1. Hypnotics and anxiolytics
16. Antidotes
4.8.2. Drugs used in status epilepticus
ใชบำ�บดอ�ก�รชกทเกดจ�กย�หรอส�รพษ
Dipotassium clorazepate
P4 cap, tab ข 4.1. Hypnotics and anxiolytics
Ephedrine hydrochloride
P2 nasal drop (hosp) (เฉพ�ะ 0.5-3%) sterile sol
ก
ค
12.2.2. Topical nasal decongestants
2.7.2. Vasoconstrictor sympathomimetics
Fentanyl N2 sterile sol (as citrate), transdermal therapeutic system (as base)
ค 4.7.1. Opioid analgesics ใชกบผปวยโรคมะเรงทมคว�มเจบปวดรนแรง
Fentanyl citrate N2 sterile sol ค 15.1.4. Sedative and analgesic peri-operative drugs
วตถออกฤทธและย�เสพตดใหโทษ ในบญชย�หลกแหงช�ต พ.ศ.2555 (ฉบบท 2)จ�กประก�ศคณะกรรมก�รพฒน�ระบบย�แหงช�ตในร�ชกจจ�นเบกษ�วนท23มกร�คม2556http://www.nlem.in.th/sites/default/files/ratchakitcha_2-55.pdf
47 PN DEX 2013
PINK PAGES 2013-FINAL-July31.indd 47 8/15/2013 3:09:52 PM
ชอส�มญ(Generic Name)
กลม รปแบบ(Form, Strength)
บญช ลำ�ดบและชอกลมของย�ในบญชย�หลกแหงช�ต
เงอนไข
Ketaminehydrochloride
P2 sterile sol ง 15.1.1. Intravenous anaesthetics
1.ใชฉดเข�กล�มเนอกบผปวยทห�เสนเลอดสำ�หรบใหนำ�เกลอไมไดและใชในกรณทผปวยมคว�มดนเลอดตำ�
2.ใชในก�รระงบคว�มรสกสำ�หรบก�รทำ�หตถก�รทใชระยะเวล�สนๆ
3.ใชเปนย�เสรม(adjuncttherapy)เพอระงบอ�ก�รปวดรนแรง(intractablepain)
Lorazepam P4 tab ก 4.1. Hypnotics and anxiolytics
Methadone hydrochloride
N2 oral sol
tab, oral sol
ง
ค
4.10.3. Drugs used in opioid dependence
4.7.1. Opioid analgesics
ใชสำ�หรบผปวยตดเฮโรอน
Methylphenidate P2 tab (เฉพ�ะ10 mg) ค 4.4. Central nervous system stimulants
ใชสำ�หรบAttentionDeficitHyperactivityDisorder(ADHD)
Midazolam hydrochloride
P2 sterile sol ง 15.1.4. Sedative and analgesic peri-operative drugs
4.8.2. Drugs used in status epilepticus
เงอนไข:ใชเสรมย�ระงบคว�มรสกทวตวและใชรกษ�ผปวยทมอ�ก�รกระวนกระว�ยหรอชกหลงใหย�ระงบคว�มรสก
ใชสำ�หรบrefractorystatusepilepticus
Midazolam maleate
P2 tab ง 15.1.4. Sedative and analgesic peri-operative drugs
ใชเตรยมผปวยกอนใหย�ระงบคว�มรสก(premedication)เท�นนโดยเบกไดวนละไมเกน2เมดตอผปวยหนงร�ย
Morphine sulfate N2 cap, tab, SR cap, SR tab, oral sol, sterile sol
sterile sol
ค
ค
4.7.1. Opioid analgesics
15.1.4. Sedative and analgesic peri-operative drugs
Pethidine hydrochloride
N2 sterile sol ค 15.1.4. Sedative and analgesic peri-operative drugs
4.7.1. Opioid analgesics
Phenobarbital sodium P4 sterile pwdr, sterile sol ก
ง
4.8.2. Drugs used in status epilepticus
16. Antidotes ใชบำ�บดอ�ก�รชกทเกดจ�กย�
Pseudoephedrine hydrochloride
P2 tab, syr ก 3.7. Systemic nasal decongestants
48 PN DEX 2013
PINK PAGES 2013-FINAL-July31.indd 48 8/15/2013 3:09:53 PM
ÄRegistration expired
IMPORTANT DRUG NOTESขอมลสำ�คญของตวย�วตถออกฤทธและย�เสพตดใหโทษ
Provides Useful Information On Significant Contraindications, Precautions, Adverse Reactions And Interactions Of Drugs, Presented According To The Psychotropic & Narcotic Drugs List Of Thailand Note: I: Indications; CI: Contraindications; SP: Precautions; AR: Adverse Reactions; DI: Drug Interactions.
P2 - Psychotropic Substance Schedule 2
• Alprazolam •
ลดอ�ก�รวตกกงวลและอ�ก�รตนตระหนก
I: Management of anxiety and panic attacks.
CI: Acute narrow-angle glaucoma, pre-existing CNS depression or coma, resp depression, acute pulmonary insufficiency or sleep apnoea; severe hepatic impairment; pregnancy, lactation.
SP: Dosage reduction or gradual withdrawal. Dependence. Geriatric or debilitated patients. Muscle weakness, impaired hepatic or renal func-tion; arteriosclerosis; obesity; depression particu-larly suicidal tendency; chronic pulmonary insuf-ficiency. May impair ability to drive or operate machinery. Children <18 yr.
AR: Psychological & physical dependence, with-drawal syndrome; drowsiness, sedation, vertigo, headache, visual disturbances, photosensitivity, GI disturbances, jaundice; fatigue, muscle weakness, ataxia, seizures, delirium, dizziness, confusion & depression. Blood dyscrasias. Mania & hypomania.
DI: Potentiates action of alcohol & CNS depressants. Reduced conc w/ cigarette smoking by 50%. Cimeti-dine & fluoxetine reduce the clearance of alprazolam. Alprazolam enhances activity of imipramine & desip-ramine. Decreased metabolism w/ CYP3A4 inhibitors.
• Amfepramone • (diethylpropion)
ลดคว�มอย�กอ�ห�รในก�รรกษ�ผทมนำ�หนกเกนกว�ปกต
I: Obesity.
CI: Advanced arteriosclerosis. Hyperthyroid-ism. Hypersensitivity. Glaucoma. Agitated states. History of drug abuse. Pulmonary HTN or severe hypertension. Heart murmur or valvular disorders. Emotional instability. History of psychiatric illness. Concomitant use w/ other anorectic agents. MAOI
therapy or w/in 2 wk of discontinuation. Pregnancy & lactation. Childn & elderly.
SP: Increased risk of developing primary pulmonary HTN (PPH). HTN & severe CV disease. Prolonged use may induce dependence w/ withdrawal symp-toms on cessation of therapy; do not use for more than 3 months. May increase convulsions in some epileptic patients. Toxic psychosis. Peptic ulceration. Prostatic hyperplasia. Diabetes mellitus. May impair ability to perform hazardous activities w/c requires mental alertness or physical coordination.
AR: CV & CNS disturbances; GI effects; allergic reactions; impotence; changes in libido, gyneco-mastia, menstrual upset; hematopoietic effects; dyspnea, hair loss, muscle pain, dysuria, increased sweating, polyuria.
DI: Hypertensive risk w/ MAOIs. b-blockers, guanethidine, TCAs, urinary alkalinisers or acidifiers, sibutramine. Alters antidiabetic drug requirements.
• ÄBuprenorphine •
บรรเท�ปวดระดบป�นกล�งถงปวดรนแรงสำ�หรบใชในก�รผ�ตด
I: As a perioperative analgesic supplement. Moder-ate to severe pain. Premedication before anaesthe-sia. Management of opiate dependence. Reversal of fentanyl-induced anesthesia.
CI: Acute alcoholism; convulsive disorders; head injuries; increased intracranial pressure; comatose patients; resp depression & obstructive airway disease; patients on established opioid agonists.
SP: Hepatic or renal disease; pregnancy, lactation; hypothyroidism; adrenocortical insufficiency; asthma; prostatic hyperplasia; shock; hypotension; inflam-matory or obstructive bowel disorders; myasthae-nia gravis; infants/neonates. Reduce dose in elderly & debilitated patients. May precipitate withdrawal symptoms in narcotic addicts. Pulmonary impair-ment. Patients w/ delirium tremens, toxic psycho-ses, kyphoscoliosis, prostatic hypertrophy, urethral stricture, increased intracranial pressure, seizure disorder, dysfunction of biliary tract, hypokalemia. May impair ability to perform hazardous activities w/c requires mental alertness or physical coordination.
PINK PAGES 2013-FINAL-July31.indd 49 8/15/2013 3:09:53 PM
ÄRegistration expired
50 IMPORTANT DRUG NOTES PN DEX 2013AR: Sedation, nausea, dizziness, vertigo, hypoten-sion, miosis, headache, hypoventilation, resp or CNS depression; tachycardia, bradycardia, urinary reten-tion, coma, vomiting, drowsiness, sweating, confu-sion, dry mouth, diaphoresis, withdrawal syndrome.
DI: Plasma-buprenorphine concentrations may be affected when co-administered w/ drugs that induce or inhibit cytochrome P450 isoenzyme CYP3A4. Enhanced depressant effects w/ other CNS depressants e.g. alcohol, anaesthetics, anxi-olytics, hypnotics, opiate agonists, TCAs & anti-psychotics. Diazepam may produce resp & cardiac collapse. Increased risk of QT interval prolongation w/ anti-arrhythmic agents.
• ÄCathine • (d-norpseudoephedrine)
ลดคว�มอย�กอ�ห�รในก�รรกษ�ผทมนำ�หนกเกนกว�ปกตI: Obesity.
CI: Patients treated w/ MAOI or stopped MAOI w/in the last 2 wk; moderate or severe hyper-tension; pulmonary hypertension; structural cardiac abnormalities or advanced arteriosclerosis; adrenal tumour; hyperthyroidism or hyperexcitabil-ity; coronary thrombosis; closed-angle glaucoma; pregnancy.
SP: Heart disease, mild hypertension, CHF or angina of effort; prostate hyperplasia; patients w/ history of drug or alcohol abuse; DM; psychotic patients; renal disease. Growth retardation may occur in children.
AR: Headache, tachycardia, precordial pain, giddi-ness, restlessness or insomnia; dry mouth & thirst, nausea, vomiting, sweating; difficulty in micturi-tion; muscular weakness & tremors; tolerance &/or dependence may occur.
DI: Reduced effect of guanethidine. Increased risk of arrhythmia in patients treated w/ digitalis due to its sympathomimetic effects. Increased risk of arrhythmia w/ choroform, cyclopropane, halo-thane or other halogenated anesthetics. The effect of cathine may be reduced/enhanced by tricyclic antidepressants. Cathine should not be used in patients treated w/ a MAOI or w/in 14 days of stop-ping MAOI as hypertensive crisis may occur if used.
• Ephedrine •
บรรเท�ภ�วะหลอดลมหดเกรงเพมคว�มดนเลอดในภ�วะชอค
I: Relief of moderate to severe acute asthma, relief of bronchoconstriction.
CI: Hypersensitivity. Hypertension, thyrotoxicosis, cardiovascular disease. BPH. Lactation.
SP: Ischaemic heart disease, hyperthyroidism, diabetes mellitus, hypertension, angle-closure glaucoma, renal impairment; prostatic enlarge-ment; children, pregnancy, elderly.
AR: Anxiety, tachycardia, tremor, dry mouth, hyper-tension, cardiac arrhythmias, impaired circulation to the extremities, nervousness, insomnia, palpitations. Difficulty in micturition in patients w/ prostatic enlarge-ment. Nasal drops: Local irritation, rebound nasal congestion & drug-induced rhinitis on prolonged use. Delusions, hallucinations. Seen w/ hypersensitivity & overdosage. Acute CNS & CVS stimulation present-ing as vomiting, fever, hypertension, psychosis. Cardi-ac arrhythmias. Urinary retention. Restlessness.
DI: Reduces antihypertensive effect of bethanidine & guanethidine. May increase clearance of dexa-methasone. Increased incidence of adverse effects when used w/ theophylline. Severe HTN when combined w/ MAOIs or within 2 wk of discontinu-ance of MAOI treatment. Increased risk of arrhyth-mias w/ cardiac glycosides, quinidine or tricyclic antidepressants. Increased vasoconstriction or pressor effects w/ ergot alkaloids or oxytocin. Additive effects & increased toxicity w/ sympatho-mimetic agents. Reduced/blocked effects w/ a- & b-blocking agents.
• Flunitrazepam •
รกษ�อ�ก�รนอนไมหลบอย�งรนแรงและใชในระยะสน
I: Short-term management of severe insomnia.
CI: Preexisting CNS depression or coma, resp depression, acute pulmonary insufficiency or sleep apnoea; severe hepatic impairment; chronic psycho-sis, phobic or obsessional states; may precipitate suicide or aggressive behavior; not to be used alone to treat depression or anxiety associated w/ depres-sion; glaucoma. Pregnancy, lactation. Neonates.
SP: Chronic pulmonary insufficiency; elderly or debilitated patients; muscle weakness, impaired liver or kidney function; drowsiness may affect skilled tasks; monitor cardiorespiratory function when used for deep sedation; personality disorders or organic brain changes; history of alcohol or drug addic-tion. Resp depression & hypotension w/ parenteral admin; this route should only be used when facilities for reversing resp depression are available.
AR: Drowsiness & lightheadedness, sedation, muscle weakness & ataxia; less frequently vertigo, headache, confusion, depression, slurred speech, changes in libido, tremor, visual disturbances, urinary retention, GI disturbances, changes in sali-vation & amnesia.
DI: Enhanced sedation or resp & CV depression w/ drugs w/ CNS depressant properties eg, antide-pressants, antihistamines, antipsychotics, general
PINK PAGES 2013-FINAL-July31.indd 50 8/15/2013 3:09:53 PM
ÄRegistration expired
IMPORTANT DRUG NOTES 51 PN DEX 2013anaesthetics, other hypnotics or sedatives, opioid analgesics & cisapride. Alcohol. Calcium-channel blockers; clonidine; diaxozide; disulfiram; clozap-ine; diuretics; moxonidine; nabitone; nitrates; cimetidine, esomeprazole & omeprazole; muscle relaxants; dopaminergics; lofexidine; hydralazine, minoxidil & nitroprusside; antifungals; angiotensin II receptor antagonist; antiepileptics; b-blockers; antibacterials. Drugs which alter the hepatic microsomal enzymes.
• ÄFlurazepam •
ชวยก�รนอนไมหลบระยะสน
I: Short-term management of insomnia.
CI: Hypersensitivity; porphyria. Pregnancy (3rd trimester); neonates.
SP: Chronic pulmonary insufficiency; elderly or debilitated patients; muscle weakness, impaired liver or kidney function; drowsiness may affect skilled tasks; monitor cardiorespiratory function when used for deep sedation; personality disorders or organic brain changes; history of alcohol or drug addiction. Respiratory depression & hypotension w/ parenteral admin. Dependence; lactation. Safety & efficacy are not proven in child <15 yr.
AR: Drowsiness & lightheadedness, sedation, palpitations, chest pain, muscle weakness & atax-ia, staggering; less frequently vertigo, headache, confusion, depression, slurred speech, changes in libido, tremor, visual disturbances, urinary reten-tion, GI disturbances, heartburn, changes in saliva-tion & amnesia. heartburn, staggering.
DI: Antidepressants, antihistamines, antipsychot-ics, general anesthetics, other hypnotics or seda-tives, opioid analgesics & cisapride. Increased toxicity by amprenavir, cimetidine, ciprofloxacin, clarithromycin, clozapine, CNS depressants, diltiazem, disulfiram, digoxin, erythromycin, ethanol, levodopa, loxapine, metoprolol, metro-nidazole, miconazole, nefazodone, nelfinavir, omeprazole, phenytoin, rifabutin, rifampicin, rito-navir, troleandromycin, valproic acid & verapamil. Effect is decreased by carbamazepine, rifampicin & rifabutin. Alcohol.
• Ketamine •
เหนยวนำ�ทำ�ใหเกดก�รสลบ รกษ�สภ�วะก�รสลบ ใชรวมกบย�ระงบคว�มรสกอนเพอเหนยวนำ�และรกษ�สภ�วะก�รสลบใชรวมกบย�แกปวดกลมopioidsเพอเสรมฤทธระงบปวด
I: Induction of anaesthesia. Adjunct to opioids in management of pain.
CI: Hypertension, cardiac disease, history of cerebro-vascular accident. Eye injury, raised ocular & intracra-nial pressure. Psychotic disorders. Porphyria. Preec-lampsia, eclampsia.
SP: Minimise verbal & tactile stimulation during recovery period. Chronic alcoholic & alcohol-intoxi-cated patients. Preanaesthetic elevated CSF pres-sure. Dependence & tolerance may develop. May impair ability to drive or operate machinery. Moni-tor cardiac function in patients w/ HTN or cardiac decompensation. Pregnancy & lactation.
AR: Emergence reactions e.g. vivid dreams, hallu-cinations, confusion, irrational behaviour. Increased muscle tone sometimes resembling seizures. Tempo-rary HTN & tachycardia. Hypotension, bradycardia, arrhythmias. Respiratory depression, apnoea, laryn-gospasm, diplopia, nystagmus, nausea, vomiting, lachrymation, hypersalivation, raised intraocular & CSF pressure, skin rash & pain at inj site.
DI: May increase effects of nondepolarising muscle relaxants. May reduce hypnotic effect of thiopental. Prolonged recovery time w/ barbiturates/narcot-ics. Reduced cardiac output, BP & pulse rate w/ halothane. Increased risk of HTN & tachycardia w/ thyroid hormones. Seizures & tachycardia may occur when used w/ theophyllines.
• ÄLormetazepam •
ชวยก�รนอนไมหลบระยะสน
I: Short-term management of insomnia.
CI: CNS depression; resp depression, acute pulmonary insufficiency or sleep apnoea; severe hepatic impairment; chronic psychosis, phobic or obsessional states; not to be used alone to treat depression or associated anxiety; unstable myas-thenia gravis; glaucoma. Pregnancy & lactation, childn.
SP: Chronic pulmonary insufficiency; elderly or debilitated patients; muscle weakness, impaired liver or kidney function; personality disorders or organic brain changes; history of alcohol or drug addiction.
AR: Drowsiness & lightheadedness, muscle weak-ness & ataxia, vertigo, headache, confusion, depression, slurred speech, changes in libido, tremor, visual disturbances, urinary retention, GI disturbances, changes in salivation & amnesia.
DI: Enhanced sedation or resp & CV depression w/ drugs w/ CNS depressant properties eg, antide-pressants, antihistamines, antipsychotics, general anaesthetics, other hypnotics or sedatives, opioid analgesics & alcohol.
PINK PAGES 2013-FINAL-July31.indd 51 8/15/2013 3:09:53 PM
ÄRegistration expired
52 IMPORTANT DRUG NOTES PN DEX 2013
• Methylphenidate •
รกษ�โรคสม�ธสนและรกษ�โรคสม�ธสนอยไมนงรกษ�narcolepsy
I: Attention deficit disorder (ADD), attention deficit hyperactivity disorder (ADHD) and treatment of narcolepsy.
CI: Marked anxiety, tension, agitation; glaucoma; Tourette’s syndrome or tics. Known severe structural cardiac abnormalities, cardiomyopathy, serious heart rhythm abnormalities, or other serious cardiac disor-ders that could increase the risk of sudden death, anorexia nervosa, hyperthyroidism, phaeochromocy-toma, vasculitis, cerebrovascular disorders. Extend-ed-release form: Severe hypertension, heart failure, arrhythmia, hyperthyroidism, recent MI or angina.
SP: Pregnancy & lactation. History of alcohol or drug abuse. Hypertension & other CV disorders that might be exacerbated by increases in BP or heart rate. Pre-existing psychosis or bipolar disor-der; monitor for symptoms of aggression or hostility. History of seizure disorder. Phenylketonuria. Fruc-tose intolerance, glucose-galactose malabsorption, sucrose-isomaltase insufficiency. Children <6 yr (growth suppression); monitor growth during thera-py. May impair ability to drive or operate machinery. Transdermal: Avoid exposure of application site to any direct external heat source.
AR: Angina, arrhythmia, cerebral arteritis, cerebral occlusion, changes in BP, MI, necrotising vasculitis, palpitation, pulse changes, stroke, tachycardia; anxi-ety, abnormal behavior, depression, irritability, dizzi-ness, drowsiness, fever, headache, insomnia, nerv-ousness, neuroleptic malignant syndrome (NMS), suicidal behavior, Tourette’s syndrome, toxic psycho-sis; erythema multiforme, exfoliative dermatitis, hair loss, rash, urticaria; growth retardation; abdominal pain, anorexia, diarrhoea, dysmenorrhea, nausea, vomiting, wt loss; anaemia, leukopenia, thrombocy-topenic purpura, thrombocytopenia; abnormal LFTs, hepatic coma, increased transaminases; arthralgia, dyskinesia; blurred vision, visual accommodation disturbance; cough, pharyngitis, sinusitis, upper resp tract infection; accidental injury, hypersensi-tivity. Transdermal: Insomnia, decreased appetite; nausea; tic, emotional instability; vomiting, anorexia; nasal congestion, nasopharyngitis; wt loss.
DI: May reduce effects of antihypertensive agents. Reduced serum level w/ carbamazepine. Increased serum levels or effects w/ CYP2D6 inhibitors e.g. chlorpromazine, delavirdine, fluoxetine, miconazole, paroxetine, pergolide, quinidine, quinine, ritonavir, ropinirole. May increase serum levels of anticoagu-lants, phenylbutazone, phenytoin, TCAs. Possible severe HTN & tachycardia w/ sibutramine. CNS depression w/ alcohol. Severe toxic reactions w/ cloni-dine. Increased risk of hypertensive crisis w/ MAOIs.
• Midazolam •
ทำ�ใหสงบระงบกอนก�รผ�ตด ทำ�ใหสงบระงบกอนหรอระหว�งก�รทำ�หตถก�ร ทำ�ใหสงบสำ�หรบผปวยในภ�วะวกฤต ใชรวมกบย�ระงบคว�มรสกเพอก�รผ�ตดหรอก�รทำ�หตถก�รทกอใหเกดคว�มปวด ชวยเหนยวนำ�ใหสลบและใชเตรยมผปวยกอนใหย�ระงบคว�มรสก
I: Induction of anaesthesia. Premedication in surgery. Sedation for minor surgical procedures.
CI: Acute narrow-angle glaucoma; coma or patients in shock; acute alcohol intoxication; intrathecal & epidural admin. Acute pulmonary insufficiency or marked neuromuscular resp weakness including unstable myasthenia gravis; severe resp depres-sion. Neonates.
SP: Paediatric patients w/ CV instability; chronic renal failure; open-angle glaucoma; cardiac disease; resp disease; myasthenia gravis; neonates; histo-ry of drug or alcohol abuse; elderly & debilitated (reduce dose); avoid prolonged use or abrupt with-drawal; hepatic impairment; severe fluid or elec-trolyte disturbances. May impair ability to drive or operate machinery; titrate dose carefully; monitor for early signs of hypoventilation, airway obstruction, or apnea. Pregnancy, lactation.
AR: Physical & psychological dependence w/ with-drawal symptoms; decreased tidal vol & respira-tory rate; apnoea; headache; hiccup; nausea, increased appetite, vomiting; cough; oversedation; seizure-like activity (paediatrics); paradoxical reac-tions; kernicterus; nystagmus; skin rash, pruritus; reduced alertness, confusion, euphoria, hallucina-tions, fatigue, dizziness, ataxia, post-op sedation, anterograde amnesia; jaundice; cardiac arrest, heart rate changes, thrombosis; anaphylaxis; laryn-gospasm, bronchospasm. Respiratory depression, resp arrest; hypotension.
DI: Increased CNS depression w/ alcohol, opioids, barbiturates, other sedatives & anaesthetics. Increased resp depression w/ opiates, phenobarbi-tal, other benzodiazepines. Plasma concentrations increased by CYP3A4 inhibitors such as cimeti-dine, erythromycin, clarithromycin, diltiazem, vera-pamil, ketoconazole & itraconazole, antiretroviral agents, quinupristin w/ dalfopristin. Midazolam conc decreased by phenytoin, carbamazepine, pheno-barbital, rifampicin. Halothane, thiopental require-ments may be reduced during concurrent use.
• Nitrazepam •
ชวยทำ�ใหหลบและรกษ�โรคลมชกในเดก
I: Management of insomnia, infantile spasms.
CI: Myasthenia gravis, narrow-angle glaucoma, severe resp insufficiency, sleep apnoea syndrome,
PINK PAGES 2013-FINAL-July31.indd 52 8/15/2013 3:09:53 PM
ÄRegistration expired
IMPORTANT DRUG NOTES 53 PN DEX 2013severe hepatic impairment, porphyria, chronic psychosis.
SP: May induce anterograde amnesia; caution patients to have uninterrupted sleep of 7-8 hr after ingestion of dose. May impair ability to drive or oper-ate machinery. Depression, esp if suicidal risk may be present. History of drug abuse or acute alco-holism. Hepatic & renal impairment. Respiratory disease. Debilitated patients. Patients who are at risk of falls. Children, elderly. Pregnancy & lactation.
AR: Hypotension, palpitation; agitation, aggressive-ness, amnesia, ataxia, confusion, delusions, disori-entation, dizziness, drowsiness, fatigue, hallucina-tion, hangover, headache, irritability, nightmares, psychoses, rage, restlessness, sedation; rash; changes in libido; constipation, diarrhoea, exces-sive salivation, heartburn, nausea, vomiting; granu-locytopenia, leukopenia; falling, muscle weakness; blurred or double vision; tinnitus (associated w/ withdrawal); aspiration, increased bronchial secre-tion, dyspnoea. Acute porphyria.
DI: CNS depressant effect increased w/ alcohol, barbiturates, TCAs, phenothiazines, morphine derivatives. Effects may be antagonised by theo-phylline. Increased levels/effects w/ probenecid. Reduced levels/effects w/ rifampicin. May reduce effects of levodopa.
• Phentermine •
ลดคว�มอย�กอ�ห�รในก�รรกษ�ผทมนำ�หนกเกนกว�ปกต
I: Anorectic in short-term treatment of moderate to severe obesity.
CI: Pulmonary hypertension, advanced arterioscle-rosis, moderate to severe hypertension, hyperthy-roidism, CV disease, glaucoma, history of alcohol/drug abuse, agitated states, use during or w/in 14 days following MAOI therapy. Lactation.
SP: Hypertension, DM, seizure disorder, Tourette’s syndrome, patients who have used other anorexi-gens w/in the past year; children. May impair abil-ity to drive & operate machinery. Potential for drug dependency. Discontinue if results are not satisfac-tory w/in 4 wk or if tolerance develops. History of epilepsy. Renal or hepatic disease. Pregnancy.
AR: Urticaria, GI upsets, palpitations, tachycardia, elevated blood pressure, overstimulation, restless-ness, insomnia, tremor, headache, dry mouth, dizziness, dysphoria, euphoria, psychosis, chang-es in libido & impotence. Primary pulmonary HTN & valvular heart disease.
DI: Decreased excretion by antacids, carbonic anhy-drase inhibitors (e.g. acetazolamide, dichlorphena-mide, methazolamide). Excretion is increased by urinary acidifiers. Increased risk of adverse effects
w/ other sympathomimetic agents. There is a risk of arrhythmias when used w/ TCA. May reduce serum concentrations of phenytoin, phenobarb & etho-suximide. Severe hypertensive episodes w/ MAOIs. Primary pulmonary HTN or valvular heart disease may occur when phentermine is used concur-rently w/ fenfluramine or dexfenfluramine. Avoid concurrent use w/ sibutramine. May decrease insu-lin requirements in patients w/ diabetes. Severe adverse reactions w/ SSRIs.
• ÄPhenylpropanolamine •
บรรเท�อ�ก�รคดจมก
I: Nasal congestion.
CI: Concurrent use or w/in 14 days after stopping MAOI.
P: Hyperthyroidism, DM, ischaemic heart disease, HTN, renal impairment, closed-angle glaucoma. Patients who are overweight, or w/ eating disor-ders. May precipitate anginal pain in patients w/ angina pectoris. Pregnancy, lactation, elderly. May impair ability to drive or operate machinery.
AR: Hypertensive crisis, haemorrhagic stroke, HTN, headache, confusions, anxiety, dizziness, restlessness, insomnia, agitations, palpitations, tremors, blurred vision.
DI: Increased risk of potentially fatal hyperten-sive crisis w/ or w/in 14 days after stopping MAOI. Increased risk of severe HTN and complications w/ bromocriptine. Increased risk of psychosis w/ amantadine. Increased risk of HTN w/ indometacin.
• Pseudoephedrine •
บรรเท�อ�ก�รคดจมกอนเนองจ�กโรคหวดภมแพและโพรงอ�ก�ศอกเสบทำ�ใหก�รขบส�รคดหลงสะดวกขน
I: Nasal congestion from colds, allergy and sinusitis.
CI: Severe hypertension, phaeochromocytoma, hyperthyroidism, ischaemic heart disease, HTN or aneurysms, DM & closed-angle glaucoma.
SP: Arrhythmia or tachycardia; occlusive vascular disorders e.g. arteriosclerosis, renal impairment, prostatic enlargement. Pregnancy; lactation.
AR: Anginal pain; rebound congestion & rhinor-rhoea; fear, anxiety, restlessness, tremor, insom-nia, confusion, irritability & psychotic states; reduced appetite, nausea, vomiting; gangrene; cerebral haemorrhage & pulmonary oedema; reflex bradycardia, tachycardia & cardiac arrhythmias, palpitations & cardiac arrest, hypotension & dizzi-ness, fainting & flushing. Tissue necrosis & slough-ing; myocardial & arterial necrosis. Hallucinations,
PINK PAGES 2013-FINAL-July31.indd 53 8/15/2013 3:09:53 PM
ÄRegistration expired
54 IMPORTANT DRUG NOTES PN DEX 2013phenylketonuria, seizures, pallor.
DI: Increased risk of HTN & arrhythmias if given w/ cardiac glycosides, quinidine or TCAs. Increased risk of vasoconstrictor effects if given w/ ergot alka-loids or oxytocin. Co-admin w/ MAOIs may cause hypertensive crisis. Anaesthetics e.g. cyclopro-pane, halothane & other halogenated anaesthes-tics; antihypertensive agents. Possible additive effects & increased toxicity w/ sympathomimetic agents. Increased absorption w/ antacids.
• ÄTemazepam •
ชวยก�รนอนไมหลบระยะสน
I: Short-term management of insomnia.
CI: Severe hepatic impairment. Pregnancy.
SP: Chronic pulmonary insufficiency, elderly or debilitated patients, impaired liver or kidney func-tion, personality disorders or organic brain chang-es, history of alcohol or drug addiction, lactation.
AR: Confusion, dizziness, drowsiness, fatigue, headache, lethargy, hangover, euphoria, difficulty w/ coordination, ataxia, anorexia, tremor, vomiting & backache, behavioral changes, vertigo, weak-ness, syncope, somnolence, anterograde amnesia.
DI: Enhanced sedation, resp & CV depression w/ drugs w/ CNS depressant properties.
• ÄTriazolam •
ชวยก�รนอนไมหลบระยะสน
I: Short-term management of insomnia.
CI: Pre-existing CNS depression or coma; resp depression; acute pulmonary insufficiency or sleep apnoea; myasthenia gravis; chronic psychosis, phobic or obsessional states; may precipitate suicide or aggressive behaviour so it should not be used alone to treat depression or anxiety associated w/ depression. Porphyria. Pregnancy & lactation. Childn.
SP: Chronic pulmonary insufficiency; elderly or debilitated patients; sleep apnoea; muscle weakness; impaired liver or kidney function; drowsiness may affect skilled tasks; personality disorders or organic brain changes; history of alcohol or drug addiction.
AR: Drowsiness, lightheadedness, dizziness, sedation, agitation, hallucinations, abnormal behaviour, muscle weakness, ataxia confusion, slurred speech, changes in libido, urinary retention, anterograde amnesia.
DI: Increased plasma triazolam concentrations w/ oral contraceptives, ergotamine, ciclosporin, isoniazid, ranitidine & CYP3A inhibitors such as
some macrolide antibiotics, cimetidine, isoniazid, fluvoxamine, sertraline, paroxetine, diltiazem, vera-pamil, amiodarone. Additive CNS depression w/ other CNS depressants eg, antipsychotics, other hypnotics or sedatives, opioid analgesics & alco-hol. Increased risk of prolonged sedation w/ potent CYP3A inhibitors such as azole antifungal agents, nefazodone, HIV protease inhibitors, nonnucleo-side reverse transcriptase inhibitors. Increased exposure w/ grapefruit juice & diltiazem.
• Zolpidem •
รกษ�อ�ก�รนอนไมหลบโดยเฉพ�ะอย�งยงผทนอนหลบย�กชนดinitialinsomnia
I: Management of insomnia especially initial insom-nia.
CI: Severe hepatic insufficiency.
SP: Obstructive sleep apnoea, myasthenia gravis, compromised resp function, hepatic impairment. Caution in patients exhibiting symptoms of depres-sion. Patients should be warned from doing any work involving mental alertness or motor coordination after ingestion of the drug. Pregnancy & lactation. Re-evaulate if insomnia fails to remit after 7-10 days. Max duration of treatment: 4 wk including tapering.
AR: Amnesia, drowsiness, dizziness, diarrhoea, nausea, vomiting, abnormal thinking & behav-iour, drugged feelings, back pain, ataxia, hiccups, confusion, euphoria, insomnia, vertigo, diplopia, abnormal vision. Hepatitis, anaphylactic reactions, sleep-driving (driving while not fully awake after drug ingestion, w/ no recollection of the event).
DI: Increased sedation & incoordination w/ TCA. Increased sedation w/ haloperidol & alcohol. Small increase in zolpidem conc w/ ketoconazole. Reduced effect of hypnotic effects w/ rifampic-in. Increased risk of prolonged sedation & resp depression w/ ritonavir.
P3 - Psychotropic Substance Schedule 3
• Amobarbital •
ชวยใหนอนหลบในผปวยจตเวชทมอ�ก�รนอนไมหลบอย�งรนแรง
I: Severe intractable insomnia.
CI: Depression; pulmonary insufficiency; sleep apnoea; preexisting CNS depression or coma; severe hepatic impairment. Porphyria. Renal impairment. Pregnancy & lactation. Elderly & debili-tated patients; young adults & childn.
SP: Renal insufficiency; given to patients in pain
PINK PAGES 2013-FINAL-July31.indd 54 8/15/2013 3:09:53 PM
ÄRegistration expired
IMPORTANT DRUG NOTES 55 PN DEX 2013may provoke a paradoxical excitatory reaction, unless an analgesic is given concomitantly; may impair ability to drive or operate machinery.
AR: Dependence; drowsiness, sedation, ataxia; resp depression; headache; GI disturbances; skin reactions; confusion & memory defects; paradoxi-cal excitement, irritability; hypersensitivity reac-tions; haematologic disorders.
DI: Sedation or resp depression may be enhanced by drugs w/ CNS depressants; MAOIs may prolong the CNS depressant effects & also reduce the convulsive threshold, thereby antagonise the anti-convulsant action of barbiturates. Others: Feno-profen, methadone, pethidine & opioid analgesics; disopyramide, lidocaine & quinidine; chlorampheni-col, doxycycline; warfarin & coumarin; antidepres-sants eg, bupropion, fluoxetine, lithium & mianserin; valproate & progabide; vigabatrin, oxcarbazepine, carbamazepine, clonazepam, ethosuximide, lamo-trigine, tiagabine & zonisamide, griseofulvin; teniposide; metronidazole; chlorpromazine; HIV-protease inhibitors; b-blockers; calcium-channel blockers eg, nifedipine & verapamil; digitoxin; ciclo-sporin; corticosteroids; furosemide; montelukast; oral contraceptives; theophylline; levothyroxine; flu vaccination & vitamins. Alcohol. St. John’s wort.
• ÄMeprobamate •
บรรเท�อ�ก�รวตกกงวลนอนไมหลบระยะสนและก�รชก
I: Sedative. Short-term management of anxiety & insomnia. Seizures.
CI: Acute intermittent porphyria; pre-existing CNS depression; pregnancy & lactation.
SP: Hepatic or renal impairment; depression; muscle weakness; impaired resp function; elderly or debilitated patients; history of epilepsy; may impair ability to operate machinery.
AR: Drowsiness, dizziness, vertigo, ataxia, GI disturbances, paraesthesia, weakness; CNS effects; visual disturbances; CV disturbances; hypersensitivity reactions; blood disorders.
DI: CNS depressants, e.g. alcohol, opioids, barbi-turates & antihistamines. Increased breakthrough bleeding may occur w/ combined oral contracep-tives. Anticoagulants.
• Pentazocine •
ลดอ�ก�รปวดป�นกล�งถงปวดรนแรง
I: Moderate to severe pain.
CI: Head injury; narcotic dependence; resp depres-sion; raised intracranial pressure; acute MI; heart
failure; arterial or pulmonary hypertension; acute porphyria; pregnancy (prolonged use or high doses at term).
SP: May precipitate withdrawal in narcotic addicts. Impaired resp, renal & hepatic function; morbidly obese patients; thyroid dysfunction; prostatic hyper-plasia or urinary stricture; biliary tract impairment; adrenal insufficiency (including Addison’s disease); abdominal conditions. Patients w/ head injury, cyanosis, COPD, cardiac arrhythmias, phaeochro-mocytoma. Elderly or debilitated patients; seizure-prone patients; childn & infants (safety & efficacy not established in <1 yr); lactation. May impair abil-ity to drive or operate machinery. Administer IM rather than SC (when frequent inj are needed) & inj sites should be varied.
AR: Physical dependence, weakness or faintness; sedation, dizziness, euphoria, lightheadedness, headache, irritability, alterations of mood; disturbed dreams, insomnia; syncope; muscle tremors; resp depression; blurred vision, nystagmus, diplopia, miosis, visual hallucinations, disorientation, confu-sion; hypertension, tachycardia, circulatory depres-sion; shock; hypotension; laryngospasm, dry mouth, taste alteration, nausea, vomiting, constipa-tion; seizures, diaphoresis; rash; blood dyscrasias, agranulocytosis, granulocytopenia; local tissue damages (SC), muscle fibrosis (IM). Respiratory depression, hypotension, circulatory failure, deep-ening coma, convulsions.
DI: Depressant effects potentiated by alcohol, CNS depressants; concurrent use w/ fluoxetine may lead to diaphoresis, ataxia, flushing & tremor associated w/ serotonin syndrome. Increased metabolsim w/tobacco smoking.
• Pentobarbital •
1.ใชเปนย�สลบสำ�หรบสตวในกรณทก�รผ�ตดใชระยะเวล�สน2.ใชเปนย�ควบคมกนก�รชกในสนขทไดรบย�พษstrychnine
I: Short-term anaesthesia for animal surgery. Controls seizure of strychnine poisoning in dog.
CI: Bronchopneumonia, severe pulmonary impair-ment. History of porphyria and addiction to sedative and hypnotics. Concomitant use of sodium oxybate.
SP: Mental depression; acute and chronic pain; hepatic and renal impairment. Parenteral admin to patients w/ HTN, hypotension, cardiovascular or pulmonary disease. Too rapid IV admin may result in resp depression, apnea, laryngospasm, or vasodila-tion w/ fall in blood pressure. Pregnancy, lactation, elderly. May impair ability to perform activities requir-ing mental alertness or physical coordination (e.g. driving and operating machinery).
AR: Drowsiness, somnolence, dizziness, anxiety, insomnia; hypotension, apnea, resp depression,
PINK PAGES 2013-FINAL-July31.indd 55 8/15/2013 3:09:53 PM
ÄRegistration expired
56 IMPORTANT DRUG NOTES PN DEX 2013bronchospasm, laryngospasm, bradycardia, CNS depression, physical and psychological depend-ence, psychiatric disturbance, confusion, halluci-nations, nightmares, thinking abnormality, synco-pe, hyperkinesias, ataxia, agitation, nervousness, nausea, vomiting, constipation.
DI: Increased sleep duration and CNS depression w/ sodium oxybate. Additive effects w/ other CNS depressants. Increased plasma levels w/ MAOI. May decrease serum levels of phenytoin, carba-mazepine, valproic acid. May increase metabolism of anticoagulants, corticosteroids, griseofulvin, doxycycline, and hormonal contraceptives.
P4 - Psychotropic Substance Schedule 4
• Bromazepam •
ลดอ�ก�รวตกกงวล
I: Anxiety.
CI: Pre-existing CNS depression or coma, resp depression, acute pulmonary insufficiency or sleep apnea; severe hepatic impairment; not indicated for chronic psychosis, phobic or obsessional states; may precipitate suicide or aggressive behavior, not used alone to treat depression or anxiety associ-ated w/ depression; glaucoma.
SP: Chronic pulmonary insufficiency; elderly or debilitated patients; muscle weakness, impaired liver or kidney function; drowsiness may affect skilled tasks; monitor cardiorespiratory function when used for deep sedation; patients w/ personal-ity disorders or organic brain changes; pregnancy & lactation; history of alcohol or drug addiction due to risk of dependence. Resp depression & hypo-tension w/ parenteral administration; therefore this route should only be used when facilities for revers-ing resp depression are available.
AR: Drowsiness, sedation, muscle weakness & ataxia; less frequently vertigo, headache, confu-sion, depression, slurred speech, changes in libi-do, tremor, visual disturbances, urinary retention, GI disturbances, changes in salivation & amnesia; rarely, jaundice, blood disorders & hypersensitiv-ity reactions; pain & thrombophlebitis; raised liver enzyme values; paradoxical excitation.
DI: Enhanced sedation or resp & CV depression w/ drugs w/ CNS depressant properties eg, antide-pressants, antihistamines, antipsychotics, general anesthetics, other hypnotics or sedatives, opioid analgesics & cisapride. Alcohol. Drugs which alter the hepatic microsomal enzymes.
• ÄButobarbital •
ใชกบผปวยจตเวชทนอนไมหลบอย�งรนแรง
I: Severe intractable insomnia.
CI: Children, young adults, elderly & debilitated patients. Patients w/ depression or w/ a history of drug or alcohol abuse or addiction. Insomnia caused by pain. Acute porphyria. Severe hepatic impairment. History of CNS depression or coma, pulmonary insuf-ficiency & sleep apnoea. Pregnancy & lactation.
SP: Renal impairment. Drowsiness may persist until the next day. Tolerance & dependence likely. Must not be withdrawn abruptly as withdrawal syndrome (including mortality) may occur.
AR: Drowsiness, ataxia, paradoxical excitement, confusion, headache & CNS depression; resp depression; GI disorders; hepatitis; fever; megalo-blastic anaemia. Erythema multiforme; exfoliative dermatitis.
DI: Butobarbital is a potent liver enzyme inducer & may reduce the effect of coumarin for up to 6 wk. Additive CNS depression w/ alcohol. Reduced effect of TCAs (such as amitriptyline, clomipramine, desipramine, dosulepin, imipramine, melitracen etc), corticosteriods (such as hydrocortisone, dexameth-asone etc), coumarins, darifenacin, disopyramide, doxorubicin, metronidazole, theophylline & tolvap-tan. It is also likely that the drug level of lidocaine is reduced due to the increased liver enzyme activ-ity. May reduce drug level of memantine. Increased sedation w/ thalidomide. Concurrent long-term use w/ phenmetrazine may result in psychosis. Concur-rent use w/ Na oxybate is contraindicated due to the additive CNS depressant effect. Butobarbital is a potent inducer of CYP3A4 & is expected to reduce the AUC of gefitinib significantly.
• Chlordiazepoxide •
ลดอ�ก�รวตกกงวลและใชในผตดสร�ทมอ�ก�รข�ดสร�
I: Anxiety disorders. Acute symptoms of alcohol withdrawal.
CI: Chronic pulmonary insufficiency, resp depres-sion, patients w/ marked neuromuscular resp weakness; hypersensitivity to benzodiazepines; chronic psychosis; depressive neuroses; porphyria; pregnancy & lactation.
SP: Alcohol; sedation, dependence. Elderly & debilitated patients. Childn < 6 yr. Liver or kidney dysfunction. Avoid prolonged usage.
AR: Physical & psychological dependence; with-drawal syndrome; impairs psychomotor perfor-mance, aggression (in predisposed individuals esp
PINK PAGES 2013-FINAL-July31.indd 56 8/15/2013 3:09:53 PM
ÄRegistration expired
IMPORTANT DRUG NOTES 57 PN DEX 2013in combination w/ alcohol); sedation; blood dyscra-sias, jaundice, hepatic dysfunction. May rarely cause hypoplastic or haemolytic anaemia.
DI: Cimetidine increases serum conc of chlordiaz-epoxide. Potentiates action of major neuroleptics. Alcohol potentiates CNS depressant effect of chlor-diazepoxide.
• Clobazam •
ใชเปนย�เสรมรวมกบย�กนชกชนดอนลดอ�ก�รวตกกงวล
I: Adjunct in epilepsy. Management of anxiety.
CI: Hypersensitivity; history of drug dependence; myasthaenia gravis; pregnancy (1st trimester), lactation; serious liver damage; sleep apnoea syndrome; impaired resp function.
SP: May impair ability to perform skilled tasks & hazardous activities; elderly; renal or hepatic impairment; alcoholism; obesity; withdrawal should be gradual.
AR: Constipation, anorexia, nausea; dizziness, somnolence, sedation, muscle weakness, fine tremors; worsening of resp symptoms in predis- posed individuals; ataxia, drowsiness, headache, vertigo, depression, dysarthria, amnesia, para-doxical excitation, confusion; lethargy; urinary tract infection; loss of libido, motor dysfunction; depend-ence; visual disturbances & wt gain. Hypotension. Elevated liver enzymes. Resp depression.
DI: Increased hepatic clearance of clobazam when administered w/ phenytoin, phenobarb or carbamazepine. Cimetidine may increase levels of clobazam. Concurrent alcohol, hypnotics & seda-tive antidepressants can potentiate CNS side effects of clobazam.
• Clonazepam •
กนชกลดอ�ก�รตนตระหนก
I: Seizure disorders. Panic disorders.
CI: Hypersensitivity to benzodiazepines, acute pulmo-nary insufficiency, acute narrow angle glaucoma.
SP: Avoid abrupt withdrawal. Neonates, chronic pulmonary insufficiency, hepatic/renal dysfunc-tion, porphyria, elderly; pregnancy & lactation. May impair ability to perform activities that require mental & physical alertness. May increase suicidal-ity. Childn w/ panic & seizure disorders.
AR: Drowsiness, fatigue, muscular hypotonia, coordination disturbances, dizziness, vertigo, headache, anorexia, visual disturbances, abnormal eye movements, glassy-eyed appearance, dysar-thria. Libido changes. Behavioural disturbances (in
childn) including irritability, agitation, hyperkinesis. Forgetfulness, hallucinations, hysteria, insomnia. Salivary or bronchial hypersecretion leading to resp problems (childn). May produce diminished reflexes or coma. Sexual dysfunction, Rarely, blood dyscrasias. Thromobophlebitis (IV).
DI: Carbamazepine, phenobarb or phenytoin may accelerate clonazepam metabolism. Increased sedative effect w/ alcohol, general anaesthet-ics & TCAs. Additive CNS depression with opiate agonists, barbiturates, anxiolytics, sedatives & hypnotics, antipsychotic agents & MAOIs.
• Clorazepate •
ลดอ�ก�รวตกกงวล ใชในผตดสร�ทมอ�ก�รข�ดสร� และบรรเท�หรอรกษ�โรคลมชก
I: Management of anxiety. Alcohol withdrawal syndrome. Epilepsy & seizure disorders.
CI: Hypersensitivity (cross-sensitivity w/ other benzodiazepines may occur); narrow-angle glauco-ma. Patients w/ depressive or psychotic disorders. childn <9 yr. Pregnancy; lactation.
SP: Elderly, debilitated patients; hepatic disease, alcoholics; renal impairment; resp disease; impaired gag reflex; patients experiencing apnoea during sleep; patients with limited pulmonary reserve, unstable CV status, palpitation, tachycardia, short-ness of breath; diaphoresis, flushing; operating machines or driving; patients on CNS depressant or psychoactive drug therapy; depression, esp those w/ suicidal tendencies; history of drug dependence.
AR: Jaundice, hepatic necrosis; extrapyramidal disorders; acute attacks of porphyria in porphyric patients, hypotension; prolonged CNS depression (neonates), drowsiness, fatigue, ataxia, lighthead-edness, memory impairment, reversible dementia (prolonged use in the elderly). insomnia, anxi-ety, headache, depression, slurred speech, confu-sion, nervousness, dizziness, irritability; pruritus & erythematous rash; decreased libido; xerostomia, constipation, diarrhoea, decreased salivation, nausea, vomiting, increased or decreased appetite; dysarthria, tremor; blurred vision, diplopia. Resp depression.
DI: Potentiates CNS effects of narcotic analge-sics, barbiturates, phenothiazines, ethanol, anti-histamines, MAOIs, sedative-hypnotics, cyclic antidepressants. CYP3A4 inhibitors eg, amprena-vir, cimetidine, ciprofloxacin, clarithromycin may increase serum conc & toxicity of clorazepate. Carbamazepine, rifampin & rifabutin may decrease clorazepate therapeutic effects by enhancement of clorazepate metabolism.
PINK PAGES 2013-FINAL-July31.indd 57 8/15/2013 3:09:54 PM
ÄRegistration expired
58 IMPORTANT DRUG NOTES PN DEX 2013
• Diazepam •
แกอ�ก�รชกหรอเกรง ลดอ�ก�รวตกกงวลอย�งรนแรงและคล�ยกล�มเนอ
I: Anticonvulsant, severe anxiety, muscle spasms.
CI: Hypersensitivity; myasthenia gravis, acute angle-closure glaucoma. Chronic psychosis, phobic or obsessional states. Not used alone in the treatment of depression or anxiety associated with depression. Premature babies or neonates (parenteral).
SP: Impaired renal & hepatic function, resp disease, organic cerebral changes, arterioscle-rosis, elderly, patients with personality disorders, epileptics, history of alcohol or drug addiction, impaired gag reflex, obese patients. Pre-existing CNS depression, coma, resp depression, acute & chronic pulmonary insufficiency, debilitated patients, muscle weakness. Discontinue treatment if patient develops psychiatric & paradoxical reac-tions. Patients w/ depression or anxiety associated w/ depression esp if patient has suicidal risk. May increase risk of falls. Safety & efficacy of the inj have not been established in childn <1 mth of age. Safety & efficacy of oral use have not been estab-lished in childn <6 mth of age. Safety & efficacy of rectal gel have not been established in childn <2 yr of age. Not recommended for infants <6 months. Abrupt withdrawal or large dose reduction may cause rebound or withdrawal symptoms.
AR: Psychological & physical dependence w/ withdrawal syndrome, fatigue, drowsiness, sedation, ataxia, vertigo, confusion, depression, somnolence; GI disturbances, changes in saliva-tion, amnesia, jaundice, paradoxical excitation; focal hepatic necrosis with intracellular cholestasis, elevated liver enzyme values; muscle weakness, tremors, visual disturbances, headache, slurring of speech & dysarthria, mental changes, incon-tinence, constipation, hypotension, tachycardia, changes in libido, pain & thrombophlebitis at inj site (IV). Respiratory & CNS depression, coma. Blood disorders. Galactorrhea, gynecomastia.
DI: Decreased oral absorption with morphine or pethi-dine pretreatment. Increased half-life with isoniazid, decreased half-life with rifampicin. Reduced plasma binding of diazepam with IV heparin. Complex & unpre-dictable interactions with NNRTIs. Prolonged half-life & reduced clearance with disulfiram, cimetidine, omepra-zole & esomeprazole. Accelerated absorption of diaz-epam with metoclopramide and cisapride. Reduced clearance with fluvoxamine. Increased clearance of diazepam when used w/ phenytoin, carbamazepine & phenobarbital. Reversible deterioration of parkin-sonism may occur when given together w/ levodopa. Combination w/ lithium may produce hypothermia. May need to reduce dose of narcotics when used concurrently. Phenothiazines, barbiturates, MAOIs
potentiate action of diazepam. Additive CNS depres-sant effects w/ alcohol & CNS depressants or psycho-active medications. Mutual potentiation of action w/ analgesics, anaesthetics & some anticonvulsants, anti-depressants, sedating antihistamines & other hypnot-ics & sedatives. May reduce clearance of & increase the plasma half-life of digoxin.
• ÄEthyl loflazepate •
บรรเท�อ�ก�รวตกกงวลระยะสน
I: Short-term management of anxiety.
CI: Preexisting CNS depression or coma, resp depression, acute pulmonary insufficiency or sleep apnoea; severe hepatic impairment; not indicated for chronic psychosis, phobic or obsessional states; may precipitate suicide or aggressive behaviour, not used alone to treat depression or anxiety asso-ciated w/ depression; glaucoma.
SP: Chronic pulmonary insufficiency; elderly or debilitated patients; muscle weakness, impaired liver or kidney function; drowsiness may affect skilled tasks; monitor cardiorespiratory function when used for deep sedation; patients w/ personal-ity disorders or organic brain changes; pregnancy, lactation; history of alcohol or drug addiction due to risk of dependence. Respiratory depression & hypotension may occur w/ parenteral admin.
AR: Drowsiness, sedation, muscle weakness & ataxia; less frequently vertigo, headache, confu-sion, depression, slurred speech, changes in libi-do, tremor, visual disturbances, urinary retention or incontinence, GI disturbances, changes in saliva-tion & amnesia; rarely, jaundice, blood disorders & hypersensitivity reactions; pain & thrombophlebitis; raised liver enzyme values; paradoxical excitation.
DI: Enhanced sedation or resp & CV depression w/ drugs that have CNS depressant properties e.g. antidepressants, antihistamines, antipsychotics, general anaesthetics, other hypnotics or sedatives, opioid analgesics & cisapride. Drugs which alter the hepatic microsomal enzymes.
• Lorazepam •
ลดอ�ก�รวตกกงวลและชวยใหนอนหลบ
I: Management of anxiety and insomnia.
CI: Severe hepatic impairment; resp depression; acute narrow-angle glaucoma; pregnancy & lacta- tion. Sleep apnoea syndrome; pulmonary insuffi-ciency.
SP: Hepatic & renal dysfunction; myasthenia gravis; may impair ability to drive or operate
PINK PAGES 2013-FINAL-July31.indd 58 8/15/2013 3:09:54 PM
ÄRegistration expired
IMPORTANT DRUG NOTES 59 PN DEX 2013machinery; elderly or debilitated patients. Childn <18 yr, neonates.
AR: Drowsiness, headache, dizziness, confusion; blurred vision; nausea; weakness; unsteadiness. Respiratory depression. Changes in vital signs, e.g. respiratory rate, BP.
DI: Potentiation of CNS depression produced by alcohol; general anaesthetics; narcotic analge-sics; TCAs; MAOIs; phenothiazines; antipsychot-ics; barbiturates; scopolamine; opiate agonists or partial agonists.
• Medazepam •
ลดอ�ก�รวตกกงวล
I: Management of anxiety.
CI: Glaucoma.
SP: Severe hepatic impairment. Elderly or debilitat-ed patients; muscle weakness or myasthenia gravis; impaired liver or kidney function; predisposition to seizures; depression; severe resp dysfunction; sleep apnoea; movement disorders; drowsiness may affect skilled tasks; history of alcohol or drug addic-tion. Treatment withdrawal should be gradual. Avoid long-term use. Pregnancy & lactation.
AR: Fatigue, drowsiness, dizziness, prolonged reaction time, headache, coordination disorders (ataxia), confusion, anterograde amnesia. Rarely, GI symptoms, laryngeal spasm, chest pain, hypo-tension, bradycardia, depression, decreased libido, increased appetite, dry mouth, muscle weakness, resp failure.
DI: Additive CNS depression or sedative effects w/ drugs that have CNS depressant properties e.g. alcohol, antidepressants, sedating antihistamines, antipsychotics, general anaesthetics, other hypnot-ics or sedatives, opioid analgesics, cisapride. Increased risk of toxicity w/ hepatic microsomal enzyme inhibitors.
• Phenobarbital •
แกและกนชกสงบประส�ทกอนผ�ตด
I: Management and prevention of seizures. Pre-operative sedation.
CI: Severe renal & hepatic disorders. Severe resp depression, dyspnoea or airway obstruction; porphyria. Pregnancy.
SP: Elderly or debilitated patients, childn. Withdraw gradually. Nephritis/renal insufficiency. Impaired hepatic & resp function. Patients w/ acute pain & depressive disorders. Patients with depression, suicidal tendencies, history of drug abuse. Acute or
chronic pain. May impair ability to drive or operate machinery. Lactation.
AR: Bradycardia, hypotension, syncope; drowsi-ness, lethargy, CNS excitation or depression, sedation, subtle mood changes, impaired cogni-tion & memory, impaired judgment, hangover effect, confusion, somnolence, agitation, restless-ness, hyperkinesia, ataxia, nervousness, head-ache, insomnia, nightmares, hallucinations, anxi-ety, dizziness; rash, exfoliative dermatitis; nausea, vomiting, diarrhea, constipation; agranulocytosis, thrombocytopenic purpura, megaloblastic anaemia; pain at inj site, thrombophlebitis (IV); oliguria; laryn-gospasm, resp depression, apnoea, hypotension, shock, (especially w/ rapid IV admin), hypoven-tilation Stevens-Johnson syndrome; hyperthermia. Hepatitis, disturbances in liver function. Irritability & hyperactivity in childn.
DI: May enhance the hepatotoxic potential of parace-temol overdoses. May decrease levels/effects of various CYP isoenzyme substrates e.g. teniposide, methotrexate, antipsychotics, b-blockers, calcium- channel blockers, other anti-convulsants, chloram- phenicol, cimetidine, corti-costeroids, ciclosporin, doxycycline, oestrogens, felbamate, griseofulvin, tacrolimus, furosemide, methadone, oral contra- ceptives, theophylline, TCAs, warfarin. May reduce effects of guanfa-cine. Reduced metabolism & or increased toxic-ity w/ chloramphenicol, felbamate, MAOIs, valp-roic acid. May enhance the nephrotox- ic effects of methoxyflurane. Additive sedation &/ or resp depression w/ alcohol, sedatives, antide- pres-sants, opioid analgesics, benzodiazepines & other CNS depressants. May decrease levels/ effects of antiarrhythmic drugs e.g. disopyramide, propafenone, quinidine. Decreased antiepileptic effect with antidepressants, antiretroviral agents (tipranavir/ritonavir). Increased concentration with phenytoin, progabide, influenza vaccination.
• Pinazepam •
ลดอ�ก�รวตกกงวล
I: Management of anxiety.
CI: Pre-existing CNS depression or coma, resp depression, acute pulmonary insufficiency, myas-thenia gravis, sleep apnoea, severe hepatic impair-ment; chronic psychosis, phobic or obsessional states; glaucoma.
SP: Chronic pulmonary insufficiency; elderly or debilitated patients; childn; muscle weakness, impaired liver or kidney function; drowsiness may affect skilled tasks; monitor cardiorespiratory func-tion when used for deep sedation; patients w/ personality disorders or organic brain changes;
PINK PAGES 2013-FINAL-July31.indd 59 8/15/2013 3:09:54 PM
ÄRegistration expired
60 IMPORTANT DRUG NOTES PN DEX 2013pregnancy, lactation; history of alcohol or drug addiction, hypotension & apnoea w/ IV admin; therefore this route should only be used when facil-ities for reversing resp depression are available. Monitor for signs of suicidal tendency or aggressive behavior; not to be used alone to treat depression or anxiety associated w/ depression. Porphyria.
AR: Drowsiness, sedation, muscle weakness & ataxia; less frequently vertigo, headache, confu-sion, depression, slurred speech, changes in libi-do, tremor, visual disturbances, urinary retention, GI disturbances, changes in salivation & amnesia; rarely, jaundice, blood disorders & hypersensitiv-ity reactions; pain & thrombophloebitis; raised liver enzyme values; paradoxical excitation. Hypoten-sion & resp depression (rapid IV).
DI: Enhanced sedation or resp & CV depres-sion w/ drugs w/ CNS depressant properties e.g. alcohol, antidepressants, antihistamines, antipsy-chotics, general anaesthetics, other hypnotics or sedatives, opioid analgesics. Accelerated absorp-tion w/ cisapride.
• Prazepam •
บรรเท�อ�ก�รวตกกงวลระยะสน
I: Short-term management of anxiety.
CI: Pre-existing CNS depression or coma, resp depression, acute pulmonary insufficiency or sleep apnoea; severe hepatic impairment; chronic psychosis, phobic or obsessional states; glaucoma; porphyria. Myasthenia gravis.
SP: Chronic pulmonary insufficiency; elderly or debilitated patients; muscle weakness, impaired liver or kidney function; drowsiness may affect skilled tasks; monitor cardiorespiratory func-tion when used for deep sedation; patients w/ personality disorders or organic brain changes; pregnancy & lactation; history of alcohol or drug addiction due to risk of depression. Resp depres-sion & hypotension w/ parenteral admin; there-fore this route should only be used when facilities for reversing resp depression are available. May precipitate suicide or aggressive behavior, not used alone to treat depression or anxiety associ-ated w/ depression.
AR: Drowsiness, sedation, muscle weakness & ataxia; less frequently vertigo, headache, confu-sion, depression, slurred speech, changes in libi-do, tremor, visual disturbances, urinary retention, GI disturbances, changes in salivation & amnesia; rarely, jaundice, blood disorders & hypersensitiv-ity reactions; pain & thrombophloebitis; raised liver enzyme values; paradoxical excitation. Hypoten-sion & resp depression (rapid IV).
DI: Enhanced sedation or resp & CV depression w/ alcohol, drugs w/ CNS depressant properties eg, antidepressants, antihistamines, antipsychotics, general anaesthetics, other hypnotics or sedatives, opioid analgesics & cisapride. Decreased serum levels when used w/ phenytoin. May increase the plasma levels of bupivacaine. Serum levels may be increased by valproate & modafinil.
• Tofisopam •
บรรเท�อ�ก�รหยดเหล� และอ�ก�รวตกกงวลระยะสน
I: Alcohol withdrawal syndrome. Short-term management of anxiety.
CI: Aggressive-impulsive psychopathy. Pregnancy.
SP: Discontinue if sleep disturbances occur. Avoid sleep disturbances by taking last dose earlier (e.g. before 5 pm).
AR: Nausea, rash, epigastric pain, itching, extreme liveliness, hyperactivity, aggressiveness.
N2 - Narcotic Drug Schedule 2
• Codeine •
บรรเท�อ�ก�รปวดเลกนอยถงปวดป�นกล�ง
I: Mild to moderate pain.
CI: Respiratory depression, obstructive airway disease, asthma. Severe CNS depression, acute alcoholism, convulsive disorders, head injuries, brain tumours, comatose patients, raised intracra-nial pressure. Pregnancy (prolonged use or high doses at term).
SP: Hypothyroidism, adrenocortical insufficiency; asthma, impaired hepatic or renal function, pros-tatic hyperplasia, hypotension, shock, inflamma-tory or obstructive bowel disorders, myasthenia gravis. Infants, neonates; Reduce dose in elderly or debilitated patients. May impair ability to drive or operate machinery. Lactation. Patients who have undergone thoracotomies & laparotomies.
AR: Dependence, withdrawal symptoms; nausea, vomiting, constipation; drowsiness, confusion; difficulty in micturition, ureteric or biliary spasms, urinary retention; dry mouth, dizziness, sweating, facial flushing, headache, vertigo, visual distur-bances, mental clouding, depression, sedation, weakness, faintness, bradycardia, tachycardia, palpitations, orthostatic hypotension, hypother-mia, restlessness, agitation, nervousness, mood changes, decreased libido or potency, hallucina-tion, miosis; raised intracranial pressure, muscle
PINK PAGES 2013-FINAL-July31.indd 60 8/15/2013 3:09:54 PM
ÄRegistration expired
IMPORTANT DRUG NOTES 61 PN DEX 2013rigidity. Respiratory depression & hypotension, w/ circulatory failure & deepening coma (larger doses). Excitement & convulsions (especially in childn & infants). Rhabdomyolysis.
DI: Enhanced depressant effects w/ alcohol, anaesthetics, anxiolytics, tranquilizers, sedatives & hypnotics, TCAs, antipsychotics. Possible CNS depression or excitation w/ MAOIs. May alter effects of other compounds e.g. cyclizine, mexile-tine, cisapride, metoclopramide & domperidone.
• Fentanyl •
ใชบรรเท�อ�ก�รปวดป�นกล�งถงรนแรง เนองจ�กผปวยบ�งร�ยแพย�morphine ใชรวมกบย�ระงบคว�มรสกเพอก�รผ�ตด ใชบรรเท�อ�ก�รปวดหลงผ�ตดหรอก�รทำ�หตถก�รทกอใหเกดคว�มปวด
I: Moderate to severe pain for morphine hypersen-sitive patient. Adjunct to preoperative sedation. Relief of pain after operation.
CI: Hypersensitivity. Opioid non-tolerant patients. Acute or post-op pain, mild or intermittent chronic pain that can be managed w/ less potent anal-gesics. Transdermal: resp depression, especially when facilities for monitoring & resuscitation are unavailable. Acute or severe bronchial asthma; paralytic ileus. Intranasal spray: previous facial radiotherapy, recurrent episodes of epistaxis.
SP: Myasthaenia gravis. Head injury; increased-intracranial pressure; intracranial lesions; renal or hepatic impairment; neonates. Increased risk of resp depression in elderly, debilitated, cachectic patients, patient w/ hypoxia or hypercapnia. Hypo-thyroidism, prostatic hyperplasia, inflammatory bowel disorders, bradycardia or bradyarrhythmi-as. Rapid IV infusion may cause skeletal muscle & chest wall rigidity, impaired ventilation or resp distress/arrest. Pre-existing medical conditions that predispose patients to hypoventilation. Fever. Prolonged use may cause tolerance, psychologi-cal & physical dependence. Abrupt withdrawal after prolonged admin may lead to withdrawal symp-toms. Lactation. Pregnancy (avoid high doses or prolonged usage). Childn < 2 yr (parenteral), <16 yr (buccal lozenge), <18 yr (buccal tab).
AR: Nausea, vomiting; bradycardia, oedema, CNS depression, confusion, dizziness, drowsiness, headache, sedation, transient hypotension, periph-eral vasodilation; increased intracranial pressure.High IV dose may cause chest wall rigidity. Trans-dermal: Rash, erythema & itching. Resp depres-sion, trunk rigidity, reduced pulmonary compli-ance, apnoea, laryngospasm, bronchoconstriction. Buccal lozenges: dental decay including caries, tooth loss, gum line erosion.
DI: Depressant effects may be enhanced by other CNS depressants e.g. alcohol, anaesthet-ics, anxiolytics, hypnotics, TCAs & antipsychotics. Ammonium Cl may increase excretion of fentanyl. Phenothiazines may increase hypotensive effect of opioid analgesics. Serum levels may be increased by CYP3A4 inhibitors (e.g. azole antifungals, clarithromycin, diclofenac, doxycycline, erythromy-cin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, telithromy-cin & verapamil). May reduce the efficacy of pegvi-somant. Serum levels may be reduced by rifamycin derivatives. May increase serotonergic effect of SSRIs & sibutramine.
• Methadone •
บรรเท�อ�ก�รปวดป�นกล�งและรนแรง
I: Moderate to severe pain.
CI: Acute resp depression; acute bronchial asth-ma; acute alcoholism; risk of paralytic ileus; raised intracranial pressure or head injury. Lactation.
SP: Dose should be individualised. Prolonged QT interval; CV disease; hepatic impairment; elec-trolyte abnormalities; concommitant use of QT prolonging drug; resp disease; elderly. May impair ability to drive or operate machinery. Family history of sudden death. Pregnancy. Childn.
AR: Nausea; vomiting; constipation; anorexia; abdominal pain; drowsiness; resp depression; hypo-tension; bradycardia; euphoria; headache; dyspho-ria; urinary retention; miosis; visual disturbances; impotence; dizziness; sweating; pruritis; asthenia; arrythmias; QT prolongation. Cardiac arrest; resp arrest; shock. Pain at inj site, local tissue irritation & induration. Sleep apnoea. Pulmonary edema (overdosage), choreic movements (long-term use), hypoadrenalism (chronic addiction).
DI: Withdrawal symptoms may be experienced w/naloxone, naltrexone, pentazocine, nalbuphine, butorphanol, & buprenorphine. Increased clear-ance & possible reduced efficacy w/ some antiret-rovirals (abacavir, amprenavir, efavirenz, nelfinavir, nevirapine, ritonavir, lopinavir); rifampin; phenytoin; phenobarbital; carbamazepine. Decreased clear-ance & possibly increased toxicity w/ CYP3A4 inhibitors (e.g. ciprofloxacin, erythromycin, flucona-zole, ketoconazole, voriconazole, sertraline, fluox-etine, fluvoxamine). Increased chance of cardiac toxicity w/ other QT prolonging drugs &drugs that can cause electrolyte imbalance. Increased CNS depression w/ alcohol, other opioids or CNS depressants. Methadone may increase plasma levels of desipramine, zidovudine. Enhanced effect w/ cimetidine.
PINK PAGES 2013-FINAL-July31.indd 61 8/15/2013 3:09:54 PM
ÄRegistration expired
62 IMPORTANT DRUG NOTES PN DEX 2013
• Morphine •
บรรเท�อ�ก�รปวดป�นกล�งถงปวดรนแรงในผปวยทตองรกษ�อ�ก�รปวดอย�งตอเนอง
I: Relief of moderate to severe pain in patients requiring continuous, around-the-clock opioid therapy for an extended period of time.
CI: Resp depression, acute or severe asthma; para-lytic ileus; obstructive airway disease; acute liver disease; coma; increased intracranial pressure; acute alcoholism. Pulmonary oedema resulting from a chemical resp irritant. Phaeochromocytoma.
SP: Elderly & debilitated patients; hypothyroid-ism; renal & liver disease; head injury, intracranial lesions; toxic psychoses; hypotension, circulatory shock, MI; adrenocortical insufficiency; asthma; prostatic hyperplasia; inflammatory or obstructive bowel disease; myasthaenia gravis; childn < 18 yr, infants <3 mth; pregnancy, lactation; hypovolaemia, biliary tract disorders, ileus.
AR: Convulsions; muscle rigidity; nausea, vomiting, dry mouth, constipation; urinary retention; raised intracranial pressure, headache, vertigo; palpita-tions; hypothermia; pruritus, urticaria; tachycardia, bradycardia; blurred vision; miosis; dependence; drowsiness; confusion, restlessness, lightheaded-ness; dizziness; sweating; dysphoria; euphoria, mood changes, decreased libido, hallucinations. Respiratory depression; circulatory failure; hypo-tension; peripheral oedema; deepening coma; anaphylactic reactions. Hypogonadotrophic hypo-gonadism, adrenal insufficiency; growth hormone deficiency. Rectovaginal spasm (intrathecal). Myoclonus (high IV & spinal doses).
DI: Availability may be increased by TCAs; increased risk of serotonin syndrome w/ serotonergic drugs; risk of cardiac arrythmias w/ QT prolonging drugs; sedative effects may be increased by metoclopra-mide; antagonises efficacy of diuretics; morphine levels decreased by rifampicin. Increased CNS depression w/ other CNS depressants (e.g. other opioids, general anaesthetics, benzodiazepines, barbiturates), alcohol. Risk of severe hypotension w/ MAOIs. Increased concentration w/ cisapride.
• Pethidine •
ใชบรรเท�อ�ก�รปวดป�นกล�งถงปวดรนแรง ใชรวมกบย�ระงบคว�มรสกเพอก�รผ�ตดหรอก�รทำ�หตถก�รทกอใหเกดคว�มปวด
I: Moderate to severe acute pain. Adjunct to anaes-thesia.
SP: May impair ability to drive or operate machinery. Hypovolaemia, CV disease; adrenal insufficiency; biliary tract disorder; CNS depression or coma;
history of drug abuse or acute alcoholism; head injury, intracranial lesions, elevated intracranial pres-sure; hepatic or renal impairment; morbid obesity; prostatic hyperplasia; toxic psychoses; pre-existing resp compromise (hypoxia and/or hypercapnia), COPD or other obstructive airway disease; sickle-cell disease; supraventricular tachycardia; thyroid dysfunction. Elderly & debilitated patients. Withdraw gradually. Pregnancy (avoid prolonged use or high doses at term) & lactation. Phaeochromocytoma.
AR: Hypotension; fatigue, drowsiness, dizziness, nervousness, headache, restlessness, malaise, confusion, depression, hallucinations, tremors, muscle twitches, increased intracranial pres-sure, seizure, serotonin syndrome; rash, urticaria, erythema; nausea, vomiting, constipation, anorex-ia, stomach cramps, xerostomia, biliary spasm, paralytic ileus, sphincter of Oddi spasm; ureteral spasms, urinary retention; pain at inj site; weak-ness; dyspnoea; histamine release, physical & psychological dependence; cardiac arrhythmias, cardiac arrest, circulatory depression; increased plasma adrenaline concentrations.
DI: Increased pethidine metabolite levels w/ aciclo-vir, cimetidine, ritonavir. Reduced analgesic effects w/ phenytoin. Additive sedative and/or resp depres-sive effects w/ alcohol, barbiturates, benzodiaz-epines, phenothiazines, TCAs, other CNS depres-sants. Increased risk of serotonin syndrome w/ MAOIs (not be given concurrently or w/in 14 days of their discontinuation), serotonin agonists, serotonin reuptake inhibitors, sibutramine, TCAs. Aggravates adverse effects of isoniazid.
N3 - Narcotic Drug Schedule 3
• Codeine • (antitussive/analgesic)
บรรเท�อ�ก�รไอรนแรง บรรเท�อ�ก�รปวดเลกนอยถงปวดรนแรง
I: Severe cough. Mild to severe pain.
CI: Respiratory depression, obstructive airway disease, asthma. Severe CNS depression, acute alcoholism, convulsive disorders, head injuries, brain tumours, comatose patients, raised intracra-nial pressure. Pregnancy (prolonged use or high doses at term).
SP: Hypothyroidism, adrenocortical insufficiency; asthma, impaired hepatic or renal function, pros-tatic hyperplasia, hypotension, shock, inflamma-tory or obstructive bowel disorders, myasthenia gravis. Infants, neonates; Reduce dose in elderly or debilitated patients. May impair ability to drive or operate machinery. Lactation. Patients who have undergone thoracotomies & laparotomies.
PINK PAGES 2013-FINAL-July31.indd 62 8/16/2013 3:28:02 PM
ÄRegistration expired
IMPORTANT DRUG NOTES 63 PN DEX 2013AR: Dependence, withdrawal symptoms; nausea, vomiting, constipation; drowsiness, confusion; difficulty in micturition, ureteric or biliary spasms, urinary retention; dry mouth, dizziness, sweating, facial flushing, headache, vertigo, visual distur-bances, mental clouding, depression, sedation, weakness, faintness, bradycardia, tachycardia, palpitations, orthostatic hypotension, hypother-mia, restlessness, agitation, nervousness, mood changes, decreased libido or potency, hallucina-tion, miosis; raised intracranial pressure, muscle rigidity. Respiratory depression & hypotension, w/ circulatory failure & deepening coma (larger doses). Excitement & convulsions (especially in childn & infants). Rhabdomyolysis.
DI: Enhanced depressant effects w/ alcohol, anaesthetics, anxiolytics, tranquilizers, sedatives & hypnotics, TCAs, antipsychotics. Possible CNS depression or excitation w/ MAOIs. May alter effects of other compounds e.g. cyclizine, mexile-tine, cisapride, metoclopramide & domperidone.
• ÄDextropropoxyphene •
บรรเท�ปวดระดบนอยถงป�นกล�ง
I: Mild to moderate pain.
CI: Hypersensitivity, chronic resp diseases, porphyria, pregnancy. Patients on MAOI treatment or w/in 2 wk of stopping treatment.
SP: Suicidal patients, hepatic or renal disease; lactation, elderly.
AR: Dizziness, drowsiness, sedation, weakness; nausea, vomiting, constipation; rash, urticaria; visual disturbances; physiological dependence. Convulsions in long-term therapy. Cardiac conduc-tion abnormalities & arrhythmias; liver impairment.
DI: Inhibits hepatic metabolism of benzodiaz-epines, b-blockers, carbamazepine, phenytoin & warfarin. Increased risk of toxicity when co-admin-istered w/ ritonavir. Potentiation of depressant effects when used w/ alcohol or CNS depressants. Accidental or intentional overdosage fatal (espe-cially if combined w/ alcohol, & analgesics e.g. paracetamol & aspirin).
• Diphenoxylate •
ชวยแกทองเสยเฉยบพลนและเรอรง
I: Acute & chronic diarrhoea.
CI: Infants & childn <4 yr. Jaundice, intestinal obstruction. Diarrhoea associated w/ pseudomem-branous colitis or enterotoxin-producing bacteria.
SP: Hepatic dysfunction, inflammatory bowel disease. Pregnancy, lactation; young children.
AR: Anorexia, nausea & vomiting, abdominal distention/discomfort, paralytic ileus, toxic megaco-lon, pancreatitis; headache, drowsiness, dizziness, restlessness, euphoria, depression, sedation, lethargy or insomnia, numbness of the extremi-ties; weakness, general malaise, resp depression, coma; hypersensitivity reactions, swelling of the gums.
DI: Potentiates effects of other CNS depressants (alcohol, barbiturates) & some anxiolytics. Theoreti-cal hypertensive crisis w/ MAOIs.
• Medicinal opium preparations •
บรรเท�ปวดไอและแกทองเสย
I: Analgesia. Cough. Diarrhoea.
CI: Severe hepatic & renal diseases; raised intrac-ranial pressure; acute resp depression or obstruc-tive airways disease; coma; prolonged use or high dosage near term.
SP: Hepatic or renal diseases; head injury, CNS depression, history of opioid agonist depend-ence; biliary tract or acute abdominal disorders; Addison’s disease; obesity; urinary difficulties; resp disease, resp depression, anoxia, hypercap-nia; thyroid disease; brain tumour, elevated CSF, seizures, acute alcoholism, delirium tremens, shock; infants<3 mth, debilitated patients & elderly; pregnancy.
AR: CNS depression, hypotension, dizziness, visu-al disturbances, mental clouding, sedation, coma, euphoria, weakness, faintness, agitation, restless-ness, nervousness, seizures, delirium, insomnia, drowsiness & palpitation, bradycardia; sweat-ing, flushing, pruritis, urticaria; malaise; urinary tract spasm & reduction in urination; constipation, nausea & vomiting; miosis. Severe resp depres-sion; increased intracranial pressure.
DI: Increased CNS depression w/ alcohol, other opiate agonists, general anaesthetics, tranquil-lizers, sedatives & hypnotics. However, some tranquillizers such as phenothiazines may antagonize the effect of opiate analgesia; opium prep may increase the effect of TCAs & MAOIs. Reduced effectiveness of diuretics in patients w/ CHF. Should not be given to patients bitten by Centruroides sculpturatus Ewing & C. gertschi Stahnke scorpions as opiate agonist may potenti-ate the effect of the venoms. May cause serotonin syndrome if used w/ MAOIs.
PINK PAGES 2013-FINAL-July31.indd 63 8/15/2013 3:09:54 PM
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
P2
alprazolam
ALCELAM 0.25 mg 100ALCELAM 0.5 mg 259ALCELAM 1 mg 308ALLAM 0.25 mg 116ALLAM 0.5 mg 275ALLAM 1 mg 320ALNAX 0.25 mg 099ALNAX 0.5 mg 258ALNAX 1 mg 307ALPAZAM 0.25 mg 101ALPAZAM 0.5 mg 260ALPAZAM 1 mg 261ALPRALAN 0.25 mg 036ALPRALAN 0.5 mg 240ALPRAMED 0.25 mg 276ALPRAMED 0.5 mg 117ALPRAMED 1 mg 421ALPRAX 0.25 mg 161ALPRAX 0.5 mg 195ALPRAX 1 mg 052ALPRAXOL 0.25 mg 017ALPRAXOL 0.5 mg 235ALPRAZOLAM FRX
0.25 mg 122ALPRAZOLAM FRX
0.5 mg 282ANAX 0.25 mg 097ANAX 0.5 mg 256ANPRESS 0.25 mg 102ANPRESS 0.5 mg 274ANPRESS 1 mg 309ANZION 0.25 mg 098ANZION 0.5 mg 257ANZION 1 mg 306DIZOLAM 0.25 mg 103DIZOLAM 0.5 mg 262DIZOLAM 1 mg 324FARZOLAM 0.25 mg 104FARZOLAM 0.5 mg 263FARZOLAM 1 mg 310INZOLAM 0.25 mg 118INZOLAM 0.5 mg 277INZOLAM 1 mg 321
MANEX 0.25 mg 106MANEX 0.5 mg 264MANEX 1 mg 311MARZOLAM 0.25 mg 107MARZOLAM 0.5 mg 265MARZOLAM 1 mg 312MITRANAX 0.25 mg 119MITRANAX 0.5 mg 278MITRANAX 1 mg 322MOXINAX 0.25 mg 108MOXINAX 0.5 mg 266PHARNAX 0.25 mg 109PHARNAX 0.5 mg 267PHARNAX 1 mg 313PRAZOL 0.25 mg 110PRAZOL 0.5 mg 268PRAZOL 1 mg 314SIAMPRAXOL 0.25 mg 111SIAMPRAXOL 0.5 mg 269SIAMPRAXOL 1 mg 315SUNAX 0.25 mg 120SUNAX 0.5 mg 279XALAM 0.25 mg 112XALAM 0.5 mg 270XALAM 1 mg 316XANACINE 0.25 mg 113XANACINE 0.5 mg 271XANACINE 1 mg 317XANAX 0.25 mg 114XANAX 0.5 mg 272XANAX 1 mg 318XANAX XR 0.5 mg 372XANAX XR 1 mg 079XANAX XR 2 mg 381XIEMED 0.25 mg 121XIEMED 0.5 mg 280XIEMED 1 mg 323ZOLAM 0.25 mg 115ZOLAM 0.5 mg 273ZOLAM 1 mg 319
buprenorphine hydrochloride
BUPRINE 0.2 mg 001TEMGESIC
0.3 mg/mL x 1 mL 666TEMGESIC 0.2 mg 007
cathine
D-NORPSEUDOEPHEDRINE SR OSMOPHARM 20 mg 517
MIRAPRONT N 20 mg 516
diethylpropion hydrochloride
DIETIL RETARD 75 mg 096
PREFAMONE 75 mg 191
REGENON RETARD 75 mg 130
REGENON RETARD 75 mg 504
diethylpropion resinate
ATRACTIL 75 mg 505
ephedrine hydrochloride
EPHEDRINE GPO 30 mg/mL x 1 mL 632
flunitrazepam
ROHYPNOL 1 mg 423
flurazepam hydrochloride
DALMADORM 15 mg 512
ketamine hydrochloride
CALYPSOL 50 mg/mL x 10 mL 675
KETA-HAMELN 50 mg/mL x 10 mL 678
KETALAR 50 mg/mL x 10 mL 679
lormetazepam
LORAMET 1 mg 105
CONTROLLED SUBSTANCE CLASS INDEX
ดชนเภสชภณฑจดเรยงตามกลม/ประเภทของทะเบยน
Controlled Substance Class-Aug13.indd 64 8/14/2013 2:43:23 PM
CONTROLLED SUBSTANCE CLASS INDEX 65PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
CO
NT
RO
LL
ED
SU
BS
TAN
CE
CL
AS
S IN
DE
X
methylphenidate hydrochloride
CONCERTA 18 mg 186CONCERTA 27 mg 439CONCERTA 36 mg 129METHYLPHENIDATE
HEXAL 10 mg 060RITALIN 10 mg 042RUBIFEN 10 mg 043
midazolam
DORMICUM 5 mg/mL x 1 mL 630
DORMICUM 15 mg/3 mL x 3 mL 631
DORMICUM 15 mg 379MIDAZ
5 mg/mL x 1 mL 644MIDAZ
5 mg/mL x 3 mL 645MIDAZOLAM HEXAL
5 mg/mL x 1 mL 646MIDAZOLAM HEXAL
5 mg/mL x 3 mL 647
nitrazepam
ALODORM 5 mg 090MOGADON 5 mg 091NITRADOS 5 mg 072
phentermine hydrochloride
PANBESY 15 mg 450PANBESY 30 mg 487PHENTERMINE
OSMOPHARM 15 mg 477
phentermine resinate
DUROMINE 15 mg 527DUROMINE 30 mg 521PHENTERMINE
TRENKER 15 mg 492PHENTERMINE
TRENKER 30 mg 451
phenylpropanolamine hydrochloride
PHENYLPROPANOLAMINE PHARMASANT 25 mg 157
pseudoephedrine hydrochloride
PSEUDOEPHEDRINE ASIAN PHARM 30 mg/5 mL x 60 mL 616
PSEUDOEPHEDRINE ASIAN PHARM 30 mg 158
PSEUDOEPHEDRINE ASIAN PHARM 60 mg 048
PSEUDOEPHEDRINE BJ BENJAOSOTH 30 mg/5 mL x 60 mL 617
PSEUDOEPHEDRINE BJ BENJAOSOTH 60 mg 152
PSEUDOEPHEDRINE DEFENCE OF PHARMACEUTICAL FACTORY 30 mg 049
PSEUDOEPHEDRINE DEFENCE OF PHARMACEUTICAL FACTORY 60 mg 050
PSEUDOEPHEDRINE GPO 30 mg 062
PSEUDOEPHEDRINE GPO 60 mg 063
PSEUDOEPHEDRINE MEDICINE PRODUCTS 60 mg 207
PSEUDOEPHEDRINE MILANO 30 mg/5 mL x 60 mL 618
PSEUDOEPHEDRINE MILANO 30 mg 153
PSEUDOEPHEDRINE MILANO 60 mg 046
temazepam
EUHYPNOS 20 20 mg 427
triazolam
HALCION 0.25 mg 378
TRIALAM 0.25 mg 185
TRYCAM 0.25 mg 376
zolpidem hemitartrate
STILNOX 10 mg 123
zolpidem tartrate
DACTIVE 10 10 mg 053
ZOLPIDEM TARTRATE RIVOPHARM 10 mg 124
ZOPIM 10 mg 125
P3
amobarbital
AMA† 159AMYTAL 0.5 g 674
meprobamate
REINBAMATE 400 mg 094
pentazocine
PENTAZOCINE ALL PLANTS 30 mg/mL x 1 mL 655
TAZCINE 30 mg/mL x 1 mL 665
TAZCINE 25 mg 066TAZCINE 50 mg 252
pentazocine lactate
FORTWIN 30 mg/mL x 1 mL 641
PANGON 30 mg/mL x 1 mL 654
SOSEGON 30 mg/mL x 1 mL 664
pentobarbital sodium
NEMBUTAL 54.7 mg/mL x 100 mL 680
P4
bromazepam
LEXOTAN 1.5 mg 080LEXOTAN 3 mg 254
butobarbital
BELLOID† 139
Controlled Substance Class-Aug13.indd 65 8/14/2013 2:43:23 PM
66 CONTROLLED SUBSTANCE CLASS INDEX PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
CO
NT
RO
LL
ED
SU
BS
TAN
CE
CL
AS
S IN
DE
X
chlordiazepoxide
DIRAX† 413LIBRAX† 409
chlordiazepoxide hydrochloride
BENPINE 5 mg 435BENPINE 10 mg 526BENPINE 25 mg 218CEBARAX† 406CHLORDIAZEPOXIDE
ACDHON 10 mg 529CHLORDIAZEPOXIDE
CHAROEN BHAESAJ 10 mg 528
CHLORDIAZEPOXIDE MARCH PHARMA 25 mg 503
CHLORDIAZEPOXIDE T MAN 10 mg 401
CHLORDIBRAX† 407CHLORDIXIDE 5 mg 386CHLORDIXIDE 10 mg 220CHLORZEP 5 mg 387COMOBEN 5 mg 390COMOBEN 10 mg 510COZEP 10 mg 149COZEP 25 mg 202EPOXIDE 10 mg 211EPOXIDE 25 mg 217KENSPA† 251LICON† 410MED-ZEPOXIDE 5 mg 494MED-ZEPOXIDE 10 mg 059METAXIDE 10 mg 515MINOXIDE 10 mg 493MODURAX† 405POBRAX† 403PONDNEBIUM 5 mg 399PONDNEBIUM 10 mg 216RADIBRAX† 420TUMAX† 428UTORAX† 411ZEPOBRAX† 412ZEPOXIDE 5 mg 437ZEPOXIDE 10 mg 305ZEPOXIN 5 mg 230ZEPOXIN 10 mg 132
clobazam
FRISIUM 5 mg 038FRISIUM 10 mg 039
clonazepam
ANCORIL 0.5 mg 209CLONARIL 1 mg 370CLONARIL 2 mg 069CONVULSIL 2 mg 070POVANIL 0.5 mg 210POVANIL 1 mg 179POVANIL 2 mg 076PRENARPIL 0.5 mg 196PRENARPIL 1 mg 367PRENARPIL 2 mg 061RIVOTRIL
1 mg/mL x 1 mL 661RIVOTRIL 0.5 mg 197RIVOTRIL 2 mg 064
clorazepate dipotassium
ANXENE 5 mg 455ANXENE 10 mg 288ANXIELAX 5 mg 486CEXENE 5 mg 473CEXENE 10 mg 299CLORAMED 5 mg 456CLORAMED 10 mg 290CLORAXENE 5 mg 462CLORAZE 5 mg 458CLORAZE 10 mg 292CLOZENE 5 mg 446CLOZENE 10 mg 478CLOZEPATE 5 mg 466CONZEP 5 mg 480CONZEP 10 mg 447DEDA 5 mg 463DEDA 10 mg 291DIPOSEF 5 mg 453DIPOSEF 10 mg 284DIPOT 5 mg 459DOPAM 5 mg 148EXAN 5 mg 508EXAN 10 mg 511FLULIUM 5 mg 467FLULIUM 10 mg 300FREXENE 5 mg 441FREXENE 10 mg 445GAXENE 5 mg 474MANOTRAN 5 mg 461MANOTRAN 10 mg 289POLIZEP 5 mg 468POLIZEP 10 mg 294POMADOM 5 mg 481POMADOM 10 mg 449POSENE 5 mg 189
POSENE 10 mg 430SANOR 5 mg 454SANOR 10 mg 285SERENE MASA LAB
10 mg 286SERENE V S PHARMA
5 mg 457TAMYLAB-S 5 mg 469TENMED 5 mg 470TENMED 10 mg 296T-FIVE 5 mg 471TRANADON-S 5 mg 475TRANCAP 5 mg 496TRANCAP 10 mg 190TRANCLOR 5 mg 464TRANCLOR 10 mg 297TRANCON 5 mg 482TRANCON 10 mg 448TRANMED 5 mg 452TRANMED 10 mg 287TRANPATE 5 mg 442TRANPON 5 mg 472TRANSPON FORTE
10 mg 283TRANXENE 5 mg 465TRANXENE 10 mg 298TRANZEP 5 mg 460UPTRAN 10 mg 293UPZENE 5 mg 509ZETRAN 5 mg 476
diazepam
AZEPAM 2 mg 219AZEPAM 5 mg 326A-ZERAX 2 mg 479A-ZERAX 5 mg 489CALMIPAM 2 mg 388CALMIPAM 5 mg 302DIADON 5 mg 377DIAMED 2 mg 531DIAMED 5 mg 518DIANO 2 mg 010DIANO 5 mg 154DIAPAM 2 mg 396DIAPAM 5 mg 355DIAPINE
5 mg/mL x 1 mL 625DIAPINE
10 mg/2 mL x 2 mL 626DIAPINE CAPSULE
2 mg 499DIAPINE CAPSULE
5 mg 506
Controlled Substance Class-Aug13.indd 66 8/14/2013 2:43:23 PM
CONTROLLED SUBSTANCE CLASS INDEX 67PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
CO
NT
RO
LL
ED
SU
BS
TAN
CE
CL
AS
S IN
DE
X
DIAPINE TABLET 2 mg 011
DIAPINE TABLET 5 mg 183
DIAPINE TABLET 10 mg 414
DIAZ 2 mg 071
DIAZ 5 mg 173
DIAZ 10 mg 369
DIAZA 2 mg 361
DIAZA 5 mg 162
DIAZA 10 mg/2 mL x 2 mL 627
DIAZEPAM ACDHON 2 mg 498
DIAZEPAM BJ BENJAOSOTH 2 mg 054
DIAZEPAM BJ BENJAOSOTH 5 mg 402
DIAZEPAM BJ BENJAOSOTH 10 mg 249
DIAZEPAM CHAROEN BHAESAJ 2 mg 362
DIAZEPAM GENERAL DRUGS HOUSE 2 mg 345
DIAZEPAM GENERAL DRUGS HOUSE 5 mg 163
DIAZEPAM GPO 10 mg/2 mL x 2 mL 628
DIAZEPAM GPO 2 mg 055
DIAZEPAM GPO 5 mg 164
DIAZEPAM GPO 10 mg 363
DIAZEPAM H K PHARM 2 mg 243
DIAZEPAM H K PHARM 5 mg 176
DIAZEPAM H K PHARM 10 mg 371
DIAZEPAM LERD SINGH 2 mg 075
DIAZEPAM LERD SINGH 5 mg 177
DIAZEPAM POND'S CHEMICAL 2 mg 395
DIAZEPAM POND'S CHEMICAL 5 mg 178
DIAZEPAM POND’S CHEMICAL 5 mg 242
DIAZEPAM SAMAKEEPHAESAJ 2 mg 391
DIAZEPAM SAMAKEEPHAESAJ 5 mg 155
DIAZEPAM SOMMAI BHAESAJ 5 mg 346
DIAZEPAM T MAN 2 mg 392
DIAZEPAM T MAN 5 mg 180
DIAZEPAM T MAN 5 mg 236
DIAZEPAM T MAN 10 mg 353
DIAZEPAM T P DRUG 10 mg/2 mL x 2 mL 629
DIAZEPAM T P DRUG 2 mg 012
DIAZEPAM T P DRUG 5 mg 165
DIAZEPAM T P DRUG 10 mg 364
DIAZEPAM VESCO 2 mg 351
DIAZEPAM VESCO 5 mg 147
DIAZEPION 2 mg 514
DIAZEPION 5 mg 500
DIAZEPION 10 mg 215
DILIUM 2 mg 200
DILIUM 5 mg 354
DIMED 2 mg 078
DIMED 5 mg 181
DIPAM 2 mg 037
DIPAM 5 mg 150
DIPAM 10 mg 357
DITRAN 2 mg 444
DITRAN 5 mg 501
DIVOPAN 2 mg 056
DIVOPAN 5 mg 166
DIZAN 2 mg 483
DIZAN 5 mg 443
DIZEP 2 mg 188
DIZEP 5 mg 214
DIZEPAM 2 mg 250
DIZEPAM 5 mg 167
DZP2 2 mg 497
LAYLIUM-10 10 mg/2 mL x 2 mL 642
MANODIAZO 2 mg 495
MANODIAZO 5 mg 530
MANODIAZO 10 mg 365
MANOLIUM 10 mg/2 mL x 2 mL 643
MED-ZEPAM 2 mg 041
MED-ZEPAM 5 mg 366
MONOZIDE 2 mg 525
MONOZIDE-10 10 mg/2 mL x 2 mL 648
PAM 5 mg 231
POPAM 2 mg 126
POPAM 5 mg 187
ROPAM 10 mg/2 mL x 2 mL 662
ROPAM 5 mg 174
S.CO ZEPAM 5 mg 246
SIPAM 10 mg/2 mL x 2 mL 663
SIPAM 2 mg 065
SIPAM 5 mg 168
SIPAM 10 mg 368
STESOLID 2 mg 431
STESOLID 5 mg 507
STESOLID 10 mg 513
TRANOLAN 10 mg/2 mL x 2 mL 667
TRANOLAN 2 mg 145
TRANOLAN 5 mg 201
V DAY ZEPAM 10 mg/2 mL x 2 mL 668
V DAY ZEPAM 2 mg 502
V DAY ZEPAM 5 mg 491
V DAY ZEPAM NL 10 mg/2 mL x 2 mL 669
VALAX 2 mg 032
VALAX 5 mg 146
VALAX 10 mg 349
VALENIUM 2 mg 077
VALENIUM 5 mg 169
VALIUM 10 mg/2 mL x 2 mL 670
VALIUM 5 mg 170
VASON 2 mg 425
VESCOPAM 10 mg/2 mL x 2 mL 671
VISPAM 2 mg 394
VISPAM 5 mg 239
VISPAM 10 mg 350
VOMED 2 mg 067
VOMED 5 mg 171
VORAPAM 2 mg 073
VORAPAM 5 mg 175
WINOPAM 2 mg 074
WINOPAM 5 mg 404
ZAM 2 mg 068
ZAM 5 mg 172
ZEPAM 10 mg/2 mL x 2 mL 672
ZEPAM 2 mg 429
ZEPAM 5 mg 382
Controlled Substance Class-Aug13.indd 67 8/14/2013 2:43:23 PM
68 CONTROLLED SUBSTANCE CLASS INDEX PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
CO
NT
RO
LL
ED
SU
BS
TAN
CE
CL
AS
S IN
DE
X
ZEPAXID 10 mg/2 mL x 2 mL 673
ZEPAXID 2 mg 532ZEPAXID 5 mg 488ZOPAM 2 mg 051ZOPAM 5 mg 160ZOPAM 10 mg 359
ethyl loflazepate
MEILAX 1 mg 022MEILAX 2 mg 199VICTAN 2 mg 204
lorazepam
ANTA 0.5 mg 330ANTA 1 mg 018ANTA 2 mg 138ANXIRA 0.5 mg 327ANXIRA 1 mg 021ATIVAN 0.5 mg 332ATIVAN 1 mg 023ATIVAN 2 mg 141HAWKCOPAX 0.5 mg 348HAWKCOPAX 1 mg 393KEMORA 0.5 mg 434KEMORA 1 mg 024LIZAVAN 0.5 mg 333LIZAVAN 1 mg 025LONZA 0.5 mg 339LONZA 1 mg 020LORA 0.5 mg 397LORA 1 mg 040LORA 2 mg 244LORAMED 0.5 mg 334LORAMED 1 mg 026LORAMED 2 mg 237LORA-P 0.5 mg 347LORA-P 1 mg 013LORA-P 2 mg 137LORAPAM 0.5 mg 336LORAPAM 1 mg 027LORAPAM 2 mg 142LORAPINE 0.5 mg 340LORAPINE 1 mg 033LORAVAN 0.5 mg 329LORAVAN 1 mg 028LORAZE 1 mg 044LORAZENE 0.5 mg 328LORAZENE 1 mg 014LORAZENE 2 mg 143LORAZEP 0.5 mg 337
LORAZEP 1 mg 005
LORAZEP 2 mg 385
LORAZEPAM ACDHON 0.5 mg 344
LORAZEPAM ACDHON 1 mg 034
LORAZEPAM MACROPHAR 1 mg 400
LORAZIN 0.5 mg 352
LORAZIN 1 mg 045
LORAZIN 2 mg 253
LOZEPAM 0.5 mg 331
LOZEPAM 1 mg 193
ORA 0.5 mg 338
ORA 1 mg 029
ORA 2 mg 238
PORA 0.5 mg 398
PORA 1 mg 151
PORA 2 mg 241
RAZEPAM 0.5 mg 342
RAZEPAM 1 mg 031
RAZEPAM 2 mg 144
TRANAVAN 0.5 mg 335
TRANAVAN 1 mg 035
VEMED 0.5 mg 343
ZEDA 0.5 mg 016
ZEDA 1 mg 389
ZORA 0.5 mg 356
ZORA 2 mg 205
medazepam
CELIUM 5 mg 426MEDAZINE 5 mg 519MEDAZINE 10 mg 520
phenobarbital
BENERA† 433DONNATAL† 057MENOBARB 60 mg 208NEURAMIZONE† 432
phenobarbital sodium
BELLADONNA ALKALOIDS W/ PHENOBARBITAL† 247
BELLERGAL† 232
ELIXIR PHENOBARB 60 mL 556
GARDENAL 200 mg/4 mL 677
MENOBARB 15 mg/5 mL x 60 mL 563
MENOBARB 20 mg/5 mL x 60 mL 564
PHENOBARB 30 mg 233PHENOBARB 60 mg 047PHENOBARB ELIXIR
20 mg/5 mL x 60 mL 594PHENOBARBITAL
ACDHON 15 mg 384PHENOBARBITAL
ACDHON 30 mg 136PHENOBARBITAL
ACDHON 60 mg 030PHENOBARBITAL
ATLANTIC 16.25 mg 234PHENOBARBITAL
ATLANTIC 32.5 mg 436PHENOBARBITAL
ATLANTIC 65 mg 015PHENOBARBITAL
ATLANTIC 100 mg 303PHENOBARBITAL
CHEW BROTHERS 30 mg 341
PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 30 mL 595
PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 60 mL 596
PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 120 mL 597
PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 240 mL 598
PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 450 mL 599
PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 500 mL 600
PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 1000 mL 601
PHENOBARBITONE NEW LIFE PHARMA 30 mg 006
PHENOBARBITONE NEW LIFE PHARMA 60 mg 203
PHENOCO ELIXIR 20 mg/5 mL x 450 mL 602
PHENOCO ELIXIR 20 mg/5 mL x 3800 mL 603
PHENOCON 60 mg 255PHENOSIL ELIXIR
20 mg/5 mL x 60 mL 604
Controlled Substance Class-Aug13.indd 68 8/14/2013 2:43:23 PM
CONTROLLED SUBSTANCE CLASS INDEX 69PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
CO
NT
RO
LL
ED
SU
BS
TAN
CE
CL
AS
S IN
DE
X
PHENOSIL ELIXIR 20 mg/5 mL x 450 mL 605
PHENOTAL ELIXIR 20 mg/5 mL x 60 mL 606
pinazepam
DOMAR 5 mg 490
prazepam
POZAPAM 5 mg 485POZAPAM 10 mg 192PRASEPINE 5 mg 484
tofisopam
GRANDAXIN 50 mg 058
N2
codeine phosphate
CODEINE GPO 15 mg 003
CODEINE GPO 30 mg 019
fentanyl
DUROGESIC PATCH 12 mcg/hr 681
DUROGESIC PATCH 25 mcg/hr 682
DUROGESIC PATCH 50 mcg/hr 683
DUROGESIC PATCH 100 mcg/hr 684
FENTADUR 25 mcg/hr 685
FENTANYL ANTIGEN 0.05 mg/mL x 2 mL 633
FENTANYL ANTIGEN 0.05 mg/mL x 10 mL 634
FENTANYL GPO 12 mcg/hr 686
FENTANYL GPO 25 mcg/hr 687
FENTANYL GPO 50 mcg/hr 688
FENTANYL HEXAL 12 mcg/hr 689
FENTANYL HEXAL 25 mcg/hr 690
FENTANYL HEXAL 50 mcg/hr 691
fentanyl citrate
FENTANYL JANSSEN-CILAG 0.05 mg/mL x 2 mL 635
FENTANYL JANSSEN-CILAG 0.05 mg/mL x 10 mL 636
FENTANYL SANDOZ 0.05 mg/mL x 2 mL 637
FENTANYL SANDOZ 500 mcg/10 mL 676
FENTANYL-HAMELN 50 mcg/mL x 2 mL 638
FENTANYL-HAMELN 50 mcg/mL x 10 mL 639
FENTANYL-SNS 50 mcg/mL x 2 mL 640
methadone hydrochloride
METHADONE GPO 10 mg/mL x 1000 mL 565
METHADONE GPO 5 mg 140
morphine
OPIUM TINCTURE GPO 1% x 450 mL 585
morphine sulfate
KAPANOL 20 mg 133KAPANOL 50 mg 134KAPANOL 100 mg 135MORPHINE
SALUTAS PHARMA 10 mg 438
MORPHINE SALUTAS PHARMA 30 mg 358
MORPHINE SALUTAS PHARMA 60 mg 245
MORPHINE SULFATE GPO 10 mg/5 mL 577
MORPHINE SULFATE GPO 10 mg 156
MORPHINE SULFATE INJ BLUE 10 mg/mL x 1 mL 649
MORPHINE SULFATE INJ PURPLE 10 mg/mL x 1 mL 650
MORPHINE T P DRUG 10 mg/mL x 1 mL 651
MORPHINE T P DRUG 10 mg/mL x 1 mL 652
MORPHINE T P DRUG 10 mg/mL x 1 mL 653
MST CONTINUS 10 mg 194
MST CONTINUS 30 mg 304
MST CONTINUS 60 mg 206
ORAMORPH 10 mg/5 mL x 250 mL 586
ORAMORPH 20 mg/mL x 30 mL 587
pethidine hydrochloride
PETHIDINE BIOLAB 100 mg/2 mL x 2 mL 656
PETHIDINE HAMELN 50 mg/mL 657
PETHIDINE M & H MANUFACTURING 50 mg/mL x 1 mL 658
PETHIDINE M & H MANUFACTURING 100 mg/2 mL x 2 mL 659
PETHIDINE T P DRUG 50 mg/mL x 1 mL 660
N3
camphorated opium tincture
BROWN MIXTURE GPO† 180 mL 538
BROWN MIXTURE GPO† 450 mL 539
BROWN MIXTURE OSOTH INTERLAB† 180 mL 540
CAMPHORATED OPIUM TINCTURE GPO 1000 mL 541
COUGH SYRUP GPO† 60 mL 553
MIST TUSSIS† 450 mL 567
MIST. SCILL AMMON. GPO† 180 mL 568
MIXTURE SCILLAE AMMON† 180 mL 569
Controlled Substance Class-Aug13.indd 69 8/14/2013 2:43:23 PM
70 CONTROLLED SUBSTANCE CLASS INDEX PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
CO
NT
RO
LL
ED
SU
BS
TAN
CE
CL
AS
S IN
DE
X
MIXTURE TUSSIS† 30 mL 570
MIXTURE TUSSIS† 60 mL 571
MIXTURE TUSSIS† 120 mL 572
MIXTURE TUSSIS† 240 mL 573
MIXTURE TUSSIS† 450 mL 574
MIXTURE TUSSIS† 1800 mL 575
MIXTURE TUSSIS† 3600 mL 576
SQUILL AND AMMONIA
VIDHYASOM† 450 mL 619
codeine
CODIPRONT† 522CODIPRONT† 523CODIPRONT SYRUP†
60 mL 543
codeine phosphate
BENADRYL CD† 60 mL 533
BENADRYL CD† 1000 mL 534
BENYLIN CD† 60 mL 535BLUCO† 383BLUCON† 360BONADINE CD† 60 mL 536BROMTUSSIA DC†
60 mL 537BRONPECT† 325CEMOL CODEINE† 081CENTRODINE CD† 248CLINEPECT† 524CLINOPECT† 221CLINOPRONT† 408COCET† 082CO-COF† 182CODEE-C† 416CODENOL† 15 mg 422CODEPECT† 227CODESIA† 419CODESIA† 60 mL 542CODICET† 440CODICET BLUE 300† 380CODICET PINK† 15 mg 281CODIGESIC† 127CODYL COUGH LINCTUS†
60 mL 544
CODYL COUGH LINCTUS† 100 mL 545
CODYL COUGH LINCTUS† 1000 mL 546
CODYL COUGH LINCTUS† 4500 mL 547
COFCODYL† 60 mL 548COFCODYL† 100 mL 549COMODINE COUGH†
60 mL 550CONADYL† 60 mL 551CORYNIL† 225COSEDYL† 60 mL 552COTENOL† 085DECOS† 100 mL 554DIMETANE
EXPECTORANT DC† 2.5 L 555
HISEDYL† 60 mL 557HISEDYL† 120 mL 558MANTADYL COUGH†
60 mL 559MASADYL COUGH†
60 mL 560MASADYL COUGH†
100 mL 561MASADYL COUGH†
240 mL 562MASAPARA W/ CODEINE† 198MILA-CONO† 60 mL 566MILA-TERCON† 184NASA W/ CODEINE† 092NEO COUGH† 60 mL 578NEO COUGH† 100 mL 579NEO COUGH† 240 mL 580NEOCOD† 373NEO-CODEIN† 374NEOCOF† 212NEO-COPHEN 10 mg 222NEOPECT† 224NORDYL LINCTUS†
100 mL 581NORDYL LINCTUS†
500 mL 582NORTUSS LINCTUS†
100 mL 583NORTUSS LINCTUS†
500 mL 584PACOGESIC† 213PARA WITH CODEINE†
15 mg 083PARA WITH CODEINE†
30 mg 084PARA-CO 15 mg 375PARADEINE† 086PARADYL 8 mg 095PARAGEN CO† 128PARAMED-CO† 424
PARCOD† 089PARCONO† 093P-CODYL† 60 mL 588P-CODYL† 120 mL 589PERCIDYL COUGH†
100 mL 590PHENCODIN† 60 mL 591PHENCODIN† 500 mL 592PHENCODIN† 1000 mL 593PHENSEDYL OLIC†
100 mL 607PHENSODI† 60 mL 608PHENSODI† 120 mL 609PHENSODI† 1000 mL 610POLY-COF† 60 mL 611POLY-COF† 100 mL 612POLYDINE CD† 295PONDNADYL† 60 mL 613PONDNADYL† 100 mL 614PONDNADYL† 1000 mL 615ROLAR† 228ROPECT† 226ROTUSS† 229SECO† 417TENADRIN-C† 60 mL 620TERADENE† 60 mL 621TERADYL† 60 mL 622TERADYL† 1000 mL 623TERCO-C† 415TOCODYL† 418TUSSIDYL† 60 mL 624TYLENOL WITH
CODEINE† 087TYLENOL WITH
CODEINE† 088ZORITUSS 10 mg 223
dextropropoxyphene hydrochloride
DAVOL† 301
dextropropoxyphene napsylate
PARDEX 32.5 mg 131
diphenoxylate hydrochloride
DILOMIL† 002DITROPINE† 008LOMOTIL† 004SPASIL† 009
Controlled Substance Class-Aug13.indd 70 8/14/2013 2:43:24 PM
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
2M (Med-Maker)2 เอม (เมด-เมเกอร)
ANPRESS 0.25 mg 102ANPRESS 1 mg 309CONVULSIL 2 mg 070XIEMED 0.5 mg 280
a N H Productsเอ เอน เอช โปรดคส
COMOBEN 5 mg 390COMOBEN 10 mg 510COMODINE COUGH†
60 mL 550DIVOPAN 2 mg 056DIVOPAN 5 mg 166
acdHoNแอคดอน
CHLORDIAZEPOXIDE ACDHON 10 mg 529
DIADON 5 mg 377DIAZEPAM
ACDHON 2 mg 498LORAZEPAM
ACDHON 0.5 mg 344LORAZEPAM
ACDHON 1 mg 034PHENOBARBITAL
ACDHON 15 mg 384PHENOBARBITAL
ACDHON 30 mg 136PHENOBARBITAL
ACDHON 60 mg 030PHENOBARBITAL
ELIXIR ACDHON 20 mg/5 mL x 30 mL 595
PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 60 mL 596
PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 120 mL 597
PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 240 mL 598
PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 450 mL 599
PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 500 mL 600
PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 1000 mL 601
TRANADON-S 5 mg 475
all PlaNtsออลแพลนทส
PENTAZOCINE ALL PLANTS 30 mg/mL x 1 mL 655
alPHaPHarM/Fdaอลฟาฟารม/อย.
ALODORM 5 mg 090
TRIALAM 0.25 mg 185
aNtigeN/Fdaแอนตเจน/อย.
FENTANYL ANTIGEN 0.05 mg/mL x 2 mL 633
FENTANYL ANTIGEN 0.05 mg/mL x 10 mL 634
asiaN PHarMเอเชยนฟารมาซตคล
ALPRAXOL 0.25 mg 017
ALPRAXOL 0.5 mg 235
A-ZERAX 2 mg 479
A-ZERAX 5 mg 489
BROMTUSSIA DC† 60 mL 537
CODENOL† 15 mg 422
CODESIA† 419
CODESIA† 60 mL 542
DIPOT 5 mg 459
DITROPINE† 008
LORAZEP 0.5 mg 337
LORAZEP 1 mg 005
LORAZEP 2 mg 385
PHENOTAL ELIXIR 20 mg/5 mL x 60 mL 606
asiaN PHarM/Fdaเอเชยนฟารมาซตคล/อย.
PSEUDOEPHEDRINE ASIAN PHARM 30 mg 158
PSEUDOEPHEDRINE ASIAN PHARM 60 mg 048
PSEUDOEPHEDRINE ASIAN PHARM 30 mg/5 mL x 60 mL 616
atlaNtic labแอตแลนตค
AMA† 159BENPINE 5 mg 435BENPINE 10 mg 526BENPINE 25 mg 218DIAPINE
5 mg/mL x 1 mL 625DIAPINE
10 mg/2 mL x 2 mL 626DIAPINE CAPSULE
2 mg 499DIAPINE CAPSULE
5 mg 506DIAPINE TABLET
2 mg 011DIAPINE TABLET
5 mg 183DIAPINE TABLET
10 mg 414DIZOLAM 0.25 mg 103DIZOLAM 0.5 mg 262DIZOLAM 1 mg 324LORA 0.5 mg 397LORA 1 mg 040LORA 2 mg 244PHENOBARBITAL
ATLANTIC 16.25 mg 234PHENOBARBITAL
ATLANTIC 32.5 mg 436PHENOBARBITAL
ATLANTIC 65 mg 015PHENOBARBITAL
ATLANTIC 100 mg 303
aveNtisอเวนตส
FRISIUM 10 mg 039
MANUFACTURER’S INDEX
ดชนเภสชภณฑจดเรยงตามชอผผลต
MNF INDEX CLASS-FINAL-Aug13.indd 71 8/14/2013 2:48:37 PM
72 MANUFACTURER’S INDEX PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
Ma
Nu
Fac
tu
re
r’s
iNd
eX
b l Huaบ เอล ฮว
BLUCON† 360CODICET† 440CODICET PINK† 15 mg 281TENADRIN-C† 60 mL 620TERADENE† 60 mL 621TERCO-C† 415
baNgkok lab & cosMeticบางกอกแลปแอนดคอสเมตค
ANZION 0.25 mg 098ANZION 0.5 mg 257ANZION 1 mg 306CLINEPECT† 524CLINOPECT† 221CLINOPRONT† 408CODIGESIC† 127COFCODYL† 60 mL 548COFCODYL† 100 mL 549DIAZ 2 mg 071DIAZ 5 mg 173DIAZ 10 mg 369LIZAVAN 0.5 mg 333LIZAVAN 1 mg 025PACOGESIC† 213ZEPOBRAX† 412
bard/Fdaบารด/อย.
MST CONTINUS 10 mg 194MST CONTINUS 30 mg 304MST CONTINUS 60 mg 206
beMed PHarMaบเมดฟารมา
CHLORZEP 5 mg 387
berliN PHarMเบอรลนฟารมาซตคอล
LORAZENE 0.5 mg 328LORAZENE 1 mg 014LORAZENE 2 mg 143
biolabไบโอแลป
SANOR 5 mg 454SANOR 10 mg 285STESOLID 5 mg 507STESOLID 10 mg 513
biolab/Fdaไบโอแลป/อย.
PETHIDINE BIOLAB 100 mg/2 mL x 2 mL 656
bJ beNJaosotHบเจ (เบญจโอสถ)
DAVOL† 301DIAZEPAM
BJ BENJAOSOTH 2 mg 054
DIAZEPAM BJ BENJAOSOTH 5 mg 402
DIAZEPAM BJ BENJAOSOTH 10 mg 249
MINOXIDE 10 mg 493
bJ beNJaosotH/Fdaบเจ (เบญจโอสถ)/อย.
PSEUDOEPHEDRINE BJ BENJAOSOTH 30 mg/5 mL x 60 mL 617
PSEUDOEPHEDRINE BJ BENJAOSOTH 60 mg 152
boeHriNger iNgelHeiM/Fdaเบอรงเกอร อนเกลไฮม/อย.
ORAMORPH 10 mg/5 mL x 250 mL 586
ORAMORPH 20 mg/mL x 30 mL 587
britisH disPeNsaryองกฤษตราง (แอล พ)
ZEDA 0.5 mg 016ZEDA 1 mg 389
cadila HealtHcare/Fdaคาดลา เฮลทแคร/อย.
DACTIVE 10 10 mg 053
cardiNal HealtH australiaคารดนล เฮลท ออสเตรเลย
ROPECT† 226ROTUSS† 229
ceNeXi/Fdaซนส/อย.
DORMICUM 5 mg/mL x 1 mL 630
ceva aNiMal HealtHซวา แอนมอล เฮลท
NEMBUTAL 54.7 mg/mL x 100 mL 680
cHalerMcHaiเฉลมชยเภสช
CALMIPAM 2 mg 388CALMIPAM 5 mg 302
cHaroeN bHaesaJ labเจรญเภสช
DIAZEPAM CHAROEN BHAESAJ 2 mg 362
CHLORDIAZEPOXIDE CHAROEN BHAESAJ 10 mg 528
PARADEINE† 086PHENSODI† 60 mL 608PHENSODI† 120 mL 609PHENSODI† 1000 mL 610
cHew brotHersจวบราเดอรส
DIAZEPION 2 mg 514DIAZEPION 5 mg 500DIAZEPION 10 mg 215PHENOBARBITAL
CHEW BROTHERS 30 mg 341REINBAMATE 400 mg 094ZEPOXIN 5 mg 230ZEPOXIN 10 mg 132
cMed Productsซเมด โปรดกส
VOMED 5 mg 171
deFeNce oF PHarMaceutical Factoryโรงงานเภสชกรรมทหาร
PSEUDOEPHEDRINE DEFENCE OF PHARMACEUTICAL FACTORY 30 mg 049
MNF INDEX CLASS-FINAL-Aug13.indd 72 8/14/2013 2:48:38 PM
MANUFACTURER’S INDEX 73PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
Ma
Nu
Fac
tu
re
r’s
iNd
eX
PSEUDOEPHEDRINE DEFENCE OF PHARMACEUTICAL FACTORY 60 mg 050
deXo/Fdaเดคโซ/อย.
PREFAMONE 75 mg 191
douglas/Fdaดกลาส/อย.
DUROMINE 15 mg 527
DUROMINE 30 mg 521
NITRADOS 5 mg 072
TRYCAM 0.25 mg 376
duMeXดเมกซ
STESOLID 2 mg 431
egisอจส
GRANDAXIN 50 mg 058
eli lillyอไล ลลล
AMYTAL 0.5 g 674
gedeoN ricHterกเดยน รชเตอร
BELLOID† 139
gedeoN ricHter/Fdaกเดยน รชเตอร/อย.
CALYPSOL 50 mg/mL x 10 mL 675
geNeral drugs Houseเยนเนอรราลดรกสเฮาส
DIAZEPAM GENERAL DRUGS HOUSE 2 mg 345
DIAZEPAM GENERAL DRUGS HOUSE 5 mg 163
ZORA 0.5 mg 356
ZORA 2 mg 205
glaXosMitHkliNe/Fdaแกลกโซสมทไคลน/อย.
KAPANOL 20 mg 133KAPANOL 50 mg 134KAPANOL 100 mg 135
gold & silver bellโกลด แอนด ซลเวอรเบลล
ZORITUSS 10 mg 223
gPoองคการเภสชกรรม
BROWN MIXTURE GPO† 180 mL 538
BROWN MIXTURE GPO† 450 mL 539
CAMPHORATED OPIUM TINCTURE GPO 1000 mL 541
COUGH SYRUP GPO† 60 mL 553
DIAZEPAM GPO 10 mg/2 mL x 2 mL 628
DIAZEPAM GPO 2 mg 055DIAZEPAM GPO 5 mg 164DIAZEPAM GPO 10 mg 363MIST. SCILL AMMON.
GPO† 180 mL 568PSEUDOEPHEDRINE
GPO 30 mg 062PSEUDOEPHEDRINE
GPO 60 mg 063
gPo/Fdaองคการเภสชกรรม/อย.
CODEINE GPO 15 mg 003CODEINE GPO 30 mg 019EPHEDRINE GPO
30 mg/mL x 1 mL 632METHADONE GPO
10 mg/mL x 1000 mL 565METHADONE GPO 5 mg 140MORPHINE SULFATE
GPO 10 mg/5 mL 577MORPHINE SULFATE
GPO 10 mg 156OPIUM TINCTURE
GPO 1% x 450 mL 585
greater PHarMaเกรทเตอรฟารมา
DIAPAM 2 mg 396DIAPAM 5 mg 355
guardiaN drug Houseการเดยน ดรกเฮาส
GAXENE 5 mg 474
H k PHarMเอช เค ฟารมาซตคอล
ALLAM 0.25 mg 116ALLAM 0.5 mg 275ALLAM 1 mg 320DEDA 5 mg 463DEDA 10 mg 291DIAZEPAM
H K PHARM 2 mg 243DIAZEPAM
H K PHARM 5 mg 176DIAZEPAM
H K PHARM 10 mg 371
HaMelN/Fdaฮาเมลน/อย.
FENTANYL-HAMELN 50 mcg/mL x 2 mL 638
FENTANYL-HAMELN 50 mcg/mL x 10 mL 639
KETA-HAMELN 50 mg/mL x 10 mL 678
PETHIDINE HAMELN 50 mg/mL 657
HeXal ag/Fdaเฮกซาล เอจ/อย.
FENTANYL GPO 12 mcg/hr 686
FENTANYL GPO 25 mcg/hr 687
FENTANYL GPO 50 mcg/hr 688
FENTANYL HEXAL 12 mcg/hr 689
FENTANYL HEXAL 25 mcg/hr 690
FENTANYL HEXAL 50 mcg/hr 691
iNPac PHarMaอนแพคฟารมา
INZOLAM 0.25 mg 118INZOLAM 0.5 mg 277INZOLAM 1 mg 321LORAZIN 0.5 mg 352LORAZIN 1 mg 045
MNF INDEX CLASS-FINAL-Aug13.indd 73 8/14/2013 2:48:38 PM
74 MANUFACTURER’S INDEX PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
Ma
Nu
Fac
tu
re
r’s
iNd
eX
LORAZIN 2 mg 253TENMED 5 mg 470TENMED 10 mg 296
iNtas PHarM/Fdaอนทสฟารมาซตคอล/อย.
MIDAZ 5 mg/mL x 1 mL 644MIDAZ 5 mg/mL x 3 mL 645
iNtertHaiอนเตอรไทย
CODIPRONT† 522TRANXENE 5 mg 465
JaNsseN PHarMa/Fdaแจนเซน ฟารมา/อย.
DUROGESIC PATCH 12 mcg/hr 681
DUROGESIC PATCH 25 mcg/hr 682
DUROGESIC PATCH 50 mcg/hr 683
DUROGESIC PATCH 100 mcg/hr 684
JaNsseN-cilag/Fdaแจนเซน-ซแลก/อย.
CONCERTA 18 mg 186CONCERTA 27 mg 439CONCERTA 36 mg 129FENTANYL
JANSSEN-CILAG 0.05 mg/mL x 2 mL 635
FENTANYL JANSSEN-CILAG 0.05 mg/mL x 10 mL 636
JeNaHeXal/Fdaจนาเฮกซาล/อย.
MIDAZOLAM HEXAL 5 mg/mL x 1 mL 646
MIDAZOLAM HEXAL 5 mg/mL x 3 mL 647
keNyakuเคนยาก
BRONPECT† 325KENSPA† 251LORAZE 1 mg 044PRAZOL 0.25 mg 110PRAZOL 0.5 mg 268
PRAZOL 1 mg 314VALENIUM 2 mg 077VALENIUM 5 mg 169
l. b. s.แอล บ เอส แลบบอเรตอร
DOPAM 5 mg 148HAWKCOPAX 0.5 mg 348HAWKCOPAX 1 mg 393PANGON 30 mg/mL x 1 mL 654PARA WITH CODEINE†
15 mg 083PARA WITH CODEINE†
30 mg 084ROPAM 10 mg/2 mL x 2 mL 662ROPAM 5 mg 174
lab rubio/Fdaแลบ รบโอ/อย.
RUBIFEN 10 mg 043
lacHMaNNแลชแมน
DIZAN 2 mg 483DIZAN 5 mg 443
laviPHarM/Fdaลาวฟารม/อย.
FENTADUR 25 mcg/hr 685
lerd siNgHเลศสงห
ALPRAMED 0.25 mg 276ALPRAMED 0.5 mg 117ALPRAMED 1 mg 421CHLORDIXIDE 5 mg 386CHLORDIXIDE 10 mg 220DIAZEPAM
LERD SINGH 2 mg 075DIAZEPAM
LERD SINGH 5 mg 177TRANPON 5 mg 472TRANSPON FORTE
10 mg 283
liFe coNcerNไลฟ คอนเซน
FREXENE 5 mg 441FREXENE 10 mg 445LICON† 410
liwiNNer PHarMaลวนเนอรฟารมา
WINOPAM 2 mg 074WINOPAM 5 mg 404
M & H MaNuFacturiNgเอม แอนด เอช แมนแฟคเจอรง
BLUCO† 383CODICET BLUE 300† 380TERADYL† 60 mL 622TERADYL† 1000 mL 623
M & H MaNuFacturiNg/Fdaเอม แอนด เอช แมนแฟคเจอรง/อย.
MORPHINE SULFATE INJ BLUE 10 mg/mL x 1 mL 649
MORPHINE SULFATE INJ PURPLE 10 mg/mL x 1 mL 650
PETHIDINE M & H MANUFACTURING 50 mg/mL x 1 mL 659
PETHIDINE M & H MANUFACTURING 100 mg/2 mL x 2 mL 658
Mackแมค
CODIPRONT SYRUP† 60 mL 543
Mack/Fdaแมค/อย.
MIRAPRONT N 20 mg 516
MacroPHarแมคโครฟาร
ANXIELAX 5 mg 486AZEPAM 2 mg 219AZEPAM 5 mg 326LORAZEPAM
MACROPHAR 1 mg 400
MarcH PHarMaแหลมทองการแพทย
CHLORDIAZEPOXIDE MARCH PHARMA 25 mg 503
MANODIAZO 2 mg 495MANODIAZO 5 mg 530MANODIAZO 10 mg 365
MNF INDEX CLASS-FINAL-Aug13.indd 74 8/14/2013 2:48:38 PM
MANUFACTURER’S INDEX 75PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
Ma
Nu
Fac
tu
re
r’s
iNd
eX
MANOLIUM 10 mg/2 mL x 2 mL 643
MANOTRAN 5 mg 461MANOTRAN 10 mg 289MARZOLAM 0.25 mg 107MARZOLAM 0.5 mg 265MARZOLAM 1 mg 312
Masa labมาซาแลบ
CEBARAX† 406CONZEP 5 mg 480CONZEP 10 mg 447DIZEPAM 2 mg 250DIZEPAM 5 mg 167MASADYL COUGH†
60 mL 560MASADYL COUGH†
100 mL 561MASADYL COUGH†
240 mL 562MASAPARA W/ CODEINE† 198NEO COUGH† 60 mL 578NEO COUGH† 100 mL 579NEO COUGH† 240 mL 580NEOCOD† 373NEOCOF† 212NEOPECT† 224ORA 0.5 mg 338ORA 1 mg 029ORA 2 mg 238PARADYL 8 mg 095PHENOCON 60 mg 255SERENE
MASA LAB 10 mg 286ZETRAN 5 mg 476
Medical suPPlyเวชบรการ
MED-ZEPAM 2 mg 041MED-ZEPAM 5 mg 366MED-ZEPOXIDE 5 mg 494MED-ZEPOXIDE 10 mg 059
MedicaPเมดแคป
CORYNIL† 225
MediciNe Productsเมดซนโปรดกส
LONZA 0.5 mg 339LONZA 1 mg 020
XANACINE 0.25 mg 113XANACINE 0.5 mg 271XANACINE 1 mg 317ZAM 2 mg 068ZAM 5 mg 172
MediciNe Products/Fdaเมดซนโปรดกส/อย.
PSEUDOEPHEDRINE MEDICINE PRODUCTS 60 mg 207
MedicPHarMaสหแพทยเภสช
CODEE-C† 416CODYL COUGH
LINCTUS† 60 mL 544CODYL COUGH
LINCTUS† 100 mL 545CODYL COUGH
LINCTUS† 1000 mL 546CODYL COUGH
LINCTUS† 4500 mL 547DIAMED 2 mg 531DIAMED 5 mg 518DIMED 2 mg 078DIRAX† 413FARZOLAM 0.25 mg 104MEDAZINE 5 mg 520MEDAZINE 10 mg 519PARA-CO 15 mg 375PARAMED-CO† 424PRENARPIL 0.5 mg 196PRENARPIL 1 mg 367PRENARPIL 2 mg 061TRANMED 5 mg 452TRANMED 10 mg 287UPZENE 5 mg 509ZOLAM 0.25 mg 115ZOLAM 0.5 mg 273ZOLAM 1 mg 319
MediFiveเมดไฟว
CLORAMED 5 mg 456CLORAMED 10 mg 290LORAMED 0.5 mg 334
Mega liFescieNcesเมกา ไลฟไซแอนซ
CODEPECT† 227ROLAR† 228
MeiJiเมจ
MEILAX 1 mg 022
MEILAX 2 mg 199
MilaNoมลาโน
DIANO 2 mg 010
DIANO 5 mg 154
MENOBARB 15 mg/5 mL x 60 mL 563
MENOBARB 20 mg/5 mL x 60 mL 564
MENOBARB 60 mg 208
MILA-CONO† 60 mL 566
MILA-TERCON† 184
PARCONO† 093
MilaNo/Fdaมลาโน/อย.
PSEUDOEPHEDRINE MILANO 30 mg/5 mL x 60 mL 618
PSEUDOEPHEDRINE MILANO 30 mg 153
PSEUDOEPHEDRINE MILANO 60 mg 046
MilliMedมลลเมด
ANAX 0.25 mg 097
ANAX 0.5 mg 256
CO-COF† 182
NASA W/ CODEINE† 092
POLY-COF† 60 mL 611
POLY-COF† 100 mL 612
VASON 2 mg 425
ModerN MaNuโมเดอรนแมน
CLORAZE 5 mg 458
CLORAZE 10 mg 292
MOXINAX 0.25 mg 108
MOXINAX 0.5 mg 266
ZEPAM 10 mg/2 mL x 2 mL 672
ZEPAM 2 mg 429
ZEPAM 5 mg 382
MNF INDEX CLASS-FINAL-Aug13.indd 75 8/14/2013 2:48:38 PM
76 MANUFACTURER’S INDEX PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
Ma
Nu
Fac
tu
re
r’s
iNd
eX
New liFe PHarMaนวไลฟฟารมา
CLOZEPATE 5 mg 466COCET† 082DIPAM 2 mg 037DIPAM 5 mg 150DIPAM 10 mg 357LOZEPAM 0.5 mg 331LOZEPAM 1 mg 193PHENOBARBITONE
NEW LIFE PHARMA 30 mg 006
PHENOBARBITONE NEW LIFE PHARMA 60 mg 203
XALAM 0.25 mg 112XALAM 0.5 mg 270XALAM 1 mg 316
Novartisโนวารตส
BELLERGAL† 232
Novartis/Fdaโนวารตส/อย.
RITALIN 10 mg 042
olaN-keMedโอลน-เคมเมด
ALPRALAN 0.25 mg 036ALPRALAN 0.5 mg 240KEMORA 0.5 mg 434KEMORA 1 mg 024LORAMED 1 mg 026LORAMED 2 mg 237TRANOLAN
10 mg/2 mL x 2 mL 667TRANOLAN 2 mg 145TRANOLAN 5 mg 201
olicโอลค
ALPRAZOLAM FRX 0.25 mg 122
ALPRAZOLAM FRX 0.5 mg 282
BENADRYL CD† 60 mL 533
BENADRYL CD† 1000 mL 534
BENYLIN CD† 60 mL 535
CODIPRONT† 523LIBRAX† 409LOMOTIL† 004PHENSEDYL OLIC†
100 mL 607PRASEPINE 5 mg 484TYLENOL WITH
CODEINE† 087TYLENOL WITH
CODEINE† 088VALIUM 5 mg 170
osMoPHarM/Fdaออสโมฟารม/อย.
D-NORPSEUDOEPHEDRINE SR OSMOPHARM 20 mg 517
PANBESY 15 mg 450PANBESY 30 mg 487PHENTERMINE
OSMOPHARM 15 mg 477
osotH iNterlabโอสถอนเตอร
BROWN MIXTURE OSOTH INTERLAB† 180 mL 540
HISEDYL† 60 mL 557HISEDYL† 120 mL 558MIXTURE
SCILLAE AMMON† 180 mL 569
PARAGEN CO† 128P-CODYL† 60 mL 588P-CODYL† 120 mL 589
P P labพ พ แลบอราตอรส
EPOXIDE 10 mg 211EPOXIDE 25 mg 217LORA-P 0.5 mg 347LORA-P 1 mg 013LORA-P 2 mg 137PHENOBARB 30 mg 233PHENOBARB 60 mg 047PHENOBARB ELIXIR
20 mg/5 mL x 60 mL 594V DAY ZEPAM
10 mg/2 mL x 2 mL 668V DAY ZEPAM 2 mg 502V DAY ZEPAM 5 mg 491V DAY ZEPAM NL
10 mg/2 mL x 2 mL 669
PaNdrugsแพนดรกส
TRANZEP 5 mg 460
Parke-davis/Fdaพารคเดวส/อย.
KETALAR 50 mg/mL x 10 mL 679
PFizerไฟเซอร
XANAX 0.25 mg 114XANAX 0.5 mg 272XANAX 1 mg 318XANAX XR 0.5 mg 372XANAX XR 1 mg 079XANAX XR 2 mg 381
PHarMacia/Fdaฟารมาเซย/อย.
HALCION 0.25 mg 378
PHarMasaNt labฟารมาสนต แลบ
ALCELAM 0.25 mg 100ALCELAM 0.5 mg 259ALCELAM 1 mg 308ANTA 0.5 mg 330ANTA 1 mg 018ANTA 2 mg 138BONADINE CD† 60 mL 536CEMOL CODEINE† 081CENTRODINE CD† 248COZEP 10 mg 149COZEP 25 mg 202DZP2 2 mg 497FLULIUM 5 mg 467FLULIUM 10 mg 300POBRAX† 403POLYDINE CD† 295POMADOM 5 mg 481POMADOM 10 mg 449POPAM 2 mg 126POPAM 5 mg 187POVANIL 0.5 mg 210POVANIL 1 mg 179POVANIL 2 mg 076POZAPAM 5 mg 485POZAPAM 10 mg 192RADIBRAX† 420ZOPAM 2 mg 051
MNF INDEX CLASS-FINAL-Aug13.indd 76 8/14/2013 2:48:39 PM
MANUFACTURER’S INDEX 77PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
Ma
Nu
Fac
tu
re
r’s
iNd
eX
ZOPAM 5 mg 160ZOPAM 10 mg 359
PHarMasaNt lab/Fdaฟารมาสนต แลบ/อย.
PHENYLPROPANOLAMINE PHARMASANT 25 mg 157
PHarMiNarฟารมนา
FARZOLAM 0.5 mg 263FARZOLAM 1 mg 310
PoliPHarMโปลฟารม
DOMAR 5 mg 490MITRANAX 0.25 mg 119MITRANAX 0.5 mg 278MITRANAX 1 mg 322POLIZEP 5 mg 468POLIZEP 10 mg 294TRANAVAN 0.5 mg 335TRANAVAN 1 mg 035
PoNd's cHeMicalพอนดเคมคอล
ALNAX 0.25 mg 099ALNAX 0.5 mg 258ALNAX 1 mg 307DIAZEPAM
POND'S CHEMICAL 2 mg 395
DIAZEPAM POND'S CHEMICAL 5 mg 242
DIAZEPAM POND'S CHEMICAL 5 mg 178
NEO-CODEIN† 374NEO-COPHEN 10 mg 222PERCIDYL COUGH†
100 mL 590PONDNADYL† 60 mL 613PONDNADYL† 100 mL 614PONDNADYL† 1000 mL 615PONDNEBIUM 5 mg 399PONDNEBIUM 10 mg 216PORA 0.5 mg 398PORA 1 mg 151PORA 2 mg 241TAMYLAB-S 5 mg 469
r P scHerer/Fdaอาร พ เชอเรอร/อย.
EUHYPNOS 20 20 mg 427
raNbaXy uNicHeMแรนแบกซ
FORTWIN 30 mg/mL x 1 mL 641
reckitt beNckiser/Fdaเรกคทท เบนคเซอร/อย.
TEMGESIC 0.3 mg/mL x 1 mL 666
TEMGESIC 0.2 mg 007
rivoPHarM/Fdaรโวฟารม/อย.
ZOLPIDEM TARTRATE RIVOPHARM 10 mg 124
rocHeโรช
LEXOTAN 1.5 mg 080LEXOTAN 3 mg 254RIVOTRIL
1 mg/mL x 1 mL 661RIVOTRIL 0.5 mg 197RIVOTRIL 2 mg 064VALIUM
10 mg/2 mL x 2 mL 670
rocHe/Fdaโรช/อย.
DALMADORM 15 mg 512DORMICUM
15 mg/3 mL x 3 mL 631DORMICUM 15 mg 379MOGADON 5 mg 091ROHYPNOL 1 mg 423
roseMoNt PHarMโรสมอนท ฟารมซตคอล
NORDYL LINCTUS† 100 mL 581
NORDYL LINCTUS† 500 mL 582
NORTUSS LINCTUS† 100 mL 583
NORTUSS LINCTUS† 500 mL 584
s co PHarMaเอส โค ฟารมา
S.CO ZEPAM 5 mg 246
salutas PHarMa/Fdaซาลทส ฟารมา/อย.
METHYLPHENIDATE HEXAL 10 mg 060
MORPHINE SALUTAS PHARMA 10 mg 438
MORPHINE SALUTAS PHARMA 30 mg 358
MORPHINE SALUTAS PHARMA 60 mg 245
saMakeePHaesaJ (uNioN drug lab)สามคคเภสช
BELLADONNA ALKALOIDS W/ PHENOBARBITAL† 247
DIAZEPAM SAMAKEEPHAESAJ 2 mg 391
DIAZEPAM SAMAKEEPHAESAJ 5 mg 155
saNdoz caNada/Fdaแซนดอส แคนาดา/อย.
FENTANYL SANDOZ 0.05 mg/mL x 2 mL 637
FENTANYL SANDOZ 500 mcg/10 mL 676
saNoFi-aveNtisซาโนฟ-อเวนตส
FRISIUM 5 mg 038GARDENAL 200 mg/4 mL 677
saNoFi-syNtHelaboซาโนฟ-ซนเตลาโบ
SOSEGON 30 mg/mL x 1 mL 664
TRANXENE 10 mg 298VICTAN 2 mg 204
saNoFi-wiNtHroP/Fdaซาโนฟ-วนทรอป/อย.
STILNOX 10 mg 123
MNF INDEX CLASS-FINAL-Aug13.indd 77 8/14/2013 2:48:39 PM
78 MANUFACTURER’S INDEX PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
Ma
Nu
Fac
tu
re
r’s
iNd
eX
seNg tHaiแสงไทย
DIAZA 10 mg/2 mL x 2 mL 627
DIAZA 2 mg 361DIAZA 5 mg 162
seveN starsหางขายยาตราเจดดาว
DILIUM 2 mg 200DILIUM 5 mg 354
siaM bHeasacHสยามเภสช
DILOMIL† 002LORAPAM 0.5 mg 336LORAPAM 1 mg 027LORAPAM 2 mg 142SIAMPRAXOL 0.25 mg 111SIAMPRAXOL 0.5 mg 269SIAMPRAXOL 1 mg 315SIPAM 10 mg/2 mL x 2 mL 663SIPAM 2 mg 065SIPAM 5 mg 168SIPAM 10 mg 368TRANCLOR 5 mg 464TRANCLOR 10 mg 297
siaM bHeasacH/Fdaสยามเภสช/อย.
BUPRINE 0.2 mg 001
siaM Medicareสยามเมดแคร
POSENE 5 mg 189POSENE 10 mg 430
siloM Medicalสลมการแพทย
PHENOSIL ELIXIR 20 mg/5 mL x 60 mL 604
PHENOSIL ELIXIR 20 mg/5 mL x 450 mL 605
sNs/Fdaเอสเอนเอส/อย.
FENTANYL-SNS 50 mcg/mL x 2 mL 640
soMMai bHaesaJสมหมายเภสช
DIAZEPAM SOMMAI BHAESAJ 5 mg 346
sriPrasit PHarMaเภสชกรรมศรประสทธ
DECOS† 100 mL 554NEURAMIZONE† 432PARDEX 32.5 mg 131SECO† 417SPASIL† 009TUMAX† 428
suPHoNg bHaesaJสพงษเภสช
DIZEP 2 mg 188DIZEP 5 mg 214ELIXIR PHENOBARB
60 mL 556LORAVAN 0.5 mg 329LORAVAN 1 mg 028MIXTURE TUSSIS† 30 mL 570MIXTURE TUSSIS† 60 mL 571MIXTURE TUSSIS† 120 mL 572MIXTURE TUSSIS† 240 mL 573MIXTURE TUSSIS† 450 mL 574MIXTURE TUSSIS† 1800 mL 575MIXTURE TUSSIS† 3600 mL 576SUNAX 0.25 mg 120SUNAX 0.5 mg 279
t M N iMPeXท เอม เอน อมแพกซ
CEXENE 5 mg 473CEXENE 10 mg 299LORAPINE 0.5 mg 340VALAX 2 mg 032VALAX 10 mg 349
t P drugท พ ดรก
COSEDYL† 60 mL 552COTENOL† 085DIAZEPAM T P DRUG
10 mg/2 mL x 2 mL 629DIAZEPAM
T P DRUG 2 mg 012DIAZEPAM
T P DRUG 5 mg 165DIAZEPAM
T P DRUG 10 mg 364
TRANCAP 5 mg 496TRANCAP 10 mg 190ZEPOXIDE 5 mg 437ZEPOXIDE 10 mg 305
t P drug/Fdaท พ ดรก/อย.
MORPHINE T P DRUG 10 mg/mL x 1 mL 651
MORPHINE T P DRUG 10 mg/mL x 1 mL 652
MORPHINE T P DRUG 10 mg/mL x 1 mL 653
PETHIDINE T P DRUG 50 mg/mL x 1 mL 660
t s PHarMaท เอส ฟารมา
T-FIVE 5 mg 471
t v PHarMท ว ฟารมาซตคอล
PAM 5 mg 231
t. MaN PHarMaท แมน ฟารมา
CHLORDIAZEPOXIDE T MAN 10 mg 401
DIAZEPAM T MAN 2 mg 392DIAZEPAM T MAN 5 mg 180DIAZEPAM T MAN 5 mg 236DIAZEPAM T MAN 10 mg 353MANEX 0.25 mg 106MANEX 0.5 mg 264MANEX 1 mg 311MANTADYL COUGH†
60 mL 559PARCOD† 089TRANPATE 5 mg 442
t. o. cHeMicalsท โอ เคมคอลส
BENERA† 433CLORAXENE 5 mg 462CONADYL† 60 mL 551PHENOCO ELIXIR
20 mg/5 mL x 450 mL 602PHENOCO ELIXIR
20 mg/5 mL x 3800 mL 603TOCODYL† 418
MNF INDEX CLASS-FINAL-Aug13.indd 78 8/14/2013 2:48:39 PM
MANUFACTURER’S INDEX 79PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
Ma
Nu
Fac
tu
re
r’s
iNd
eX
taiwaN biotecH/Fdaไตหวน ไบโอเทค/อย.
ZOPIM 10 mg 125
taNaPat bHaesaJธนพฒนเภสช
DIMED 5 mg 181
teMMler/Fdaเทมเลอร/อย.
REGENON RETARD 75 mg 504REGENON RETARD 75 mg 130
tHai NakorN PataNaไทยนครพฒนา
ALPAZAM 0.25 mg 101ALPAZAM 0.5 mg 260ALPAZAM 1 mg 261RAZEPAM 0.5 mg 342RAZEPAM 1 mg 031RAZEPAM 2 mg 144
tHai P d cHeMicalsไทย พ ด เคมคอลส
MONOZIDE 2 mg 525MONOZIDE-10
10 mg/2 mL x 2 mL 648
tHaiPHarMed 1942หางยาไทย 1942
DITRAN 2 mg 444DITRAN 5 mg 501
torreNtทอรเรนท
ALPRAX 0.25 mg 161ALPRAX 0.5 mg 195ALPRAX 1 mg 052
treNker/Fdaเทรนเกอร/อย.
ATRACTIL 75 mg 505DIETIL RETARD 75 mg 096PHENTERMINE TRENKER
15 mg 492PHENTERMINE TRENKER
30 mg 451
udoMPHoN (PHiHalab)อดมพร (ฟฮาแลบ)
METAXIDE 10 mg 515TAZCINE
30 mg/mL x 1 mL 665TAZCINE 25 mg 066TAZCINE 50 mg 252ZEPAXID
10 mg/2 mL x 2 mL 673ZEPAXID 2 mg 532ZEPAXID 5 mg 488
uMedaยเมดา
CLOZENE 5 mg 446CLOZENE 10 mg 478LAYLIUM-10
10 mg/2 mL x 2 mL 642
uNisoNยนซน
DIPOSEF 5 mg 453DIPOSEF 10 mg 284EXAN 5 mg 508EXAN 10 mg 511
uPsoNอพซน
UPTRAN 10 mg 293
utoPiaNยโทเปยน
ANCORIL 0.5 mg 209ANPRESS 0.5 mg 274ANXENE 5 mg 455ANXENE 10 mg 288ANXIRA 0.5 mg 327ANXIRA 1 mg 021CELIUM 5 mg 426CHLORDIBRAX† 407CLONARIL 1 mg 370CLONARIL 2 mg 069LORAPINE 1 mg 033MODURAX† 405TRANCON 5 mg 482TRANCON 10 mg 448UTORAX† 411VALAX 5 mg 146VEMED 0.5 mg 343VISPAM 2 mg 394VISPAM 5 mg 239
VISPAM 10 mg 350
VOMED 2 mg 067
XIEMED 0.25 mg 121
XIEMED 1 mg 323
v s PHarMa
ว เอส ฟารมา
PHARNAX 0.25 mg 109
PHARNAX 0.5 mg 267
PHARNAX 1 mg 313
PHENCODIN† 60 mL 591
PHENCODIN† 500 mL 592
PHENCODIN† 1000 mL 593
SERENE V S PHARMA 5 mg 457
TUSSIDYL† 60 mL 624
VORAPAM 2 mg 073
VORAPAM 5 mg 175
vesco PHarMa
เวสโกฟารมาซตคอล
DIAZEPAM VESCO 2 mg 351
DIAZEPAM VESCO 5 mg 147
VESCOPAM 10 mg/2 mL x 2 mL 671
vidHyasoM
วทยาศรม
MIST TUSSIS† 450 mL 567
SQUILL AND AMMONIA VIDHYASOM† 450 mL 619
wHiteHall
ไวทฮอลล
DIMETANE EXPECTORANT DC† 2.5 L 555
DONNATAL† 057
wyetH
ไวเอท (ประเทศไทย)
ATIVAN 0.5 mg 332
ATIVAN 1 mg 023
ATIVAN 2 mg 141
wyetH-ayerst/Fda
ไวเอท-เอเยรสท/อย.
LORAMET 1 mg 105
MNF INDEX CLASS-FINAL-Aug13.indd 79 8/16/2013 3:36:12 PM
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
- ALPRAX 0.5 mg - 195
- ALPRAX 1 mg - 052
- ALPRAXOL 0.25 mg - 017
- ALPRAXOL 0.5 mg - 235
- ALPRAZOLAM FRX 0.25 mg - 122
- ALPRAZOLAM FRX 0.5 mg - 282
- ANAX 0.25 mg - 097
- ANAX 0.5 mg - 256
- ANPRESS 0.25 mg - 102
- ANPRESS 0.5 mg - 274
- ANPRESS 1 mg - 309
- ANZION 0.25 mg - 098
- ANZION 0.5 mg - 257
- ANZION 1 mg - 306
- DIZOLAM 0.25 mg - 103
- DIZOLAM 0.5 mg - 262
- DIZOLAM 1 mg - 324
- FARZOLAM 0.25 mg - 104
- FARZOLAM 0.5 mg - 263
- FARZOLAM 1 mg - 310
- INZOLAM 0.25 mg - 118
- INZOLAM 0.5 mg - 277
- INZOLAM 1 mg - 321
- MANEX 0.25 mg - 106
- MANEX 0.5 mg - 264
- MANEX 1 mg - 311
- MARZOLAM 0.25 mg - 107
- MARZOLAM 0.5 mg - 265
- MARZOLAM 1 mg - 312
- MITRANAX 0.25 mg - 119
- MITRANAX 0.5 mg - 278
- MITRANAX 1 mg - 322
- MOXINAX 0.25 mg - 108
- MOXINAX 0.5 mg - 266
- PHARNAX 0.25 mg - 109
- PHARNAX 0.5 mg - 267
- PHARNAX 1 mg - 313
- PRAZOL 0.25 mg - 110
- PRAZOL 0.5 mg - 268
- PRAZOL 1 mg - 314
- SIAMPRAXOL 0.25 mg - 111
AALCELAM 0.25 mg - 100ALCELAM 0.5 mg - 259ALCELAM 1 mg - 308ALLAM 0.25 mg - 116ALLAM 0.5 mg - 275ALLAM 1 mg - 320ALNAX 0.25 mg - 099ALNAX 0.5 mg - 258ALNAX 1 mg - 307ALODORM 5 mg - 090ALPAZAM 0.25 mg - 101ALPAZAM 0.5 mg - 260ALPAZAM 1 mg - 261ALPRALAN 0.25 mg - 036ALPRALAN 0.5 mg - 240ALPRAMED 0.25 mg - 276ALPRAMED 0.5 mg - 117ALPRAMED 1 mg - 421ALPRAX 0.25 mg - 161ALPRAX 0.5 mg - 195ALPRAX 1 mg - 052ALPRAXOL 0.25 mg - 017ALPRAXOL 0.5 mg - 235
alprazolam:
- ALCELAM 0.25 mg - 100
- ALCELAM 0.5 mg - 259
- ALCELAM 1 mg - 308
- ALLAM 0.25 mg - 116
- ALLAM 0.5 mg - 275
- ALLAM 1 mg - 320
- ALNAX 0.25 mg - 099
- ALNAX 0.5 mg - 258
- ALNAX 1 mg - 307
- ALPAZAM 0.25 mg - 101
- ALPAZAM 0.5 mg - 260
- ALPAZAM 1 mg - 261
- ALPRALAN 0.25 mg - 036
- ALPRALAN 0.5 mg - 240
- ALPRAMED 0.25 mg - 276
- ALPRAMED 0.5 mg - 117
- ALPRAMED 1 mg - 421
- ALPRAX 0.25 mg - 161
Registration No. Frame No. Registration No. Frame No.
BRAND & GENERIC NAME INDEX
ดชนรวมชอการคาและชอสามญ
B&G Name Index-FINAL-Aug13.indd 80 8/14/2013 2:45:17 PM
BRAND & GENERIC NAME INDEX 81PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
BR
AN
D &
GE
NE
RIC
NA
ME
IND
EX
- SIAMPRAXOL 0.5 mg - 269
- SIAMPRAXOL 1 mg - 315
- SUNAX 0.25 mg - 120
- SUNAX 0.5 mg - 279
- XALAM 0.25 mg - 112
- XALAM 0.5 mg - 270
- XALAM 1 mg - 316
- XANACINE 0.25 mg - 113
- XANACINE 0.5 mg - 271
- XANACINE 1 mg - 317
- XANAX 0.25 mg - 114
- XANAX 0.5 mg - 272
- XANAX 1 mg - 318
- XANAX XR 0.5 mg - 372
- XANAX XR 1 mg - 079
- XANAX XR 2 mg - 381
- XIEMED 0.25 mg - 121
- XIEMED 0.5 mg - 280
- XIEMED 1 mg - 323
- ZOLAM 0.25 mg - 115
- ZOLAM 0.5 mg - 273
- ZOLAM 1 mg - 319
ALPRAZOLAM FRX 0.25 mg - 122
ALPRAZOLAM FRX 0.5 mg - 282
AMA† P2A 20/55 159
amobarbital:
- AMA† P2A 20/55 159
- AMYTAL 0.5 g - 674
AMYTAL 0.5 g - 674ANAX 0.25 mg - 097ANAX 0.5 mg - 256ANCORIL 0.5 mg P1A 14/51 209ANPRESS 0.25 mg - 102ANPRESS 0.5 mg - 274ANPRESS 1 mg - 309ANTA 0.5 mg P1A 36/53 330ANTA 1 mg P1A 12/54 018ANTA 2 mg P1A 29/52 138ANXENE 5 mg - 455ANXENE 10 mg - 288ANXIELAX 5 mg - 486ANXIRA 0.5 mg P1A 24/52 327ANXIRA 1 mg P1A 25/52 021ANZION 0.25 mg - 098ANZION 0.5 mg - 257ANZION 1 mg - 306ATIVAN 0.5 mg - 332ATIVAN 1 mg - 023ATIVAN 2 mg - 141
ATRACTIL 75 mg - 505AZEPAM 2 mg - 219AZEPAM 5 mg - 326A-ZERAX 2 mg P1A 37/52 479A-ZERAX 5 mg P1A 38/52 489
BBELLADONNA ALKALOIDS W/
PHENOBARBITAL† - 247BELLERGAL† - 232BELLOID† - 139BENADRYL CD†
60 mL - 533BENADRYL CD†
1000 mL - 534BENERA† - 433BENPINE 5 mg P1A 32/54 435BENPINE 10 mg P1A 17/54 526BENPINE 25 mg P1A 1/49 218BENYLIN CD† 60 mL - 535BLUCO† - 383BLUCON† - 360BONADINE CD† 60 mL - 536
bromazepam:
- LEXOTAN 1.5 mg P1C 26/55 080
- LEXOTAN 3 mg P1C 27/55 254
BROMTUSSIA DC† 60 mL - 537
BRONPECT† - 325BROWN MIXTURE
GPO† 180 mL N2A 7/56 538BROWN MIXTURE
GPO† 450 mL N2A 7/56 539BROWN MIXTURE
OSOTH INTERLAB† 180 mL N2A 13/53 540
buprenorphine hydrochloride:
- BUPRINE 0.2 mg - 001
- TEMGESIC 0.3 mg/mL x 1 mL - 666
- TEMGESIC 0.2 mg - 007
BUPRINE 0.2 mg - 001
butobarbital:
- BELLOID† - 139
CCALMIPAM 2 mg - 388CALMIPAM 5 mg - 302CALYPSOL
50 mg/mL x 10 mL - 675CAMPHORATED
OPIUM TINCTURE GPO 1000 mL N2A 6/53 541
Registration No. Frame No. Registration No. Frame No.
B&G Name Index-FINAL-Aug13.indd 81 8/14/2013 2:45:17 PM
82 BRAND & GENERIC NAME INDEX PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
BR
AN
D &
GE
NE
RIC
NA
ME
IND
EX
camphorated opium tincture:
- BROWN MIXTURE GPO† 180 mL N2A 7/56 538
- BROWN MIXTURE GPO† 450 mL N2A 7/56 539
- BROWN MIXTURE OSOTH INTERLAB† 180 mL N2A 13/53 540
- CAMPHORATED OPIUM TINCTURE GPO 1000 mL N2A 6/53 541
- COUGH SYRUP GPO† 60 mL - 553
- MIST TUSSIS† 450 mL - 567
- MIST. SCILL AMMON. GPO† 180 mL - 568
- MIXTURE SCILLAE AMMON† 180 mL - 569
- MIXTURE TUSSIS† 30 mL N2A 11/55 570
- MIXTURE TUSSIS† 60 mL N2A 11/55 571
- MIXTURE TUSSIS† 120 mL N2A 11/55 572
- MIXTURE TUSSIS† 240 mL N2A 11/55 573
- MIXTURE TUSSIS† 450 mL N2A 11/55 574
- MIXTURE TUSSIS† 1800 mL - 575
- MIXTURE TUSSIS† 3600 mL - 576
- SQUILL AND AMMONIA VIDHYASOM† 450 mL - 619
cathine:
- D-NORPSEUDOEPHEDRINE SR OSMOPHARM 20 mg - 517
- MIRAPRONT N 20 mg - 516
CEBARAX† P2A 22/51 406CELIUM 5 mg P1A 27/54 426CEMOL CODEINE† - 081CENTRODINE CD† N2A 11/47 248CEXENE 5 mg - 473CEXENE 10 mg - 299
chlordiazepoxide:
- DIRAX† P2A 31/54 413
- LIBRAX† P2A 3/55 409
CHLORDIAZEPOXIDE ACDHON 10 mg - 529
CHLORDIAZEPOXIDE CHAROEN BHAESAJ 10 mg - 528
chlordiazepoxide hydrochloride:
- BENPINE 5 mg P1A 32/54 435
- BENPINE 10 mg P1A 17/54 526
- BENPINE 25 mg P1A 1/49 218
- CEBARAX† P2A 22/51 406
- CHLORDIAZEPOXIDE ACDHON 10 mg - 529
- CHLORDIAZEPOXIDE CHAROEN BHAESAJ 10 mg - 528
- CHLORDIAZEPOXIDE MARCH PHARMA 25 mg - 503
- CHLORDIAZEPOXIDE T MAN 10 mg P1A 21/55 401
- CHLORDIBRAX† - 407
- CHLORDIXIDE 5 mg - 386
- CHLORDIXIDE 10 mg - 220
- CHLORZEP 5 mg - 387
- COMOBEN 5 mg P1A 1/55 390
- COMOBEN 10 mg P1A 2/55 510
- COZEP 10 mg P1A 3/50 149
- COZEP 25 mg P1A 39/53 202
- EPOXIDE 10 mg - 211
- EPOXIDE 25 mg - 217
- KENSPA† P2A 36/52 251
- LICON† - 410
- MED-ZEPOXIDE 5 mg - 494
- MED-ZEPOXIDE 10 mg - 059
- METAXIDE 10 mg - 515
- MINOXIDE 10 mg P1A 44/52 493
- MODURAX† - 405
- POBRAX† - 403
- PONDNEBIUM 5 mg - 399
- PONDNEBIUM 10 mg - 216
- RADIBRAX† - 420
- TUMAX† P2A 25/55 428
- UTORAX† - 411
- ZEPOBRAX† - 412
- ZEPOXIDE 5 mg - 437
- ZEPOXIDE 10 mg P1A 35/52 305
- ZEPOXIN 5 mg - 230
- ZEPOXIN 10 mg - 132
CHLORDIAZEPOXIDE MARCH PHARMA 25 mg - 503
CHLORDIAZEPOXIDE T MAN 10 mg P1A 21/55 401
CHLORDIBRAX† - 407CHLORDIXIDE 5 mg - 386CHLORDIXIDE 10 mg - 220CHLORZEP 5 mg - 387CLINEPECT† - 524CLINOPECT† - 221
Registration No. Frame No. Registration No. Frame No.
B&G Name Index-FINAL-Aug13.indd 82 8/14/2013 2:45:17 PM
BRAND & GENERIC NAME INDEX 83PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
BR
AN
D &
GE
NE
RIC
NA
ME
IND
EX
CLINOPRONT† N2A 1/50 408
clobazam:
- FRISIUM 5 mg P1C 12/53, P1B 13/53 038
- FRISIUM 10 mg - 039
CLONARIL 1 mg P1A 15/51 370CLONARIL 2 mg P1A 16/51 069
clonazepam:
- ANCORIL 0.5 mg P1A 14/51 209
- CLONARIL 1 mg P1A 15/51 370
- CLONARIL 2 mg P1A 16/51 069
- CONVULSIL 2 mg P1A 18/53 070
- POVANIL 0.5 mg P1A 33/52 210
- POVANIL 1 mg P1A 13/54 179
- POVANIL 2 mg P1A 34/52 076
- PRENARPIL 0.5 mg P1A 4/55 196
- PRENARPIL 1 mg P1A 5/55 367
- PRENARPIL 2 mg P1A 6/55 061
- RIVOTRIL 1 mg/mL x 1 mL - 661
- RIVOTRIL 0.5 mg P1A 6/53 197
- RIVOTRIL 2 mg P1A 7/53 064
CLORAMED 5 mg - 456CLORAMED 10 mg - 290CLORAXENE 5 mg P1A 33/54 462CLORAZE 5 mg P1A 24/55 458CLORAZE 10 mg - 292CLOZENE 5 mg - 446CLOZENE 10 mg - 478CLOZEPATE 5 mg - 466COCET† - 082CO-COF† N2A 6/51 182CODEE-C† N2A 6/52 416
clorazepate dipotassium:
- ANXENE 5 mg - 455
- ANXENE 10 mg - 288
- ANXIELAX 5 mg - 486
- CEXENE 5 mg - 473
- CEXENE 10 mg - 299
- CLORAMED 5 mg - 456
- CLORAMED 10 mg - 290
- CLORAXENE 5 mg P1A 33/54 462
- CLORAZE 5 mg P1A 24/55 458
- CLORAZE 10 mg - 292
- CLOZENE 5 mg - 446
- CLOZENE 10 mg - 478
- CLOZEPATE 5 mg - 466
- CONZEP 5 mg - 480
- CONZEP 10 mg - 447
- DEDA 5 mg - 463
- DEDA 10 mg - 291
- DIPOSEF 5 mg - 453
- DIPOSEF 10 mg - 284
- DIPOT 5 mg P1A 40/52 459
- DOPAM 5 mg - 148
- EXAN 5 mg - 508
- EXAN 10 mg - 511
- FLULIUM 5 mg P1A 28/55 467
- FLULIUM 10 mg - 300
- FREXENE 5 mg - 441
- FREXENE 10 mg - 445
- GAXENE 5 mg - 474
- MANOTRAN 5 mg - 461
- MANOTRAN 10 mg - 289
- POLIZEP 5 mg P1A 23/50 468
- POLIZEP 10 mg - 294
- POMADOM 5 mg - 481
- POMADOM 10 mg - 449
- POSENE 5 mg - 189
- POSENE 10 mg - 430
- SANOR 5 mg - 454
- SANOR 10 mg - 285
- SERENE MASA LAB 10 mg - 286
- SERENE V S PHARMA 5 mg - 457
- TAMYLAB-S 5 mg - 469
- TENMED 5 mg P1A 47/52 470
- TENMED 10 mg - 296
- T-FIVE 5 mg - 471
- TRANADON-S 5 mg - 475
- TRANCAP 5 mg - 496
- TRANCAP 10 mg - 190
- TRANCLOR 5 mg - 464
- TRANCLOR 10 mg - 297
- TRANCON 5 mg P1A 20/53 482
- TRANCON 10 mg - 448
- TRANMED 5 mg P1A 39/52 452
- TRANMED 10 mg - 287
- TRANPATE 5 mg - 442
- TRANPON 5 mg - 472
- TRANSPON FORTE 10 mg - 283
- TRANXENE 5 mg P1A 14/54 465
- TRANXENE 10 mg - 298
- TRANZEP 5 mg - 460
- UPTRAN 10 mg - 293
- UPZENE 5 mg - 509
Registration No. Frame No. Registration No. Frame No.
B&G Name Index-FINAL-Aug13.indd 83 8/14/2013 2:45:17 PM
84 BRAND & GENERIC NAME INDEX PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
BR
AN
D &
GE
NE
RIC
NA
ME
IND
EX
- ZETRAN 5 mg - 476
codeine:
- CODIPRONT† - 522
- CODIPRONT† N2A 9/51 523
- CODIPRONT SYRUP† 60 mL - 543
CODEINE GPO 15 mg - 003CODEINE GPO 30 mg - 019
codeine phosphate:
- BENADRYL CD† 60 mL - 533
- BENADRYL CD† 1000 mL - 534
- BENYLIN CD† 60 mL - 535
- BLUCO† - 383
- BLUCON† - 360
- BONADINE CD† 60 mL - 536
- BROMTUSSIA DC† 60 mL - 537
- BRONPECT† - 325
- CEMOL CODEINE† - 081
- CENTRODINE CD† N2A 11/47 248
- CLINEPECT† - 524
- CLINOPECT† - 221
- CLINOPRONT† N2A 1/50 408
- COCET† - 082
- CO-COF† N2A 6/51 182
- CODEE-C† N2A 6/52 416
- CODEINE GPO 15 mg - 003
- CODEINE GPO 30 mg - 019
- CODENOL† 15 mg N2A 1/56 422
- CODEPECT† N2A 10/55 227
- CODESIA† N2A 6/55 419
- CODESIA† 60 mL N2A 5/55 542
- CODICET† - 440
- CODICET BLUE 300† N2A 10/51 380
- CODICET PINK† 15 mg N2A 1/52 281
- CODIGESIC† N2A 3/50 127
- CODYL COUGH LINCTUS† 60 mL N2A 3/55 544
- CODYL COUGH LINCTUS† 100 mL N2A 3/55 545
- CODYL COUGH LINCTUS† 1000 mL - 546
- CODYL COUGH LINCTUS† 4500 mL - 547
- COFCODYL† 60 mL N2A 1/54 548
- COFCODYL† 100 mL N2A 1/54 549
- COMODINE COUGH† 60 mL - 550
- CONADYL† 60 mL - 551
- CORYNIL† - 225
- COSEDYL† 60 mL - 552
- COTENOL† - 085
- DECOS† 100 mL N2A 2/55 554
- DIMETANE EXPECTORANT DC† 2.5 L - 555
- HISEDYL† 60 mL - 557
- HISEDYL† 120 mL - 558
- MANTADYL COUGH† 60 mL - 559
- MASADYL COUGH† 60 mL - 560
- MASADYL COUGH† 100 mL - 561
- MASADYL COUGH† 240 mL - 562
- MASAPARA W/ CODEINE† N2A 7/55 198
- MILA-CONO† 60 mL - 566
- MILA-TERCON† - 184
- NASA W/ CODEINE† N2A 4/51 092
- NEO COUGH† 60 mL - 578
- NEO COUGH† 100 mL - 579
- NEO COUGH† 240 mL - 580
- NEOCOD† - 373
- NEO-CODEIN† - 374
- NEOCOF† - 212
- NEO-COPHEN 10 mg - 222
- NEOPECT† N2A 11/52 224
- NORDYL LINCTUS† 100 mL - 581
- NORDYL LINCTUS† 500 mL - 582
- NORTUSS LINCTUS† 100 mL - 583
- NORTUSS LINCTUS† 500 mL - 584
- PACOGESIC† - 213
- PARA WITH CODEINE† 15 mg N2A 4/56 083
- PARA WITH CODEINE† 30 mg N2A 5/56 084
- PARA-CO 15 mg N2A 7/52 375
- PARADEINE† N2A 2/54 086
- PARADYL 8 mg - 095
- PARAGEN CO† - 128
- PARAMED-CO† - 424
- PARCOD† - 089
Registration No. Frame No. Registration No. Frame No.
B&G Name Index-FINAL-Aug13.indd 84 8/14/2013 2:45:17 PM
BRAND & GENERIC NAME INDEX 85PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
BR
AN
D &
GE
NE
RIC
NA
ME
IND
EX
- PARCONO† - 093
- P-CODYL† 60 mL - 588
- P-CODYL† 120 mL - 589
- PERCIDYL COUGH† 100 mL - 590
- PHENCODIN† 60 mL - 591
- PHENCODIN† 500 mL - 592
- PHENCODIN† 1000 mL - 593
- PHENSEDYL OLIC† 100 mL - 607
- PHENSODI† 60 mL - 608
- PHENSODI† 120 mL - 609
- PHENSODI† 1000 mL - 610
- POLY-COF† 60 mL N2A 5/51 611
- POLY-COF† 100 mL N2A 5/51 612
- POLYDINE CD† - 295
- PONDNADYL† 60 mL - 613
- PONDNADYL† 100 mL - 614
- PONDNADYL† 1000 mL - 615
- ROLAR† N2A 9/55 228
- ROPECT† N2A 1/55 226
- ROTUSS† N2C 9/52 229
- SECO† N2A 4/55 417
- TENADRIN-C† 60 mL - 620
- TERADENE† 60 mL - 621
- TERADYL† 60 mL - 622
- TERADYL† 1000 mL - 623
- TERCO-C† N2A 11/53 415
- TOCODYL† - 418
- TUSSIDYL† 60 mL - 624
- TYLENOL WITH CODEINE† N2A 9/53 087
- TYLENOL WITH CODEINE† - 088
- ZORITUSS 10 mg - 223
CODENOL† 15 mg N2A 1/56 422CODEPECT† N2A 10/55 227CODESIA† N2A 6/55 419CODESIA† 60 mL N2A 5/55 542CODICET† - 440CODICET BLUE 300† N2A 10/51 380CODICET PINK†
15 mg N2A 1/52 281CODIGESIC† N2A 3/50 127CODIPRONT† - 522CODIPRONT† N2A 9/51 523CODIPRONT SYRUP†
60 mL - 543CODYL COUGH
LINCTUS† 60 mL N2A 3/55 544
CODYL COUGH LINCTUS† 100 mL N2A 3/55 545
CODYL COUGH LINCTUS† 1000 mL - 546
CODYL COUGH LINCTUS† 4500 mL - 547
COFCODYL† 60 mL N2A 1/54 548COFCODYL† 100 mL N2A 1/54 549COMOBEN 5 mg P1A 1/55 390COMOBEN 10 mg P1A 2/55 510COMODINE COUGH†
60 mL - 550CONADYL† 60 mL - 551CONCERTA 18 mg - 186CONCERTA 27 mg - 439CONCERTA 36 mg - 129CONVULSIL 2 mg P1A 18/53 070CONZEP 5 mg - 480CONZEP 10 mg - 447CORYNIL† - 225COSEDYL† 60 mL - 552COTENOL† - 085COUGH SYRUP GPO†
60 mL - 553COZEP 10 mg P1A 3/50 149COZEP 25 mg P1A 39/53 202
DDACTIVE 10 10 mg - 053DALMADORM 15 mg - 512DAVOL† - 301DECOS† 100 mL N2A 2/55 554DEDA 5 mg - 463DEDA 10 mg - 291
dextropropoxyphene hydrochloride:
- DAVOL† - 301
dextropropoxyphene napsylate:
- PARDEX 32.5 mg - 131
DIADON 5 mg - 377DIAMED 2 mg P1A 14/53 531DIAMED 5 mg P1A 15/53 518DIANO 2 mg P1A 5/54 010DIANO 5 mg P1A 6/54 154DIAPAM 2 mg P1A 15/54 396DIAPAM 5 mg P1A 16/54 355DIAPINE
5 mg/mL x 1 mL P1A 10/55 626DIAPINE
10 mg/2 mL x 2 mL P1A 10/55 625DIAPINE
CAPSULE 2 mg P1A 47/53 499DIAPINE
CAPSULE 5 mg P1A 48/53 506
Registration No. Frame No. Registration No. Frame No.
B&G Name Index-FINAL-Aug13.indd 85 8/14/2013 2:45:18 PM
86 BRAND & GENERIC NAME INDEX PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
BR
AN
D &
GE
NE
RIC
NA
ME
IND
EX
DIAPINE TABLET 2 mg P1A 33/53 011
DIAPINE TABLET 5 mg P1A 34/53 183
DIAPINE TABLET 10 mg P1A 35/53 414
DIAZ 2 mg - 071DIAZ 5 mg - 173DIAZ 10 mg - 369DIAZA
10 mg/2 mL x 2 mL - 627DIAZA 2 mg - 361DIAZA 5 mg - 162diazepam:
- AZEPAM 2 mg - 219
- AZEPAM 5 mg - 326
- A-ZERAX 2 mg P1A 37/52 479
- A-ZERAX 5 mg P1A 38/52 489
- CALMIPAM 2 mg - 388
- CALMIPAM 5 mg - 302
- DIADON 5 mg - 377
- DIAMED 2 mg P1A 14/53 531
- DIAMED 5 mg P1A 15/53 518
- DIANO 2 mg P1A 5/54 010
- DIANO 5 mg P1A 6/54 154
- DIAPAM 2 mg P1A 15/54 396
- DIAPAM 5 mg P1A 16/54 355
- DIAPINE 5 mg/mL x 1 mL P1A 10/55 626
- DIAPINE 10 mg/2 mL x 2 mL P1A 10/55 625
- DIAPINE CAPSULE 2 mg P1A 47/53 499
- DIAPINE CAPSULE 5 mg P1A 48/53 506
- DIAPINE TABLET 2 mg P1A 33/53 011
- DIAPINE TABLET 5 mg P1A 34/53 183
- DIAPINE TABLET 10 mg P1A 35/53 414
- DIAZ 2 mg - 071
- DIAZ 5 mg - 173
- DIAZ 10 mg - 369
DIAZA 10 mg/2 mL x 2 mL - 627
- DIAZA 2 mg - 361
- DIAZA 5 mg - 162
- DIAZEPAM ACDHON 2 mg - 498
- DIAZEPAM BJ BENJAOSOTH 10 mg - 249
- DIAZEPAM BJ BENJAOSOTH 2 mg - 054
- DIAZEPAM BJ BENJAOSOTH 5 mg P1A 44/54 402
- DIAZEPAM CHAROEN BHAESAJ 2 mg - 362
- DIAZEPAM GENERAL DRUGS HOUSE 2 mg P1A 44/53 345
- DIAZEPAM GENERAL DRUGS HOUSE 5 mg P1A 8/54 163
- DIAZEPAM GPO 10 mg/2 mL x 2 mL - 628
- DIAZEPAM GPO 2 mg - 055
- DIAZEPAM GPO 5 mg - 164
- DIAZEPAM GPO 10 mg - 363
- DIAZEPAM H K PHARM 2 mg P1A 51/54 243
- DIAZEPAM H K PHARM 5 mg P1A 52/54 176
- DIAZEPAM H K PHARM 10 mg P1A 53/54 371
- DIAZEPAM LERD SINGH 2 mg P1A 25/54 075
- DIAZEPAM LERD SINGH 5 mg P1A 26/54 177
- DIAZEPAM POND'S CHEMICAL 2 mg P1A 40/53 395
- DIAZEPAM POND'S CHEMICAL 5 mg P1A 41/53 242
- DIAZEPAM POND'S CHEMICAL 5 mg - 178
- DIAZEPAM SAMAKEEPHAESAJ 2 mg - 391
- DIAZEPAM SAMAKEEPHAESAJ 5 mg - 155
- DIAZEPAM SOMMAI BHAESAJ 5 mg - 346
- DIAZEPAM T MAN 2 mg P1A 24/53 392
- DIAZEPAM T MAN 5 mg P1A 42/54 236
- DIAZEPAM T MAN 5 mg P1A 42/54 180
- DIAZEPAM T MAN 10 mg - 353
Registration No. Frame No. Registration No. Frame No.
B&G Name Index-FINAL-Aug13.indd 86 8/14/2013 2:45:18 PM
BRAND & GENERIC NAME INDEX 87PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
BR
AN
D &
GE
NE
RIC
NA
ME
IND
EX
- DIAZEPAM T P DRUG 10 mg/2 mL x 2 mL P1A 47/54 629
- DIAZEPAM T P DRUG 2 mg - 012
- DIAZEPAM T P DRUG 5 mg - 165
- DIAZEPAM T P DRUG 10 mg - 364
- DIAZEPAM VESCO 2 mg P1A 8/55 351
- DIAZEPAM VESCO 5 mg P1A 9/55 147
- DIAZEPION 2 mg - 514
- DIAZEPION 5 mg - 500
- DIAZEPION 10 mg - 215
- DILIUM 2 mg - 200
- DILIUM 5 mg - 354
- DIMED 2 mg - 078
- DIMED 5 mg - 181
- DIPAM 2 mg - 037
- DIPAM 5 mg - 150
- DIPAM 10 mg - 357
- DITRAN 2 mg P1A 16/53 444
- DITRAN 5 mg - 501
- DIVOPAN 2 mg P1A 42/53 056
- DIVOPAN 5 mg P1A 43/53 166
- DIZAN 2 mg - 483
- DIZAN 5 mg - 443
- DIZEP 2 mg P1A 54/54 188
- DIZEP 5 mg P1A 55/54 214
- DIZEPAM 2 mg P1A 45/53 250
- DIZEPAM 5 mg P1A 46/53 167
- DZP2 2 mg - 497
- LAYLIUM-10 10 mg/2 mL x 2 mL - 642
- MANODIAZO 2 mg P1A 9/56 495
- MANODIAZO 5 mg P1A 10/56 530
- MANODIAZO 10 mg P1A 11/55 365
- MANOLIUM 10 mg/2 mL x 2 mL P1A 11/54 643
- MED-ZEPAM 2 mg - 041
- MED-ZEPAM 5 mg - 366
- MONOZIDE 2 mg - 525
- MONOZIDE-10 10 mg/2 mL x 2 mL - 648
- PAM 5 mg - 231
- POPAM 2 mg - 126
- POPAM 5 mg - 187
- ROPAM 10 mg/2 mL x 2 mL P1A 49/53 662
- ROPAM 5 mg - 174
- S.CO ZEPAM 5 mg - 246
- SIPAM 10 mg/2 mL x 2 mL P1A 26/53 663
- SIPAM 2 mg P1A 12/56 065
- SIPAM 5 mg P1A 13/56 168
- SIPAM 10 mg - 368
- STESOLID 2 mg - 431
- STESOLID 5 mg - 507
- STESOLID 10 mg - 513
- TRANOLAN 10 mg/2 mL x 2 mL P1A 41/52 667
- TRANOLAN 2 mg P1A 9/54 145
- TRANOLAN 5 mg P1A 10/54 201
- V DAY ZEPAM 10 mg/2 mL x 2 mL - 668
- V DAY ZEPAM 2 mg - 502
- V DAY ZEPAM 5 mg - 491
- V DAY ZEPAM NL 10 mg/2 mL x 2 mL - 669
- VALAX 2 mg - 032
- VALAX 5 mg - 146
- VALAX 10 mg - 349
- VALENIUM 2 mg - 077
- VALENIUM 5 mg - 169
- VALIUM 10 mg/2 mL x 2 mL - 670
- VALIUM 5 mg - 170
- VASON 2 mg P1A 25/53 425
- VESCOPAM 10 mg/2 mL x 2 mL P1A 50/53 671
- VISPAM 2 mg - 394
- VISPAM 5 mg - 239
- VISPAM 10 mg - 350
- VOMED 2 mg - 067
- VOMED 5 mg - 171
- VORAPAM 2 mg P1A 45/54 073
- VORAPAM 5 mg P1A 46/54 175
- WINOPAM 2 mg - 074
- WINOPAM 5 mg - 404
- ZAM 2 mg P1A 1/51 068
- ZAM 5 mg P1A 2/51 172
- ZEPAM 10 mg/2 mL x 2 mL - 672
- ZEPAM 2 mg - 429
- ZEPAM 5 mg - 382
- ZEPAXID 10 mg/2 mL x 2 mL - 673
- ZEPAXID 2 mg - 532
- ZEPAXID 5 mg P1A 21/50 488
- ZOPAM 2 mg P1A 31/53 051
- ZOPAM 5 mg P1A 32/53 160
Registration No. Frame No. Registration No. Frame No.
B&G Name Index-FINAL-Aug13.indd 87 8/14/2013 2:45:18 PM
88 BRAND & GENERIC NAME INDEX PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
BR
AN
D &
GE
NE
RIC
NA
ME
IND
EX
- ZOPAM 10 mg P1A 8/53 359
DIAZEPAM ACDHON 2 mg - 498
DIAZEPAM BJ BENJAOSOTH 2 mg - 054
DIAZEPAM BJ BENJAOSOTH 5 mg P1A 44/54 402
DIAZEPAM CHAROEN BHAESAJ 2 mg - 362
DIAZEPAM GENERAL DRUGS HOUSE 2 mg P1A 44/53 345
DIAZEPAM GENERAL DRUGS HOUSE 5 mg P1A 8/54 163
DIAZEPAM GPO 10 mg/2 mL x 2 mL - 628
DIAZEPAM GPO 2 mg - 055
DIAZEPAM GPO 5 mg - 164
DIAZEPAM GPO 10 mg - 363
DIAZEPAM H K PHARM 2 mg P1A 51/54 243
DIAZEPAM H K PHARM 5 mg P1A 52/54 176
DIAZEPAM H K PHARM 10 mg P1A 53/54 371
DIAZEPAM LERD SINGH 2 mg P1A 25/54 075
DIAZEPAM LERD SINGH 5 mg P1A 26/54 177
DIAZEPAM POND'S CHEMICAL 2 mg P1A 40/53 395
DIAZEPAM POND’S CHEMICAL 5 mg - 178
DIAZEPAM POND'S CHEMICAL 5 mg P1A 41/53 242
DIAZEPAM SAMAKEEPHAESAJ 2 mg - 391
DIAZEPAM SAMAKEEPHAESAJ 5 mg - 155
DIAZEPAM SOMMAI BHAESAJ 5 mg - 346
DIAZEPAM T MAN 2 mg P1A 24/53 392
DIAZEPAM T MAN 5 mg P1A 42/54 180
DIAZEPAM T MAN 5 mg P1A 42/54 236
DIAZEPAM T MAN 10 mg - 353
DIAZEPAM T P DRUG 10 mg/2 mL x 2 mL P1A 47/54 629
DIAZEPAM T P DRUG 2 mg - 012
DIAZEPAM T P DRUG 5 mg - 165
DIAZEPAM T P DRUG 10 mg - 364
DIAZEPAM VESCO 2 mg P1A 8/55 351
DIAZEPAM VESCO 5 mg P1A 9/55 147
DIAZEPION 2 mg - 514DIAZEPION 5 mg - 500DIAZEPION 10 mg - 215
diethylpropion hydrochloride:
- DIETIL RETARD 75 mg - 096
- PREFAMONE 75 mg - 191
- REGENON RETARD 75 mg - 504
- REGENON RETARD 75 mg - 130
diethylpropion resinate:
- ATRACTIL 75 mg - 505
DIETIL RETARD 75 mg - 096DILIUM 2 mg - 200DILIUM 5 mg - 354DILOMIL† - 002DIMED 2 mg - 078DIMED 5 mg - 181DIMETANE
EXPECTORANT DC† 2.5 L - 555
DIPAM 2 mg - 037DIPAM 5 mg - 150DIPAM 10 mg - 357
diphenoxylate hydrochloride:
- DILOMIL† - 002
- DITROPINE† - 008
- LOMOTIL† N2A 12/53 004
- SPASIL† N2A 2/51 009
DIPOSEF 5 mg - 453DIPOSEF 10 mg - 284DIPOT 5 mg P1A 40/52 459DIRAX† P2A 31/54 413DITRAN 2 mg P1A 16/53 444DITRAN 5 mg - 501DITROPINE† - 008DIVOPAN 2 mg P1A 42/53 056DIVOPAN 5 mg P1A 43/53 166
Registration No. Frame No. Registration No. Frame No.
B&G Name Index-FINAL-Aug13.indd 88 8/14/2013 2:45:18 PM
BRAND & GENERIC NAME INDEX 89PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
BR
AN
D &
GE
NE
RIC
NA
ME
IND
EX
DIZAN 2 mg - 483DIZAN 5 mg - 443DIZEP 2 mg P1A 54/54 188DIZEP 5 mg P1A 55/54 214DIZEPAM 2 mg P1A 45/53 250DIZEPAM 5 mg P1A 46/53 167DIZOLAM 0.25 mg - 103DIZOLAM 0.5 mg - 262DIZOLAM 1 mg - 324D-NORPSEUDOEPHEDRINE
SR OSMOPHARM 20 mg - 517DOMAR 5 mg P1A 5/52 490DONNATAL† - 057DOPAM 5 mg - 148DORMICUM
5 mg/mL x 1 mL - 630DORMICUM
15 mg/3 mL x 3 mL - 631DORMICUM 15 mg - 379DUROGESIC
PATCH 12 mcg/hr - 681DUROGESIC
PATCH 25 mcg/hr - 682DUROGESIC
PATCH 50 mcg/hr - 683DUROGESIC PATCH
100 mcg/hr - 684DUROMINE 15 mg - 527DUROMINE 30 mg - 521DZP2 2 mg - 497
EELIXIR PHENOBARB
60 mL - 556EPHEDRINE GPO
30 mg/mL x 1 mL - 632
ephedrine hydrochloride:
- EPHEDRINE GPO 30 mg/mL x 1 mL - 632
EPOXIDE 10 mg - 211EPOXIDE 25 mg - 217
ethyl loflazepate:
- MEILAX 1 mg - 022
- MEILAX 2 mg - 199
- VICTAN 2 mg - 204
EUHYPNOS 20 20 mg - 427EXAN 5 mg - 508EXAN 10 mg - 511
FFARZOLAM 0.25 mg - 104FARZOLAM 0.5 mg - 263FARZOLAM 1 mg - 310
FENTADUR 25 mcg/hr - 685
fentanyl:
- DUROGESIC PATCH 12 mcg/hr - 681
- DUROGESIC PATCH 25 mcg/hr - 682
- DUROGESIC PATCH 50 mcg/hr - 683
- DUROGESIC PATCH 100 mcg/hr - 684
- FENTADUR 25 mcg/hr - 685
- FENTANYL ANTIGEN 0.05 mg/mL x 2 mL - 633
- FENTANYL ANTIGEN 0.05 mg/mL x 10 mL - 634
- FENTANYL GPO 12 mcg/hr - 686
- FENTANYL GPO 25 mcg/hr - 687
- FENTANYL GPO 50 mcg/hr - 688
- FENTANYL HEXAL 12 mcg/hr - 689
- FENTANYL HEXAL 25 mcg/hr - 690
- FENTANYL HEXAL 50 mcg/hr - 691
FENTANYL ANTIGEN 0.05 mg/mL x 2 mL - 633
FENTANYL ANTIGEN 0.05 mg/mL x 10 mL - 634
fentanyl citrate:
- FENTANYL JANSSEN-CILAG 0.05 mg/mL x 2 mL - 635
- FENTANYL JANSSEN-CILAG 0.05 mg/mL x 10 mL - 636
- FENTANYL SANDOZ 0.05 mg/mL x 2 mL - 637
- FENTANYL SANDOZ 500 mcg/10 mL - 676
- FENTANYL-HAMELN 50 mcg/mL x 2 mL - 638
- FENTANYL-HAMELN 50 mcg/mL x 10 mL - 639
- FENTANYL-SNS 50 mcg/mL x 2 mL - 640
FENTANYL GPO 12 mcg/hr - 686
FENTANYL GPO 25 mcg/hr - 687
FENTANYL GPO 50 mcg/hr - 688
Registration No. Frame No. Registration No. Frame No.
B&G Name Index-FINAL-Aug13.indd 89 8/14/2013 2:45:18 PM
90 BRAND & GENERIC NAME INDEX PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
BR
AN
D &
GE
NE
RIC
NA
ME
IND
EX
FENTANYL HEXAL 12 mcg/hr - 689
FENTANYL HEXAL 25 mcg/hr - 690
FENTANYL HEXAL 50 mcg/hr - 691
FENTANYL JANSSEN-CILAG 0.05 mg/mL x 2 mL - 635
FENTANYL JANSSEN-CILAG 0.05 mg/mL x 10 mL - 636
FENTANYL SANDOZ 0.05 mg/mL x 2 mL - 637
FENTANYL SANDOZ 500 mcg/10 mL - 676
FENTANYL-HAMELN 50 mcg/mL x 2 mL - 638
FENTANYL-HAMELN 50 mcg/mL x 10 mL - 639
FENTANYL-SNS 50 mcg/mL x 2 mL - 640
FLULIUM 5 mg P1A 28/55 467FLULIUM 10 mg - 300
flunitrazepam:
- ROHYPNOL 1 mg - 423
flurazepam hydrochloride:
- DALMADORM 15 mg - 512
FORTWIN 30 mg/mL x 1 mL - 641
FREXENE 5 mg - 441FREXENE 10 mg - 445FRISIUM 5 mg P1C 12/53,
P1B 13/53 038FRISIUM 10 mg - 039
GGARDENAL
200 mg/4 mL P1C 1/50 677GAXENE 5 mg - 474GRANDAXIN 50 mg P1C 27/53 058
HHALCION 0.25 mg - 378HAWKCOPAX 0.5 mg P1A 7/55 348HAWKCOPAX 1 mg - 393HISEDYL† 60 mL - 557HISEDYL† 120 mL - 558
IINZOLAM 0.25 mg - 118INZOLAM 0.5 mg - 277INZOLAM 1 mg - 321
KKAPANOL 20 mg - 133KAPANOL 50 mg - 134KAPANOL 100 mg - 135KEMORA 0.5 mg P1A 48/54 434KEMORA 1 mg P1A 49/54 024KENSPA† P2A 36/52 251KETA-HAMELN
50 mg/mL x 10 mL - 678KETALAR
50 mg/mL x 10 mL - 679
ketamine hydrochloride:
- CALYPSOL 50 mg/mL x 10 mL - 675
- KETA-HAMELN 50 mg/mL x 10 mL - 678
- KETALAR 50 mg/mL x 10 mL - 679
LLAYLIUM-10
10 mg/2 mL x 2 mL - 642LEXOTAN 1.5 mg P1C 26/55 080LEXOTAN 3 mg P1C 27/55 254LIBRAX† P2A 3/55 409LICON† - 410LIZAVAN 0.5 mg - 333LIZAVAN 1 mg - 025LOMOTIL† N2A 12/53 004LONZA 0.5 mg P1A 1/54 339LONZA 1 mg P1A 2/54 020LORA 0.5 mg P1A 28/54 397LORA 1 mg P1A 29/54 040LORA 2 mg P1A 30/54 244LORAMED 0.5 mg - 334LORAMED 1 mg - 026LORAMED 2 mg P1A 50/54 237LORAMET 1 mg - 105LORA-P 0.5 mg - 347LORA-P 1 mg - 013LORA-P 2 mg - 137LORAPAM 0.5 mg - 336LORAPAM 1 mg - 027LORAPAM 2 mg - 142LORAPINE 0.5 mg - 340LORAPINE 1 mg - 033LORAVAN 0.5 mg P1A 22/50 329LORAVAN 1 mg - 028LORAZE 1 mg P1A 31/51 044LORAZENE 0.5 mg - 328LORAZENE 1 mg - 014LORAZENE 2 mg - 143
Registration No. Frame No. Registration No. Frame No.
B&G Name Index-FINAL-Aug13.indd 90 8/14/2013 2:45:18 PM
BRAND & GENERIC NAME INDEX 91PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
BR
AN
D &
GE
NE
RIC
NA
ME
IND
EX
LORAZEP 0.5 mg P1A 51/53 337LORAZEP 1 mg P1A 52/53 005LORAZEP 2 mg P1A 53/53 385
lorazepam:
- ANTA 0.5 mg P1A 36/53 330
- ANTA 1 mg P1A 12/54 018
- ANTA 2 mg P1A 29/52 138
- ANXIRA 0.5 mg P1A 24/52 327
- ANXIRA 1 mg P1A 25/52 021
- ATIVAN 0.5 mg - 332
- ATIVAN 1 mg - 023
- ATIVAN 2 mg - 141
- HAWKCOPAX 0.5 mg P1A 7/55 348
- HAWKCOPAX 1 mg - 393
- KEMORA 0.5 mg P1A 48/54 434
- KEMORA 1 mg P1A 49/54 024
- LIZAVAN 0.5 mg - 333
- LIZAVAN 1 mg - 025
- LONZA 0.5 mg P1A 1/54 339
- LONZA 1 mg P1A 2/54 020
- LORA 0.5 mg P1A 28/54 397
- LORA 1 mg P1A 29/54 040
- LORA 2 mg P1A 30/54 244
- LORAMED 0.5 mg - 334
- LORAMED 1 mg - 026
- LORAMED 2 mg P1A 50/54 237
- LORA-P 0.5 mg - 347
- LORA-P 1 mg - 013
- LORA-P 2 mg - 137
- LORAPAM 0.5 mg - 336
- LORAPAM 1 mg - 027
- LORAPAM 2 mg - 142
- LORAPINE 0.5 mg - 340
- LORAPINE 1 mg - 033
- LORAVAN 0.5 mg P1A 22/50 329
- LORAVAN 1 mg - 028
- LORAZE 1 mg P1A 31/51 044
- LORAZENE 0.5 mg - 328
- LORAZENE 1 mg - 014
- LORAZENE 2 mg - 143
- LORAZEP 0.5 mg P1A 51/53 337
- LORAZEP 1 mg P1A 52/53 005
- LORAZEP 2 mg P1A 53/53 385
- LORAZEPAM ACDHON 0.5 mg - 344
- LORAZEPAM ACDHON 1 mg - 034
- LORAZEPAM MACROPHAR 1 mg - 400
- LORAZIN 0.5 mg P1A 26/52 352
- LORAZIN 1 mg P1A 27/52 045
- LORAZIN 2 mg P1A 28/52 253
- LOZEPAM 0.5 mg - 331
- LOZEPAM 1 mg - 193
- ORA 0.5 mg P1A 12/51 338
- ORA 1 mg P1A 13/51 029
- ORA 2 mg - 238
- PORA 0.5 mg - 398
- PORA 1 mg - 151
- PORA 2 mg - 241
- RAZEPAM 0.5 mg - 342
- RAZEPAM 1 mg - 031
- RAZEPAM 2 mg - 144
- TRANAVAN 0.5 mg P1A 22/55 335
- TRANAVAN 1 mg P1A 23/55 035
- VEMED 0.5 mg - 343
- ZEDA 0.5 mg P1A 8/52 016
- ZEDA 1 mg P1A 9/52 389
- ZORA 0.5 mg P1A 3/54 356
- ZORA 2 mg P1A 4/54 205
LORAZEPAM ACDHON 0.5 mg - 344
LORAZEPAM ACDHON 1 mg - 034
LORAZEPAM MACROPHAR 1 mg - 400
LORAZIN 0.5 mg P1A 26/52 352LORAZIN 1 mg P1A 27/52 045LORAZIN 2 mg P1A 28/52 253
lormetazepam:
- LORAMET 1 mg - 105
LOZEPAM 0.5 mg - 331LOZEPAM 1 mg - 193
MMANEX 0.25 mg - 106MANEX 0.5 mg - 264MANEX 1 mg - 311MANODIAZO 2 mg P1A 9/56 495MANODIAZO 5 mg P1A 10/56 530MANODIAZO 10 mg P1A 11/55 365MANOLIUM
10 mg/2 mL x 2 mL P1A 11/54 643MANOTRAN 5 mg - 461MANOTRAN 10 mg - 289MANTADYL COUGH†
60 mL - 559MARZOLAM 0.25 mg - 107MARZOLAM 0.5 mg - 265MARZOLAM 1 mg - 312MASADYL COUGH†
60 mL - 560
Registration No. Frame No. Registration No. Frame No.
B&G Name Index-FINAL-Aug13.indd 91 8/14/2013 2:45:18 PM
92 BRAND & GENERIC NAME INDEX PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
BR
AN
D &
GE
NE
RIC
NA
ME
IND
EX
MASADYL COUGH† 100 mL - 561
MASADYL COUGH† 240 mL - 562
MASAPARA W/ CODEINE† N2A 7/55 198
medazepam:
- CELIUM 5 mg P1A 27/54 426
- MEDAZINE 5 mg P1A 30/50 520
- MEDAZINE 10 mg P1A 31/50 519
MEDAZINE 5 mg P1A 30/50 520MEDAZINE 10 mg P1A 31/50 519MED-ZEPAM 2 mg - 041MED-ZEPAM 5 mg - 366MED-ZEPOXIDE 5 mg - 494MED-ZEPOXIDE 10 mg - 059MEILAX 1 mg - 022MEILAX 2 mg - 199MENOBARB
15 mg/5 mL x 60 mL - 563MENOBARB
20 mg/5 mL x 60 mL - 564MENOBARB 60 mg - 208
meprobamate:
- REINBAMATE 400 mg - 094
METAXIDE 10 mg - 515METHADONE GPO
10 mg/mL x 1000 mL - 565METHADONE GPO 5 mg - 140
methadone hydrochloride:
- METHADONE GPO 10 mg/mL x 1000 mL - 565
- METHADONE GPO 5 mg - 140
METHYLPHENIDATE HEXAL 10 mg - 060
methylphenidate hydrochloride:
- CONCERTA 18 mg - 186
- CONCERTA 27 mg - 439
- CONCERTA 36 mg - 129
- METHYLPHENIDATE HEXAL 10 mg - 060
- RITALIN 10 mg - 042
- RUBIFEN 10 mg - 043
MIDAZ 5 mg/mL x 1 mL - 644MIDAZ 5 mg/mL x 3 mL - 645
midazolam:
- DORMICUM 5 mg/mL x 1 mL - 630
- DORMICUM 15 mg/3 mL x 3 mL - 631
- DORMICUM 15 mg - 379
- MIDAZ 5 mg/mL x 1 mL - 644
- MIDAZ 5 mg/mL x 3 mL - 645
- MIDAZOLAM HEXAL 5 mg/mL x 1 mL - 646
- MIDAZOLAM HEXAL 5 mg/mL x 3 mL - 647
MIDAZOLAM HEXAL 5 mg/mL x 1 mL - 646
MIDAZOLAM HEXAL 5 mg/mL x 3 mL - 647
MILA-CONO† 60 mL - 566MILA-TERCON† - 184MINOXIDE 10 mg P1A 44/52 493MIRAPRONT N 20 mg - 516MIST TUSSIS† 450 mL - 567MIST. SCILL AMMON.
GPO† 180 mL - 568MITRANAX 0.25 mg - 119MITRANAX 0.5 mg - 278MITRANAX 1 mg - 322MIXTURE SCILLAE
AMMON† 180 mL - 569MIXTURE TUSSIS†
30 mL N2A 11/55 570MIXTURE TUSSIS†
60 mL N2A 11/55 571MIXTURE TUSSIS†
120 mL N2A 11/55 572MIXTURE TUSSIS†
240 mL N2A 11/55 573MIXTURE TUSSIS†
450 mL N2A 11/55 574MIXTURE TUSSIS†
1800 mL - 575MIXTURE TUSSIS†
3600 mL - 576MODURAX† - 405MOGADON 5 mg - 091MONOZIDE 2 mg - 525MONOZIDE-10
10 mg/2 mL x 2 mL - 648
morphine:
- OPIUM TINCTURE GPO 1% x 450 mL - 585
MORPHINE SALUTAS PHARMA 10 mg - 438
MORPHINE SALUTAS PHARMA 30 mg - 358
MORPHINE SALUTAS PHARMA 60 mg - 245
morphine sulfate:
- KAPANOL 20 mg - 133
Registration No. Frame No. Registration No. Frame No.
B&G Name Index-FINAL-Aug13.indd 92 8/14/2013 2:45:18 PM
BRAND & GENERIC NAME INDEX 93PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
BR
AN
D &
GE
NE
RIC
NA
ME
IND
EX
- KAPANOL 50 mg - 134
- KAPANOL 100 mg - 135
- MORPHINE SALUTAS PHARMA 10 mg - 438
- MORPHINE SALUTAS PHARMA 30 mg - 358
- MORPHINE SALUTAS PHARMA 60 mg - 245
- MORPHINE SULFATE GPO 10 mg/5 mL - 577
- MORPHINE SULFATE GPO 10 mg - 156
- MORPHINE SULFATE INJ BLUE 10 mg/mL x 1 mL - 649
- MORPHINE SULFATE INJ PURPLE 10 mg/mL x 1 mL - 650
- MORPHINE T P DRUG 10 mg/mL x 1 mL - 651
- MORPHINE T P DRUG 10 mg/mL x 1 mL - 652
- MORPHINE T P DRUG 10 mg/mL x 1 mL - 653
- MST CONTINUS 10 mg - 194
- MST CONTINUS 30 mg - 304
- MST CONTINUS 60 mg - 206
- ORAMORPH 10 mg/5 mL x 250 mL - 586
- ORAMORPH 20 mg/mL x 30 mL - 587
MORPHINE SULFATE GPO 10 mg/5 mL - 577
MORPHINE SULFATE GPO 10 mg - 156
MORPHINE SULFATE INJ BLUE 10 mg/mL x 1 mL - 649
MORPHINE SULFATE INJ PURPLE 10 mg/mL x 1 mL - 650
MORPHINE T P DRUG 10 mg/mL x 1 mL - 651
MORPHINE T P DRUG 10 mg/mL x 1 mL - 652
MORPHINE T P DRUG 10 mg/mL x 1 mL - 653
MOXINAX 0.25 mg - 108
MOXINAX 0.5 mg - 266
MST CONTINUS 10 mg - 194
MST CONTINUS 30 mg - 304
MST CONTINUS 60 mg - 206
NNASA W/ CODEINE† N2A 4/51 092NEMBUTAL
54.7 mg/mL x 100 mL P1F 2/50 680NEO COUGH† 60 mL - 578NEO COUGH† 100 mL - 579NEO COUGH† 240 mL - 580NEOCOD† - 373NEO-CODEIN† - 374NEOCOF† - 212NEO-COPHEN 10 mg - 222NEOPECT† N2A 11/52 224NEURAMIZONE† P2A 7/54 432NITRADOS 5 mg - 072
nitrazepam:
- ALODORM 5 mg - 090
- MOGADON 5 mg - 091
- NITRADOS 5 mg - 072
NORDYL LINCTUS† 100 mL - 581
NORDYL LINCTUS† 500 mL - 582
NORTUSS LINCTUS† 100 mL - 583
NORTUSS LINCTUS† 500 mL - 584
OOPIUM TINCTURE GPO
1% x 450 mL - 585ORA 0.5 mg P1A 12/51 338ORA 1 mg P1A 13/51 029ORA 2 mg - 238ORAMORPH
10 mg/5 mL x 250 mL - 586ORAMORPH 20 mg/mL x 30 mL - 587
PPACOGESIC† - 213PAM 5 mg - 231PANBESY 15 mg - 450PANBESY 30 mg - 487PANGON
30 mg/mL x 1 mL P1A 19/53 654PARA WITH CODEINE†
15 mg N2A 4/56 083PARA WITH CODEINE†
30 mg N2A 5/56 084PARA-CO 15 mg N2A 7/52 375PARADEINE† N2A 2/54 086
Registration No. Frame No. Registration No. Frame No.
B&G Name Index-FINAL-Aug13.indd 93 8/14/2013 2:45:19 PM
94 BRAND & GENERIC NAME INDEX PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
BR
AN
D &
GE
NE
RIC
NA
ME
IND
EX
PARADYL 8 mg - 095PARAGEN CO† - 128PARAMED-CO† - 424PARCOD† - 089PARCONO† - 093PARDEX 32.5 mg - 131P-CODYL† 60 mL - 588P-CODYL† 120 mL - 589
pentazocine:
- PENTAZOCINE ALL PLANTS 30 mg/mL x 1 mL - 655
- TAZCINE 30 mg/mL x 1 mL - 665
- TAZCINE 25 mg - 066
- TAZCINE 50 mg - 252
PENTAZOCINE ALL PLANTS 30 mg/mL x 1 mL - 655
pentazocine lactate:
- FORTWIN 30 mg/mL x 1 mL - 641
- PANGON 30 mg/mL x 1 mL P1A 19/53 654
- SOSEGON 30 mg/mL x 1 mL - 664
pentobarbital sodium:
- NEMBUTAL 54.7 mg/mL x 100 mL P1F 2/50 680
PERCIDYL COUGH† 100 mL - 590
PETHIDINE BIOLAB 100 mg/2 mL x 2 mL - 656
PETHIDINE HAMELN 50 mg/mL - 657
pethidine hydrochloride:
- PETHIDINE BIOLAB 100 mg/2 mL x 2 mL - 656
- PETHIDINE HAMELN 50 mg/mL - 657
- PETHIDINE M & H MANUFACTURING 50 mg/mL x 1 mL - 658
- PETHIDINE M & H MANUFACTURING 100 mg/2 mL x 2 mL - 659
- PETHIDINE T P DRUG 50 mg/mL x 1 mL - 660
PETHIDINE M & H MANUFACTURING 50 mg/mL x 1 mL - 658
PETHIDINE M & H MANUFACTURING 100 mg/2 mL x 2 mL - 659
PETHIDINE T P DRUG 50 mg/mL x 1 mL - 660
PHARNAX 0.25 mg - 109PHARNAX 0.5 mg - 267PHARNAX 1 mg - 313PHENCODIN† 60 mL - 591PHENCODIN† 500 mL - 592PHENCODIN†
1000 mL - 593PHENOBARB 30 mg - 233PHENOBARB 60 mg - 047PHENOBARB ELIXIR
20 mg/5 mL x 60 mL - 594
phenobarbital:
- BENERA† - 433
- DONNATAL† - 057
- MENOBARB 60 mg - 208
- NEURAMIZONE† P2A 7/54 432
PHENOBARBITAL ACDHON 15 mg - 384
PHENOBARBITAL ACDHON 30 mg - 136
PHENOBARBITAL ACDHON 60 mg - 030
PHENOBARBITAL ATLANTIC 16.25 mg - 234
PHENOBARBITAL ATLANTIC 32.5 mg P1A 33/51 436
PHENOBARBITAL ATLANTIC 65 mg P1A 34/51 015
PHENOBARBITAL ATLANTIC 100 mg P1A 35/51 303
PHENOBARBITAL CHEW BROTHERS 30 mg - 341
PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 30 mL - 595
PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 60 mL - 596
PHENOBARBITAL | ELIXIR ACDHON 20 mg/5 mL x 120 mL - 597
PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 240 mL - 598
PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 450 mL - 599
PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 500 mL - 600
PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 1000 mL - 601
Registration No. Frame No. Registration No. Frame No.
B&G Name Index-FINAL-Aug13.indd 94 8/14/2013 2:45:19 PM
BRAND & GENERIC NAME INDEX 95PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
BR
AN
D &
GE
NE
RIC
NA
ME
IND
EX
phenobarbital sodium:
- BELLADONNA ALKALOIDS W/ PHENOBARBITAL† - 247
- BELLERGAL† - 232
- ELIXIR PHENOBARB 60 mL - 556
- GARDENAL 200 mg/4 mL P1C 1/50 677
- MENOBARB 15 mg/5 mL x 60 mL - 563
- MENOBARB 20 mg/5 mL x 60 mL - 564
- PHENOBARB 30 mg - 233
- PHENOBARB 60 mg - 047
- PHENOBARBITAL ACDHON 15 mg - 384
- PHENOBARBITAL ACDHON 30 mg - 136
- PHENOBARBITAL ACDHON 60 mg - 030
- PHENOBARBITAL ATLANTIC 16.25 mg - 234
- PHENOBARBITAL ATLANTIC 32.5 mg P1A 33/51 436
- PHENOBARBITAL ATLANTIC 65 mg P1A 34/51 015
- PHENOBARBITAL ATLANTIC 100 mg P1A 35/51 303
- PHENOBARBITAL CHEW BROTHERS 30 mg - 341
- PHENOBARB ELIXIR 20 mg/5 mL x 60 mL - 594
- PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 30 mL - 595
- PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 60 mL - 596
- PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 120 mL - 597
- PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 240 mL - 598
- PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 450 mL - 599
- PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 500 mL - 600
- PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 1000 mL - 601
- PHENOBARBITONE NEW LIFE PHARMA 30 mg - 006
- PHENOBARBITONE NEW LIFE PHARMA 60 mg - 203
- PHENOCO ELIXIR 20 mg/5 mL x 450 mL - 602
- PHENOCO ELIXIR 20 mg/5 mL x 3800 mL - 603
- PHENOCON 60 mg - 255
- PHENOSIL ELIXIR 20 mg/5 mL x 60 mL - 604
- PHENOSIL ELIXIR 20 mg/5 mL x 450 mL - 605
- PHENOTAL ELIXIR 20 mg/5 mL x 60 mL P1A 16/52 606
PHENOBARBITONE NEW LIFE PHARMA 30 mg - 006
PHENOBARBITONE NEW LIFE PHARMA 60 mg - 203
PHENOCO ELIXIR 20 mg/5 mL x 450 mL - 602
PHENOCO ELIXIR 20 mg/5 mL x 3800 mL - 603
PHENOCON 60 mg - 255PHENOSIL ELIXIR
20 mg/5 mL x 60 mL - 604PHENOSIL ELIXIR
20 mg/5 mL x 450 mL - 605PHENOTAL ELIXIR
20 mg/5 mL x 60 mL P1A 16/52 606PHENSEDYL OLIC†
100 mL - 607PHENSODI† 60 mL - 608PHENSODI† 120 mL - 609PHENSODI† 1000 mL - 610
phentermine hydrochloride:
- PANBESY 15 mg - 450
- PANBESY 30 mg - 487
- PHENTERMINE OSMOPHARM 15 mg - 477
PHENTERMINE OSMOPHARM 15 mg - 477
phentermine resinate:
- DUROMINE 15 mg - 527
- DUROMINE 30 mg - 521
- PHENTERMINE TRENKER 15 mg - 492
- PHENTERMINE TRENKER 30 mg - 451
PHENTERMINE TRENKER 15 mg - 492
Registration No. Frame No. Registration No. Frame No.
B&G Name Index-FINAL-Aug13.indd 95 8/14/2013 2:45:19 PM
96 BRAND & GENERIC NAME INDEX PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
BR
AN
D &
GE
NE
RIC
NA
ME
IND
EX
PHENTERMINE TRENKER 30 mg - 451
phenylpropanolamine hydrochloride:
- CLINEPECT† - 524
- DIMETANE EXPECTORANT DC† 2.5 L - 555
- PHENYLPROPANOLAMINE PHARMASANT 25 mg - 157
PHENYLPROPANOLAMINE PHARMASANT 25 mg - 157
pinazepam:
- DOMAR 5 mg P1A 5/52 490
POBRAX† - 403POLIZEP 5 mg P1A 23/50 468POLIZEP 10 mg - 294POLY-COF† 60 mL N2A 5/51 611POLY-COF† 100 mL N2A 5/51 612POLYDINE CD† - 295POMADOM 5 mg - 481POMADOM 10 mg - 449PONDNADYL† 60 mL - 613PONDNADYL† 100 mL - 614PONDNADYL† 1000 mL - 615PONDNEBIUM 5 mg - 399PONDNEBIUM 10 mg - 216POPAM 2 mg - 126POPAM 5 mg - 187PORA 0.5 mg - 398PORA 1 mg - 151PORA 2 mg - 241POSENE 5 mg - 189POSENE 10 mg - 430POVANIL 0.5 mg P1A 33/52 210POVANIL 1 mg P1A 13/54 179POVANIL 2 mg P1A 34/52 076POZAPAM 5 mg P1A 23/52 485POZAPAM 10 mg P1A 39/51 192PRASEPINE 5 mg - 484
prazepam:
- POZAPAM 5 mg P1A 23/52 485
- POZAPAM 10 mg P1A 39/51 192
- PRASEPINE 5 mg - 484
PRAZOL 0.25 mg - 110PRAZOL 0.5 mg - 268PRAZOL 1 mg - 314PREFAMONE 75 mg - 191PRENARPIL 0.5 mg P1A 4/55 196PRENARPIL 1 mg P1A 5/55 367PRENARPIL 2 mg P1A 6/55 061PSEUDOEPHEDRINE
ASIAN PHARM 30 mg/5 mL x 60 mL - 616
PSEUDOEPHEDRINE ASIAN PHARM 30 mg - 158
PSEUDOEPHEDRINE ASIAN PHARM 60 mg - 048
PSEUDOEPHEDRINE BJ BENJAOSOTH 30 mg/5 mL x 60 mL - 617
PSEUDOEPHEDRINE BJ BENJAOSOTH 60 mg - 152
PSEUDOEPHEDRINE DEFENCE OF PHARMACEUTICAL FACTORY 30 mg - 049
PSEUDOEPHEDRINE DEFENCE OF PHARMACEUTICAL FACTORY 60 mg - 050
PSEUDOEPHEDRINE GPO 30 mg - 062
PSEUDOEPHEDRINE GPO 60 mg - 063
pseudoephedrine hydrochloride:
- BLUCO† - 383
- BLUCON† - 360
- PSEUDOEPHEDRINE ASIAN PHARM 30 mg/5 mL x 60 mL - 616
- PSEUDOEPHEDRINE ASIAN PHARM 30 mg - 158
- PSEUDOEPHEDRINE ASIAN PHARM 60 mg - 048
- PSEUDOEPHEDRINE BJ BENJAOSOTH 30 mg/5 mL x 60 mL - 617
- PSEUDOEPHEDRINE BJ BENJAOSOTH 60 mg - 152
- PSEUDOEPHEDRINE DEFENCE OF PHARMACEUTICAL FACTORY 30 mg - 049
- PSEUDOEPHEDRINE DEFENCE OF PHARMACEUTICAL FACTORY 60 mg - 050
- PSEUDOEPHEDRINE GPO 30 mg - 062
- PSEUDOEPHEDRINE GPO 60 mg - 063
- PSEUDOEPHEDRINE MEDICINE PRODUCTS 60 mg - 207
- PSEUDOEPHEDRINE MILANO 30 mg/5 mL x 60 mL - 618
- PSEUDOEPHEDRINE MILANO 30 mg - 153
- PSEUDOEPHEDRINE MILANO 60 mg - 046
Registration No. Frame No. Registration No. Frame No.
B&G Name Index-FINAL-Aug13.indd 96 8/14/2013 2:45:19 PM
BRAND & GENERIC NAME INDEX 97PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
BR
AN
D &
GE
NE
RIC
NA
ME
IND
EX
SQUILL AND AMMONIA VIDHYASOM† 450 mL - 619
STESOLID 2 mg - 431STESOLID 5 mg - 507STESOLID 10 mg - 513STILNOX 10 mg - 123SUNAX 0.25 mg - 120SUNAX 0.5 mg - 279
TTAMYLAB-S 5 mg - 469TAZCINE 30 mg/mL x 1 mL - 665TAZCINE 25 mg - 066TAZCINE 50 mg - 252
temazepam:
- EUHYPNOS 20 20 mg - 427
TEMGESIC 0.3 mg/mL x 1 mL - 666
TEMGESIC 0.2 mg - 007TENADRIN-C† 60 mL - 620TENMED 5 mg P1A 47/52 470TENMED 10 mg - 296TERADENE† 60 mL - 621TERADYL† 1000 mL - 623TERADYL† 60 mL - 622TERCO-C† N2A 11/53 415T-FIVE 5 mg - 471TOCODYL† - 418
tofisopam:
- GRANDAXIN 50 mg P1C 27/53 058
TRANADON-S 5 mg - 475TRANAVAN 0.5 mg P1A 22/55 335TRANAVAN 1 mg P1A 23/55 035TRANCAP 5 mg - 496TRANCAP 10 mg - 190TRANCLOR 5 mg - 464TRANCLOR 10 mg - 297TRANCON 5 mg P1A 20/53 482TRANCON 10 mg - 448TRANMED 5 mg P1A 39/52 452TRANMED 10 mg - 287TRANOLAN
10 mg/2 mL x 2 mL P1A 41/52 667TRANOLAN 2 mg P1A 9/54 145TRANOLAN 5 mg P1A 10/54 201TRANPATE 5 mg - 442TRANPON 5 mg - 472TRANSPON FORTE
10 mg - 283TRANXENE 5 mg P1A 14/54 465TRANXENE 10 mg - 298TRANZEP 5 mg - 460TRIALAM 0.25 mg - 185
- TERADENE† 60 mL - 621
PSEUDOEPHEDRINE MEDICINE PRODUCTS 60 mg - 207
PSEUDOEPHEDRINE MILANO 30 mg/5 mL x 60 mL - 618
PSEUDOEPHEDRINE MILANO 30 mg - 153
PSEUDOEPHEDRINE MILANO 60 mg - 046
RRADIBRAX† - 420RAZEPAM 0.5 mg - 342RAZEPAM 1 mg - 031RAZEPAM 2 mg - 144REGENON RETARD
75 mg - 130REGENON RETARD
75 mg - 504REINBAMATE 400 mg - 094RITALIN 10 mg - 042RIVOTRIL
1 mg/mL x 1 mL - 661RIVOTRIL 0.5 mg P1A 6/53 197RIVOTRIL 2 mg P1A 7/53 064ROHYPNOL 1 mg - 423ROLAR† N2A 9/55 228ROPAM
10 mg/2 mL x 2 mL P1A 49/53 662ROPAM 5 mg - 174ROPECT† N2A 1/55 226ROTUSS† N2C 9/52 229RUBIFEN 10 mg - 043
SS.CO ZEPAM 5 mg - 246SANOR 5 mg - 454SANOR 10 mg - 285SECO† N2A 4/55 417SERENE
MASA LAB 10 mg - 286SERENE
V S PHARMA 5 mg - 457SIAMPRAXOL 0.25 mg - 111SIAMPRAXOL 0.5 mg - 269SIAMPRAXOL 1 mg - 315SIPAM 10 mg/2 mL x 2 mL P1A 26/53 663SIPAM 2 mg P1A 12/56 065SIPAM 5 mg P1A 13/56 168SIPAM 10 mg - 368SOSEGON
30 mg/mL x 1 mL - 664SPASIL† N2A 2/51 009
Registration No. Frame No. Registration No. Frame No.
B&G Name Index-FINAL-Aug13.indd 97 8/14/2013 2:45:19 PM
98 BRAND & GENERIC NAME INDEX PN DEX 2013
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient
BR
AN
D &
GE
NE
RIC
NA
ME
IND
EX
XANACINE 0.25 mg - 113XANACINE 0.5 mg - 271XANACINE 1 mg - 317XANAX 0.25 mg - 114XANAX 0.5 mg - 272XANAX 1 mg - 318XANAX XR 0.5 mg - 372XANAX XR 1 mg - 079XANAX XR 2 mg - 381XIEMED 0.25 mg - 121XIEMED 0.5 mg - 280XIEMED 1 mg - 323
ZZAM 2 mg P1A 1/51 068ZAM 5 mg P1A 2/51 172ZEDA 0.5 mg P1A 8/52 016ZEDA 1 mg P1A 9/52 389ZEPAM
10 mg/2 mL x 2 mL - 672ZEPAM 2 mg - 429ZEPAM 5 mg - 382ZEPAXID
10 mg/2 mL x 2 mL - 673ZEPAXID 2 mg - 532ZEPAXID 5 mg P1A 21/50 488ZEPOBRAX† - 412ZEPOXIDE 5 mg - 437ZEPOXIDE 10 mg P1A 35/52 305ZEPOXIN 5 mg - 230ZEPOXIN 10 mg - 132ZETRAN 5 mg - 476ZOLAM 0.25 mg - 115ZOLAM 0.5 mg - 273ZOLAM 1 mg - 319
zolpidem hemitartrate:
- STILNOX 10 mg - 123
zolpidem tartrate:
- DACTIVE 10 10 mg - 053
- ZOLPIDEM TARTRATE RIVOPHARM 10 mg - 124
- ZOPIM 10 mg - 125
ZOLPIDEM TARTRATE RIVOPHARM 10 mg - 124
ZOPAM 2 mg P1A 31/53 051ZOPAM 5 mg P1A 32/53 160ZOPAM 10 mg P1A 8/53 359ZOPIM 10 mg - 125ZORA 0.5 mg P1A 3/54 356ZORA 2 mg P1A 4/54 205ZORITUSS 10 mg - 223
triazolam:
- HALCION 0.25 mg - 378
- TRIALAM 0.25 mg - 185
- TRYCAM 0.25 mg - 376
TRYCAM 0.25 mg - 376TUMAX† P2A 25/55 428TUSSIDYL† 60 mL - 624TYLENOL WITH
CODEINE† N2A 9/53 087TYLENOL WITH CODEINE† - 088
UUPTRAN 10 mg - 293UPZENE 5 mg - 509UTORAX† - 411
VV DAY ZEPAM
10 mg/2 mL x 2 mL - 668V DAY ZEPAM 2 mg - 502V DAY ZEPAM 5 mg - 491V DAY ZEPAM NL
10 mg/2 mL x 2 mL - 669VALAX 2 mg - 032VALAX 5 mg - 146VALAX 10 mg - 349VALENIUM 2 mg - 077VALENIUM 5 mg - 169VALIUM
10 mg/2 mL x 2 mL - 670VALIUM 5 mg - 170VASON 2 mg P1A 25/53 425VEMED 0.5 mg - 343VESCOPAM
10 mg/2 mL x 2 mL P1A 50/53 671VICTAN 2 mg - 204VISPAM 2 mg - 394VISPAM 5 mg - 239VISPAM 10 mg - 350VOMED 2 mg - 067VOMED 5 mg - 171VORAPAM 2 mg P1A 45/54 073VORAPAM 5 mg P1A 46/54 175
WWINOPAM 2 mg - 074WINOPAM 5 mg - 404
XXALAM 0.25 mg - 112XALAM 0.5 mg - 270XALAM 1 mg - 316
Registration No. Frame No. Registration No. Frame No.
B&G Name Index-FINAL-Aug13.indd 98 8/14/2013 2:45:19 PM
Çѵ¶ØÍÍ¡Ä·¸Ôì»ÃÐàÀ· 2 (P2)
Generic Nameª×èÍÊÒÁÑÞ
Manufacturer¼ÙŒ¼ÅÔµ
Brand Nameª×èÍ¡ÒäŒÒ
Presentation & PackingÃٻẺ-¢¹Ò´-ºÃèØ
ephedrine hydrochloride GPO Ephedrine GPO Inj (amp) 30 mg/mL x 1 mL.
fl unitrazepam Roche Rohypnol Tab 1 mg.
ketamine hydrochloride Gedeon Richter Calypsol Inj (vial) 50 mg/mL x 10 mL.
methylphenidate hydrochloride
Janssen-Cilag Concerta Tab 18 mg. 27 mg. 36 mg.
Lab Rubio Rubifen Tab 10 mg.
Novartis Ritalin Tab 10 mg.
18 mg
27 mg
36 mg
(¢ŒÍÁÙŶ֧à´×͹ ¡.¤. 2556)
List of Products Sold by FDAÃÒ¡ÒÃÂÒ·Õè¨íÒ˹‹ÒÂâ´Â¡ÅØ‹Áà§Ô¹·Ø¹ËÁعàÇÕ¹ÂÒàʾµÔ´
PNDEX 2013 - DRUG LIST SOLD BY FDA-Aug14.indd 99 8/14/2013 6:01:28 PM
100 PRODUCTS SOLD BY FDA PN DEX 2013
Çѵ¶ØÍÍ¡Ä·¸Ôì»ÃÐàÀ· 2 (P2)
Generic Nameª×èÍÊÒÁÑÞ
Manufacturer¼ÙŒ¼ÅÔµ
Brand Nameª×èÍ¡ÒäŒÒ
Presentation & PackingÃٻẺ-¢¹Ò´-ºÃèØ
methylphenidate hydrochloride(continued)
Salutas Pharma Methylphenidate Hexal
Tab 10 mg.
midazolam Cenexi Dormicum Inj (amp) 5 mg/mL x 1 mL.
Jenahexal Midazolam Hexal Inj (amp) 5 mg/mL x 1 mL, 3 mL.
Roche Dormicum Tab 15 mg.
nitrazepam Alphapharm Alodorm Tab 5 mg.
phentermine hydrochloride Osmopharm Panbesy Cap 15 mg. 30 mg.
phentermine resinate Douglas Duromine Cap 15 mg. 30 mg.
zolpidem hemitartrate Sanofi -Winthrop Stilnox Tab 10 mg.
1 mL 3 mL
15 mg
30 mg
15 mg
30 mg
PNDEX 2013 - DRUG LIST SOLD BY FDA-Aug14.indd 100 8/14/2013 6:01:28 PM
PRODUCTS SOLD BY FDA 101PN DEX 2013
Çѵ¶ØÍÍ¡Ä·¸Ôì»ÃÐàÀ· 2 (P2)
Generic Nameª×èÍÊÒÁÑÞ
Manufacturer¼ÙŒ¼ÅÔµ
Brand Nameª×èÍ¡ÒäŒÒ
Presentation & PackingÃٻẺ-¢¹Ò´-ºÃèØ
zolpidem tartrate
Cadila Healthcare Dactive 10 Tab 10 mg.
Rivopharm Zolpidem Tartrate Rivopharm
Tab 10 mg.
Taiwan Biotech Zopim Tab 10 mg.
ÂÒàʾµÔ´ãËŒâ·É»ÃÐàÀ· 2 (N2)
Generic Nameª×èÍÊÒÁÑÞ
Manufacturer¼ÙŒ¼ÅÔµ
Brand Nameª×èÍ¡ÒäŒÒ
Presentation & PackingÃٻẺ-¢¹Ò´-ºÃèØ
codeine phosphate GPO Codeine GPO Tab 15 mg. 30 mg.
15 mg
30 mg
fentanyl Hexal AG Fentanyl Hexal TTS 12 mcg/hr. 25 mcg/hr. 50 mcg/hr.
25 mcg/hr
12 mcg/hr
50 mcg/hr
PNDEX 2013 - DRUG LIST SOLD BY FDA-Aug14.indd 101 8/14/2013 6:01:28 PM
102 PRODUCTS SOLD BY FDA PN DEX 2013
ÂÒàʾµÔ´ãËŒâ·É»ÃÐàÀ· 2 (N2)
Generic Nameª×èÍÊÒÁÑÞ
Manufacturer¼ÙŒ¼ÅÔµ
Brand Nameª×èÍ¡ÒäŒÒ
Presentation & PackingÃٻẺ-¢¹Ò´-ºÃèØ
fentanyl(continued)
Janssen Pharma Durogesic Patch TTS 12 mcg/hr. 25 mcg/hr. 50 mcg/hr.
12 mcg/hr
25 mcg/hr
50 mcg/hr
Lavipharm Fentadur TTS 25 mcg/hr.
fentanyl citrate Hameln Fentanyl-Hameln Inj (amp) 0.05 mg/mL x 2 mL, 10 mL.
2 mL 10 mL
Janssen-Cilag Fentanyl Janssen-Cilag
Inj (amp) 0.05 mg/mL x 2 mL, 10 mL.
2 mL 10 mL
SNS Fentanyl-SNS Inj (amp) 0.05 mg/mL x 2 mL.
PNDEX 2013 - DRUG LIST SOLD BY FDA-Aug14.indd 102 8/14/2013 6:01:29 PM
PRODUCTS SOLD BY FDA 103PN DEX 2013
ÂÒàʾµÔ´ãËŒâ·É»ÃÐàÀ· 2 (N2)
Generic Nameª×èÍÊÒÁÑÞ
Manufacturer¼ÙŒ¼ÅÔµ
Brand Nameª×èÍ¡ÒäŒÒ
Presentation & PackingÃٻẺ-¢¹Ò´-ºÃèØ
fentanyl citrate(continued)
Sandoz Canada Fentanyl Sandoz Inj 0.05 mg/mL x 2 mL, 10 mL.
2 mL 10 mL
methadone hydrochloride
GPO Methadone GPO Tab 5 mg. Soln 10 mg/mL x 1,000 mL.
Tab
Soln
morphine sulfate Bard MST Continus Tab 10 mg. 30 mg. 60 mg.
10 mg
10 mg. 30 mg. 60 mg.
30 mg
60 mg
GlaxoSmithKline Kapanol Cap 20 mg. 50 mg. 100 mg.
20 mg
50 mg
100 mg
GPO Morphine Sulfate GPO
Tab 10 mg. Oral soln 10 mg/5 mL.
Tab
Oral soln
PNDEX 2013 - DRUG LIST SOLD BY FDA-Aug14.indd 103 8/14/2013 6:01:30 PM
104_MIMS PNDEX.pdf 1 8/17/13 5:12 PM